Document and Entity Information
Document and Entity Information - USD ($) shares in Millions, $ in Billions | 12 Months Ended | ||
Dec. 31, 2021 | Feb. 18, 2022 | Jun. 30, 2021 | |
Document Information [Line Items] | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Period End Date | Dec. 31, 2021 | ||
Document Fiscal Year Focus | 2021 | ||
Document Fiscal Period Focus | FY | ||
Trading Symbol | MPW | ||
Entity Registrant Name | Medical Properties Trust, Inc | ||
Entity Central Index Key | 0001287865 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Shell Company | false | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Common Stock, Shares Outstanding | 599.9 | ||
Entity Public Float | $ 11.7 | ||
Title of 12(b) Security | Common stock, par value $0.001 per share, of Medical Properties Trust, Inc. | ||
Security Exchange Name | NYSE | ||
Entity File Number | 001-32559 | ||
Entity Tax Identification Number | 20-0191742 | ||
Entity Address, Address Line One | 1000 Urban Center Drive | ||
Entity Address, Address Line Two | Suite 501 | ||
Entity Address, City or Town | Birmingham | ||
Entity Address, State or Province | AL | ||
Entity Address, Postal Zip Code | 35242 | ||
City Area Code | 205 | ||
Local Phone Number | 969-3755 | ||
Entity Incorporation, State or Country Code | MD | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Entity Interactive Data Current | Yes | ||
Auditor Name | PricewaterhouseCoopers LLP | ||
Auditor Location | Birmingham, Alabama | ||
Auditor Firm ID | 238 | ||
Document Type | 10-K | ||
Documents Incorporated by Reference | Portions of the definitive Proxy Statement of Medical Properties Trust, Inc. for the Annual Meeting of Stockholders to be held on May 26, 2022 are incorporated by reference into Items 10 through 14 of Part III, of this Annual Report on Form 10-K. | ||
MPT Operating Partnership, L.P. [Member] | |||
Document Information [Line Items] | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Period End Date | Dec. 31, 2021 | ||
Document Fiscal Year Focus | 2021 | ||
Document Fiscal Period Focus | FY | ||
Entity Registrant Name | MPT Operating Partnership, L.P. | ||
Entity Central Index Key | 0001524607 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Shell Company | false | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity File Number | 333-177186 | ||
Entity Tax Identification Number | 20-0242069 | ||
Entity Address, Address Line One | 1000 Urban Center Drive | ||
Entity Address, Address Line Two | Suite 501 | ||
Entity Address, City or Town | Birmingham | ||
Entity Address, State or Province | AL | ||
Entity Address, Postal Zip Code | 35242 | ||
City Area Code | 205 | ||
Local Phone Number | 969-3755 | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Interactive Data Current | Yes | ||
Auditor Name | PricewaterhouseCoopers LLP | ||
Auditor Location | Birmingham, Alabama | ||
Auditor Firm ID | 238 | ||
Document Type | 10-K |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 |
Real estate assets | ||
Land | $ 1,961,478 | $ 1,463,200 |
Buildings and improvements | 10,581,992 | 9,286,507 |
Construction in progress | 101,439 | 30,139 |
Intangible lease assets | 1,417,813 | 1,299,081 |
Investment in financing leases | 2,053,327 | 2,010,922 |
Real estate held for sale | 1,096,505 | |
Mortgage loans | 213,211 | 248,080 |
Gross investment in real estate assets | 17,425,765 | 14,337,929 |
Accumulated depreciation | (853,879) | (728,176) |
Accumulated amortization | (139,221) | (105,353) |
Net investment in real estate assets | 16,432,665 | 13,504,400 |
Cash and cash equivalents | 459,227 | 549,884 |
Interest and rent receivables | 56,229 | 46,208 |
Straight-line rent receivables | 728,522 | 490,462 |
Equity investments | 1,181,025 | 1,123,623 |
Other loans | 1,328,653 | 858,368 |
Other assets | 333,480 | 256,069 |
Total Assets | 20,519,801 | 16,829,014 |
Liabilities | ||
Debt, net | 11,282,770 | 8,865,458 |
Accounts payable and accrued expenses | 607,792 | 438,750 |
Deferred revenue | 25,563 | 36,177 |
Obligations to tenants and other lease liabilities | 158,005 | 144,772 |
Total Liabilities | 12,074,130 | 9,485,157 |
Commitments and Contingencies | ||
Equity / Capital | ||
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding | ||
Common stock, $0.001 par value. Authorized 750,000 shares; issued and outstanding — 596,814 shares at December 31, 2021 and 541,419 shares at December 31, 2020 | 597 | 541 |
Additional paid-in capital | 8,564,786 | 7,461,503 |
Distributions in excess of net income | (87,691) | (71,411) |
Accumulated other comprehensive loss | (36,727) | (51,324) |
Treasury shares, at cost | (777) | (777) |
Total Medical Properties Trust, Inc. Stockholders' Equity (MPT Operating Partnership, L.P. capital) | 8,440,188 | 7,338,532 |
Non-controlling interests | 5,483 | 5,325 |
Total Equity / Capital | 8,445,671 | 7,343,857 |
Total Liabilities and Equity / Capital | 20,519,801 | 16,829,014 |
MPT Operating Partnership, L.P. [Member] | ||
Real estate assets | ||
Land | 1,961,478 | 1,463,200 |
Buildings and improvements | 10,581,992 | 9,286,507 |
Construction in progress | 101,439 | 30,139 |
Intangible lease assets | 1,417,813 | 1,299,081 |
Investment in financing leases | 2,053,327 | 2,010,922 |
Real estate held for sale | 1,096,505 | |
Mortgage loans | 213,211 | 248,080 |
Gross investment in real estate assets | 17,425,765 | 14,337,929 |
Accumulated depreciation | (853,879) | (728,176) |
Accumulated amortization | (139,221) | (105,353) |
Net investment in real estate assets | 16,432,665 | 13,504,400 |
Cash and cash equivalents | 459,227 | 549,884 |
Interest and rent receivables | 56,229 | 46,208 |
Straight-line rent receivables | 728,522 | 490,462 |
Equity investments | 1,181,025 | 1,123,623 |
Other loans | 1,328,653 | 858,368 |
Other assets | 333,480 | 256,069 |
Total Assets | 20,519,801 | 16,829,014 |
Liabilities | ||
Debt, net | 11,282,770 | 8,865,458 |
Accounts payable and accrued expenses | 430,908 | 290,757 |
Deferred revenue | 25,563 | 36,177 |
Obligations to tenants and other lease liabilities | 158,005 | 144,772 |
Payable due to Medical Properties Trust, Inc. | 176,494 | 147,603 |
Total Liabilities | 12,073,740 | 9,484,767 |
Commitments and Contingencies | ||
Equity / Capital | ||
General partner — issued and outstanding — 5,968 units at December 31, 2021 and 5,414 units at December 31, 2020 | 84,847 | 73,977 |
Accumulated other comprehensive loss | (36,727) | (51,324) |
Total Medical Properties Trust, Inc. Stockholders' Equity (MPT Operating Partnership, L.P. capital) | 8,440,578 | 7,338,922 |
Non-controlling interests | 5,483 | 5,325 |
Total Equity / Capital | 8,446,061 | 7,344,247 |
Total Liabilities and Equity / Capital | 20,519,801 | 16,829,014 |
MPT Operating Partnership, L.P. [Member] | Common Units | ||
Equity / Capital | ||
Limited Partners — issued and outstanding — 590,846 units at December 31, 2021 and 536,005 units at December 31, 2020 | $ 8,392,458 | $ 7,316,269 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares | Dec. 31, 2021 | Dec. 31, 2020 |
Preferred stock, par value | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 750,000,000 | 750,000,000 |
Common stock, shares issued | 596,814,000 | 541,419,000 |
Common stock, shares outstanding | 596,814,000 | 541,419,000 |
General Partner [Member] | MPT Operating Partnership, L.P. [Member] | ||
General partner, units issued | 5,968,000 | 5,414,000 |
General partner, units outstanding | 5,968,000 | 5,414,000 |
Common Units | MPT Operating Partnership, L.P. [Member] | ||
Limited Partners, units issued | 590,846,000 | 536,005,000 |
Limited Partners, units outstanding | 590,846,000 | 536,005,000 |
Consolidated Statements of Net
Consolidated Statements of Net Income - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Revenues | |||
Rent billed | $ 931,942 | $ 741,311 | $ 474,151 |
Straight-line rent | 241,433 | 158,881 | 110,456 |
Income from financing leases | 202,599 | 206,550 | 119,617 |
Interest and other income | 168,695 | 142,496 | 149,973 |
Total revenues | 1,544,669 | 1,249,238 | 854,197 |
Expenses | |||
Interest | 367,393 | 328,728 | 237,830 |
Real estate depreciation and amortization | 321,249 | 264,245 | 152,313 |
Property-related | 39,098 | 24,890 | 23,992 |
General and administrative | 145,638 | 131,663 | 96,411 |
Total expenses | 873,378 | 749,526 | 510,546 |
Other income (expense) | |||
Gain (loss) on sale of real estate | 52,471 | (2,833) | 41,560 |
Real estate impairment charges | (19,006) | (21,031) | |
Earnings from equity interests | 28,488 | 20,417 | 16,051 |
Debt refinancing and unutilized financing costs | (27,650) | (28,180) | (6,106) |
Other (including mark-to-market adjustments on equity securities) | 6,288 | (6,782) | (345) |
Total other income (expense) | 59,597 | (36,384) | 30,129 |
Income before income tax | 730,888 | 463,328 | 373,780 |
Income tax (expense) benefit | (73,948) | (31,056) | 2,621 |
Net income | 656,940 | 432,272 | 376,401 |
Net income attributable to non-controlling interests | (919) | (822) | (1,717) |
Net income attributable to MPT common stockholders (Operating Partnership partners) | $ 656,021 | $ 431,450 | $ 374,684 |
Earnings per common share — basic and diluted | |||
Net income attributable to MPT common stockholders (Operating Partnership partners) | $ 1.11 | $ 0.81 | $ 0.87 |
Weighted average shares (units) outstanding basic | 588,817 | 529,239 | 427,075 |
Weighted average shares (units) outstanding diluted | 590,139 | 530,461 | 428,299 |
MPT Operating Partnership, L.P. [Member] | |||
Revenues | |||
Rent billed | $ 931,942 | $ 741,311 | $ 474,151 |
Straight-line rent | 241,433 | 158,881 | 110,456 |
Income from financing leases | 202,599 | 206,550 | 119,617 |
Interest and other income | 168,695 | 142,496 | 149,973 |
Total revenues | 1,544,669 | 1,249,238 | 854,197 |
Expenses | |||
Interest | 367,393 | 328,728 | 237,830 |
Real estate depreciation and amortization | 321,249 | 264,245 | 152,313 |
Property-related | 39,098 | 24,890 | 23,992 |
General and administrative | 145,638 | 131,663 | 96,411 |
Total expenses | 873,378 | 749,526 | 510,546 |
Other income (expense) | |||
Gain (loss) on sale of real estate | 52,471 | (2,833) | 41,560 |
Real estate impairment charges | (19,006) | (21,031) | |
Earnings from equity interests | 28,488 | 20,417 | 16,051 |
Debt refinancing and unutilized financing costs | (27,650) | (28,180) | (6,106) |
Other (including mark-to-market adjustments on equity securities) | 6,288 | (6,782) | (345) |
Total other income (expense) | 59,597 | (36,384) | 30,129 |
Income before income tax | 730,888 | 463,328 | 373,780 |
Income tax (expense) benefit | (73,948) | (31,056) | 2,621 |
Net income | 656,940 | 432,272 | 376,401 |
Net income attributable to non-controlling interests | (919) | (822) | (1,717) |
Net income attributable to MPT common stockholders (Operating Partnership partners) | $ 656,021 | $ 431,450 | $ 374,684 |
Earnings per common share — basic and diluted | |||
Net income attributable to MPT common stockholders (Operating Partnership partners) | $ 1.11 | $ 0.81 | $ 0.87 |
Weighted average shares (units) outstanding basic | 588,817 | 529,239 | 427,075 |
Weighted average shares (units) outstanding diluted | 590,139 | 530,461 | 428,299 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Net income | $ 656,940 | $ 432,272 | $ 376,401 |
Other comprehensive income: | |||
Unrealized gain (loss) on interest rate swaps, net of tax | 52,288 | (33,091) | (9,033) |
Foreign currency translation (loss) gain | (37,691) | 44,672 | 4,330 |
Total comprehensive income | 671,537 | 443,853 | 371,698 |
Comprehensive income attributable to non-controlling interests | (919) | (822) | (1,717) |
Comprehensive income attributable to MPT common stockholders (Operating Partnership Partners) | 670,618 | 443,031 | 369,981 |
MPT Operating Partnership, L.P. [Member] | |||
Net income | 656,940 | 432,272 | 376,401 |
Other comprehensive income: | |||
Unrealized gain (loss) on interest rate swaps, net of tax | 52,288 | (33,091) | (9,033) |
Foreign currency translation (loss) gain | (37,691) | 44,672 | 4,330 |
Total comprehensive income | 671,537 | 443,853 | 371,698 |
Comprehensive income attributable to non-controlling interests | (919) | (822) | (1,717) |
Comprehensive income attributable to MPT common stockholders (Operating Partnership Partners) | $ 670,618 | $ 443,031 | $ 369,981 |
Consolidated Statements of Equi
Consolidated Statements of Equity / Capital - USD ($) shares in Thousands, $ in Thousands | Total | MPT Operating Partnership, L.P. [Member] | MPT Operating Partnership, L.P. [Member]General Partner [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]MPT Operating Partnership, L.P. [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]MPT Operating Partnership, L.P. [Member]General Partner [Member] | Common Par Value [Member] | Common Par Value [Member]MPT Operating Partnership, L.P. [Member]Limited Partner [Member] | Common Par Value [Member]Cumulative Effect, Period of Adoption, Adjustment [Member]MPT Operating Partnership, L.P. [Member]Limited Partner [Member] | Additional Paid-in Capital [Member] | Retained Earnings (Deficit) [Member] | Retained Earnings (Deficit) [Member]Cumulative Effect, Period of Adoption, Adjustment [Member] | Accumulated Other Comprehensive Loss [Member] | Accumulated Other Comprehensive Loss [Member]MPT Operating Partnership, L.P. [Member] | Treasury Shares [Member] | Non-Controlling Interests [Member] | Non-Controlling Interests [Member]MPT Operating Partnership, L.P. [Member] | Long Term Incentive Plan [Member]MPT Operating Partnership, L.P. [Member]Limited Partner [Member] |
Beginning balance at Dec. 31, 2018 | $ 4,560,938 | $ 4,561,328 | $ 46,084 | $ 371 | $ 4,559,616 | $ 4,442,948 | $ 162,768 | $ (58,202) | $ (58,202) | $ (777) | $ 13,830 | $ 13,830 | ||||||
Beginning balance (in shares) at Dec. 31, 2018 | 3,706 | 370,637 | 366,931 | 232 | ||||||||||||||
Net income | 376,401 | 376,401 | $ 3,746 | $ 370,938 | 374,684 | 1,717 | 1,717 | |||||||||||
Unrealized gain (loss) on interest rate swaps, net of tax | (9,033) | (9,033) | (9,033) | (9,033) | ||||||||||||||
Foreign currency translation gain (loss) | 4,330 | 4,330 | 4,330 | 4,330 | ||||||||||||||
Stock vesting and amortization of stock-based compensation | 32,188 | 32,188 | $ 322 | $ 2 | $ 31,866 | 32,186 | ||||||||||||
Stock (Unit) vesting and amortization of stock (unit)-based compensation (shares) | 15 | 1,536 | 1,521 | |||||||||||||||
Distributions to non-controlling interests, net | (15,440) | (15,440) | (15,440) | (15,440) | ||||||||||||||
Proceeds from offering (net of offering costs) | 2,533,210 | 2,533,210 | $ 25,332 | $ 145 | $ 2,507,878 | 2,533,065 | ||||||||||||
Proceeds from offering (net of offering costs) (shares) | 1,455 | 145,349 | 143,894 | |||||||||||||||
Dividends (Distributions) declared | (454,440) | (454,440) | $ (4,545) | $ (449,895) | (454,440) | |||||||||||||
Ending balance at Dec. 31, 2019 | 7,028,154 | 7,028,544 | $ 70,939 | $ 518 | $ 7,020,403 | 7,008,199 | 83,012 | (62,905) | (62,905) | (777) | 107 | 107 | ||||||
Ending balance (Accounting Standards Update 2016-13) at Dec. 31, 2019 | $ (8,399) | $ (84) | $ (8,315) | |||||||||||||||
Ending balance (in shares) at Dec. 31, 2019 | 5,176 | 517,522 | 512,346 | 232 | ||||||||||||||
Net income | 432,272 | 432,272 | $ 4,315 | $ 427,135 | 431,450 | 822 | 822 | |||||||||||
Unrealized gain (loss) on interest rate swaps, net of tax | (33,091) | (33,091) | (33,091) | (33,091) | ||||||||||||||
Foreign currency translation gain (loss) | 44,672 | 44,672 | 44,672 | 44,672 | ||||||||||||||
Stock vesting and amortization of stock-based compensation | 47,154 | 47,154 | $ 472 | $ 2 | $ 46,682 | 47,152 | ||||||||||||
Stock (Unit) vesting and amortization of stock (unit)-based compensation (shares) | 29 | 2,893 | 2,864 | |||||||||||||||
Sale of non-controlling interests | 5,097 | 5,097 | 5,097 | 5,097 | ||||||||||||||
Redemption of MOP units | (4,928) | (4,928) | $ (4,928) | (4,928) | ||||||||||||||
Redemption of common units (shares) | (232) | |||||||||||||||||
Conversion of LTIP units to common units (shares) | 232 | (232) | ||||||||||||||||
Distributions to non-controlling interests, net | (701) | (701) | (701) | (701) | ||||||||||||||
Proceeds from offering (net of offering costs) | 411,101 | 411,101 | $ 4,111 | $ 21 | $ 406,990 | 411,080 | ||||||||||||
Proceeds from offering (net of offering costs) (shares) | 209 | 21,004 | 20,795 | |||||||||||||||
Dividends (Distributions) declared | (577,474) | (577,474) | $ (5,776) | $ (571,698) | (577,474) | |||||||||||||
Ending balance at Dec. 31, 2020 | 7,343,857 | 7,344,247 | $ 73,977 | $ 541 | $ 7,316,269 | 7,461,503 | (71,411) | (51,324) | (51,324) | (777) | 5,325 | 5,325 | ||||||
Ending balance (Accounting Standards Update 2016-02) at Dec. 31, 2020 | $ (8,399) | $ (8,399) | ||||||||||||||||
Ending balance (in shares) at Dec. 31, 2020 | 5,414 | 541,419 | 536,005 | |||||||||||||||
Net income | 656,940 | 656,940 | $ 6,560 | $ 649,461 | 656,021 | 919 | 919 | |||||||||||
Unrealized gain (loss) on interest rate swaps, net of tax | 52,288 | 52,288 | 52,288 | 52,288 | ||||||||||||||
Foreign currency translation gain (loss) | (37,691) | (37,691) | (37,691) | (37,691) | ||||||||||||||
Stock vesting and amortization of stock-based compensation | 52,110 | 52,110 | $ 521 | $ 3 | $ 51,589 | 52,107 | ||||||||||||
Stock (Unit) vesting and amortization of stock (unit)-based compensation (shares) | 23 | 2,332 | 2,309 | |||||||||||||||
Distributions to non-controlling interests, net | (761) | (761) | (761) | (761) | ||||||||||||||
Proceeds from offering (net of offering costs) | 1,051,229 | 1,051,229 | $ 10,512 | $ 53 | $ 1,040,717 | 1,051,176 | ||||||||||||
Proceeds from offering (net of offering costs) (shares) | 531 | 53,063 | 52,532 | |||||||||||||||
Dividends (Distributions) declared | (672,301) | (672,301) | $ (6,723) | $ (665,578) | (672,301) | |||||||||||||
Ending balance at Dec. 31, 2021 | $ 8,445,671 | $ 8,446,061 | $ 84,847 | $ 597 | $ 8,392,458 | $ 8,564,786 | $ (87,691) | $ (36,727) | $ (36,727) | $ (777) | $ 5,483 | $ 5,483 | ||||||
Ending balance (in shares) at Dec. 31, 2021 | 5,968 | 596,814 | 590,846 |
Consolidated Statements of Eq_2
Consolidated Statements of Equity / Capital (Parenthetical) - $ / shares | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
MPT Operating Partnership, L.P. [Member] | |||
Dividends (Distributions) declared per common share / unit | $ 1.12 | $ 1.08 | $ 1.02 |
MPT Operating Partnership, L.P. [Member] | General Partner [Member] | |||
Dividends (Distributions) declared per common share / unit | 1.12 | 1.08 | 1.02 |
Retained Earnings (Deficit) [Member] | |||
Dividends (Distributions) declared per common share / unit | 1.12 | 1.08 | 1.02 |
Common Par Value [Member] | MPT Operating Partnership, L.P. [Member] | Limited Partner [Member] | |||
Dividends (Distributions) declared per common share / unit | $ 1.12 | $ 1.08 | $ 1.02 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Operating activities | |||
Net income | $ 656,940 | $ 432,272 | $ 376,401 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Depreciation and amortization | 333,781 | 275,953 | 156,575 |
Amortization of deferred financing costs and debt discount | 16,856 | 13,099 | 8,881 |
Straight-line rent revenue and other | (288,717) | (226,906) | (138,806) |
Share / (Unit)-based compensation expense | 52,110 | 47,154 | 32,188 |
(Gain) loss from sale of real estate | (52,471) | 2,833 | (41,560) |
Impairment charges | 19,006 | 21,031 | |
Straight-line rent and other (recovery) write-off | (2,271) | 26,415 | 22,447 |
Debt refinancing and unutilized financing costs | 27,650 | 28,180 | 6,106 |
Tax rate and other changes | 42,746 | 9,295 | |
Pre-acquisition rent collected - Circle Transaction | (35,020) | ||
Other adjustments | 11,913 | 8,134 | (2,271) |
Changes in: | |||
Interest and rent receivables | (23,867) | (2,438) | 12,906 |
Other assets | (4,375) | 18,264 | (4,992) |
Accounts payable and accrued expenses | 54,058 | (18,424) | 39,630 |
Deferred revenue | (12,697) | 19,819 | 5,581 |
Net cash provided by operating activities | 811,656 | 617,636 | 494,117 |
Investing activities | |||
Cash paid for acquisitions and other related investments | (5,350,239) | (4,249,180) | (4,565,594) |
Net proceeds from sale of real estate | 246,468 | 94,177 | 111,766 |
Principal received on loans receivable | 1,595,708 | 1,306,187 | 920 |
Investment in loans receivable | (58,932) | (62,651) | (54,088) |
Construction in progress and other | (67,725) | (68,350) | (83,798) |
Proceeds from sale and return of equity investment | 65,546 | 69,224 | |
Capital additions and other investments, net | (289,239) | (36,180) | (293,163) |
Net cash used for investing activities | (3,858,413) | (2,946,773) | (4,883,957) |
Financing activities | |||
Proceeds from term debt, net of discount | 3,407,535 | 2,215,950 | 3,048,424 |
Payments of term debt | (1,390,994) | (800,000) | |
Revolving credit facilities, net | 559,985 | 162,633 | (65,736) |
Dividends / Distribution paid | (643,473) | (567,969) | (411,697) |
Lease deposits and other obligations to tenants | 17,815 | 21,706 | (12,260) |
Proceeds from sale of common shares, net of offering costs | 1,051,229 | 411,101 | 2,533,210 |
Payment of debt refinancing, deferred financing costs and other financing activities | (54,489) | (42,347) | (50,057) |
Net cash provided by financing activities | 2,947,608 | 1,401,074 | 5,041,884 |
(Decrease) increase in cash, cash equivalents, and restricted cash for the year | (99,149) | (928,063) | 652,044 |
Effect of exchange rate changes | 4,662 | 16,441 | (6,478) |
Cash, cash equivalents, and restricted cash at beginning of year | 556,369 | 1,467,991 | 822,425 |
Cash, cash equivalents, and restricted cash at end of year | 461,882 | 556,369 | 1,467,991 |
Interest paid, including capitalized interest of $3,289 in 2021, $3,030 in 2020, and $3,936 in 2019 | 326,406 | 309,920 | 211,163 |
Supplemental schedule of non-cash financing activities: | |||
Dividends declared, unpaid | 176,494 | 147,666 | 138,161 |
Cash, cash equivalents, and restricted cash are comprised of the following: | |||
Cash and cash equivalents at beginning of period | 549,884 | 1,462,286 | 820,868 |
Restricted cash, included in Other assets at beginning of period | $ 6,485 | $ 5,705 | $ 1,557 |
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] | Other Assets | Other Assets | Other Assets |
Cash, cash equivalents, and restricted cash at beginning of year | $ 556,369 | $ 1,467,991 | $ 822,425 |
Cash and cash equivalents at end of period | 459,227 | 549,884 | 1,462,286 |
Restricted cash, included in Other assets at end of period | $ 2,655 | $ 6,485 | $ 5,705 |
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] | Other Assets | Other Assets | Other Assets |
Cash, cash equivalents, and restricted cash at end of year | $ 461,882 | $ 556,369 | $ 1,467,991 |
MPT Operating Partnership, L.P. [Member] | |||
Operating activities | |||
Net income | 656,940 | 432,272 | 376,401 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Depreciation and amortization | 333,781 | 275,953 | 156,575 |
Amortization of deferred financing costs and debt discount | 16,856 | 13,099 | 8,881 |
Straight-line rent revenue and other | (288,717) | (226,906) | (138,806) |
Share / (Unit)-based compensation expense | 52,110 | 47,154 | 32,188 |
(Gain) loss from sale of real estate | (52,471) | 2,833 | (41,560) |
Impairment charges | 19,006 | 21,031 | |
Straight-line rent and other (recovery) write-off | (2,271) | 26,415 | 22,447 |
Debt refinancing and unutilized financing costs | 27,650 | 28,180 | 6,106 |
Tax rate and other changes | 42,746 | 9,295 | |
Pre-acquisition rent collected - Circle Transaction | (35,020) | ||
Other adjustments | 11,913 | 8,134 | (2,271) |
Changes in: | |||
Interest and rent receivables | (23,867) | (2,438) | 12,906 |
Other assets | (4,375) | 18,264 | (4,992) |
Accounts payable and accrued expenses | 54,058 | (18,424) | 39,630 |
Deferred revenue | (12,697) | 19,819 | 5,581 |
Net cash provided by operating activities | 811,656 | 617,636 | 494,117 |
Investing activities | |||
Cash paid for acquisitions and other related investments | (5,350,239) | (4,249,180) | (4,565,594) |
Net proceeds from sale of real estate | 246,468 | 94,177 | 111,766 |
Principal received on loans receivable | 1,595,708 | 1,306,187 | 920 |
Investment in loans receivable | (58,932) | (62,651) | (54,088) |
Construction in progress and other | (67,725) | (68,350) | (83,798) |
Proceeds from sale and return of equity investment | 65,546 | 69,224 | |
Capital additions and other investments, net | (289,239) | (36,180) | (293,163) |
Net cash used for investing activities | (3,858,413) | (2,946,773) | (4,883,957) |
Financing activities | |||
Proceeds from term debt, net of discount | 3,407,535 | 2,215,950 | 3,048,424 |
Payments of term debt | (1,390,994) | (800,000) | |
Revolving credit facilities, net | 559,985 | 162,633 | (65,736) |
Dividends / Distribution paid | (643,473) | (567,969) | (411,697) |
Lease deposits and other obligations to tenants | 17,815 | 21,706 | (12,260) |
Proceeds from sale of units, net of offering costs | 1,051,229 | 411,101 | 2,533,210 |
Payment of debt refinancing, deferred financing costs and other financing activities | (54,489) | (42,347) | (50,057) |
Net cash provided by financing activities | 2,947,608 | 1,401,074 | 5,041,884 |
(Decrease) increase in cash, cash equivalents, and restricted cash for the year | (99,149) | (928,063) | 652,044 |
Effect of exchange rate changes | 4,662 | 16,441 | (6,478) |
Cash, cash equivalents, and restricted cash at beginning of year | 556,369 | 1,467,991 | 822,425 |
Cash, cash equivalents, and restricted cash at end of year | 461,882 | 556,369 | 1,467,991 |
Interest paid, including capitalized interest of $3,289 in 2021, $3,030 in 2020, and $3,936 in 2019 | 326,406 | 309,920 | 211,163 |
Supplemental schedule of non-cash financing activities: | |||
Dividends declared, unpaid | 176,494 | 147,666 | 138,161 |
Cash, cash equivalents, and restricted cash are comprised of the following: | |||
Cash and cash equivalents at beginning of period | 549,884 | 1,462,286 | 820,868 |
Restricted cash, included in Other assets at beginning of period | $ 6,485 | $ 5,705 | $ 1,557 |
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] | Other Assets | Other Assets | Other Assets |
Cash, cash equivalents, and restricted cash at beginning of year | $ 556,369 | $ 1,467,991 | $ 822,425 |
Cash and cash equivalents at end of period | 459,227 | 549,884 | 1,462,286 |
Restricted cash, included in Other assets at end of period | $ 2,655 | $ 6,485 | $ 5,705 |
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] | Other Assets | Other Assets | Other Assets |
Cash, cash equivalents, and restricted cash at end of year | $ 461,882 | $ 556,369 | $ 1,467,991 |
Consolidated Statements of Ca_2
Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Interest paid, capitalized | $ 3,289 | $ 3,030 | $ 3,936 |
MPT Operating Partnership, L.P. [Member] | |||
Interest paid, capitalized | $ 3,289 | $ 3,030 | $ 3,936 |
Organization
Organization | 12 Months Ended |
Dec. 31, 2021 | |
Organization Consolidation And Presentation Of Financial Statements [Abstract] | |
Organization | 1. Organization Medical Properties Trust, Inc., a Maryland corporation, was formed on August 27, 2003, under the Maryland General Corporation Law for the purpose of engaging in the business of investing in, owning, and leasing healthcare real estate. Our operating partnership subsidiary, MPT Operating Partnership, L.P. (the “Operating Partnership”), through which we conduct all of our operations, was formed in September 2003. At present, we own all of the partnership interests in the Operating Partnership and have elected to report our required disclosures and that of the Operating Partnership on a combined basis, except where material differences exist. We operate as a real estate investment trust (“REIT”). Accordingly, we will generally not be subject to United States (“U.S.”) federal income tax, provided that we continue to qualify as a REIT and our distributions to our stockholders equal or exceed our taxable income. Certain non-real estate activities we undertake are conducted by entities which we elected to be treated as taxable REIT subsidiaries (“TRS”). Our TRS entities are subject to both U.S. federal and state income taxes. For our properties located outside the U.S., we are subject to the local taxes of the jurisdictions where our properties reside and/or legal entities are domiciled; however, we do not expect to incur additional taxes, of a significant nature, in the U.S. from foreign-based income as the majority of such income flows through our REIT. Our primary business strategy is to acquire and develop real estate and improvements, primarily for long-term lease to providers of healthcare services, such as operators of general acute care hospitals, behavioral health facilities, inpatient physical rehabilitation hospitals, long-term acute care hospitals, and freestanding ER/urgent care facilities. We also make mortgage and other loans to operators of similar facilities. In addition, we may obtain profits or equity interests in our tenants, from time-to-time, in order to enhance our overall return. Our business model facilitates acquisitions and recapitalizations, and allows operators of healthcare facilities to unlock the value of their real estate to fund facility improvements, technology upgrades, and other investments in operations. At December 31, 2021, we have investments in 438 facilities in 32 states in the U.S., in six countries in Europe, one country in South America, and across Australia. We manage our business as a single business segment. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | 2. Summary of Significant Accounting Policies Use of Estimates: The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We believe the estimates and assumptions underlying our consolidated financial statements are reasonable and supportable based on the information available as of December 31, 2021 (particularly as it relates to our assessments of the recoverability of our real estate and the adequacy of our credit loss reserves on loans and financing receivables). Although the effects of COVID-19 and related variants seem to be lessening, government restrictions appear to be easing, and most hospitals around the world have generally returned to their normal operations, the ultimate impact to our tenants’ results of operations and liquidity and their ability to pay our rent and interest due to the impact of COVID-19 still cannot be predicted with 100% confidence. This makes any estimates and assumptions as of December 31, 2021, inherently less certain than they would be absent the potential impact of COVID-19. Actual results could differ from those estimates. Principles of Consolidation: Property holding entities and other subsidiaries of which we own 100% of the equity or have a controlling financial interest evidenced by ownership of a majority voting interest are consolidated. All inter-company balances and transactions are eliminated. For entities in which we own less than 100% of the equity interest, we consolidate the property if we have the direct or indirect ability to control the entities’ activities based upon the terms of the respective entities’ ownership agreements. For these entities, we record a non-controlling interest representing equity held by non-controlling interests. We continually evaluate all of our transactions and investments to determine if they represent variable interests in a variable interest entity. If we determine that we have a variable interest in a variable interest entity, we then evaluate if we are the primary beneficiary of the variable interest entity. The evaluation is a qualitative assessment as to whether we have the ability to direct the activities of a variable interest entity that most significantly impact the entity’s economic performance. We consolidate each variable interest entity in which we, by virtue of or transactions with our investments in the entity, are considered to be the primary beneficiary. At December 31, 2021, we had loans and/or equity investments in certain variable interest entities approximating $570 million, which represents our maximum exposure to loss as a result of our involvement in such entities. We have determined that we were not the primary beneficiary of any variable interest entity in which we hold a variable interest because we do not control the activities (such as the day-to-day operations) that most significantly impact the economic performance of these entities . Investments in Unconsolidated Entities: Investments in entities in which we have the ability to significantly influence (but not control) are accounted for by the equity method, such as our joint venture with Primotop Holdings S.à.r.l. (“Primotop”). Under the equity method of accounting, our share of the investee’s earnings or losses are included in the “Earnings from equity interests” line of our consolidated statements of net income. Except for our joint venture with Primotop, we have elected to record our share of such investee’s earnings or losses on a lag basis. The initial carrying value of investments in unconsolidated entities is based on the amount paid to purchase the interest in the investee entity. Subsequently, our investments are increased/decreased by our share in the investees’ earnings/losses and decreased by cash distributions from our investees. To the extent that our cost basis is different from the basis reflected at the investee entity level, the basis difference is generally amortized over the lives of the related assets and liabilities, and such amortization is included in our share of equity in earnings of the investee. We evaluate our equity method investments for impairment based upon a comparison of the fair value of the equity method investment to its carrying value, when impairment indicators exist. If we determine a decline in the fair value of an investment in an unconsolidated investee entity below its carrying value is other-than-temporary, an impairment is recorded. Investments in entities in which we do not control nor do we have the ability to significantly influence and for which there is no readily determinable fair value (such as our investment in Steward Health Care System LLC (“Steward”)) are accounted for at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions involving the investee. Cash distributions on these types of investments are recorded to either income upon receipt (if a return on investment) or as a reduction of our investment (if the distributions received are in excess of our share of the investee’s earnings). For similar investments but for which there are readily determinable fair values, such investments are measured at fair value, with unrealized gains and losses recorded in income. Cash and Cash Equivalents: Certificates of deposit, short-term investments with original maturities of three months or less, and money-market mutual funds are considered cash equivalents. The majority of our cash and cash equivalents are held at major commercial banks, which at times may exceed the Federal Deposit Insurance Corporation limit. We have not experienced any losses to-date on our invested cash. Cash and cash equivalents which have been restricted as to its use are recorded in other assets. Revenue Recognition: Our revenues are primarily from leases and loans. For leases, we follow Accounting Standards Update (“ASU”) 2016-02, “Leases”, (“ASU 2016-02”). ASU 2016-02 sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a contract (i.e. lessees and lessors). For lessors, we apply this standard as follows: Operating Lease Revenue We receive income from operating leases based on the fixed required rents (base rents) per the lease agreements. Rent revenue from base rents is recorded on the straight-line method over the terms of the related lease agreements for new leases and the remaining terms of existing leases for those acquired as part of a property acquisition. The straight-line method records the periodic average amount of base rents earned over the term of a lease, taking into account contractual rent increases over the lease term. The straight-line method typically has the effect of recording more rent revenue from a lease than a tenant is required to pay early in the term of the lease. During the later parts of a lease term, this effect reverses with less rent revenue recorded than a tenant is required to pay. Rent revenue, as recorded on the straight-line method, in our consolidated statements of net income is presented as two amounts: rent billed and straight-line rent. Rent billed revenue is the amount of base rent actually billed to our tenants each period as required by the lease. Straight-line rent revenue is the difference between rent revenue earned based on the straight-line method and the amount recorded as rent billed revenue. We record the difference between rent revenues earned and amounts due per the respective lease agreements, as applicable, as an increase or decrease to straight-line rent receivables. Rental payments received prior to their recognition as income are classified as deferred revenue. Financing Lease Revenue Under ASU 2016-02, if an acquisition and subsequent lease of a property back to the seller does not meet the definition of a sale, we must account for the transaction as a financing lease with income recognized using the imputed interest method. Another type of financing lease is a direct financing lease (“DFL”). For leases accounted for as DFLs, the future minimum lease payments are recorded as a receivable at lease inception, while, the difference between the future minimum lease payments and the estimated residual values less the cost of the properties is recorded as unearned income. Unearned income is deferred and amortized to income over the lease term to provide a constant yield when collectability of the lease payments is reasonably assured. Investments in DFLs are presented net of unearned income. Other Leasing Revenue We begin recording base rent income from our development projects when the lessee takes physical possession of the facility, which may be different from the stated start date of the lease. Also, during construction of our development projects, we may be entitled to accrue rent based on the cost paid during the construction period (construction period rent). We accrue construction period rent as a receivable with a corresponding offset to deferred revenue during the construction period. When the lessee takes physical possession of the facility, we begin recognizing the deferred construction period revenue on the straight-line method over the term of the lease. We also receive additional rent (contingent rent) under some leases based on increases in the consumer price index (“CPI”) (or similar index outside the U.S.) or when CPI exceeds the annual minimum percentage increase as stipulated in the lease. Contingent rents are recorded as rent billed revenue in the period earned. Tenant payments for ground leases along with other operating expenses, such as property taxes and insurance, that are paid directly by us and reimbursed by our tenants are presented on a gross basis with the related revenues recorded in “Interest and other income” and the related expenses in “Property-related” in our consolidated statements of net income. All payments of other operating expenses made directly by the tenant to the applicable government or appropriate third-party vendor are recorded on a net basis. Interest Revenue We receive interest income from our tenants/borrowers on mortgage loans, working capital loans, and other long-term loans. Interest income from these loans is recognized as earned based upon the principal outstanding and terms of the loans. Other Revenue Commitment fees received from lessees for development and leasing services are initially recorded as deferred revenue and recognized as income over the initial term of a lease to produce a constant effective yield on the lease (interest method). Commitment and origination fees from lending services are also recorded as deferred revenue initially and recognized as income over the life of the loan using the interest method. Acquired Real Estate Purchase Price Allocation: We account for acquisitions of real estate under asset acquisition accounting rules. Under this accounting standard, we allocate the purchase price (including any third-party transaction costs directly related to the acquisition) of acquired properties to tangible and identified intangible assets acquired and liabilities assumed (if any) based on their relative fair values. In making estimates of fair values for purposes of allocating purchase prices of acquired real estate, we may utilize a number of sources, from time-to-time, including available real estate broker data, independent appraisals that may be obtained in connection with the acquisition, internal data from previous acquisitions or developments, and other market data, including market comparables for significant assumptions such as market rental, capitalization, and discount rates. We also consider information obtained about each property as a result of our pre-acquisition due diligence, marketing, and leasing activities in estimating the fair value of the tangible and intangible assets acquired. We measure the aggregate value of lease intangible assets acquired based on the difference between (i) the property valued with new or in-place leases adjusted to market rental rates and (ii) the property valued as if vacant. Management’s estimates of value are made using methods similar to those used by independent appraisers (e.g., discounted cash flow analysis). Factors considered by management in our analysis include an estimate of carrying costs during hypothetical expected lease-up periods, considering current market conditions, and costs to execute similar leases. We also consider information obtained about each targeted facility as a result of our pre-acquisition due diligence, marketing, and leasing activities in estimating the fair value of the intangible assets acquired. In estimating carrying costs, management includes real estate taxes, insurance, and other operating expenses and estimates of lost rentals at market rates during the expected lease-up periods, which we expect to be about six months, but can be longer depending on specific local market conditions. Management also estimates costs to execute similar leases including leasing commissions, legal costs, and other related expenses to the extent that such costs are not already incurred in connection with a new lease origination as part of the transaction. Other intangible assets acquired may include customer relationship intangible values which are based on management’s evaluation of the specific characteristics of each prospective tenant’s lease and our overall relationship with that tenant. Characteristics to be considered by management in allocating these values include the nature and extent of our existing business relationships with the tenant, growth prospects for developing new business with the tenant, the tenant’s credit quality, and expectations of lease renewals, including those existing under the terms of the lease agreement, among other factors. We amortize the value of our lease intangible assets to expense over the term of the respective leases. If a lease is terminated early, the unamortized portion of the lease intangibles are charged to expense. We record above-market and below-market in-place lease values, if any, for our facilities, which are based on the present value of the difference between (i) the contractual amounts to be paid pursuant to the in-place leases and (ii) management’s estimate of fair market lease rates for the corresponding in-place leases, measured over a period equal to the remaining non-cancelable term of the lease. We amortize any resulting capitalized above-market lease values as a reduction of rental income over the lease term. We amortize any resulting capitalized below-market lease values as an increase to rental income over the lease term. If a lease is terminated early, the unamortized portion of the capitalized above/below market lease value is recognized in rental income at that time. Real Estate and Depreciation: Real estate, consisting of land, buildings and improvements, are maintained at cost. Although typically paid by our tenants, any expenditure for ordinary maintenance and repairs that we pay are expensed to operations as incurred. Significant renovations and improvements which improve and/or extend the useful life of the asset are capitalized and depreciated over their estimated useful lives. We record impairment losses on long-lived assets used in operations when events and circumstances indicate that the assets might be impaired and the undiscounted cash flows estimated to be generated by those assets, including an estimated liquidation amount, during the expected holding periods are less than the carrying amounts of those assets. Impairment losses are measured as the difference between carrying value and fair value of the assets. For assets held for sale, we cease recording depreciation expense and adjust the assets’ value to the lower of its carrying value or fair value, less cost of disposal. Fair value is based on estimated cash flows discounted at a risk-adjusted rate of interest. We classify real estate assets as held for sale when we have commenced an active program to sell the assets, and in the opinion of management, it is probable the asset will be sold within the next 12 months. Construction in progress includes the cost of land, the cost of construction of buildings, improvements, and fixed equipment, and costs for design and engineering. Other costs, such as interest, legal, property taxes, and corporate project supervision, which can be directly associated with the project during construction, are also included in construction in progress. We commence capitalization of costs associated with a development project when the development of the future asset is probable and activities necessary to get the underlying property ready for its intended use have been initiated. We stop the capitalization of costs when the property is substantially complete and ready for its intended use. Depreciation is calculated on the straight-line method over the estimated useful lives of the related real estate and other assets. Our weighted-average useful lives at December 31, 2021 are as follows: Buildings and improvements 35.8 years Lease intangibles 24.9 years Leasehold improvements 17.0 years Furniture, equipment, and other 7.6 years Credit Losses: Losses from Rent Receivables: Losses from Operating Lease Receivables: Losses on Financing Lease Receivables: receivable is under performing and is deemed uncollectible based on the lessee’s overall financial condition, we will adju st the credit loss reserve based on the fair value of the underlying collateral. With the adoption of ASU 2016-13, we made the accounting policy election to exclude interest receivables from the credit loss reserve analysis. Such receivables are impaired and an allowance recorded when it is deemed probable that we will be unable to collect all amounts due. Like operating lease receivables, the need for an allowance is based upon our assessment of the lessee’s overall financial condition, economic resources and payment record, the prospects for support from any financially responsible guarantors, and, if appropriate, the realizable value of any collateral. Financing leases are placed on non-accrual status when we determine that the collectability of contractual amounts is not reasonably assured. If on non-accrual status, we generally account for the financing lease on a cash basis, in which income is recognized only upon receipt of cash. Loans The following table summarizes our credit loss reserves (in thousands): December 31, 2021 December 31, 2020 Balance at beginning of the year $ 8,726 $ — Cumulative effect of change in accounting principle — 8,399 Provision for credit loss 41,710 3,255 Expected credit losses related to financial instruments sold or repaid (1,909 ) (2,928 ) Balance at end of year $ 48,527 $ 8,726 Earnings Per Share/Units: Basic earnings per common share/unit is computed by dividing net income by the weighted-average number of shares/units outstanding during the period. Diluted earnings per common share/unit is calculated by including the effect of dilutive securities. Our unvested restricted stock awards contain non-forfeitable rights to dividends, and accordingly, these awards are deemed to be participating securities. These participating securities are included in the earnings allocation in computing both basic and diluted earnings per common share/unit. Income Taxes: We conduct our business as a REIT under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended (“the Code”). To qualify as a REIT, we must meet certain organizational and operational requirements, including a requirement to distribute to stockholders at least 90% of our REIT’s ordinary taxable income. As a REIT, we generally pay little U.S. federal and state income tax because of the dividends paid deduction that we are allowed to take. If we fail to qualify as a REIT in any taxable year, we will then be subject to U.S. federal income taxes on our taxable income at regular corporate rates and will not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year during which qualification is lost, unless the Internal Revenue Service grants us relief under certain statutory provisions. Such an event could materially adversely affect our net income and net cash available for distribution to stockholders. However, we intend to operate in such a manner so that we will remain qualified as a REIT for U.S. federal income tax purposes. Our financial statements include the operations of TRS entities, including MPT Development Services, Inc. (“MDS”) and many other entities, which are single member LLCs that are disregarded for tax purposes and are reflected in the tax returns of MDS. None of our TRS entities are entitled to a dividends paid deduction and are subject to U.S. federal, state, and local income taxes. Our TRS entities are authorized to provide property development, leasing, and management services for third-party owned properties, and we will make non-mortgage loans to and/or investments in our lessees through these entities. With the property acquisitions and investments in Europe, Australia, and South America, we are subject to income taxes internationally. However, we do not expect to incur any additional income taxes, of a significant nature, in the U.S. as the majority such income from our international properties flows through our REIT income tax returns. For our TRS entities and international subsidiaries, we determine deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in our deferred tax assets /liabilities that results from a change in circumstances and that causes us to change our judgment about expected future tax consequences of events, is reflected in our tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss carryforwards. A valuation allowance is provided if we believe it is more likely than not that all or some portion of our deferred tax assets will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes us to change our judgment about our ability to realize the related deferred tax asset, is reflected in our tax provision when such changes occur. The calculation of our income taxes involves dealing with uncertainties in the application of complex tax laws and regulations in a multitude of jurisdictions across our global operations. An income tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, on the basis of technical merits. However, if a more likely than not position cannot be reached, we record a liability as an offset to the tax benefit and adjust the liabilities when our judgment changes as a result of the evaluation of new information not previously available. Because of the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from our current estimate of the uncertain tax position liabilities. These differences will be reflected as increases or decreases to income tax expense in the period in which new information is available. Stock-Based Compensation: We adopted the 2019 Equity Incentive Plan (the “Equity Incentive Plan”) during the second quarter of 2019. Awards of restricted stock and other equity-based awards with service conditions are valued at the average stock price per share on the date of grant and are amortized to compensation expense over the service periods (typically three years), using the straight-line method. Awards that contain market conditions are valued on the grant date using a Monte Carlo valuation model and are amortized to compensation expense over the derived service periods, which correspond to the periods over which we estimate the awards will be earned, which generally range from three to five years, using the straight-line method. Awards with performance conditions are valued at the average stock price per share on the date of grant and are amortized using the straight-line method over the service period, adjusted for the probability of achieving the performance conditions. Forfeitures of stock-based awards are recognized as they occur. Deferred Costs: Costs incurred that directly relate to the offerings of stock are deferred and netted against proceeds received from the offering. Leasing commissions and other leasing costs that would not have been incurred if the lease was not obtained are capitalized as deferred leasing costs and amortized on the straight-line method over the terms of the related lease agreements. Costs identifiable with loans made to borrowers are capitalized and recognized as a reduction in interest income over the life of the loan. Deferred Financing Costs: We generally capitalize financing costs incurred in connection with new financings and refinancings of debt. These costs are amortized over the lives of the related debt as an addition to interest expense. For debt with defined principal re-payment terms, the deferred costs are amortized to produce a constant effective yield on the debt (interest method) and are included within “Debt, net” on our consolidated balance sheets. For debt without defined principal repayment terms, such as our revolving credit facility, the deferred costs are amortized on the straight-line method over the term of the debt and are included as a component of “Other assets” on our consolidated balance sheets. Foreign Currency Translation and Transactions: Certain of our international subsidiaries’ functional currencies are the local currencies of their respective countries. We translate the results of operations of our foreign subsidiaries into U.S. dollars using average rates of exchange in effect during the period, and we translate balance sheet accounts using exchange rates in effect at the end of the period. We record resulting currency translation adjustments in accumulated other comprehensive income (loss), a component of stockholders’ equity/partnership capital on our consolidated balance sheets. Certain of our U.S. subsidiaries will enter into short-term and long-term transactions denominated in a foreign currency from time-to-time. Gains or losses resulting from these foreign currency transactions are revalued into U.S. dollars at the rates of exchange prevailing at the dates of the transactions. The effects of revaluation gains or losses on our short-term transactions are included in other income in the consolidated statements of income, while the revaluation effects on our long-term investments are recorded in accumulated other comprehensive income (loss) on our consolidated balance sheets. Derivative Financial Investments and Hedging Activities: During our normal course of business, we may use certain types of derivative instruments for the purpose of managing interest rate and/or foreign currency risk. We record our derivative and hedging instruments at fair value on the balance sheet. Changes in the estimated fair value of derivative instruments that are not designated as hedges or that do not meet the criteria for hedge accounting are recognized in earnings. For derivatives designated as cash flow hedges, the change in the estimated fair value of the effective portion of the derivative is recognized in accumulated other comprehensive income (loss) on our consolidated balance sheets, whereas the change in the estimated fair value of the ineffective portion is recognized in earnings. For derivatives designated as fair value hedges, the change in the estimated fair value of the effective portion of the derivatives offsets the change in the estimated fair value of the hedged item, whereas the change in the estimated fair value of the ineffective portion is recognized in earnings. To qualify for hedge accounting, we formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking the hedge prior to entering into a derivative transaction. This process includes specific identification of the hedging instrument and the hedge transaction, the nature of the risk being hedged and how the hedging instrument’s effectiveness in hedging the exposure to the hedged transaction’s variability in cash flows attributable to the hedged risk will be assessed. Both at the inception of the hedge and on an ongoing basis, we assess whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flows or fair values of hedged items. In addition, for cash flow hedges, we assess whether the underlying forecasted transaction will occur. We discontinue hedge accounting if a derivative is not determined to be highly effective as a hedge or that it is probable that the underlying forecasted transaction will not occur. Fair Value Measurement: We measure and disclose the estimated fair value of financial assets and liabilities utilizing a hierarchy of valuation techniques based on whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy: • Level 1 — quoted prices for identical instruments in active markets; • Level 2 — quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and • Level 3 — fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable . We measure fair value using a set of standardized procedures that are outlined herein for all assets and liabilities which are required to be measured at their estimated fair value on either a recurring or non-recurring basis. When available, we utilize quoted market prices from an independent third party source to determine fair value and classify such items in Level 1. In some instances where a market price is available, but the instrument is in an inactive or over-the-counter market, we apply the dealer (market maker) pricing estimate and classify the asset or liability in Level 2. If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads, market capitalization rates, etc. Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement. As a result, the asset or liability could be classified in either Level 2 or 3 even though there may be some significant inputs that are readily observable. Internal fair value models and techniques that have been used by us include discounted cash flow and Monte Carlo valuation models. We also consider counterparty’s and our own credit risk on derivatives and other liabilities measured at their estimated fair value. Fair Value Option Election: For our equity investment in the international joint venture and equity interest in Springstone, LLC (“Springstone”), along with any related investments such as loans (see Note 3 for more details), we have elected to account for these investments at fair value due to the size of the investments and because we believe this method is more reflective of current values. We have not made a similar election for other investments that existed at December 31, 2021. Leases (Lessee) Pursuant to ASU 2016-02, we are required to apply a dual approach, classifying leases as either financing or operating leases based on the principle of whether or |
Real Estate and Other Activitie
Real Estate and Other Activities | 12 Months Ended |
Dec. 31, 2021 | |
Real Estate [Abstract] | |
Real Estate and Other Activities | 3. Real Estate and Other Activities New Investments For the years ended December 31, 2021, 2020, and 2019, we acquired or invested in the following net assets (in thousands): 2021 2020 2019 Land and land improvements $ 642,312 $ 365,281 $ 400,539 Buildings 2,381,654 2,547,313 1,951,066 Intangible lease assets — subject to amortization (weighted-average useful life of 34.5 years in 2021, 27.5 years in 2020, and 19.1 years in 2019) 262,385 642,699 227,468 Investment in financing leases — 114,797 1,386,797 Equity investments 123,427 233,593 415,836 Mortgage loans 1,113,300 176,840 51,267 Other loans and assets 909,669 309,523 135,258 Liabilities assumed (82,508 ) (140,866 ) (2,637 ) $ 5,350,239 $ 4,249,180 $ 4,565,594 Loans repaid(1) (1,103,410 ) (834,743 ) — Total net assets acquired $ 4,246,829 $ 3,414,437 $ 4,565,594 (1) The 2021 column includes an £800 million mortgage loan advanced to the Priory Group (“Priory”) in the first quarter of 2021 and converted to fee simple ownership in a portfolio of 35 properties in the second quarter of 2021 as described below. The 2020 column includes approximately $740 million of loans advanced to Steward in 2017 and exchanged for the fee simple real estate of two hospitals as described below, as well as approximately $100 million of loans advanced to Ernest Health, Inc. (“Ernest”) in 2012 and exchanged for the fee simple real estate of four hospitals as described below. 2021 Activity Priory Group Transaction On January 19, 2021, we completed the first of two phases in the Priory transaction in which we funded an £800 million interim mortgage loan on an identified portfolio of Priory real estate assets in the United Kingdom. On June 25, 2021, we completed the second phase of the transaction in which we converted this mortgage loan to fee simple ownership in a portfolio of 35 select real estate assets from Priory (which is currently owned by Waterland Private Equity Fund VII C.V. (“Waterland VII”)) in individual sale-and-leaseback transactions. The applicable purchase price for the assets was paid by us by proportionally converting and reducing the principal balance of the interim mortgage loan we made to Waterland VII in phase one. Therefore, the net aggregate purchase price for the real estate assets we acquired from Priory was approximately £800 million, plus customary stamp duty, tax, and other transaction costs. As part of the real estate acquisition (for which some of the assets were acquired by the share purchase of real estate holding entities), we incurred deferred income tax liabilities and other liabilities of approximately £47.1 million. In addition to the real estate investment, on January 19, 2021, we made a £250 million acquisition loan to Waterland VII, in connection with the closing of Waterland VII’s acquisition of Priory, which was repaid in full plus interest on October 22, 2021. Finally, we acquired a 9.9% passive equity interest in the Waterland VII affiliate that indirectly owns Priory. Other Transactions On December 2, 2021, we acquired the remaining 50% interest in a general acute hospital operated by IMED Hospitales in Valencia, Spain, which was formerly owned by our joint venture partner. We followed the asset acquisition cost accumulation model to account for this acquisition and included the carrying amount of our previously held equity interest, along with the approximately €46 million consideration paid and direct transaction costs incurred, in determining the total cost allocated to the net assets acquired. On October 21, 2021, we acquired an acute care facility in Portugal for €17.8 million. This facility is leased to Atrys Health pursuant to a long-term master lease with annual escalations. On October 19, 2021, we invested in 18 inpatient behavioral health facilities throughout the U.S. and an interest in the operations of Springstone for total consideration of $950 million (including an acquisition loan of approximately $185 million), plus closing and other transaction costs. We also incurred deferred income tax liabilities of approximately $8.0 million. These facilities are leased to Springstone pursuant to a long-term master lease with annual escalations and multiple extension options. On August 1, 2021, we completed the acquisition of five general acute care hospitals located in South Florida for approximately $900 million, plus closing and other transaction costs. These hospitals are leased to Steward pursuant to the master lease, with annual inflation-based escalators, that had its initial fixed term recently extended by 10 years to 2041. On July 6, 2021, we acquired four acute care hospitals and two on-campus medical office buildings in Los Angeles, California for $215 million. These hospitals are leased to Pipeline Health Systems pursuant to a long-term lease with annual inflation-based escalators. On July 6, 2021, we also acquired an acute care hospital in Stirling, Scotland for £15.6 million. This hospital is leased to Circle Health Ltd. (“Circle”) pursuant to a long-term lease with annual inflation-based escalators. On April 16, 2021, we made a CHF 145 million investment in Swiss Medical Network, our tenant via our Infracore SA (“Infracore”) equity investment. On January 8, 2021, we made a $335 million loan to affiliates of Steward, all of the proceeds of which were used to redeem a similarly sized convertible loan from Steward’s former private equity sponsor. 2020 Activity Circle Transaction On January 8, 2020, we acquired a portfolio of 30 acute care hospitals located throughout the United Kingdom for approximately £1.5 billion from affiliates of BMI Healthcare, Inc. (“BMI”). In a related transaction, affiliates of Circle acquired BMI and assumed its operations in the United Kingdom. As part of our acquisition, we inherited 30 existing leases with the operator that had initial fixed terms ending in 2050, with no renewal options but with annual inflation-based escalators. Effective June 16, 2020, these 30 leases were amended to include two five-year Other Transactions On December 31, 2020, we acquired an inpatient rehabilitation hospital in South Carolina for approximately $17 million. As part of the transaction, we acquired the fee simple real estate of three inpatient rehabilitation hospitals and one long-term acute care hospital in exchange for the reduction of the mortgage loans made to Ernest for such properties in 2012. The approximate $115 million investment in all five of these facilities is leased to Ernest pursuant to an existing long-term master lease with multiple extension options and annual escalation provisions. On December 29, 2020, we increased our equity ownership and related investment in Infracore by investing an additional CHF 206.5 million. We are accounting for our total investment in this joint venture (this investment along with our initial investment in 2019 as noted below) under the equity method. On August 13, 2020, we acquired a general acute care hospital in Lynwood, California for a total investment of approximately $300 million. This property is leased to Prime Healthcare Services, Inc. (“Prime”) pursuant to a long-term master lease with annual escalations and multiple extension options. On July 8, 2020, we acquired the fee simple real estate of two general acute care hospitals located in the Salt Lake City, Utah area, Davis Hospital & Medical Center and Jordan Valley Medical Center, in exchange for the reduction of the mortgage loans made to Steward for such properties and additional cash consideration of $200 million based on their relative fair value. The approximate $950 million investment in these two facilities is subject to the Steward master lease. On June 24, 2020, we originated a CHF 45 million secured loan to Infracore, which was paid in full on December 2, 2020. On May 13, 2020, we formed a joint venture for the purpose of investing in the operations of international hospitals. As part of the formation, we originated a $205 million acquisition loan. We have a 49% interest in this joint venture and are accounting for our investment using the fair value option election. The joint venture simultaneously purchased from Steward the rights and existing assets related to all present and future international opportunities previously owned by Steward for strategic, regulatory, and risk management purposes. Through this joint venture, we invested, on November 17, 2020, in the real estate of three general acute care hospitals in Colombia for approximately $135 million. These properties are operated by the international joint venture. Other acquisitions in 2020 included three inpatient rehabilitation hospitals, two general acute care hospitals, and one private acute care hospital totaling approximately $300 million. One inpatient rehabilitation facility, located in Dahlen, Germany, was acquired on August 5, 2020 for €12.5 million and is leased to MEDIAN Kliniken S.á.r.l. (“MEDIAN”) pursuant to the existing master lease. One of the general acute care facilities, located in Darlington, United Kingdom, was acquired on August 7, 2020 for £29.4 million and is leased to Circle pursuant to a long-term lease. The other general acute care hospital, located in London, United Kingdom, was acquired on November 25, 2020 for £50 million via the purchase of a 999-year ground lease and is leased to The Royal Marsden NHS Foundation Trust pursuant to a long-term lease. The inpatient rehabilitation hospitals, one in Texas and one in Indiana, were acquired on December 17, 2020 for approximately $58 million and are leased to Curahealth Hospitals (now Post Acute Medical, LLC) pursuant to a long-term lease. The private acute care hospital, located in Reading, United Kingdom, was acquired on December 18, 2020 for £85.0 million and is leased to Circle pursuant to the existing long-term Circle master lease. 2019 Activity LifePoint Acquisition On December 17, 2019, we acquired a portfolio of 10 acute care hospitals owned and operated by LifePoint Health, Inc. (“LifePoint”) for a combined purchase price of approximately $700 million. The properties were leased to LifePoint under one master lease agreement. The master lease had a 20-year initial term and two five-year Prospect Transaction On August 23, 2019, we invested in a portfolio of 14 acute care hospitals and two behavioral health facilities operated by Prospect Medical Holdings, Inc. (“Prospect”) for a combined purchase price of approximately $1.55 billion. Our investment included the acquisition of the real estate of 11 acute care hospitals and two behavioral health facilities for $1.4 billion. We are accounting for these properties as a financing (as presented in the “Investment in financing leases” line of the consolidated balance sheets) under lease accounting rules due to certain lessee end-of-term purchase options. In addition, we originated a $51.3 million mortgage loan, secured by a first mortgage on an acute care hospital, and a $112.9 million term loan. The master leases and mortgage loan have substantially similar terms, with an initial 15-year fixed term subject to three extension options, plus annual inflation-based escalators. The agreements provide for the potential for a future purchase price adjustment of up to an additional $250.0 million, based on achievement of certain performance thresholds over a three-year Ramsay Acquisition On August 16, 2019, we acquired freehold interests in eight acute care hospitals located throughout England for an aggregate purchase price of approximately £347 million. The hospitals are leased to Ramsay pursuant to in-place net leases that include annual fixed and periodic market-based escalations. Australia Transaction On June 6, 2019, we acquired 11 hospitals in Australia for a purchase price of approximately A$1.2 billion plus stamp duties and registration fees of A$66.6 million. The properties are leased to Healthscope, pursuant to master lease agreements that had an average initial term of 20 years, upon our acquisition, with annual fixed escalations and multiple extension options. Switzerland Transactions On May 27, 2019, we invested in a portfolio of 13 acute care campuses and two additional properties in Switzerland for an aggregate purchase price of approximately CHF 236.6 million. The investment (which we account for under the equity method) was effected through our purchase of a stake in a Swiss healthcare real estate company, Infracore, from the previous majority shareholder, Aevis Victoria SA (“Aevis”). The facilities are leased to Swiss Medical Network, a wholly-owned Aevis subsidiary, pursuant to leases that had an average 23-year remaining term upon our acquisition and are subject to annual escalation provisions. Additionally, we purchased a 4.9% stake in Aevis for approximately CHF 47 million on June 28, 2019 that we mark to fair value through income. Other Transactions On December 3, 2019, we invested in two acute care hospitals in Spain for a purchase price of approximately €117.3 million. The investment was effected through our purchase of a 45% stake in a Spanish entity. The facilities are leased to HM Hospitales pursuant to a master lease that had an initial lease term of 25 years upon our investment. The lease provides for annual inflation-based escalators. We are accounting for our 45% interest in this joint venture under the equity method. On November 28, 2019, we acquired an acute care hospital in Portugal for approximately €28.2 On August 30, 2019, we invested in a portfolio of facilities throughout various states for approximately $254 million. The properties are leased to Vibra Healthcare, LLC (“Vibra”) five-year On June 10, 2019, we acquired seven community hospitals in Kansas for approximately $145.4 million. The properties are leased to an affiliate of Saint Luke’s Health System (“SLHS”) pursuant to seven individual in-place leases that had an average remaining lease term of 14 years upon our acquisition. The leases provide for fixed escalations every five years, include two five-year Other acquisitions during 2019 included three acute care hospitals and one inpatient rehabilitation second third Development Activities 2021 Activity In the fourth quarter of 2021, we agreed to finance the development of and lease an acute care facility in Texarkana, Texas for $169.4 million. This facility will be leased to Steward and is expected to commence rent in the second quarter of 2024. 2020 Activity On November 23, 2020, we agreed to finance the development of and lease an inpatient rehabilitation facility in Stockton, California for $47.7 million. This facility will be leased to Ernest and is expected to commence rent in the second quarter of 2022. On May 15, 2020, we agreed to finance the development of and lease an inpatient rehabilitation facility in Bakersfield, California for $47.9 million. This facility will be leased to Ernest and is expected to commence rent in the first quarter of 2022. During the 2020 second quarter, we completed construction on one general acute care facility and one inpatient rehabilitation facility, both located in Birmingham, England. We began recognizing revenue on these two properties on June 29, 2020. These facilities are being leased to Circle pursuant to a long-term lease. During the 2020 first quarter, we completed construction and began recording rental income on a general acute care facility located in Idaho Falls, Idaho. This facility commenced rent on January 21, 2020 and is leased to Surgery Partners, Inc. pursuant to an existing long-term lease. 2019 Activity On October 25, 2019, we entered into an agreement to finance the development of and lease a behavioral hospital in Houston, Texas, for $27.5 million. This facility commenced rent on December 18, 2020 and is leased to NeuroPsychiatric Hospitals pursuant to a long-term lease. See table below for a status summary of our current development projects (in thousands): Property Commitment Costs Incurred as of December 31, 2021 Estimated Rent Commencement Date Ernest (Bakersfield, California) $ 47,929 $ 42,132 1Q 2022 Ernest (Stockton, California) 47,700 31,197 2Q 2022 Steward (Texarkana, Texas) 169,408 28,110 2Q 2024 $ 265,037 $ 101,439 Disposals 2021 Activity Joint Venture Transaction On August 28, 2021, we entered into a definitive agreement with Macquarie Asset Management (“MAM”) to form a partnership (the “Macquarie Transaction”), pursuant to which a fund managed by MAM will acquire, for cash consideration, a 50% interest in a portfolio of eight Massachusetts-based general acute care hospitals that we currently own and lease to Steward. The transaction values the portfolio at approximately $1.7 billion. We expect to recognize a gain, net of transaction costs, of approximately $0.5 billion from this transaction, which we expect to close in the 2022 first quarter. The partnership plans to raise nonrecourse secured debt of up to 55% of asset value, and we expect to receive total proceeds, including proceeds from the expected secured debt, of approximately $1.3 billion. There is no certainty as to the amount or terms of expected secured debt financing, and the ultimate amount and terms may affect the completion of the transaction, the transaction value, proceeds, and gain on real estate. At December 31, 2021, the eight facilities subject to the joint venture were designated as held for sale and made up of the following net assets (in thousands): As of December 31, 2021 Real estate held for sale $ 1,096,505 Straight-line rent receivables 120,268 Other assets, net 4,234 Total $ 1,221,007 Other Disposal Transactions During the 2021 fourth quarter, we sold our interest in the operations of three operators (two of which were in Germany) for proceeds of approximately $54.5 million, resulting in a net gain of approximately $40 million. During 2021, we also completed the sale of 16 facilities and an ancillary property for approximately $246 million, resulting in a net gain on real estate of approximately $52.5 million. 2020 Activity During 2020, we completed the sale of nine facilities and six ancillary properties for approximately $94 million, resulting in a net loss of $2.8 million. 2019 Activity During 2019, we completed the sale of five facilities resulting in a gain on real estate of $41.6 million. Intangible Assets At December 31, 2021 and 2020, our intangible lease assets were $1.4 billion ($1.3 billion, net of accumulated amortization) and $1.3 billion ($1.2 billion, net of accumulated amortization), respectively. We recorded amortization expense related to intangible lease assets of $56.0 million, $42.4 million, and $21.5 million in 2021, 2020, and 2019, respectively, and expect to recognize amortization expense from existing lease intangible assets as follows (amounts in thousands): For the Year Ended December 31: 2022 $ 57,433 2023 57,368 2024 57,334 2025 57,186 2026 56,917 As of December 31, 2021, capitalized lease intangibles have a weighted-average remaining life of 22.9 years. Leasing Operations (Lessor) We acquire and develop healthcare facilities and lease the facilities to healthcare operating companies under long-term net leases (typical initial fixed terms of at least 15 years) and most include renewal options at the election of our tenants, generally in five year increments. Over 99% of our leases provide annual rent escalations based on increases in the CPI (or similar index outside the U.S.) and/or fixed minimum annual rent escalations. Many of our domestic leases contain purchase options with pricing set at various terms but in no case less than our total investment. For five properties with a carrying value of $231 million, our leases require a residual value guarantee from the tenant. Our leases typically require the tenant to handle and bear most of the costs associated with our properties including repair/maintenance, property taxes, and insurance. We routinely inspect our properties to ensure the residual value of each of our assets is being maintained. Except for leases classified as financing leases as noted below, all of our leases are classified as operating leases. The following table summarizes total future minimum lease payments to be received, excluding operating expense reimbursements, from tenants under noncancelable leases as of December 31, 2021 (amounts in thousands): Total Under Operating Leases Total Under Financing Leases Total 2022 $ 1,078,148 $ 168,190 $ 1,246,338 2023 1,099,027 171,553 1,270,580 2024 1,117,353 174,984 1,292,337 2025 1,135,695 178,484 1,314,179 2026 1,154,286 182,054 1,336,340 Thereafter 29,555,221 4,513,925 34,069,146 $ 35,139,730 $ 5,389,190 $ 40,528,920 At December 31, 2021, leases on 13 Ernest facilities and five Prime facilities are accounted for as DFLs and leases on 13 of our Prospect facilities and five of our Ernest facilities are accounted for as a financing. The components of our total investment in financing leases consisted of the following (in thousands): As of December 31, 2021 As of December 31, 2020 Minimum lease payments receivable $ 1,183,855 $ 1,228,966 Estimated residual values 203,818 203,818 Less: Unearned income and allowance for credit loss (918,584 ) (969,061 ) Net investment in direct financing leases 469,089 463,723 Other financing leases (net of allowance for credit loss) 1,584,238 1,547,199 Total investment in financing leases $ 2,053,327 $ 2,010,922 COVID-19 Rent Deferrals Due to the COVID-19 pandemic and its impact on our tenants’ business during 2020, we agreed to defer collection of less than 2% of our annual rent. In 2021, we collected approximately $2.8 million of previously deferred rent. Pursuant to our agreements with certain tenants, we expect the remaining outstanding deferred rent balance of approximately $8.6 million as of December 31, 2021, to be paid over specified periods in the future, with interest. Adeptus Health As discussed in previous filings, our original real estate portfolio of approximately 60 properties leased to Adeptus Health, Inc. (“Adeptus”) has gone through significant changes starting with Adeptus filing for Chapter 11 bankruptcy in 2017. With this filing and other subsequent events (including COVID-19 implications in 2020), we transitioned all of our facilities away from Adeptus, which resulted in impairment charges including approximately $20 million (of which one-half related to straight-line rent write-offs) and $2 million in 2020 and 2019, respectively. However, these transition measures have also provided for new tenant relationships being formed with strong credit worthy operators such as Ochsner Health System, Dignity Health, UC Health (University of Colorado), and HCA Healthcare, Inc. (“HCA”), that are now leasing over 40 of these transitional facilities under long-term leases. In addition, we have been able to dispose of 12 properties generating cash proceeds for re-investment purposes, including the sale of our Carrollton, Texas property in February 2022 for approximately $43 million, which exceeded our net book value. At December 31, 2021, only three of these transitional properties, representing less than 0.5% of our total assets, remain vacant, and each of these properties are in various stages of being re-leased or sold. At December 31, 2021, we believe our investment in these real estate assets are fully recoverable, but no assurances can be given that we will not have any further impairments in future periods. Alecto Facilities As noted in previous filings, we originally leased four acute care facilities to and had a mortgage loan on a fifth property (Olympia Medical Center) with Alecto Healthcare Services LLC (“Alecto”), along with working capital loans. During 2019, we incurred approximately $20 million in real estate impairment charges. During the first quarter of 2020, we donated the Wheeling facility to a local municipality, resulting in a $9.1 million real estate impairment charge. In addition, we re-leased one acute care facility and sold another facility in 2020. In the first quarter of 2021, Alecto completed the sale of Olympia Medical Center to the UCLA Health System. Our proceeds of approximately $51 million from this sale were used to pay off the mortgage and working capital loans in full, with the remaining proceeds used to recover certain previously reserved past due receivables. At December 31, 2021, we continue to lease one acute care facility to Alecto, representing less than 0.1% of our total assets. Halsen Healthcare On September 30, 2019, we acquired the real estate of Watsonville Community Hospital in Watsonville, California for $40 million, which was then leased to Halsen Healthcare. In addition, we made a working capital loan to Halsen Healthcare. The hospital operator faced significant financial challenges over a two-year period that were worsened by revenue losses during the COVID-19 pandemic. During this time, we increased the working capital loan balance in an effort to support the operator of this facility. On December 5, 2021, Halsen Healthcare filed Chapter 11 bankruptcy in order to reorganize, while keeping the hospital open. As such, we recorded a credit loss reserve (approximately $40 million) in the fourth quarter of 2021 and wrote off approximately $2.5 million of billed and straight-line rent receivables. At December 31, 2021, we believe our total investment in the Watsonville property, representing less than 0.5% of total assets, is fully recoverable, but no assurances can be given that we will not have any further write-offs or impairments in future periods. Other Leasing Activity 2021 Activity On December 23, 2021, LifePoint announced the completion of the transaction with Kindred Healthcare (“Kindred”), in which LifePoint acquired Kindred, and announced the related launch of ScionHealth, a new healthcare company made up of a combination of former Kindred and LifePoint hospitals. With this transaction, we have eight properties leased to ScionHealth and nine properties leased to LifePoint. 2020 Activity On July 24, 2020, we re-leased our five San Antonio, Texas free standing emergency facilities (with a total investment of approximately $30 million) to Methodist Healthcare System of San Antonio, a joint venture between HCA and Methodist Healthcare Ministries of South Texas, pursuant to a long-term master lease. As a result, we recorded an approximate $1.5 million write-off of straight-line rent in the 2020 third quarter. Loans The following is a summary of our loans (net of allowance for credit loss) ($ amounts in thousands): As of December 31, 2021 As of December 31, 2020 Balance Weighted-Average Interest Rate Balance Weighted-Average Interest Rate Mortgage loans $ 213,211 8.7 % $ 248,080 8.5 % Acquisition loans 523,829 7.7 % 338,273 7.6 % Other loans 804,824 6.2 % 520,095 5.8 % $ 1,541,864 $ 1,106,448 Our mortgage loans at December 31, 2021 cover five of our properties with three operators. The increase in acquisition loans primarily relates to the $185 million loan to Springstone in the fourth quarter of 2021. Other loans consist of loans to our tenants for working capital and other purposes and include our shareholder loan made in 2018 to the joint venture with Primotop in the amount of €297 million. The increase in other loans is primarily related to the $335 million loan to affiliates of Steward (as more fully described above), partially offset by the repayment of $75 million in other loans from Prime. Other Investment Activities On October 13, 2021, we funded an additional €27 million to Priory in order to maintain our 9.9% equity interest. Pursuant to our existing 9.9% equity interest in Steward, we received an $11 million cash distribution during the first quarter of 2021, which was accounted for as a return of capital. Pursuant to our 4.9% stake in Aevis, we recorded an $8.2 million favorable non-cash fair value adjustment to mark our investment in Aevis stock to market during 2021; whereas, this was a $5.8 million unfavorable non-cash fair value adjustment for 2020. Concentration of Credit Risks We monitor concentration risk in several ways due to the nature of our real estate assets that are vital to the communities in which they are located and given our history of being able to replace inefficient operators of our facilities, if needed, with more effective operators: 1) Facility concentration – At December 31, 2021, our largest single property represented approximately 2.7% of our total assets, slightly down from the 3.2% at December 31, 2020. 2) Operator concentration – For the year ended December 31, 2021, revenue from Steward, Circle, and Prospect individually represented more than 10% of our total revenues. In comparison, Steward, Circle, Prospect, and Prime individually represented more than 10% of our total revenues for the year ended December 31, 2020. 3) Geographic concentration – At December 31, 2021, investments in the U.S, Europe, Australia, and South America represented approximately 64%, 30%, 5%, and 1%, respectively, of our total assets compared to 65%, 28%, 6%, and 1%, respectively, of our total assets at December 31, 2020. 4) Facility type concentration – For the year ended December 31, 2021, approximately 81% of our revenues were generated from our general acute care facilities, while revenues from our behavioral and rehabilitation facilities made up 8% and 7%, respectively. Freestanding ER/urgent care facilities and long-term acute care facilities combined to make up the remaining 4%. In comparison, general acute care, rehabilitation, and long-term acute care facilities made up 87%, 8%, and 3%, respectively, of our total revenues for the year ended December 31, 2020, while freestanding ER/urgent care facilities and behavioral health facilities combined to make up the remaining 2%. Related Party Transactions Lease and interest revenue earned from tenants and real estate joint ventures in which we had an equity interest (accounted for under either the equity or fair value option methods) during the year were $63.9 million, $29.8 million, and $85.3 million for 2021, 2020, and 2019, respectively. See subsections “New Investments” and “Disposals” in this Note 3 as it relates to our investments in Springstone and the new international, Primotop, and Infracore ventures for other related party transactions during 2021, 2020, and 2019. |
Debt
Debt | 12 Months Ended |
Dec. 31, 2021 | |
Debt Disclosure [Abstract] | |
Debt | 4. Debt The following is a summary of debt (dollar amounts in thousands): As of December 31, 2021 As of December 31, 2020 Revolving credit facility(A) $ 730,000 $ 165,407 Interim credit facilities 869,606 — Term loan 200,000 200,000 British pound sterling term loan(B) 947,240 956,900 Australian term loan facility(B) 871,560 923,280 4.000% Senior Unsecured Notes due 2022(B) — 610,800 2.550% Senior Unsecured Notes due 2023(B) 541,280 546,800 3.325% Senior Unsecured Notes due 2025(B) 568,500 610,800 0.993% Senior Unsecured Notes due 2026(B) 568,500 — 2.500% Senior Unsecured Notes due 2026(B) 676,600 — 5.250% Senior Unsecured Notes due 2026 500,000 500,000 5.000% Senior Unsecured Notes due 2027 1,400,000 1,400,000 3.692% Senior Unsecured Notes due 2028(B) 811,920 820,200 4.625% Senior Unsecured Notes due 2029 900,000 900,000 3.375% Senior Unsecured Notes due 2030(B) 473,620 — 3.500% Senior Unsecured Notes due 2031 1,300,000 1,300,000 $ 11,358,826 $ 8,934,187 Debt issue costs and discount, net (76,056 ) (68,729 ) $ 11,282,770 $ 8,865,458 (A) The 2020 column includes £121 million of GBP-denominated borrowings that reflect the exchange rate at December 31, 2020. (B) Non-U.S. dollar denominated debt that reflects the exchange rate at period-end. As of December 31, 2021, principal payments due on our debt (which exclude the effects of any discounts, premiums, or debt issue costs recorded) are as follows (amounts in thousands): 2022 $ 869,606 2023 541,280 2024 1,601,560 2025 1,515,740 2026 1,945,100 Thereafter 4,885,540 Total $ 11,358,826 Credit Facility Our current unsecured credit facility (“Credit Facility”) includes a $1.3 billion unsecured revolving loan facility and a $200 million unsecured term loan facility. On January 15, 2021, we amended our Credit Facility. The amendment extended the maturity of our unsecured revolving loan facility to February 1, 2024 and can be extended for an additional 12 months at our option. The maturity date of our term loan facility was extended to February 1, 2026. In addition to extending the maturity date, the amendment improved interest rate pricing for both facilities. Under the amended Credit Facility and at our election, loans may be made as either ABR Loans or Eurocurrency Loans. The applicable margin for term loans that are ABR Loans is adjustable on a sliding scale from 0.00% to 0.85% based on our current credit rating. The applicable margin for term loans that are Eurocurrency Loans is adjustable on a sliding scale from 0.85% to 1.85% based on our current credit rating. The applicable margin for revolving loans that are ABR Loans is adjustable on a sliding scale from 0.00% to 0.55% based on our current credit rating. The applicable margin for revolving loans that are Eurocurrency Loans is adjustable on a sliding scale from 0.825% to 1.55% based on our current credit rating. The amended Credit Facility retained the facility fee that is adjustable on a sliding scale from 0.125% to 0.30% based on our current credit rating and is payable on the revolving loan facility. At December 31, 2021, we had $730.0 million outstanding on the revolving credit facility, whereas, we had $165.4 million outstanding on our revolving credit facility at December 31, 2020. At December 31, 2021 and 2020, our availability under our revolving credit facility was $0.6 billion and $1.1 billion, respectively. The weighted-average interest rate on the revolving facility was 1.3% and 1.4% during 2021 and 2020, respectively. At December 31, 2021 and 2020, the interest rate in effect on our term loan was 1.56% and 1.65%, respectively. Interim Credit Facilities January 2021 Interim Credit Facility On January 15, 2021, we entered into a $900 million interim credit facility (“January 2021 Interim Credit Facility”), of which we borrowed £500 million to partially fund the Priory Group Transaction. We paid off and terminated this facility on March 26, 2021 with the issuance of the 2.500% Senior Unsecured Notes due 2026 and the 3.375% Senior Unsecured Notes due 2030. July 2021 Interim Credit Facility On July 27, 2021, we entered into a $1 billion interim credit facility with Barclays Bank PLC as administrative agent (“July 2021 Interim Credit Facility”), and several lenders from time-to-time are parties thereto. This facility matures on July 28, 2022 and bears interest at a variable rate. We used this facility to partially fund the acquisition of five South Florida facilities in August 2021 and the Springstone investments in October 2021. At December 31, 2021, the outstanding balance under this facility was $869.6 million at a rate of 1.610%. Non-U.S. Term Loans British Pound Sterling Term Loan On January 6, 2020, we entered into a £700 million unsecured sterling-denominated term loan with Bank of America, N.A., as administrative agent, and several lenders from time-to-time are parties thereto. The term loan matures on January 15, 2025. The applicable margin under the term loan is adjustable based on a pricing grid from 0.85% to 1.65% dependent on our current credit rating. On March 4, 2020, we entered into an interest rate swap transaction (effective March 6, 2020) to fix the interest rate to approximately 0.70% for the duration of the loan. The current applicable margin for the pricing grid (which can vary based on our credit rating) is 1.25% for an all-in fixed rate of 1.95%. Australian Term Loan On May 23, 2019, we entered into an A$1.2 billion term loan with Bank of America, N.A., as administrative agent, and several lenders from time-to-time are parties thereto. The term loan matures on May 23, 2024. The interest rate under the term loan is adjustable based on a pricing grid from 0.85% to 1.65%, dependent on our current senior unsecured credit rating. On June 27, 2019, we entered into an interest rate swap transaction (effective July 3, 2019) to fix the interest rate to approximately 1.20% for the duration of the loan as long as the reference rate stays above 0.00%. The current applicable margin for the pricing grid (which can vary based on our credit rating) is 1.25% for an all-in fixed rate of 2.45%. At December 31, 2021, we had a derivative asset of approximately $12.4 million related to the sterling-denominated term loan interest rate swap and a derivative liability of approximately $4.2 million related to the Australian dollar term loan interest rate swap, included in “Other assets” and "Accounts payable and accrued expenses" , respectively, on our consolidated balance sheets . At December 31, 2020, we had a derivative liability of approximately $ 51.3 million associated with these interest rate swaps , included in “Accounts payable and accrued expenses” on our consolidated balance sheets . Senior Unsecured Notes The following are the basic terms of our senior unsecured notes at December 31, 2021 (par value amounts in thousands): Offering Completion Date Maturity Date Par Value % of Par Value Interest Payment Frequency 2.550% Senior Unsecured Notes due 2023 December 5, 2019 December 5, 2023 £ 400,000 100.000 % Annually 3.325% Senior Unsecured Notes due 2025 March 24, 2017 March 24, 2025 € 500,000 100.000 % Annually 0.993% Senior Unsecured Notes due 2026 October 6, 2021 October 15, 2026 € 500,000 100.000 % Annually 2.500% Senior Unsecured Notes due 2026 March 24, 2021 March 24, 2026 £ 500,000 99.937 % Annually 5.250% Senior Unsecured Notes due 2026 July 22, 2016 August 1, 2026 $ 500,000 100.000 % Semi-annually 5.000% Senior Unsecured Notes due 2027 September 7, 2017 October 15, 2027 $ 1,400,000 100.000 % Semi-annually 3.692% Senior Unsecured Notes due 2028 December 5, 2019 June 5, 2028 £ 600,000 99.998 % Annually 4.625% Senior Unsecured Notes due 2029 July 26, 2019 August 1, 2029 $ 900,000 99.500 % Semi-annually 3.375% Senior Unsecured Notes due 2030 March 24, 2021 April 24, 2030 £ 350,000 99.448 % Annually 3.500% Senior Unsecured Notes due 2031 December 4, 2020 March 15, 2031 $ 1,300,000 100.000 % Semi-annually Typically, we may redeem some or all of the notes at any time, but may require a redemption premium that will decrease over time. In the event of a change of control, each holder of the notes may require us to repurchase some or all of our notes at a repurchase price equal to 101% of the aggregate principal amount of the notes plus accrued and unpaid interest to the date of purchase. Debt Refinancing and Unutilized Financing Costs 2021 With the amendment of our Credit Facility, the termination of our January 2021 Interim Credit Facility, and duration fees incurred on our July 2021 Interim Credit Facility, we incurred approximately $7.3 million of debt refinancing costs in 2021. With proceeds from our 0.993% Senior Unsecured Notes due 2026 offering, on October 22, 2021, we redeemed all of our outstanding €500 million aggregate principal amount of 4.000% senior unsecured notes that were due in 2022, including accrued and unpaid interest. As a result of this redemption, we incurred a charge of approximately $20 million (including redemption premiums and accelerated amortization of deferred debt issuance costs). 2020 With proceeds from our 3.500% Senior Unsecured Notes due 2031 offering in 2020, we redeemed all of our outstanding $500.0 million aggregate principal amount of 6.375% senior unsecured notes that were due in 2024 and $300.0 million aggregate principal amount of 5.500% senior unsecured notes that were due in 2024, including accrued and unpaid interest. As a result of these redemptions, we incurred a charge of approximately $28 million (including redemption premiums and accelerated amortization of deferred debt issuance costs). 2019 On July 10, 2019, we received a commitment to provide a senior unsecured bridge loan facility to fund our investment in Prospect. With this commitment, we paid approximately $4 million of underwriting and other fees. However, this commitment was cancelled with the completion of the debt and equity offerings in July 2019 (as more fully described in the table above and in Note 9 ), which resulted in fully expensing the total amount of underwriting and other fees that were paid. In anticipation of funding our Australian acquisition in June 2019 and the Circle transaction in January 2020, we entered into term loans on the date these deals were signed that had a delayed draw feature. This feature allowed for us to not draw on the term loans until needed to fund these transactions. However, with this type of structure, we incurred approximately $2.0 million in accelerated debt issue cost amortization expense during 2019. Covenants Our debt facilities impose certain restrictions on us, including restrictions on our ability to: incur debts; create or incur liens; provide guarantees in respect of obligations of any other entity; make redemptions and repurchases of our capital stock; prepay, redeem, or repurchase debt; engage in mergers or consolidations; enter into affiliated transactions; dispose of real estate or other assets; and change our business. In addition, the credit agreements governing our Credit Facility limit the amount of dividends we can pay as a percentage of normalized adjusted funds from operations (“NAFFO”), as defined in the agreements, on a rolling four quarter basis. At December 31, 2021, the dividend restriction was 95% of NAFFO. The indentures governing our senior unsecured notes also limit the amount of dividends we can pay based on the sum of 95% of NAFFO, proceeds of equity issuances, and certain other net cash proceeds. Finally, our senior unsecured notes require us to maintain total unencumbered assets (as defined in the related indenture) of not less than 150% of our unsecured indebtedness. In addition to these restrictions, the Credit Facility contains customary financial and operating covenants, including covenants relating to our total leverage ratio, fixed charge coverage ratio, secured leverage ratio, consolidated adjusted net worth, unsecured leverage ratio, and unsecured interest coverage ratio. The Credit Facility also contains customary events of default, including among others, nonpayment of principal or interest, material inaccuracy of representations, and failure to comply with our covenants. If an event of default occurs and is continuing under the Credit Facility, the entire outstanding balance may become immediately due and payable. At December 31, 2021, we were in compliance with all such financial and operating covenants. |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | 5. Income Taxes Medical Properties Trust, Inc. We have maintained and intend to maintain our election as a REIT under the Code. To qualify as a REIT, we must meet a number of organizational and operational requirements, including a requirement to distribute at least 90% of our taxable income to our stockholders. As a REIT, we generally will not be subject to U.S. federal income tax if we distribute 100% of our taxable income to our stockholders and satisfy certain other requirements; instead, income tax is paid directly by our stockholders on the dividends distributed to them. If our taxable income exceeds our dividends in a tax year, REIT tax rules allow us to designate dividends from the subsequent tax year in order to avoid current taxation on undistributed income. If we fail to qualify as a REIT in any taxable year, we will be subject to federal income taxes at regular corporate rates, including any applicable alternative minimum tax. Taxable income from non-REIT activities managed through our TRS entities is subject to applicable U.S. federal, state, and local income taxes. Our international subsidiaries are also subject to income taxes in the jurisdictions in which they operate. From our TRS entities and our foreign operations, income tax (expense) benefit were as follows (in thousands): For the Years Ended December 31, 2021 2020 2019 Current income tax (expense) benefit: Domestic $ (1,559 ) $ 63 $ 61 Foreign (18,964 ) (10,203 ) (1,669 ) (20,523 ) (10,140 ) (1,608 ) Deferred income tax (expense) benefit: Domestic 6,915 (10,680 ) 5,490 Foreign (60,340 ) (10,236 ) (1,261 ) (53,425 ) (20,916 ) 4,229 Income tax (expense) benefit $ (73,948 ) $ (31,056 ) $ 2,621 A reconciliation of income tax (expense) benefit from the statutory income tax rate to the effective tax rate based on income before income taxes for the years ended December 31, 2021, 2020, and 2019 is as follows (in thousands): For the Years Ended December 31, 2021 2020 2019 Income before income tax $ 730,888 $ 463,328 $ 373,780 Income tax at the U.S. statutory federal rate (21% in 2021, 2020, and 2019) (153,486 ) (97,299 ) (78,494 ) Decrease (increase) in income tax resulting from: Foreign rate differential 2,742 2,160 438 State income taxes, net of federal benefit — 970 1,621 U.S. earnings not subject to federal income tax 132,266 82,921 85,495 Equity investments — 380 1,091 Change in valuation allowance (10,040 ) (8,514 ) (7,911 ) Statutory tax rate change (43,924 ) (9,471 ) — Interest disallowance (646 ) — — Other items, net (860 ) (2,203 ) 381 Total income tax (expense) benefit $ (73,948 ) $ (31,056 ) $ 2,621 The foreign provision for income taxes is based on foreign profit before income taxes of $164.0 million, $62.1 million, and $10.7 million in 2021, 2020, and 2019, respectively. The domestic provision for income taxes is based on income (loss) before income taxes of $(29.7) million in 2021, $6.4 million in 2020, and $(44.1) million in 2019 from our TRS entities. At December 31, 2021 and 2020, components of our deferred tax assets and liabilities were as follows (in thousands): 2021 2020 Deferred tax assets: Operating loss and interest deduction carry forwards $ 197,876 $ 150,001 Interest rate swap — 9,150 Other 1,815 6,973 Total deferred tax assets 199,691 166,124 Valuation allowance (61,747 ) (36,977 ) Total net deferred tax assets $ 137,944 $ 129,147 Deferred tax liabilities: Property and equipment $ (320,546 ) $ (211,018 ) Net unbilled revenue (43,366 ) (14,776 ) Partnership investments (15,963 ) — Other (3,836 ) (4,010 ) Total deferred tax liabilities (383,711 ) (229,804 ) Net deferred tax asset (liability) $ (245,767 ) $ (100,657 ) During the 2021 second quarter, the United Kingdom enacted an increase in its corporate income tax rates from 19% to 25% effective April 1, 2023, which resulted in a one-time adjustment to our net deferred tax liabilities of approximately $43 million. Similarly, in the 2020 third quarter, we incurred an approximate $9 million charge for the change in the corporate income tax rate from 17% to 19% in the United Kingdom. At December 31, 2021, we had net NOL and other tax attribute carryforwards as follows (in thousands): U.S. Foreign Gross NOL carryforwards $ 239,520 $ 699,514 Tax-effected NOL carryforwards $ 28,837 $ 169,039 Valuation allowance (6,291 ) (45,578 ) Net deferred tax asset - NOL carryforwards $ 22,546 $ 123,461 Expiration periods 2030-indefinite indefinite Valuation Allowance A valuation allowance has been recorded on certain foreign and domestic net operating loss carryforwards and other net deferred tax assets that may not be realized. As of each reporting date, we consider all new evidence that could impact the future realization of our deferred tax assets. In the evaluation of the need for a valuation allowance on our deferred income tax assets, we consider all available positive and negative evidence, including scheduled reversals of deferred income tax liabilities, carryback of future period losses to prior periods, projected future taxable income, tax planning strategies, and recent financial performance. During 2021, a valuation allowance of $24.8 million has been recorded against a portion of our international deferred tax assets to recognize only the components of the deferred tax assets that is more likely than not to be realized. The valuation allowance was primarily recorded against deferred tax assets for NOLs, non-depreciable basis of real property, and other tax attributes that we believe will not be realized. Valuation allowance activity recorded generally follows the activity of the associated deferred tax asset that is not expected to be recognized. From time-to-time, we may acquire deferred tax assets as part of real estate transactions and will assess the need for a valuation allowance as part of the opening balance sheet. Additionally, valuation allowances will be remeasured for foreign currency translation fluctuations through other comprehensive income. We have no material uncertain tax position liabilities and related interest or penalties. REIT Status We have met the annual REIT distribution requirements by payment of at least 90% of our taxable income in 2021, 2020, and 2019. Earnings and profits, which determine the taxability of such distributions, will differ from net income reported for financial reporting purposes due primarily to differences in cost basis, differences in the estimated useful lives used to compute depreciation, and differences between the allocation of our net income and loss for financial reporting purposes and for tax reporting purposes. A schedule of per share distributions we paid and reported to our stockholders is set forth in the following: For the Years Ended December 31, 2021 2020 2019 Common share distribution $ 1.110000 $ 1.070000 $ 1.010000 Ordinary income 0.764580 0.603050 0.701910 Capital gains(1) 0.165420 — 0.275040 Unrecaptured Sec. 1250 gain 0.058270 — 0.041160 Section 199A Dividends 0.764580 0.603050 0.701910 Return of capital 0.180000 0.466950 0.033050 (1) Capital gains include unrecaptured Sec. 1250 gains. MPT Operating Partnership, L.P. As a partnership, the allocated share of income of the Operating Partnership is included in the income tax returns of the general and limited partners. Accordingly, no accounting for income taxes is generally required for such income of the Operating Partnership. However, the Operating Partnership has formed TRS entities on behalf of Medical Properties Trust, Inc., which are subject to U.S. federal, state, and local income taxes at regular corporate rates, and its international subsidiaries are subject to income taxes in the jurisdictions in which they operate. See discussion above under Medical Properties Trust, Inc. for more details of income taxes associated with our TRS entities and international operations. |
Earnings Per Share_Unit
Earnings Per Share/Unit | 12 Months Ended |
Dec. 31, 2021 | |
Earnings Per Share [Abstract] | |
Earnings Per Share/Unit | 6. Earnings Per Share/Unit Medical Properties Trust, Inc. Our earnings per share were calculated based on the following (amounts in thousands): For the Years Ended December 31, 2021 2020 2019 Numerator: Net income $ 656,940 $ 432,272 $ 376,401 Non-controlling interests’ share in earnings (919 ) (822 ) (1,717 ) Participating securities’ share in earnings (2,161 ) (2,105 ) (2,308 ) Net income, less participating securities’ share in earnings $ 653,860 $ 429,345 $ 372,376 Denominator: Basic weighted-average common shares 588,817 529,239 427,075 Dilutive potential common shares 1,322 1,222 1,224 Diluted weighted-average common shares 590,139 530,461 428,299 MPT Operating Partnership, L.P. Our earnings per unit were calculated based on the following (amounts in thousands): For the Years Ended December 31, 2021 2020 2019 Numerator: Net income $ 656,940 $ 432,272 $ 376,401 Non-controlling interests’ share in earnings (919 ) (822 ) (1,717 ) Participating securities’ share in earnings (2,161 ) (2,105 ) (2,308 ) Net income, less participating securities’ share in earnings $ 653,860 $ 429,345 $ 372,376 Denominator: Basic weighted-average units 588,817 529,239 427,075 Dilutive potential units 1,322 1,222 1,224 Diluted weighted-average units 590,139 530,461 428,299 |
Stock Awards
Stock Awards | 12 Months Ended |
Dec. 31, 2021 | |
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |
Stock Awards | 7. Stock Awards Stock Awards Our Equity Incentive Plan, adopted during the second quarter of 2019 and replacing the previous plan, authorizes the issuance of common stock options, restricted stock, restricted stock units, deferred stock units, stock appreciation rights, performance units, and awards of interests in our Operating Partnership. Our Equity Incentive Plan is administered by the Compensation Committee of the Board of Directors. We have reserved 12.9 ten years For the past three years, we have only granted restricted stock and restricted stock units pursuant to our Equity Incentive Plan. These stock-based awards have been granted in the form of service-based awards and performance awards based on company-specific performance hurdles. See below for further details on each of these stock-based awards: Service-Based Awards In 2021, 2020, and 2019, the Compensation Committee granted service-based awards to employees and non-employee directors. Service-based awards vest as the employee/director provides the required service (typically over three years Performance-Based Awards In 2021, 2020, and 2019, the Compensation Committee granted performance-based awards to employees. Generally, dividends are not paid on performance awards until the award is earned. See below for details of such performance-based award grants: In 2021, 2020, and 2019, a target number of stock awards were granted to employees that could be earned based on the achievement of specific performance thresholds as set by our Compensation Committee. The performance thresholds were based on a three-year Certain performance awards granted were subject to a modifier which increases or decreases the actual shares earned in each performance period. The modifier for the 2021 and 2020 awards was based on two components: 1) how our total shareholder return (“TSR”) compared to the SNL U.S. REIT Healthcare Index (“SNL Index”) and 2) how our TSR compared to a threshold set by the Compensation Committee. For 2019 awards, the modifier was based on how our TSR compared to the SNL Index. The following summarizes stock-based award activity in 2021 and 2020 (which includes awards granted in 2021, 2020, 2019, and any applicable prior years), respectively: For the Year Ended December 31, 2021: Vesting Based on Service Vesting Based on Market/Performance Conditions Shares Weighted-Average Value at Award Date Shares Weighted-Average Value at Award Date Nonvested awards at beginning of the year 1,057,054 $ 18.79 5,086,983 $ 14.41 Awarded 651,113 $ 20.83 1,957,802 $ 17.94 Vested (781,076 ) $ 18.77 (1,551,482 ) $ 13.73 Forfeited (4,137 ) $ 18.69 (15,767 ) $ 16.72 Nonvested awards at end of year 922,954 $ 20.26 5,477,536 $ 15.86 For the Year Ended December 31, 2020: Vesting Based on Service Vesting Based on Market/Performance Conditions Shares Weighted-Average Value at Award Date Shares Weighted-Average Value at Award Date Nonvested awards at beginning of the year 1,122,440 $ 17.11 5,481,155 $ 11.66 Awarded 635,855 $ 19.65 1,800,898 $ 19.42 Vested (699,215 ) $ 16.80 (2,193,906 ) $ 11.35 Forfeited (2,026 ) $ 18.40 (1,164 ) $ 18.22 Nonvested awards at end of year 1,057,054 $ 18.79 5,086,983 $ 14.41 The value of stock-based awards is charged to compensation expense over the service periods. For the years ended December 31, 2021, 2020, and 2019, we recorded $52.1 million, $47.2 million, and $32.2 million, respectively, of non-cash compensation expense. The remaining unrecognized cost from stock-based awards at December 31, 2021, is $49.9 million, which will be recognized over a weighted-average period of 1.1 years. Stock-based awards that vested in 2021, 2020, and 2019, had a value of $49.9 million, $58.9 million, and $25.9 million, respectively. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2021 | |
Commitments And Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | 8. Commitments and Contingencies Commitments On September 15, 2021, we entered into definitive agreements to lease five general acute care hospitals, representing 5.5% of our total assets at December 31, 2021, located in Utah to HCA following an agreement by HCA to purchase the operations of these five facilities from Steward. Upon completion of the transaction between HCA and Steward, we will enter into a new master lease with HCA for these five facilities (the “HCA Transaction”). The consummation of the HCA Transaction, which is subject to regulatory approval, is expected in the first half of 2022. Contingencies We are a party to various legal proceedings incidental to our business. In the opinion of management, after consultation with legal counsel, the ultimate liability, if any, with respect to those proceedings is not presently expected to materially affect our financial position, results of operations, or cash flows. |
Common Stock_Partner's Capital
Common Stock/Partner's Capital | 12 Months Ended |
Dec. 31, 2021 | |
Equity [Abstract] | |
Common Stock/Partner's Capital | 9. Common Stock/Partner’s Capital Medical Properties Trust, Inc. 2021 Activity On January 11, 2021, we completed an underwritten public offering of 36.8 million shares of our common stock, resulting in net proceeds of approximately $711 million, after deducting underwriting discounts and commissions and offering expenses. In addition, we sold 16.3 million shares of common stock under our at-the-market equity offering program during 2021, resulting in net proceeds of approximately $340 million. 2020 Activity In 2020, we sold 21.0 million shares of common stock under our at-the-market equity offering program, resulting in net proceeds of approximately $411 million. 2019 Activity On November 8, 2019, we completed an underwritten public offering of 57.5 million shares of our common stock, resulting in net proceeds of $1.026 billion, after deducting underwriting discounts and commissions and offering expenses. On July 18, 2019, we completed an underwritten public offering of 51.75 million shares of our common stock, resulting in net proceeds of $858.1 million, after deducting underwriting discounts and commissions and offering expenses. In 2019, we sold 36.1 million shares of common stock under our at-the-market equity offering program, resulting in net proceeds of approximately $650 million. MPT Operating Partnership, L.P. At December 31, 2021, the Operating Partnership is made up of a general partner, Medical Properties Trust, LLC (“General Partner”) and limited partners, including the Company (which owns 100% of the General Partner) and MPT TRS, Inc. (which is 100% owned by the General Partner). By virtue of its ownership of the General Partner, the Company has a 100% ownership interest in the Operating Partnership. In regards to distributions, the Operating Partnership shall distribute cash at such times and in such amounts as are determined by the General Partner in its sole and absolute discretion, to common unit holders who are common unit holders on the record date. However, per the Second Amended and Restated Agreement of Limited Partnership of MPT Operating Partnership, L.P. (“Operating Partnership Agreement”), the General Partner shall use its reasonable efforts to cause the Operating Partnership to distribute amounts sufficient to enable the Company to pay stockholder dividends that will allow the Company to (i) meet its distribution requirement for qualification as a REIT and (ii) avoid any U.S. federal income or excise tax liability imposed by the Code, other than to the extent the Company elects to retain and pay income tax on its net capital gain. In accordance with the Operating Partnership Agreement, LTIP units are treated as common units for distribution purposes. The Operating Partnership’s net income will generally be allocated first to the General Partner to the extent of any cumulative losses and then to the limited partners in accordance with their respective percentage interests in the common units issued by the Operating Partnership. Any losses of the Operating Partnership will generally be allocated first to the limited partners until their capital account is zero and then to the General Partner. In accordance with the Operating Partnership Agreement, LTIP units are treated as common units for purposes of income and loss allocations. Limited partners have the right to require the Operating Partnership to redeem part or all of their common units. It is at the Operating Partnership’s discretion to redeem such common units for cash based on the fair market value of an equivalent number of shares of the Company’s common stock at the time of redemption or, alternatively, redeem the common units for shares of the Company’s common stock on a one-for-one basis, subject to adjustment in the event of stock splits, stock dividends, or similar events. LTIP units must wait two years from the issuance of the LTIP units to be redeemed, and then converted to common units. On December 28, 2020, approximately 232 thousand LTIP units were converted to common units and then redeemed for approximately $ 4.9 million of cash. For each share of common stock issued by Medical Properties Trust, Inc., the Operating Partnership issues a corresponding number of operating partnership units. |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 12 Months Ended |
Dec. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Financial Instruments | 10. Fair Value of Financial Instruments We have various assets and liabilities that are considered financial instruments. We estimate that the carrying value of cash and cash equivalents and accounts payable and accrued expenses approximate their fair values. We estimate the fair value of our interest and rent receivables using Level 2 inputs such as discounting the estimated future cash flows using the current rates at which similar receivables would be made to others with similar credit ratings and for the same remaining maturities. The fair value of our mortgage loans and other loans are estimated by using Level 2 inputs such as discounting the estimated future cash flows using the current rates which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. We determine the fair value of our senior unsecured notes using Level 2 inputs such as quotes from securities dealers and market makers. We estimate the fair value of our revolving credit facility and term loans using Level 2 inputs based on the present value of future payments, discounted at a rate which we consider appropriate for such debt. Fair value estimates are made at a specific point in time, are subjective in nature, and involve uncertainties and matters of significant judgment. Settlement of such fair value amounts may not be a prudent management decision. The following table summarizes fair value estimates for our financial instruments (in thousands): December 31, 2021 December 31, 2020 Asset (Liability) Book Value Fair Value Book Value Fair Value Interest and rent receivables $ 56,229 $ 56,564 $ 46,208 $ 45,381 Loans(1) 991,609 991,954 751,341 756,608 Debt, net (11,282,770 ) (11,526,388 ) (8,865,458 ) (9,226,564 ) (1) Excludes the acquisition loan and mortgage loan made in October 2021 to Springstone and the acquisition loan made in May 2020 to our international joint venture, along with the related subsequent investment in the real estate of three hospitals in Colombia (see Note 3 for further details), as these assets are accounted for under the fair value option method . Items Measured at Fair Value on a Recurring Basis Our equity investment and related loan to the international joint venture, our loan investment in the real estate of three hospitals operated by subsidiaries of the international joint venture in Colombia, and our equity investment and related loans in Springstone are measured at fair value on a recurring basis as we elected to account for these investments using the fair value option at the point of initial investment. We elected to account for these investments at fair value due to the size of the investments and because we believe this method was more reflective of current values. At December 31, 2021 and 2020, the amounts recorded under the fair value option method were as follows (in thousands): As of December 31, 2021 As of December 31, 2020 Asset (Liability) Fair Value Original Cost Fair Value Original Cost Asset Type Classification Mortgage loans $ 143,068 $ 143,068 $ 136,332 $ 136,332 Mortgage loans Equity investment and other loans 409,638 409,638 218,775 218,775 Equity investments/Other loans Our loans to Springstone and the international joint venture and its subsidiaries are recorded at fair value based on Level 2 inputs by discounting the estimated cash flows using the market rates at which similar loans would be made to borrowers with similar credit ratings and the same remaining maturities. Our equity investment in Springstone and the international joint venture is recorded at fair value based on Level 3 inputs, by using a discounted cash flow model, which requires significant estimates of our investee such as projected revenue and expenses and appropriate consideration of the underlying risk profile of the forecasted assumptions associated with the investee. We classify our valuations of equity investment s as Level 3, as we use certain unobservable inputs to the valuation methodology that are significant to the fair value measurement, and the valuation s require management judgment due to absence of quoted market prices. For th e cash flow model s , our observable inputs include use of a capitalization rate and discount rate (which is based on a weighted-average cost of capital) and our unobservable input includes an adjustment for a marketability discount (“DLOM”). I n regards to the underlying projections used in the discounted cash flow model, such projections are provided by the investee s . However, we will modify such projections as needed based on our review and analysis of historical results, meetings with key members of management, and our understanding of trends and developments within the healthcare industry. Given our international joint venture equity investment is in an entity that was a start-up company in 2020 and given our equity investment in Springstone was made late in 2021, we believe the fair value of these equity investments are in line with our cost basis. Thus, we have not recognized any unrealized gain/loss on such investments in 2020 or 2021. The DLOM on our Springstone and international joint venture equity investments was 40% at December 31, 2021. In arriving at the DLOM, we started with a DLOM range based on the results of studies supporting valuation discounts for other transactions or structures without a public market. To select the appropriate DLOM within the range, we then considered many qualitative factors, including the percent of control, the nature of the underlying investee’s business along with our rights as an investor pursuant to the operating agreement, the size of investment, expected holding period, number of shareholders, access to capital marketplace, etc. To illustrate the effect of movements in the DLOM, we performed a sensitivity analysis below by using basis point variations (dollars in thousands): Basis Point Change in Marketability Discount Estimated Increase (Decrease) in Fair Value + 100 basis points $ (41 ) - 100 basis points 41 Items Measured at Fair Value on a Nonrecurring Basis In addition to items that are measured at fair value on a recurring basis, we have assets and liabilities that are measured, from time-to-time, at fair value on a nonrecurring basis, such as for long-lived asset impairment purposes (see Note 3 ). In these cases, fair value is based on estimated cash flows discounted at a risk-adjusted rate of interest by using Level 2 inputs as more fully described in Note 2 . |
Leases (Lessee)
Leases (Lessee) | 12 Months Ended |
Dec. 31, 2021 | |
Leases [Abstract] | |
Leases (Lessee) | 11. Leases (Lessee) We lease the land underlying certain of our facilities (for which we sublease to our tenants), along with corporate offices and equipment. Our leases have remaining lease terms that vary in years, and some of the leases have initial fixed terms (or renewal options available) that extend the leases up to, or just beyond, the depreciable life of the properties that occupy the leased land. Renewal options that we are reasonably certain to exercise are recognized in our right-of-use assets and lease liabilities. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at lease commencement date in determining the present value of future payments. The following is a summary of our lease expense (in thousands): Income Statement For the Years Ended December 31, Classification 2021 2020 Operating lease cost (1) (2) $ 10,694 $ 9,910 Finance lease cost: Amortization of right-of-use assets Real estate depreciation and amortization 51 51 Interest on lease liabilities Interest 128 128 Sublease income Other (4,466 ) (2,614 ) Total lease cost $ 6,407 $ 7,475 (1) Includes short-term leases. (2) $6.3 million and $6.0 million included in “Property-related”, with the remainder reflected in the “General and administrative” line of our consolidated statements of net income for 2021 and 2020, respectively. Fixed minimum payments due over the remaining lease term under non-cancelable leases of more than one year and amounts to be received in the future from non-cancelable subleases over their remaining lease term at December 31, 2021 are as follows (amounts in thousands): Operating Leases Finance Leases Amounts To Be Received From Subleases Net Payments 2022 $ 7,376 $ 128 $ (4,143 ) $ 3,361 2023 7,448 129 (3,963 ) 3,614 2024 6,559 130 (3,987 ) 2,702 2025 5,666 131 (4,044 ) 1,753 2026 5,255 133 (4,015 ) 1,373 Thereafter 239,727 4,650 (71,286 ) 173,091 (1) Total undiscounted minimum lease payments $ 272,031 $ 5,301 $ (91,438 ) $ 185,894 Less: interest (186,814 ) (3,364 ) Present value of lease liabilities $ 85,217 $ 1,937 (1) Reflects certain ground leases, in which we are the lessee, that have longer initial fixed terms than our existing sublease to our tenants. However, we would expect to either renew the related sublease, enter into a lease with a new tenant, or early terminate the ground lease to reduce or avoid any significant impact from such ground leases. Supplemental balance sheet information is as follows (in thousands, except lease terms and discount rate): Balance Sheet Classification December 31, 2021 December 31, 2020 Right of use assets: Operating leases - real estate Land $ 68,616 $ 73,373 Finance leases - real estate Land 1,785 1,836 Total real estate right of use assets $ 70,401 $ 75,209 Operating leases - corporate Other assets 7,458 8,234 Total right of use assets $ 77,859 $ 83,443 Lease liabilities: Operating leases Obligations to tenants and other lease liabilities $ 85,217 $ 90,006 Financing leases Obligations to tenants and other lease liabilities 1,937 1,935 Total lease liabilities $ 87,154 $ 91,941 Weighted-average remaining lease term: Operating leases 40.6 41.1 Finance leases 34.9 35.9 Weighted-average discount rate: Operating leases 6.4 % 6.4 % Finance leases 6.6 % 6.6 % The following is supplemental cash flow information (in thousands): For the Years Ended December 31, 2021 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 7,330 $ 6,080 Operating cash flows from finance leases 126 125 Non-cash activities - Right-of-use assets obtained in exchange for lease obligations: Operating leases 1,120 13,832 |
Other Assets
Other Assets | 12 Months Ended |
Dec. 31, 2021 | |
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract] | |
Other Assets | 12. Other Assets The following is a summary of our other assets on our consolidated balance sheets (in thousands): As of December 31, 2021 2020 Debt issue costs, net(1) $ 5,488 $ 192 Other corporate assets 193,749 167,929 Prepaids and other assets 134,243 87,948 Total other assets $ 333,480 $ 256,069 (1) Relates to our revolving credit facility Other corporate assets include land and land improvements associated with our corporate offices, furniture and fixtures, equipment, corporate vehicles, aircraft, enterprise and other software, deposits, and right-of-use assets associated with corporate leases. Included in prepaids and other assets is prepaid insurance, prepaid taxes, deferred income tax assets (net of valuation allowances, if any), and lease inducements made to tenants, among other items. In addition to the assets above, we have equity investments of $1.2 billion and $1.1 billion at December 31, 2021 and 2020, respectively. The increase year-over-year is primarily related to new investments in Swiss Medical Network, Priory, and Aspris Children’s Services during 2021, partially offset by the sale of three equity investments during 2021, as discussed further in Note 3 |
Schedule II_ Valuation and Qual
Schedule II: Valuation and Qualifying Accounts | 12 Months Ended |
Dec. 31, 2021 | |
Valuation And Qualifying Accounts [Abstract] | |
Schedule II: Valuation and Qualifying Accounts | Schedule II: Valuation and Qualifying Accounts Medical Properties Trust, Inc. and MPT Operating Partnership, L.P. December 31, 2021 Additions Deductions Year Ended December 31, Balance at Beginning of Year(1) Charged Against Operations(1) Charged to Other Accounts Net Recoveries/ Write-offs(1) Balance at End of Year(1) (In thousands) 2021 $ 146,637 $ 69,131 (2) $ 7,340 (3) $ (68,947 ) (4) $ 154,161 2020 $ 109,803 $ 58,044 (5) $ 22,944 (6) $ (44,154 ) (7) $ 146,637 2019 $ 66,131 $ 50,893 (8) $ — $ (7,221 ) (9) $ 109,803 (1) Includes real estate impairment reserves, allowance for doubtful accounts, straight-line rent reserves, credit loss reserves, tax valuation allowances, and other reserves. (2) Represents a $41.7 million increase in credit loss reserves on financing-type receivables, $8 million increase in accounts receivable and other reserves, and an approximately $20 million increase in valuation allowances to reserve against our net deferred tax assets in 2021. (3) Represents $7.3 million of tax valuation allowances recorded as part of the purchase price allocation of the Priory Transaction as disclosed in Note 3 to Item 8 of this Annual Report on Form 10-K. (4) Includes a $22.4 million decrease in real estate impairment reserves related to disposals in 2021, a $38.7 million decrease in accounts receivable and other reserves, $6.0 million decrease of equity investment impairment reserve related to disposals in 2021, and $1.9 million of credit loss recovery related to loan paydowns in 2021. (5) Represents a $19.0 million increase to real estate impairment reserves, $23.9 million increase in accounts receivable and other reserves, $3.3 million increase in credit loss reserves on financing-type receivables, and a $11.9 million increase in valuation allowances to reserve against our net deferred tax assets in 2020. (6) Reflects $8.4 million of a credit loss reserve recorded on January 1, 2020 to equity as the cumulative effect of a change in accounting principle adjustment upon adoption of ASU No. 2016-13, “Measurement of Credit Losses on Financial Instruments” along with $14.5 million of tax valuation allowances recorded as part of the purchase price allocation of the Circle Transaction as disclosed in Note 3 to Item 8 of this Annual Report on Form 10-K. (7) Includes a $40.5 million decrease in real estate impairment reserves related to disposals in 2020, $2.9 million of credit loss recovery related to loan paydowns in 2020, and a $0.8 million decrease in tax valuation allowances. (8) Represents a $21.0 million increase to real estate impairment reserves, $22.0 million increase in accounts receivable and other reserves, and a $7.9 million increase in our tax valuation allowance to reserve against an increase in our net deferred tax assets in 2019. (9) Includes a $7.2 million decrease in real estate impairment reserves related to disposals in 2019. |
SCHEDULE III - REAL ESTATE INVE
SCHEDULE III - REAL ESTATE INVESTMENTS AND ACCUMULATED DEPRECIATION | 12 Months Ended |
Dec. 31, 2021 | |
Real Estate And Accumulated Depreciation Disclosure [Abstract] | |
SCHEDULE III - REAL ESTATE INVESTMENTS AND ACCUMULATED DEPRECIATION | SCHEDULE III — REAL ESTATE INVESTMENTS AND ACCUMULATED DEPRECIATION December 31, 2021 Initial Costs Additions Subsequent to Acquisition Cost at December 31, 2021(1) Accumulated Life on which depreciation in latest income statements is Location Type of Property Land Buildings Improve- ments Carrying Costs Land Buildings Total Depreciation Encum- brances Date of Construction Date Acquired computed (Years) (Dollar amounts in thousands) Aberdeen, UK Acute care general hospital $ 4,384 $ 107,058 $ 135 $ — $ 4,519 $ 107,058 $ 111,577 $ 5,371 $ — 1985 January 9, 2020 40 Altoona, WI Acute care general hospital — 29,062 — — — 29,062 29,062 5,328 — 2014 August 31, 2014 40 Alvin, TX Freestanding ER 105 4,087 — — 105 4,087 4,192 769 — 2014 March 19, 2014 40 Anaheim, CA Acute care general hospital 1,875 21,813 — 10 1,875 21,823 23,698 8,275 — 1964 November 8, 2006 40 Arnold, UK Behavioral health facility 147 10,540 360 — 507 10,540 11,047 145 — 2008 June 25, 2021 40 Ashtead, UK Acute care general hospital 39,119 75,253 1,019 — 40,138 75,253 115,391 4,588 — 1981 August 16, 2019 40 Aurora, CO Freestanding ER 2,891 4,812 — — 2,891 4,812 7,703 752 — 2015 September 17, 2015 40 Austin, TX Freestanding ER 3,722 4,200 — — 3,722 4,200 7,922 538 — 2017 March 2, 2017 40 Avondale, AZ Behavioral health facility 5,383 65,080 — — 5,383 65,080 70,463 293 — 2016 October 19, 2021 40 Ayer, MA Acute care general hospital 9,048 77,913 4,548 — 9,048 82,461 91,509 5,898 — 1970-2013 June 27, 2018 47 Ayr, UK Behavioral health facility 17,729 51,716 329 — 18,058 51,716 69,774 661 — 2004 June 25, 2021 40 Bad Salzuflen, Germany Rehabilitation hospital 9,888 27,378 930 — 10,818 27,378 38,196 3,048 — 1974, 2016 November 30, 2017 40 Bad Salzuflen, Germany Rehabilitation hospital 7,002 24,077 350 — 7,352 24,077 31,429 2,553 — 1989, 2016 November 30, 2017 40 Bad Oeynhausen, Germany Rehabilitation hospital 1,033 2,835 126 — 1,159 2,835 3,994 324 — 1973, 2010 November 30, 2017 40 Basingstoke, UK Acute care general hospital 13,532 53,347 203 — 13,735 53,347 67,082 2,694 — 1984 January 9, 2020 40 Bassenheim, Germany Rehabilitation hospital 999 5,448 170 — 1,169 5,448 6,617 441 — 1887, 1983 February 9, 2019 39 Bath, UK Acute care general hospital 1,604 33,245 — — 1,604 33,245 34,849 6,233 — 2008, 2009 July 1, 2014 40 Bath, UK Acute care general hospital 7,443 13,874 203 — 7,646 13,874 21,520 721 — 1992 January 9, 2020 40 Beckenham, UK Acute care general hospital 5,751 22,266 54 — 5,805 22,266 28,071 1,121 — 1981 January 9, 2020 40 Bedford, UK Acute care general hospital 1,583 7,976 54 — 1,637 7,976 9,613 406 — 1982 January 9, 2020 40 Bellflower, CA Behavioral health facility 2,563 — — — 2,563 — 2,563 — — 1972 August 23, 2019 — Bennettsville, SC Acute care general hospital 794 15,773 — — 794 15,773 16,567 7,689 — 1984 April 1, 2008 42 Big Spring, TX Acute care general hospital 1,655 21,254 816 — 1,655 22,070 23,725 1,671 — 1973 April 12, 2019 41 Birmingham, UK Acute care general hospital 9,103 47,756 — — 9,103 47,756 56,859 1,784 — 2017 April 3, 2017 40 Birmingham, UK Acute care general hospital 10,098 99,773 386 — 10,484 99,773 110,257 5,040 — 1982 January 9, 2020 40 Birmingham, UK Rehabilitation hospital — 19,885 — — — 19,885 19,885 743 — 2018 June 29, 2020 40 Birmingham, UK Behavioral health facility — 20,376 438 — 438 20,376 20,814 273 — 1900, 1984, 2016 June 25, 2021 40 Blackburn, UK Acute care general hospital 2,706 54,210 122 — 2,828 54,210 57,038 2,727 — 1957 January 9, 2020 40 Blackburn, UK Behavioral health facility 19,620 57,757 1,670 — 21,290 57,757 79,047 792 — 1930 June 25, 2021 40 Bloomington, IN Acute care general hospital 2,392 28,212 5,000 408 2,392 33,620 36,012 12,608 — 2006 August 8, 2006 40 Blue Springs, MO Acute care general hospital 4,347 23,494 — — 4,347 23,494 27,841 4,269 — 1980 February 13, 2015 40 Boardman, OH Long term acute care hospital 79 275 — — 79 275 354 18 — 2008 August 30, 2019 40 Boise, ID Long term acute care hospital 1,558 11,027 — — 1,558 11,027 12,585 864 — 2008 February 29, 2012 50 Bolton, UK Acute care general hospital 1,624 47,335 61 — 1,685 47,335 49,020 2,375 — 1989 January 9, 2020 40 Boonton Township, NJ Behavioral health facility 6,712 17,031 — — 6,712 17,031 23,743 556 — 1952, 1971-1978 September 30, 2015 40 Initial Costs Additions Subsequent to Acquisition Cost at December 31, 2021(1) Accumulated Life on which depreciation in latest income statements is Location Type of Property Land Buildings Improve- ments Carrying Costs Land Buildings Total Depreciation Encum- brances Date of Construction Date Acquired computed (Years) (Dollar amounts in thousands) Bossier City, LA Long term acute care hospital 900 17,818 944 — 900 18,762 19,662 6,214 — 1982 April 1, 2008 40 Bowling Green, KY Rehabilitation hospital 3,486 56,296 — — 3,486 56,296 59,782 3,662 — 1992 August 30, 2019 40 Braunfels, Germany Acute care general hospital 2,183 13,954 57 — 2,240 13,954 16,194 2,292 — 1977 June 30, 2015 40 Brighton, MA Acute care general hospital 18,540 146,491 52,118 — 18,540 198,609 217,149 19,400 — 1917-2009 October 3, 2016 41 Brockton, MA Acute care general hospital 18,328 67,248 5,358 — 18,328 72,606 90,934 10,793 — 1965-2010 October 3, 2016 41 Bromley, UK Behavioral health facility 7,084 16,503 594 — 7,678 16,503 24,181 229 — 1714, 1830, 2021 June 25, 2021 40 Broomfield, CO Freestanding ER 825 3,895 — — 825 3,895 4,720 730 — 2014 July 3, 2014 40 Bundoora, Australia Acute care general hospital 6,654 64,096 4,482 — 6,940 68,292 75,232 4,607 — 1979 June 7, 2019 37 Bury, UK Behavioral health facility 8,173 20,617 872 — 9,045 20,617 29,662 298 — 2003 June 25, 2021 40 Bussage, UK Behavioral health facility 8,848 3,990 176 — 9,024 3,990 13,014 56 — 1970 June 25, 2021 40 Campbelltown, Australia Acute care general hospital 1,055 54,756 51 — 1,106 54,756 55,862 3,546 — 2007 June 7, 2019 40 Canterbury, UK Acute care general hospital 9,675 29,325 88 — 9,763 29,325 39,088 1,478 — 1982 January 9, 2020 40 Carmarthen, UK Acute care general hospital 866 27,185 101 — 967 27,185 28,152 1,373 — 1990 January 9, 2020 40 Carrollton, TX Acute care general hospital 729 34,342 374 — 729 34,716 35,445 5,559 — 2015 July 17, 2015 40 Carrollton, TX Behavioral health facility 4,941 52,579 — — 4,941 52,579 57,520 237 — 2012 October 19, 2021 40 Casper, WY Rehabilitation hospital 1,785 — — — 1,785 — 1,785 — — 2012 February 29, 2012 — Caterham, UK Acute care general hospital 10,816 22,158 400 — 11,216 22,158 33,374 1,370 — 1982 August 16, 2019 40 Chandler, AZ Freestanding ER 3,619 4,783 — — 3,619 4,783 8,402 797 — 2015 April 24, 2015 40 Chandler, AZ Freestanding ER 750 3,853 — — 750 3,853 4,603 602 — 2015 October 7, 2015 40 Cheadle, UK Acute care general hospital 32,477 173,216 406 — 32,883 173,216 206,099 8,715 — 1981 January 9, 2020 40 Cheadle, UK Behavioral health facility 29,205 100,805 2,485 — 31,690 100,805 132,495 1,365 — 1849, 2018 June 25, 2021 40 Cheraw, SC Acute care general hospital 657 19,576 — — 657 19,576 20,233 9,542 — 1982 April 1, 2008 42 Clarksville, TX Rehabilitation hospital 2,460 25,540 — — 2,460 25,540 28,000 710 — 2019 December 17, 2020 39 Cologne, Germany Acute care general hospital 4,456 15,413 103 — 4,559 15,413 19,972 1,765 — 2011 June 23, 2017 40 Colorado Springs, CO Freestanding ER 600 4,231 — — 600 4,231 4,831 802 — 2014 June 5, 2014 40 Columbus, OH Behavioral health facility 2,101 44,504 — — 2,101 44,504 46,605 203 — 2017 October 19, 2021 40 Commerce City, TX Freestanding ER 707 4,248 — — 707 4,248 4,955 752 — 2014 December 11, 2014 40 Conroe, TX Behavioral health facility 3,855 39,156 — — 3,855 39,156 43,011 182 — 2018 October 19, 2021 40 Converse, TX Freestanding ER 750 4,423 — — 750 4,423 5,173 746 — 2015 April 10, 2015 40 Coral Gables, FL Acute care general hospital 26,215 84,584 — — 26,215 84,584 110,799 913 — 1959 August 1, 2021 40 Crown Point, IN Long term acute care hospital 302 528 — — 302 528 830 39 — 2008 August 30, 2019 40 Croydon, UK Acute care general hospital 10,352 44,330 217 — 10,569 44,330 54,899 2,245 — 1982 January 9, 2020 40 Dahlen, Germany Rehabilitation hospital 948 11,679 434 — 1,382 11,679 13,061 455 — 1994 July 8, 2020 40 Dallas, TX Long term acute care hospital 1,000 13,589 — 368 1,421 13,536 14,957 5,189 — 2006 September 5, 2006 40 Darlington, UK Acute care general hospital 1,854 38,071 365 — 2,219 38,071 40,290 1,383 — 2001 August 7, 2020 40 Darlington, UK Behavioral health facility 20,168 51,315 2,415 — 22,583 51,315 73,898 752 — 1935, 2018, 2020 June 25, 2021 40 Darlington, UK Behavioral health facility 5,108 28,014 449 — 5,557 28,014 33,571 369 — 1960, 1990 June 25, 2021 40 Denver, CO Freestanding ER 1,276 4,276 — — 1,276 4,276 5,552 704 — 2015 June 8, 2015 40 Denville, NJ Acute care general hospital 15,709 55,772 — — 15,709 55,772 71,481 1,781 — 1953, 1969-2008 September 30, 2015 40 Detroit, MI Long term acute care hospital 1,220 8,687 — (364 ) 1,220 8,323 9,543 2,893 — 1956 May 22, 2008 40 Diss, UK Behavioral health facility 2,406 11,034 687 — 3,093 11,034 14,127 169 — 1840 (2) June 25, 2021 40 Dodge City, KS Acute care general hospital 1,124 52,705 — — 1,124 52,705 53,829 2,844 — 1976 December 17, 2019 40 Dorchester, MA Acute care general hospital 14,428 219,575 6,725 — 14,428 226,300 240,728 16,117 — 1953-2015 October 15, 2018 42 Dorchester, UK Acute care general hospital 513 33,313 61 — 574 33,313 33,887 1,674 — 1981 January 9, 2020 40 Dormagen, Germany Rehabilitation hospital 1,827 5,818 139 — 1,966 5,818 7,784 516 — 1993, 2006 August 28, 2018 40 Dover, NJ Acute care general hospital 3,865 8,693 — — 3,865 8,693 12,558 295 — 1925, 1927-2008 September 30, 2015 40 Initial Costs Additions Subsequent to Acquisition Cost at December 31, 2021(1) Accumulated Life on which depreciation in latest income statements is Location Type of Property Land Buildings Improve- ments Carrying Costs Land Buildings Total Depreciation Encum- brances Date of Construction Date Acquired computed (Years) (Dollar amounts in thousands) Droitwich, UK Acute care general hospital — 16,261 81 — 81 16,261 16,342 824 — 1984 January 9, 2020 40 Dublin, OH Behavioral health facility 5,118 70,305 — — 5,118 70,305 75,423 312 — 2012 October 19, 2021 40 El Paso, TX Rehabilitation hospital 4,268 21,345 — — 4,268 21,345 25,613 620 — 2018 December 17, 2020 38 Englewood, CO Behavioral health facility 3,369 65,905 — — 3,369 65,905 69,274 297 — 2017 October 19, 2021 40 Euxton, UK Acute care general hospital 4,047 37,797 861 — 4,908 37,797 42,705 2,372 — 1981 August 16, 2019 40 Fall River, MA Acute care general hospital 3,526 82,358 28,556 — 3,526 110,914 114,440 12,508 — 1950-2012 October 3, 2016 41 Firestone, TX Freestanding ER 495 3,963 — — 495 3,963 4,458 751 — 2014 June 6, 2014 40 Flagstaff, AZ Rehabilitation hospital 3,049 22,464 — — 3,049 22,464 25,513 2,153 — 2016 August 23, 2016 40 Florence, AZ Acute care general hospital 900 28,462 105 — 900 28,567 29,467 6,960 — 2012 February 7, 2012 40 Folsom, CA Long term acute care hospital 3,291 21,293 — — 3,291 21,293 24,584 1,475 — 2009 August 30, 2019 40 Fort Worth, TX Freestanding ER 2,701 4,392 — — 2,701 4,392 7,093 741 — 2015 March 27, 2015 40 Fort Worth, TX Behavioral health facility 3,406 34,862 — — 3,406 34,862 38,268 161 — 2014 October 19, 2021 40 Fountain, CO Freestanding ER 1,508 4,131 — — 1,508 4,131 5,639 766 — 2014 July 31, 2014 40 Fresno, CA Rehabilitation hospital 5,507 70,473 — — 5,507 70,473 75,980 4,430 — 1991 August 30, 2019 40 Frome, UK Behavioral health facility 2,419 18,655 660 — 3,079 18,655 21,734 263 — 1980 June 25, 2021 40 Frome, UK Behavioral health facility 9,920 11,388 1,660 — 11,580 11,388 22,968 212 — 1700, 2015, 2017 June 25, 2021 40 Garden Grove, CA Acute care general hospital 5,502 10,748 — 51 5,502 10,799 16,301 3,547 — 1982 November 25, 2008 40 Garden Grove, CA Medical Office Building 862 7,888 — 28 862 7,916 8,778 2,594 — 1982 November 25, 2008 40 Gardena, CA Acute care general hospital 14,010 65,288 — — 14,010 65,288 79,298 882 — 1966 July 6, 2021 40 Georgetown, TX Behavioral health facility 4,569 23,028 — — 4,569 23,028 27,597 106 — 2014 October 19, 2021 40 Gilbert, AZ Freestanding ER 1,517 4,661 — — 1,517 4,661 6,178 748 — 2015 July 22, 2015 40 Gilbert, AZ Behavioral health facility 4,790 45,384 — — 4,790 45,384 50,174 201 — 2020 October 19, 2021 40 Glasgow, UK Acute care general hospital 6,698 139,848 149 — 6,847 139,848 146,695 7,012 — 1983 January 9, 2020 40 Glasgow, UK Behavioral health facility 1,135 16,606 383 — 1,518 16,606 18,124 225 — 1900, 1980 June 25, 2021 40 Glen Waverly, Australia Rehabilitation hospital 30,764 23,768 835 — 31,599 23,768 55,367 2,189 — 1972 June 7, 2019 32 Glendale, AZ Freestanding ER 1,144 6,087 — — 1,144 6,087 7,231 786 — 2016 October 21, 2016 40 Glendale, AZ Freestanding ER 1,210 4,046 — — 1,210 4,046 5,256 666 — 2015 June 5, 2015 40 Gloucester, UK Acute care general hospital 4,869 65,235 1,062 — 5,931 65,235 71,166 4,031 — 1990 August 16, 2019 40 Godalming, UK Behavioral health facility 9,059 20,181 886 — 9,945 20,181 30,126 293 — 1796, 2007 June 25, 2021 40 Goodyear, AZ Freestanding ER 1,800 4,713 — — 1,800 4,713 6,513 677 — 2016 April 4, 2016 40 Great Missenden, UK Acute care general hospital 12,179 111,784 332 — 12,511 111,784 124,295 5,633 — 1981 January 9, 2020 40 Grefath, Germany Rehabilitation hospital 1,136 3,119 101 — 1,237 3,119 4,356 282 — 1886, 1983 August 28, 2018 40 Guildford, UK Acute care general hospital 7,185 38,719 129 — 7,314 38,719 46,033 1,953 — 1989 January 9, 2020 40 Halsall, UK Acute care general hospital 1,524 33,120 618 — 2,142 33,120 35,262 2,052 — 1986 August 16, 2019 40 Harrow, UK Acute care general hospital 40,596 42,958 223 — 40,819 42,958 83,777 2,178 — 1980 January 9, 2020 40 Hartsville, SC Acute care general hospital 2,050 43,970 — — 2,050 43,970 46,020 8,038 — 1999 August 31, 2015 34 Hassocks, UK Behavioral health facility 3,557 30,479 2,272 — 5,829 30,479 36,308 469 — 1998 June 25, 2021 40 Hastings, PA Acute care general hospital 603 8,834 — — 603 8,834 9,437 726 — 1924 December 17, 2019 30 Hausman, TX Acute care general hospital 1,500 8,957 — — 1,500 8,957 10,457 1,958 — 2013 March 1, 2013 40 Haverhill, MA Acute care general hospital 5,651 105,848 3,185 — 5,651 109,033 114,684 8,594 — 1982-2005 August 31, 2018 40 Heidelberg, Germany Rehabilitation hospital 6,350 36,693 74 — 6,424 36,693 43,117 5,072 — 1885, 1991 June 22, 2016 40 Helotes, TX Freestanding ER 1,900 5,115 — — 1,900 5,115 7,015 746 — 2016 March 10, 2016 40 Hemel Hempstead, UK Behavioral health facility 12,480 6,702 795 — 13,275 6,702 19,977 117 — 1901, 1990 June 25, 2021 40 Hialeah, FL Acute care general hospital 18,802 107,783 — — 18,802 107,783 126,585 1,189 — 1950 August 1, 2021 40 Initial Costs Additions Subsequent to Acquisition Cost at December 31, 2021(1) Accumulated Life on which depreciation in latest income statements is Location Type of Property Land Buildings Improve- ments Carrying Costs Land Buildings Total Depreciation Encum- brances Date of Construction Date Acquired computed (Years) (Dollar amounts in thousands) Hialeah, FL Acute care general hospital 75,339 222,399 75,000 — 75,339 297,399 372,738 2,647 — 1969 August 1, 2021 40 Highland Hills, OH Behavioral health facility 3,148 44,181 — — 3,148 44,181 47,329 202 — 2015 October 19, 2021 40 Highland Village, TX Freestanding ER 3,265 1,551 — — 3,265 1,551 4,816 411 — 2015 September 22, 2015 40 Highlands Ranch, CO Freestanding ER 4,200 4,779 — — 4,200 4,779 8,979 647 — 2016 July 25, 2016 40 Hill County, TX Acute care general hospital 1,120 17,882 374 — 1,120 18,256 19,376 13,549 — 1980 September 17, 2010 15 Hinckley, UK Behavioral health facility 2,175 17,867 446 — 2,621 17,867 20,488 242 — 1892, 2007 June 25, 2021 40 Hook, UK Behavioral health facility 5,269 10,968 487 — 5,756 10,968 16,724 162 — 1980 June 25, 2021 40 Hoover, AL Freestanding ER — 7,581 — — — 7,581 7,581 1,476 — 2015 May 1, 2015 34 Hoover, AL Freestanding ER — 1,034 296 — — 1,330 1,330 228 — 2015 May 1, 2015 34 Hope, AR Acute care general hospital 1,651 3,359 2,732 — 1,651 6,091 7,742 897 — 1984-2001 September 29, 2017 41 Hot Springs, AR Acute care general hospital 5,844 59,432 21,221 — 5,844 80,653 86,497 13,122 — 1985 August 31, 2015 40 Houston, TX Acute care general hospital 28,687 104,028 52,051 — 28,687 156,079 184,766 9,735 — 1940-1950 September 29, 2017 41 Houston, TX Freestanding ER 950 3,996 — — 950 3,996 4,946 525 — 2016 September 26, 2016 40 Houston, TX Behavioral health facility 6,063 19,881 2,565 — 6,063 22,446 28,509 561 — 2020 October 25, 2019 40 Houston, TX Acute care general hospital 3,501 34,530 8,477 16,589 3,274 59,823 63,097 17,863 — 1960 August 10, 2007 40 Houston, TX Acute care general hospital 4,047 36,862 — — 4,047 36,862 40,909 5,069 — 2016 July 7, 2016 40 Huntington Park, CA Acute care general hospital 3,132 5,002 — — 3,132 5,002 8,134 77 — 1967 July 6, 2021 40 Huntington Park, CA Acute care general hospital 3,935 6,103 — — 3,935 6,103 10,038 92 — 1960-1969 July 6, 2021 40 Idaho Falls, ID Acute care general hospital 1,823 37,467 11,236 4,665 1,823 53,368 55,191 14,993 — 2002 April 1, 2008 40 Idaho Falls, ID Acute care general hospital 1,880 107,403 — — 1,880 107,403 109,283 5,146 — 2020 December 19, 2017 40 Johnstown, PA Acute care general hospital 8,877 247,042 — 117 8,877 247,159 256,036 16,717 — 1924 December 17, 2019 30 Kansas City, KS Acute care general hospital 2,351 13,665 — — 2,351 13,665 16,016 763 — 2017 June 10, 2019 50 Kansas City, MO Acute care general hospital 10,497 64,419 — — 10,497 64,419 74,916 11,354 — 1978 February 13, 2015 40 Katy, TX Freestanding ER 1,580 4,174 — — 1,580 4,174 5,754 548 — 2016 October 10, 2016 40 Katy, TX Freestanding ER 2,178 3,873 — — 2,178 3,873 6,051 597 — 2015 October 21, 2015 40 Kingswood, Australia Acute care general hospital 24,282 80,488 3,346 — 24,751 83,365 108,116 5,292 — 2000 June 7, 2019 40 Lafayette, IN Rehabilitation hospital 800 14,968 (25 ) — 800 14,943 15,743 3,320 — 2013 February 1, 2013 40 Lafayette, IN Behavioral health facility 3,321 10,884 — — 3,321 10,884 14,205 60 — 2012 October 19, 2021 40 Lander, WY Acute care general hospital 761 42,849 — — 761 42,849 43,610 2,290 — 1983 December 17, 2019 40 Lauderdale Lakes, FL Acute care general hospital 10,657 150,313 — — 10,657 150,313 160,970 1,776 — 1975 August 1, 2021 40 Lawton, OK Acute care general hospital 3,944 63,031 — — 3,944 63,031 66,975 3,385 — 1985 December 17, 2019 40 Layton, UT Acute care general hospital 14,360 370,154 5,369 — 14,360 375,523 389,883 13,647 — 1976-2010 September 29, 2017 40 League City, TX Freestanding ER 1,316 3,901 — — 1,316 3,901 5,217 634 — 2015 June 19, 2015 40 Leawood, KS Acute care general hospital 2,513 13,938 — — 2,513 13,938 16,451 774 — 2017 June 10, 2019 50 Leeds, UK Behavioral health facility 2,065 10,123 358 — 2,423 10,123 12,546 142 — 1990 June 25, 2021 40 Lehi, UT Acute care general hospital 13,403 29,950 1,675 (35 ) 13,368 31,625 44,993 3,812 — 2015 September 29, 2017 45 Lewiston, ID Acute care general hospital 5,389 75,435 — — 5,389 75,435 80,824 11,904 — 1922 May 1, 2017 40 Little Elm, TX Freestanding ER 1,241 3,491 — — 1,241 3,491 4,732 703 — 2013 December 1, 2013 40 Liverpool, Australia Acute care general hospital 13,786 43,209 96 — 13,882 43,209 57,091 3,745 — 1975 June 7, 2019 30 London, UK Acute care general hospital 9,743 64,842 81 — 9,824 64,842 74,666 3,253 — 1984 January 9, 2020 40 London, UK Acute care general hospital 3,464 4,409 27 — 3,491 4,409 7,900 224 — 1987 January 9, 2020 40 London, UK Acute care general hospital 13,207 86,380 27 — 13,234 86,380 99,614 4,323 — 1977 January 9, 2020 40 London, UK Behavioral health facility 6,133 16,640 416 — 6,549 16,640 23,189 229 — 1900, 1960 June 25, 2021 40 London, UK Behavioral health facility 14,391 7,241 288 14,679 7,241 21,920 104 — 1992 June 25, 2021 40 Longmont, CO Freestanding ER 1,799 4,181 — — 1,799 4,181 5,980 618 — 2016 February 10, 2016 40 Initial Costs Additions Subsequent to Acquisition Cost at December 31, 2021(1) Accumulated Life on which depreciation in latest income statements is Location Type of Property Land Buildings Improve- ments Carrying Costs Land Buildings Total Depreciation Encum- brances Date of Construction Date Acquired computed (Years) (Dollar amounts in thousands) Los Angeles, CA Acute care general hospital 12,562 40,164 — — 12,562 40,164 52,726 519 — 1972 July 6, 2021 40 Lubbock, TX Rehabilitation hospital 1,376 28,292 3,648 — 1,376 31,940 33,316 5,094 — 2008 June 16, 2015 40 Lynwood, CA Acute care general hospital 30,116 148,527 — — 30,116 148,527 178,643 5,286 — 1940, 1989-2000 August 13, 2020 40 Mandeville, LA Freestanding ER 2,800 5,370 — — 2,800 5,370 8,170 694 — 2016 October 28, 2016 40 Marrero, LA Freestanding ER 1,608 5,801 — — 1,608 5,801 7,409 798 — 2016 July 15, 2016 40 McKinney, TX Freestanding ER 2,668 4,060 — — 2,668 4,060 6,728 876 — 2015 July 31, 2015 30 McKinney, TX Behavioral health facility 2,934 — — — 2,934 — 2,934 — — 2021 October 19, 2021 - McMinnville, OR Acute care general hospital 5,000 97,900 — — 5,000 97,900 102,900 14,135 — 1996 August 31, 2015 41 Melbourne, FL Acute care general hospital 5,642 17,087 21,214 — 5,642 38,301 43,943 2,947 — 2002 May 1, 2017 42 Melton Mowbray, UK Behavioral health facility 5,387 16,993 673 — 6,060 16,993 23,053 243 — 1990 June 25, 2021 40 Mesa, AZ Acute care general hospital 6,534 100,042 4,136 — 6,534 104,178 110,712 21,948 — 2007 September 26, 2013 40 Methuen, MA Acute care general hospital 23,809 89,505 13,365 — 23,809 102,870 126,679 13,187 — 1950-2011 October 3, 2016 41 Meyersdale, PA Acute care general hospital 390 4,280 — — 390 4,280 4,670 365 — 1960 December 17, 2019 30 Miami, FL Acute care general hospital 44,400 107,203 — — 44,400 107,203 151,603 1,395 — 1955 August 1, 2021 40 Milton Keynes, UK Acute care general hospital 5,480 38,117 95 — 5,575 38,117 43,692 1,918 — 1983 January 9, 2020 40 Monmouth, UK Behavioral health facility 15,189 12,283 1,293 — 16,482 12,283 28,765 208 — 2017 June 25, 2021 40 Montclair, NJ Acute care general hospital 7,900 99,640 577 — 8,477 99,640 108,117 19,799 — 1920-2000 April 1, 2014 40 Mount Pleasant, SC Long term acute care hospital 597 2,198 — — 597 2,198 2,795 149 — 2012 August 30, 2019 40 New Braunfels, TX Rehabilitation hospital 1,853 10,622 — — 1,853 10,622 12,475 299 — 2011 February 29, 2012 40 New Orleans, LA Freestanding ER 2,850 6,125 — — 2,850 6,125 8,975 804 — 2016 September 23, 2016 40 Newark, NJ Acute care general hospital 32,957 24,553 — — 32,957 24,553 57,510 744 — 1919, 1920-2003 May 2, 2016 40 Newburgh, IN Behavioral health facility 1,215 7,266 — — 1,215 7,266 8,481 36 — 2010 October 19, 2021 40 Northland, MO Long term acute care hospital 834 17,182 — — 834 17,182 18,016 4,689 — 2007 February 14, 2011 40 Norwalk, CA Acute care general hospital 2,811 5,940 — — 2,811 5,940 8,751 93 — 1959, 1995 July 6, 2021 40 Norwalk, CA Acute care general hospital 7,925 30,465 — — 7,925 30,465 38,390 407 — 1958-1978 July 6, 2021 40 Norwood, MA Acute care general hospital 7,073 154,496 16,180 — 7,073 170,676 177,749 12,760 — 1926-2001 June 27, 2018 46 Nottingham, UK Acute care general hospital 5,007 48,842 257 — 5,264 48,842 54,106 2,476 — 1983 January 9, 2020 40 Nottingham, UK Behavioral health facility 9,748 9,526 894 — 10,642 9,526 20,168 157 — 2000 June 25, 2021 40 Nottingham, UK Behavioral health facility 10,678 3,451 121 — 10,799 3,451 14,250 48 — 1980 June 25, 2021 40 Odessa, TX Acute care general hospital 6,535 123,518 11,629 — 6,535 135,147 141,682 13,569 — 1973-2004 September 29, 2017 41 Ogden, UT Rehabilitation hospital 1,759 16,414 — — 1,759 16,414 18,173 3,203 — 2014 March 1, 2014 40 Oklahoma City, OK Behavioral health facility 3,641 3,091 — — 3,641 3,091 6,732 26 — 2017 October 19, 2021 40 Olathe, KS Behavioral health facility 5,966 56,125 — — 5,966 56,125 62,091 260 — 2015 October 19, 2021 40 Olathe, KS Acute care general hospital 3,485 14,484 — — 3,485 14,484 17,969 813 — 2018 June 10, 2019 50 Orpington, UK Acute care general hospital 10,826 45,401 162 — 10,988 45,401 56,389 2,292 — 1987 January 9, 2020 40 Ottumwa, IA Acute care general hospital 2,377 48,697 — — 2,377 48,697 51,074 3,623 — 1950 December 17, 2019 30 Overland Park, KS Acute care general hospital 2,974 14,405 — — 2,974 14,405 17,379 812 — 2017 June 10, 2019 50 Overland Park, KS Acute care general hospital 3,191 14,263 — — 3,191 14,263 17,454 845 — 2019 June 10, 2019 50 Overlook, TX Acute care general hospital 2,452 9,666 7 — 2,452 9,673 12,125 2,140 — 2012 February 1, 2013 40 Palestine, TX Acute care general hospital 1,848 95,257 — — 1,848 95,257 97,105 4,993 — 1988 December 17, 2019 40 Parker, CO Freestanding ER 1,300 4,448 — — 1,300 4,448 5,748 686 — 2015 November 6, 2015 40 Pasco, WA Acute care general hospital 2,594 13,195 — — 2,594 13,195 15,789 1,503 — 1920 August 31, 2018 30 Pearland, TX Freestanding ER 1,075 3,577 — — 1,075 3,577 4,652 656 — 2014 September 8, 2014 40 Perth, Australia Acute care general hospital 106,021 37,654 2,528 — 106,241 39,962 146,203 3,386 — 1965 June 7, 2019 30 Initial Costs Additions Subsequent to Acquisition Cost at December 31, 2021(1) Accumulated Life on which depreciation in latest income statements is Location Type of Property Land Buildings Improve- ments Carrying Costs Land Buildings Total Depreciation Encum- brances Date of Construction Date Acquired computed (Years) (Dollar amounts in thousands) Petersburg, VA Rehabilitation hospital 1,302 9,121 — — 1,302 9,121 10,423 3,078 — 2006 July 1, 2008 40 Phoenix, AZ Behavioral health facility 2,396 26,521 2,985 — 2,396 29,506 31,902 3,360 — 1979 September 29, 2017 42 Phoenix, AZ Acute care general hospital 12,695 73,773 4,499 — 12,695 78,272 90,967 8,821 — 1968-1976 September 29, 2017 43 Phoenix, AZ Acute care general hospital 5,576 45,782 — — 5,576 45,782 51,358 5,627 — 2017 February 10, 2017 40 Phoenix, AZ Freestanding ER 1,132 5,052 — — 1,132 5,052 6,184 600 — 2017 April 13, 2017 40 Plano, TX Freestanding ER 4,272 2,492 — — 4,272 2,492 6,764 435 — 2016 September 30, 2016 40 Poole, UK Acute care general hospital 1,922 40,797 549 — 2,471 40,797 43,268 2,905 — 1996 April 3, 2019 40 Poplar Bluff, MO Acute care general hospital 2,659 38,693 — 1 2,659 38,694 41,353 13,247 — 1980 April 22, 2008 40 Port Arthur, TX Acute care general hospital 12,972 78,051 6,877 — 12,972 84,928 97,900 16,573 — 2005 September 26, 2013 40 Port Huron, MI Acute care general hospital 2,531 14,252 — — 2,531 14,252 16,783 2,921 — 1953, 1973-1983 December 31, 2015 30 Post Falls, ID Rehabilitation hospital 417 12,175 1,905 — 767 13,730 14,497 2,755 — 2013 December 31, 2013 40 Preston, UK Behavioral health facility 8,748 27,645 542 — 9,290 27,645 36,935 371 — 1850, 2018, 2021 June 25, 2021 40 Princes Risborough, UK Acute care general hospital 4,955 — — — 4,955 — 4,955 — — N/A January 9, 2020 40 Raleigh, NC Behavioral health facility 3,469 27,707 — — 3,469 27,707 31,176 136 — 2018 October 19, 2021 40 Reading, UK Acute care general hospital 36,489 49,078 496 — 36,985 49,078 86,063 2,991 — 1990 August 16, 2019 40 Reading, UK Acute care general hospital 26,996 88,538 635 — 27,631 88,538 116,169 2,256 — 2012 December 18, 2020 40 Redding, CA Acute care general hospital 1,555 53,863 — 13 1,555 53,876 55,431 19,425 — 1974 August 10, 2007 40 Remscheid, Germany Rehabilitation hospital 1,021 2,603 59 — 1,080 2,603 3,683 230 — 1951, 1983 August 28, 2018 40 Richmond, TX Behavioral health facility 4,602 6,224 — — 4,602 6,224 10,826 36 — 2014 October 19, 2021 40 Richmond, VA Long term acute care hospital 1,302 10,071 — — 1,302 10,071 11,373 761 — 1989 August 30, 2019 40 Ringwood, Australia Acute care general hospital 4,166 19,323 138 — 4,304 19,323 23,627 1,469 — 1973 June 7, 2019 35 Riverton, WY Acute care general hospital 1,163 29,647 — — 1,163 29,647 30,810 1,838 — 1983 December 17, 2019 36 Roaring Springs, PA Acute care general hospital 1,446 9,549 — — 1,446 9,549 10,995 811 — 1924 December 17, 2019 30 Rochdale, MA Long term acute care hospital 654 3,368 — — 654 3,368 4,022 230 — 1989 August 30, 2019 40 Rochdale, MA Acute care general hospital 67 344 — — 67 344 411 23 — 1989 August 30, 2019 40 Rochdale, UK Acute care general hospital 3,654 43,317 149 — 3,803 43,317 47,120 2,186 — 1965 January 9, 2020 40 Rockledge, FL Acute care general hospital 13,919 23,282 7,565 — 13,919 30,847 44,766 4,458 — 1950, 1970 May 1, 2017 42 Roeland Park, KS Acute care general hospital 1,569 15,103 — — 1,569 15,103 16,672 830 — 2018 June 10, 2019 50 Romford, UK Behavioral health facility 4,958 9,317 733 — 5,691 9,317 15,008 147 — 1980 June 25, 2021 40 Rosenberg, TX Freestanding ER 1,289 4,505 — — 1,289 4,505 5,794 676 — 2016 January 15, 2016 40 Rowley, UK Acute care general hospital 2,489 19,453 602 — 3,091 19,453 22,544 1,243 — 1986 August 16, 2019 40 Royston, UK Behavioral health facility 5,636 21,310 1,521 — 7,157 21,310 28,467 336 — 1906, 1970 June 25, 2021 40 Salt Lake City, UT Acute care general hospital 13,590 101,915 15,268 — 13,590 117,183 130,773 11,686 — 1906-1987 September 29, 2017 41 San Antonio, TX Acute care general hospital 8,053 29,333 7,981 — 8,053 37,314 45,367 3,671 — 1978-2002 September 29, 2017 41 San Antonio, TX Freestanding ER 3,167 4,801 — — 3,167 4,801 7,968 610 — 2016 December 9, 2016 40 San Antonio, TX Freestanding ER 351 3,952 — — 351 3,952 4,303 765 — 2014 January 1, 2014 40 San Antonio, TX Acute care general hospital 2,248 5,880 — — 2,248 5,880 8,128 1,346 — 2012 October 2, 2012 40 San Antonio, TX Freestanding ER 2,448 4,253 — — 2,448 4,253 6,701 549 — 2016 October 27, 2016 40 San Bernardino, CA Acute care general hospital 2,209 37,498 — — 2,209 37,498 39,707 2,390 — 1993 August 30, 2019 40 San Diego, CA Acute care general hospital 12,663 52,431 — — 12,663 52,431 65,094 14,309 — 1973 February 9, 2011 40 San Diego, CA Acute care general hospital 6,550 15,653 — 77 6,550 15,730 22,280 5,766 — 1964 May 9, 2007 40 San Dimas, CA Acute care general hospital 6,160 6,839 — 34 6,160 6,873 13,033 2,252 — 1972 November 25, 2008 40 The changes in total real estate assets (excluding construction in progress, intangible lease assets, investment in financing leases, and mortgage loans) are as follows for the years ended (in thousands): December 31, 2021 December 31, 2020 December 31, 2019 COST Balance at beginning of period $ 10,749,707 $ 7,312,486 $ 4,781,149 Acquisitions 3,023,966 2,912,594 2,436,265 Transfers from construction in progress — 202,999 — Additions 167,164 55,137 173,785 Dispositions (229,584 ) (105,360 ) (106,536 ) Other (82,504 ) (3) 371,851 (3) 27,823 (3) Balance at end of period $ 13,628,749 (4) $ 10,749,707 $ 7,312,486 The changes in accumulated depreciation are as follows for the years ended (in thousands): December 31, 2021 December 31, 2020 December 31, 2019 ACCUMULATED DEPRECIATION Balance at beginning of period $ 728,176 $ 504,651 $ 414,331 Depreciation 262,063 222,580 130,851 Depreciation on disposed property (35,551 ) (6,653 ) (40,952 ) Other (4,319 ) 7,598 421 Balance at end of period $ 950,369 (5) $ 728,176 $ 504,651 (3) Includes foreign currency fluctuations for all years and $13.8 million and $61.4 million of right-of-use assets in 2020 and 2019, respectively. (4) Includes $1.1 billion of land and building cost reflected in real estate held for sale at December 31, 2021. Excludes intangible lease assets that are included in real estate held for sale of $125.1 million at December 31, 2021. (5) Includes $96.5 million of accumulated depreciation reflected in real estate held for sale at December 31, 2021. Excludes accumulated amortization related to intangible lease assets that are included in real estate held for sale of $17.5 million at December 31, 2021. |
SCHEDULE IV - MORTGAGE LOANS ON
SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE | 12 Months Ended |
Dec. 31, 2021 | |
Mortgage Loans On Real Estate [Abstract] | |
SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE | SCHEDULE IV — MORTGAGE LOANS ON REAL ESTATE MEDICAL PROPERTIES TRUST, INC. AND MPT OPERATING PARTNERSHIP, L.P. December 31, 2021 Column A Column B Column C Column D Column E Column F Column G(1) Column H Description Interest Rate Final Maturity Date Periodic Payment Terms Prior Liens Face Amount of Mortgages Carrying Amount of Mortgages Principal Amount of Loans Subject to Delinquent Principal or Interest (Dollar amounts in thousands) Long-term first mortgage loan: Payable in monthly installments of interest plus principal payable in full at maturity Colombia(4) 8.95 % 2035 (2 ) $ 120,167 $ 120,167 (3 ) Vibra 11.50 % 2024 (2 ) 18,986 18,986 (3 ) Prospect 7.65 % 2034 (2 ) 51,267 51,267 (3 ) Springstone 7.00 % 2041 (2 ) 22,900 22,900 (3 ) $ 213,320 $ 213,320 (5 ) (1) The aggregate cost for federal income tax purposes is $213.3 million. ( 2 ) There were no prior liens on loans as of December 31, 2021. ( 3 ) The mortgage loan was not delinquent with respect to principal or interest. ( 4 ) Mortgage loans covering three properties. ( 5 ) Excludes allowance for credit loss of $0.1 million at December 31, 2021. Changes in mortgage loans (excluding allowance for credit loss for 2021 and 2020 only and unamortized loan issue costs for 2019 only) for the years ended December 31, 2021, 2020, and 2019 are summarized as follows: Year Ended December 31, 2021 2020 2019 (Dollar amounts in thousands) Balance at beginning of year $ 248,335 $ 1,274,995 $ 1,213,283 Additions during year: New mortgage loans and additional advances on existing loans 1,128,695 (6) 193,590 61,712 Exchange rate fluctuations (3,640 ) 9,785 — 1,373,390 1,478,370 1,274,995 Deductions during year: Collection of principal (1,160,070 ) (6) (1,230,035 ) (7) — (1,160,070 ) (1,230,035 ) — Balance at end of year $ 213,320 $ 248,335 $ 1,274,995 ( 6 ) Includes an £800 million mortgage loan advanced to Priory in the first quarter of 2021 that was redeemed as part of the acquisition of the underlying fee simple real estate in the second quarter of 2021 as more fully described in Note 3 to Item 8 of this Annual Report on Form 10-K. (7) Includes $835 million of mortgage loans that were used to acquire the underlying fee simple real estate as more fully described in Note 3 |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Use of Estimates | Use of Estimates: The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We believe the estimates and assumptions underlying our consolidated financial statements are reasonable and supportable based on the information available as of December 31, 2021 (particularly as it relates to our assessments of the recoverability of our real estate and the adequacy of our credit loss reserves on loans and financing receivables). Although the effects of COVID-19 and related variants seem to be lessening, government restrictions appear to be easing, and most hospitals around the world have generally returned to their normal operations, the ultimate impact to our tenants’ results of operations and liquidity and their ability to pay our rent and interest due to the impact of COVID-19 still cannot be predicted with 100% confidence. This makes any estimates and assumptions as of December 31, 2021, inherently less certain than they would be absent the potential impact of COVID-19. Actual results could differ from those estimates. |
Principles of Consolidation | Principles of Consolidation: Property holding entities and other subsidiaries of which we own 100% of the equity or have a controlling financial interest evidenced by ownership of a majority voting interest are consolidated. All inter-company balances and transactions are eliminated. For entities in which we own less than 100% of the equity interest, we consolidate the property if we have the direct or indirect ability to control the entities’ activities based upon the terms of the respective entities’ ownership agreements. For these entities, we record a non-controlling interest representing equity held by non-controlling interests. We continually evaluate all of our transactions and investments to determine if they represent variable interests in a variable interest entity. If we determine that we have a variable interest in a variable interest entity, we then evaluate if we are the primary beneficiary of the variable interest entity. The evaluation is a qualitative assessment as to whether we have the ability to direct the activities of a variable interest entity that most significantly impact the entity’s economic performance. We consolidate each variable interest entity in which we, by virtue of or transactions with our investments in the entity, are considered to be the primary beneficiary. At December 31, 2021, we had loans and/or equity investments in certain variable interest entities approximating $570 million, which represents our maximum exposure to loss as a result of our involvement in such entities. We have determined that we were not the primary beneficiary of any variable interest entity in which we hold a variable interest because we do not control the activities (such as the day-to-day operations) that most significantly impact the economic performance of these entities . |
Investments in Unconsolidated Entities | Investments in Unconsolidated Entities: Investments in entities in which we have the ability to significantly influence (but not control) are accounted for by the equity method, such as our joint venture with Primotop Holdings S.à.r.l. (“Primotop”). Under the equity method of accounting, our share of the investee’s earnings or losses are included in the “Earnings from equity interests” line of our consolidated statements of net income. Except for our joint venture with Primotop, we have elected to record our share of such investee’s earnings or losses on a lag basis. The initial carrying value of investments in unconsolidated entities is based on the amount paid to purchase the interest in the investee entity. Subsequently, our investments are increased/decreased by our share in the investees’ earnings/losses and decreased by cash distributions from our investees. To the extent that our cost basis is different from the basis reflected at the investee entity level, the basis difference is generally amortized over the lives of the related assets and liabilities, and such amortization is included in our share of equity in earnings of the investee. We evaluate our equity method investments for impairment based upon a comparison of the fair value of the equity method investment to its carrying value, when impairment indicators exist. If we determine a decline in the fair value of an investment in an unconsolidated investee entity below its carrying value is other-than-temporary, an impairment is recorded. Investments in entities in which we do not control nor do we have the ability to significantly influence and for which there is no readily determinable fair value (such as our investment in Steward Health Care System LLC (“Steward”)) are accounted for at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions involving the investee. Cash distributions on these types of investments are recorded to either income upon receipt (if a return on investment) or as a reduction of our investment (if the distributions received are in excess of our share of the investee’s earnings). For similar investments but for which there are readily determinable fair values, such investments are measured at fair value, with unrealized gains and losses recorded in income. |
Cash and Cash Equivalents | Cash and Cash Equivalents: Certificates of deposit, short-term investments with original maturities of three months or less, and money-market mutual funds are considered cash equivalents. The majority of our cash and cash equivalents are held at major commercial banks, which at times may exceed the Federal Deposit Insurance Corporation limit. We have not experienced any losses to-date on our invested cash. Cash and cash equivalents which have been restricted as to its use are recorded in other assets. |
Revenue Recognition | Revenue Recognition: Our revenues are primarily from leases and loans. For leases, we follow Accounting Standards Update (“ASU”) 2016-02, “Leases”, (“ASU 2016-02”). ASU 2016-02 sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a contract (i.e. lessees and lessors). For lessors, we apply this standard as follows: Operating Lease Revenue We receive income from operating leases based on the fixed required rents (base rents) per the lease agreements. Rent revenue from base rents is recorded on the straight-line method over the terms of the related lease agreements for new leases and the remaining terms of existing leases for those acquired as part of a property acquisition. The straight-line method records the periodic average amount of base rents earned over the term of a lease, taking into account contractual rent increases over the lease term. The straight-line method typically has the effect of recording more rent revenue from a lease than a tenant is required to pay early in the term of the lease. During the later parts of a lease term, this effect reverses with less rent revenue recorded than a tenant is required to pay. Rent revenue, as recorded on the straight-line method, in our consolidated statements of net income is presented as two amounts: rent billed and straight-line rent. Rent billed revenue is the amount of base rent actually billed to our tenants each period as required by the lease. Straight-line rent revenue is the difference between rent revenue earned based on the straight-line method and the amount recorded as rent billed revenue. We record the difference between rent revenues earned and amounts due per the respective lease agreements, as applicable, as an increase or decrease to straight-line rent receivables. Rental payments received prior to their recognition as income are classified as deferred revenue. Financing Lease Revenue Under ASU 2016-02, if an acquisition and subsequent lease of a property back to the seller does not meet the definition of a sale, we must account for the transaction as a financing lease with income recognized using the imputed interest method. Another type of financing lease is a direct financing lease (“DFL”). For leases accounted for as DFLs, the future minimum lease payments are recorded as a receivable at lease inception, while, the difference between the future minimum lease payments and the estimated residual values less the cost of the properties is recorded as unearned income. Unearned income is deferred and amortized to income over the lease term to provide a constant yield when collectability of the lease payments is reasonably assured. Investments in DFLs are presented net of unearned income. Other Leasing Revenue We begin recording base rent income from our development projects when the lessee takes physical possession of the facility, which may be different from the stated start date of the lease. Also, during construction of our development projects, we may be entitled to accrue rent based on the cost paid during the construction period (construction period rent). We accrue construction period rent as a receivable with a corresponding offset to deferred revenue during the construction period. When the lessee takes physical possession of the facility, we begin recognizing the deferred construction period revenue on the straight-line method over the term of the lease. We also receive additional rent (contingent rent) under some leases based on increases in the consumer price index (“CPI”) (or similar index outside the U.S.) or when CPI exceeds the annual minimum percentage increase as stipulated in the lease. Contingent rents are recorded as rent billed revenue in the period earned. Tenant payments for ground leases along with other operating expenses, such as property taxes and insurance, that are paid directly by us and reimbursed by our tenants are presented on a gross basis with the related revenues recorded in “Interest and other income” and the related expenses in “Property-related” in our consolidated statements of net income. All payments of other operating expenses made directly by the tenant to the applicable government or appropriate third-party vendor are recorded on a net basis. Interest Revenue We receive interest income from our tenants/borrowers on mortgage loans, working capital loans, and other long-term loans. Interest income from these loans is recognized as earned based upon the principal outstanding and terms of the loans. Other Revenue Commitment fees received from lessees for development and leasing services are initially recorded as deferred revenue and recognized as income over the initial term of a lease to produce a constant effective yield on the lease (interest method). Commitment and origination fees from lending services are also recorded as deferred revenue initially and recognized as income over the life of the loan using the interest method. |
Acquired Real Estate Purchase Price Allocation | Acquired Real Estate Purchase Price Allocation: We account for acquisitions of real estate under asset acquisition accounting rules. Under this accounting standard, we allocate the purchase price (including any third-party transaction costs directly related to the acquisition) of acquired properties to tangible and identified intangible assets acquired and liabilities assumed (if any) based on their relative fair values. In making estimates of fair values for purposes of allocating purchase prices of acquired real estate, we may utilize a number of sources, from time-to-time, including available real estate broker data, independent appraisals that may be obtained in connection with the acquisition, internal data from previous acquisitions or developments, and other market data, including market comparables for significant assumptions such as market rental, capitalization, and discount rates. We also consider information obtained about each property as a result of our pre-acquisition due diligence, marketing, and leasing activities in estimating the fair value of the tangible and intangible assets acquired. We measure the aggregate value of lease intangible assets acquired based on the difference between (i) the property valued with new or in-place leases adjusted to market rental rates and (ii) the property valued as if vacant. Management’s estimates of value are made using methods similar to those used by independent appraisers (e.g., discounted cash flow analysis). Factors considered by management in our analysis include an estimate of carrying costs during hypothetical expected lease-up periods, considering current market conditions, and costs to execute similar leases. We also consider information obtained about each targeted facility as a result of our pre-acquisition due diligence, marketing, and leasing activities in estimating the fair value of the intangible assets acquired. In estimating carrying costs, management includes real estate taxes, insurance, and other operating expenses and estimates of lost rentals at market rates during the expected lease-up periods, which we expect to be about six months, but can be longer depending on specific local market conditions. Management also estimates costs to execute similar leases including leasing commissions, legal costs, and other related expenses to the extent that such costs are not already incurred in connection with a new lease origination as part of the transaction. Other intangible assets acquired may include customer relationship intangible values which are based on management’s evaluation of the specific characteristics of each prospective tenant’s lease and our overall relationship with that tenant. Characteristics to be considered by management in allocating these values include the nature and extent of our existing business relationships with the tenant, growth prospects for developing new business with the tenant, the tenant’s credit quality, and expectations of lease renewals, including those existing under the terms of the lease agreement, among other factors. We amortize the value of our lease intangible assets to expense over the term of the respective leases. If a lease is terminated early, the unamortized portion of the lease intangibles are charged to expense. We record above-market and below-market in-place lease values, if any, for our facilities, which are based on the present value of the difference between (i) the contractual amounts to be paid pursuant to the in-place leases and (ii) management’s estimate of fair market lease rates for the corresponding in-place leases, measured over a period equal to the remaining non-cancelable term of the lease. We amortize any resulting capitalized above-market lease values as a reduction of rental income over the lease term. We amortize any resulting capitalized below-market lease values as an increase to rental income over the lease term. If a lease is terminated early, the unamortized portion of the capitalized above/below market lease value is recognized in rental income at that time. |
Real Estate and Depreciation | Real Estate and Depreciation: Real estate, consisting of land, buildings and improvements, are maintained at cost. Although typically paid by our tenants, any expenditure for ordinary maintenance and repairs that we pay are expensed to operations as incurred. Significant renovations and improvements which improve and/or extend the useful life of the asset are capitalized and depreciated over their estimated useful lives. We record impairment losses on long-lived assets used in operations when events and circumstances indicate that the assets might be impaired and the undiscounted cash flows estimated to be generated by those assets, including an estimated liquidation amount, during the expected holding periods are less than the carrying amounts of those assets. Impairment losses are measured as the difference between carrying value and fair value of the assets. For assets held for sale, we cease recording depreciation expense and adjust the assets’ value to the lower of its carrying value or fair value, less cost of disposal. Fair value is based on estimated cash flows discounted at a risk-adjusted rate of interest. We classify real estate assets as held for sale when we have commenced an active program to sell the assets, and in the opinion of management, it is probable the asset will be sold within the next 12 months. Construction in progress includes the cost of land, the cost of construction of buildings, improvements, and fixed equipment, and costs for design and engineering. Other costs, such as interest, legal, property taxes, and corporate project supervision, which can be directly associated with the project during construction, are also included in construction in progress. We commence capitalization of costs associated with a development project when the development of the future asset is probable and activities necessary to get the underlying property ready for its intended use have been initiated. We stop the capitalization of costs when the property is substantially complete and ready for its intended use. Depreciation is calculated on the straight-line method over the estimated useful lives of the related real estate and other assets. Our weighted-average useful lives at December 31, 2021 are as follows: Buildings and improvements 35.8 years Lease intangibles 24.9 years Leasehold improvements 17.0 years Furniture, equipment, and other 7.6 years |
Losses from Rent Receivables | Credit Losses: Losses from Rent Receivables: Losses from Operating Lease Receivables: Losses on Financing Lease Receivables: receivable is under performing and is deemed uncollectible based on the lessee’s overall financial condition, we will adju st the credit loss reserve based on the fair value of the underlying collateral. With the adoption of ASU 2016-13, we made the accounting policy election to exclude interest receivables from the credit loss reserve analysis. Such receivables are impaired and an allowance recorded when it is deemed probable that we will be unable to collect all amounts due. Like operating lease receivables, the need for an allowance is based upon our assessment of the lessee’s overall financial condition, economic resources and payment record, the prospects for support from any financially responsible guarantors, and, if appropriate, the realizable value of any collateral. Financing leases are placed on non-accrual status when we determine that the collectability of contractual amounts is not reasonably assured. If on non-accrual status, we generally account for the financing lease on a cash basis, in which income is recognized only upon receipt of cash. |
Loans | Loans The following table summarizes our credit loss reserves (in thousands): December 31, 2021 December 31, 2020 Balance at beginning of the year $ 8,726 $ — Cumulative effect of change in accounting principle — 8,399 Provision for credit loss 41,710 3,255 Expected credit losses related to financial instruments sold or repaid (1,909 ) (2,928 ) Balance at end of year $ 48,527 $ 8,726 |
Earnings Per Share/Units | Earnings Per Share/Units: Basic earnings per common share/unit is computed by dividing net income by the weighted-average number of shares/units outstanding during the period. Diluted earnings per common share/unit is calculated by including the effect of dilutive securities. Our unvested restricted stock awards contain non-forfeitable rights to dividends, and accordingly, these awards are deemed to be participating securities. These participating securities are included in the earnings allocation in computing both basic and diluted earnings per common share/unit. |
Income Taxes | Income Taxes: We conduct our business as a REIT under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended (“the Code”). To qualify as a REIT, we must meet certain organizational and operational requirements, including a requirement to distribute to stockholders at least 90% of our REIT’s ordinary taxable income. As a REIT, we generally pay little U.S. federal and state income tax because of the dividends paid deduction that we are allowed to take. If we fail to qualify as a REIT in any taxable year, we will then be subject to U.S. federal income taxes on our taxable income at regular corporate rates and will not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year during which qualification is lost, unless the Internal Revenue Service grants us relief under certain statutory provisions. Such an event could materially adversely affect our net income and net cash available for distribution to stockholders. However, we intend to operate in such a manner so that we will remain qualified as a REIT for U.S. federal income tax purposes. Our financial statements include the operations of TRS entities, including MPT Development Services, Inc. (“MDS”) and many other entities, which are single member LLCs that are disregarded for tax purposes and are reflected in the tax returns of MDS. None of our TRS entities are entitled to a dividends paid deduction and are subject to U.S. federal, state, and local income taxes. Our TRS entities are authorized to provide property development, leasing, and management services for third-party owned properties, and we will make non-mortgage loans to and/or investments in our lessees through these entities. With the property acquisitions and investments in Europe, Australia, and South America, we are subject to income taxes internationally. However, we do not expect to incur any additional income taxes, of a significant nature, in the U.S. as the majority such income from our international properties flows through our REIT income tax returns. For our TRS entities and international subsidiaries, we determine deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in our deferred tax assets /liabilities that results from a change in circumstances and that causes us to change our judgment about expected future tax consequences of events, is reflected in our tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss carryforwards. A valuation allowance is provided if we believe it is more likely than not that all or some portion of our deferred tax assets will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes us to change our judgment about our ability to realize the related deferred tax asset, is reflected in our tax provision when such changes occur. The calculation of our income taxes involves dealing with uncertainties in the application of complex tax laws and regulations in a multitude of jurisdictions across our global operations. An income tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, on the basis of technical merits. However, if a more likely than not position cannot be reached, we record a liability as an offset to the tax benefit and adjust the liabilities when our judgment changes as a result of the evaluation of new information not previously available. Because of the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from our current estimate of the uncertain tax position liabilities. These differences will be reflected as increases or decreases to income tax expense in the period in which new information is available. |
Stock-Based Compensation | Stock-Based Compensation: We adopted the 2019 Equity Incentive Plan (the “Equity Incentive Plan”) during the second quarter of 2019. Awards of restricted stock and other equity-based awards with service conditions are valued at the average stock price per share on the date of grant and are amortized to compensation expense over the service periods (typically three years), using the straight-line method. Awards that contain market conditions are valued on the grant date using a Monte Carlo valuation model and are amortized to compensation expense over the derived service periods, which correspond to the periods over which we estimate the awards will be earned, which generally range from three to five years, using the straight-line method. Awards with performance conditions are valued at the average stock price per share on the date of grant and are amortized using the straight-line method over the service period, adjusted for the probability of achieving the performance conditions. Forfeitures of stock-based awards are recognized as they occur. |
Deferred Costs | Deferred Costs: Costs incurred that directly relate to the offerings of stock are deferred and netted against proceeds received from the offering. Leasing commissions and other leasing costs that would not have been incurred if the lease was not obtained are capitalized as deferred leasing costs and amortized on the straight-line method over the terms of the related lease agreements. Costs identifiable with loans made to borrowers are capitalized and recognized as a reduction in interest income over the life of the loan. |
Deferred Financing Costs | Deferred Financing Costs: We generally capitalize financing costs incurred in connection with new financings and refinancings of debt. These costs are amortized over the lives of the related debt as an addition to interest expense. For debt with defined principal re-payment terms, the deferred costs are amortized to produce a constant effective yield on the debt (interest method) and are included within “Debt, net” on our consolidated balance sheets. For debt without defined principal repayment terms, such as our revolving credit facility, the deferred costs are amortized on the straight-line method over the term of the debt and are included as a component of “Other assets” on our consolidated balance sheets. |
Foreign Currency Translation and Transactions | Foreign Currency Translation and Transactions: Certain of our international subsidiaries’ functional currencies are the local currencies of their respective countries. We translate the results of operations of our foreign subsidiaries into U.S. dollars using average rates of exchange in effect during the period, and we translate balance sheet accounts using exchange rates in effect at the end of the period. We record resulting currency translation adjustments in accumulated other comprehensive income (loss), a component of stockholders’ equity/partnership capital on our consolidated balance sheets. Certain of our U.S. subsidiaries will enter into short-term and long-term transactions denominated in a foreign currency from time-to-time. Gains or losses resulting from these foreign currency transactions are revalued into U.S. dollars at the rates of exchange prevailing at the dates of the transactions. The effects of revaluation gains or losses on our short-term transactions are included in other income in the consolidated statements of income, while the revaluation effects on our long-term investments are recorded in accumulated other comprehensive income (loss) on our consolidated balance sheets. |
Derivative Financial Investments and Hedging Activities | Derivative Financial Investments and Hedging Activities: During our normal course of business, we may use certain types of derivative instruments for the purpose of managing interest rate and/or foreign currency risk. We record our derivative and hedging instruments at fair value on the balance sheet. Changes in the estimated fair value of derivative instruments that are not designated as hedges or that do not meet the criteria for hedge accounting are recognized in earnings. For derivatives designated as cash flow hedges, the change in the estimated fair value of the effective portion of the derivative is recognized in accumulated other comprehensive income (loss) on our consolidated balance sheets, whereas the change in the estimated fair value of the ineffective portion is recognized in earnings. For derivatives designated as fair value hedges, the change in the estimated fair value of the effective portion of the derivatives offsets the change in the estimated fair value of the hedged item, whereas the change in the estimated fair value of the ineffective portion is recognized in earnings. To qualify for hedge accounting, we formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking the hedge prior to entering into a derivative transaction. This process includes specific identification of the hedging instrument and the hedge transaction, the nature of the risk being hedged and how the hedging instrument’s effectiveness in hedging the exposure to the hedged transaction’s variability in cash flows attributable to the hedged risk will be assessed. Both at the inception of the hedge and on an ongoing basis, we assess whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flows or fair values of hedged items. In addition, for cash flow hedges, we assess whether the underlying forecasted transaction will occur. We discontinue hedge accounting if a derivative is not determined to be highly effective as a hedge or that it is probable that the underlying forecasted transaction will not occur. |
Fair Value Measurement | Fair Value Measurement: We measure and disclose the estimated fair value of financial assets and liabilities utilizing a hierarchy of valuation techniques based on whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy: • Level 1 — quoted prices for identical instruments in active markets; • Level 2 — quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and • Level 3 — fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable . We measure fair value using a set of standardized procedures that are outlined herein for all assets and liabilities which are required to be measured at their estimated fair value on either a recurring or non-recurring basis. When available, we utilize quoted market prices from an independent third party source to determine fair value and classify such items in Level 1. In some instances where a market price is available, but the instrument is in an inactive or over-the-counter market, we apply the dealer (market maker) pricing estimate and classify the asset or liability in Level 2. If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads, market capitalization rates, etc. Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement. As a result, the asset or liability could be classified in either Level 2 or 3 even though there may be some significant inputs that are readily observable. Internal fair value models and techniques that have been used by us include discounted cash flow and Monte Carlo valuation models. We also consider counterparty’s and our own credit risk on derivatives and other liabilities measured at their estimated fair value. Fair Value Option Election: For our equity investment in the international joint venture and equity interest in Springstone, LLC (“Springstone”), along with any related investments such as loans (see Note 3 for more details), we have elected to account for these investments at fair value due to the size of the investments and because we believe this method is more reflective of current values. We have not made a similar election for other investments that existed at December 31, 2021. |
Leases (Lessee) | Leases (Lessee) Pursuant to ASU 2016-02, we are required to apply a dual approach, classifying leases as either financing or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification determines whether lease expense is recognized based on an effective interest method (for finance leases) or on a straight-line basis (for operating leases) over the term of the lease. We record a right-of-use asset and a lease liability for all material leases with a term greater than 12 months regardless of their classification. Leases with a term of 12 months or less are off balance sheet with lease expense recognized on a straight-line basis over the lease term. |
Reclassification | Reclassifications: Certain amounts in the consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. |
Recent Accounting Developments | Recent Accounting Developments Reference Rate Reform In March 2020, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”) to simplify the accounting for contract modifications made to replace the London Interbank Offered Rate (“LIBOR”) or other reference rates that are expected to be discontinued because of reference rate reform. The guidance provides optional expedients and exceptions for applying generally accepted accounting principles (“GAAP”) to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criterion are met. The optional expedients and exceptions can be applied to contract modifications made until December 31, 2022. On January 7, 2021, the FASB issued ASU No. 2021-01, “Reference Rate Reform (Topic 848)” (“ASU 2021-01”), which clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the transition. We have evaluated our contracts that are referenced to LIBOR or other reference rates expected to be discontinued. Our British pound sterling term loan and corresponding interest rate swap were modified with the Sterling Overnight Index Average (SONIA) Rate as a replacement reference rate during the fourth quarter of 2021, and we accounted for such modifications using the expedients and exceptions provided for in ASU 2020-04 and ASU 2021-01. We are continuing to evaluate the need to modify our U.S. dollar LIBOR contracts, such as our unsecured credit facility, but the requirement to replace the U.S. dollar LIBOR has been extended to June 30, 2023. Moreover, we do not expect any impact to our Australian dollar term loan and corresponding interest rate swap, as these contracts are not referenced to rates that are expected to be discontinued. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Estimated Useful Lives of Related Real Estate and Other Assets | Depreciation is calculated on the straight-line method over the estimated useful lives of the related real estate and other assets. Our weighted-average useful lives at December 31, 2021 are as follows: Buildings and improvements 35.8 years Lease intangibles 24.9 years Leasehold improvements 17.0 years Furniture, equipment, and other 7.6 years |
Summary of Credit Loss Reserves | The following table summarizes our credit loss reserves (in thousands): December 31, 2021 December 31, 2020 Balance at beginning of the year $ 8,726 $ — Cumulative effect of change in accounting principle — 8,399 Provision for credit loss 41,710 3,255 Expected credit losses related to financial instruments sold or repaid (1,909 ) (2,928 ) Balance at end of year $ 48,527 $ 8,726 |
Real Estate and Other Activit_2
Real Estate and Other Activities (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Real Estate [Abstract] | |
Net Assets Acquired | For the years ended December 31, 2021, 2020, and 2019, we acquired or invested in the following net assets (in thousands): 2021 2020 2019 Land and land improvements $ 642,312 $ 365,281 $ 400,539 Buildings 2,381,654 2,547,313 1,951,066 Intangible lease assets — subject to amortization (weighted-average useful life of 34.5 years in 2021, 27.5 years in 2020, and 19.1 years in 2019) 262,385 642,699 227,468 Investment in financing leases — 114,797 1,386,797 Equity investments 123,427 233,593 415,836 Mortgage loans 1,113,300 176,840 51,267 Other loans and assets 909,669 309,523 135,258 Liabilities assumed (82,508 ) (140,866 ) (2,637 ) $ 5,350,239 $ 4,249,180 $ 4,565,594 Loans repaid(1) (1,103,410 ) (834,743 ) — Total net assets acquired $ 4,246,829 $ 3,414,437 $ 4,565,594 (1) The 2021 column includes an £800 million mortgage loan advanced to the Priory Group (“Priory”) in the first quarter of 2021 and converted to fee simple ownership in a portfolio of 35 properties in the second quarter of 2021 as described below. The 2020 column includes approximately $740 million of loans advanced to Steward in 2017 and exchanged for the fee simple real estate of two hospitals as described below, as well as approximately $100 million of loans advanced to Ernest Health, Inc. (“Ernest”) in 2012 and exchanged for the fee simple real estate of four hospitals as described below. |
Summary of Status on Current Development Projects | See table below for a status summary of our current development projects (in thousands): Property Commitment Costs Incurred as of December 31, 2021 Estimated Rent Commencement Date Ernest (Bakersfield, California) $ 47,929 $ 42,132 1Q 2022 Ernest (Stockton, California) 47,700 31,197 2Q 2022 Steward (Texarkana, Texas) 169,408 28,110 2Q 2024 $ 265,037 $ 101,439 |
Summary of Joint Venture Designated as Held for Sale | As of December 31, 2021 Real estate held for sale $ 1,096,505 Straight-line rent receivables 120,268 Other assets, net 4,234 Total $ 1,221,007 |
Amortization Expense from Existing Lease Intangible Assets | We recorded amortization expense related to intangible lease assets of $56.0 million, $42.4 million, and $21.5 million in 2021, 2020, and 2019, respectively, and expect to recognize amortization expense from existing lease intangible assets as follows (amounts in thousands): For the Year Ended December 31: 2022 $ 57,433 2023 57,368 2024 57,334 2025 57,186 2026 56,917 |
Summary of Total Future Minimum Lease Payments to be Received | The following table summarizes total future minimum lease payments to be received, excluding operating expense reimbursements, from tenants under noncancelable leases as of December 31, 2021 (amounts in thousands): Total Under Operating Leases Total Under Financing Leases Total 2022 $ 1,078,148 $ 168,190 $ 1,246,338 2023 1,099,027 171,553 1,270,580 2024 1,117,353 174,984 1,292,337 2025 1,135,695 178,484 1,314,179 2026 1,154,286 182,054 1,336,340 Thereafter 29,555,221 4,513,925 34,069,146 $ 35,139,730 $ 5,389,190 $ 40,528,920 |
Components of Total Investment in Financing Leases | The components of our total investment in financing leases consisted of the following (in thousands): As of December 31, 2021 As of December 31, 2020 Minimum lease payments receivable $ 1,183,855 $ 1,228,966 Estimated residual values 203,818 203,818 Less: Unearned income and allowance for credit loss (918,584 ) (969,061 ) Net investment in direct financing leases 469,089 463,723 Other financing leases (net of allowance for credit loss) 1,584,238 1,547,199 Total investment in financing leases $ 2,053,327 $ 2,010,922 |
Summary of Loans (Net of Allowance for Credit Loss) | The following is a summary of our loans (net of allowance for credit loss) ($ amounts in thousands): As of December 31, 2021 As of December 31, 2020 Balance Weighted-Average Interest Rate Balance Weighted-Average Interest Rate Mortgage loans $ 213,211 8.7 % $ 248,080 8.5 % Acquisition loans 523,829 7.7 % 338,273 7.6 % Other loans 804,824 6.2 % 520,095 5.8 % $ 1,541,864 $ 1,106,448 |
Debt (Tables)
Debt (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Debt Disclosure [Abstract] | |
Summary of Debt | The following is a summary of debt (dollar amounts in thousands): As of December 31, 2021 As of December 31, 2020 Revolving credit facility(A) $ 730,000 $ 165,407 Interim credit facilities 869,606 — Term loan 200,000 200,000 British pound sterling term loan(B) 947,240 956,900 Australian term loan facility(B) 871,560 923,280 4.000% Senior Unsecured Notes due 2022(B) — 610,800 2.550% Senior Unsecured Notes due 2023(B) 541,280 546,800 3.325% Senior Unsecured Notes due 2025(B) 568,500 610,800 0.993% Senior Unsecured Notes due 2026(B) 568,500 — 2.500% Senior Unsecured Notes due 2026(B) 676,600 — 5.250% Senior Unsecured Notes due 2026 500,000 500,000 5.000% Senior Unsecured Notes due 2027 1,400,000 1,400,000 3.692% Senior Unsecured Notes due 2028(B) 811,920 820,200 4.625% Senior Unsecured Notes due 2029 900,000 900,000 3.375% Senior Unsecured Notes due 2030(B) 473,620 — 3.500% Senior Unsecured Notes due 2031 1,300,000 1,300,000 $ 11,358,826 $ 8,934,187 Debt issue costs and discount, net (76,056 ) (68,729 ) $ 11,282,770 $ 8,865,458 (A) The 2020 column includes £121 million of GBP-denominated borrowings that reflect the exchange rate at December 31, 2020. (B) Non-U.S. dollar denominated debt that reflects the exchange rate at period-end. |
Principal Payments Due on Debt | As of December 31, 2021, principal payments due on our debt (which exclude the effects of any discounts, premiums, or debt issue costs recorded) are as follows (amounts in thousands): 2022 $ 869,606 2023 541,280 2024 1,601,560 2025 1,515,740 2026 1,945,100 Thereafter 4,885,540 Total $ 11,358,826 |
Basic Terms of Senior Unsecured Notes | The following are the basic terms of our senior unsecured notes at December 31, 2021 (par value amounts in thousands): Offering Completion Date Maturity Date Par Value % of Par Value Interest Payment Frequency 2.550% Senior Unsecured Notes due 2023 December 5, 2019 December 5, 2023 £ 400,000 100.000 % Annually 3.325% Senior Unsecured Notes due 2025 March 24, 2017 March 24, 2025 € 500,000 100.000 % Annually 0.993% Senior Unsecured Notes due 2026 October 6, 2021 October 15, 2026 € 500,000 100.000 % Annually 2.500% Senior Unsecured Notes due 2026 March 24, 2021 March 24, 2026 £ 500,000 99.937 % Annually 5.250% Senior Unsecured Notes due 2026 July 22, 2016 August 1, 2026 $ 500,000 100.000 % Semi-annually 5.000% Senior Unsecured Notes due 2027 September 7, 2017 October 15, 2027 $ 1,400,000 100.000 % Semi-annually 3.692% Senior Unsecured Notes due 2028 December 5, 2019 June 5, 2028 £ 600,000 99.998 % Annually 4.625% Senior Unsecured Notes due 2029 July 26, 2019 August 1, 2029 $ 900,000 99.500 % Semi-annually 3.375% Senior Unsecured Notes due 2030 March 24, 2021 April 24, 2030 £ 350,000 99.448 % Annually 3.500% Senior Unsecured Notes due 2031 December 4, 2020 March 15, 2031 $ 1,300,000 100.000 % Semi-annually |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Schedule of Income Tax Benefit (Expense) | From our TRS entities and our foreign operations, income tax (expense) benefit were as follows (in thousands): For the Years Ended December 31, 2021 2020 2019 Current income tax (expense) benefit: Domestic $ (1,559 ) $ 63 $ 61 Foreign (18,964 ) (10,203 ) (1,669 ) (20,523 ) (10,140 ) (1,608 ) Deferred income tax (expense) benefit: Domestic 6,915 (10,680 ) 5,490 Foreign (60,340 ) (10,236 ) (1,261 ) (53,425 ) (20,916 ) 4,229 Income tax (expense) benefit $ (73,948 ) $ (31,056 ) $ 2,621 |
Summary of Reconciliation of Income Tax Benefit (Expense) from the Statutory Income Tax Rate to the Effective Tax Rate Based on Income before Income Taxes | A reconciliation of income tax (expense) benefit from the statutory income tax rate to the effective tax rate based on income before income taxes for the years ended December 31, 2021, 2020, and 2019 is as follows (in thousands): For the Years Ended December 31, 2021 2020 2019 Income before income tax $ 730,888 $ 463,328 $ 373,780 Income tax at the U.S. statutory federal rate (21% in 2021, 2020, and 2019) (153,486 ) (97,299 ) (78,494 ) Decrease (increase) in income tax resulting from: Foreign rate differential 2,742 2,160 438 State income taxes, net of federal benefit — 970 1,621 U.S. earnings not subject to federal income tax 132,266 82,921 85,495 Equity investments — 380 1,091 Change in valuation allowance (10,040 ) (8,514 ) (7,911 ) Statutory tax rate change (43,924 ) (9,471 ) — Interest disallowance (646 ) — — Other items, net (860 ) (2,203 ) 381 Total income tax (expense) benefit $ (73,948 ) $ (31,056 ) $ 2,621 |
Schedule of Deferred Tax Assets and Liabilities | At December 31, 2021 and 2020, components of our deferred tax assets and liabilities were as follows (in thousands): 2021 2020 Deferred tax assets: Operating loss and interest deduction carry forwards $ 197,876 $ 150,001 Interest rate swap — 9,150 Other 1,815 6,973 Total deferred tax assets 199,691 166,124 Valuation allowance (61,747 ) (36,977 ) Total net deferred tax assets $ 137,944 $ 129,147 Deferred tax liabilities: Property and equipment $ (320,546 ) $ (211,018 ) Net unbilled revenue (43,366 ) (14,776 ) Partnership investments (15,963 ) — Other (3,836 ) (4,010 ) Total deferred tax liabilities (383,711 ) (229,804 ) Net deferred tax asset (liability) $ (245,767 ) $ (100,657 ) |
Schedule of Net NOL and Other Tax Attribute Carryforwards | At December 31, 2021, we had net NOL and other tax attribute carryforwards as follows (in thousands): U.S. Foreign Gross NOL carryforwards $ 239,520 $ 699,514 Tax-effected NOL carryforwards $ 28,837 $ 169,039 Valuation allowance (6,291 ) (45,578 ) Net deferred tax asset - NOL carryforwards $ 22,546 $ 123,461 Expiration periods 2030-indefinite indefinite |
Schedule of Per Share Distributions to Stockholders | A schedule of per share distributions we paid and reported to our stockholders is set forth in the following: For the Years Ended December 31, 2021 2020 2019 Common share distribution $ 1.110000 $ 1.070000 $ 1.010000 Ordinary income 0.764580 0.603050 0.701910 Capital gains(1) 0.165420 — 0.275040 Unrecaptured Sec. 1250 gain 0.058270 — 0.041160 Section 199A Dividends 0.764580 0.603050 0.701910 Return of capital 0.180000 0.466950 0.033050 (1) Capital gains include unrecaptured Sec. 1250 gains. |
Earnings Per Share_Unit (Tables
Earnings Per Share/Unit (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Earnings Per Share [Abstract] | |
Calculation of Earnings Per Share | Medical Properties Trust, Inc. Our earnings per share were calculated based on the following (amounts in thousands): For the Years Ended December 31, 2021 2020 2019 Numerator: Net income $ 656,940 $ 432,272 $ 376,401 Non-controlling interests’ share in earnings (919 ) (822 ) (1,717 ) Participating securities’ share in earnings (2,161 ) (2,105 ) (2,308 ) Net income, less participating securities’ share in earnings $ 653,860 $ 429,345 $ 372,376 Denominator: Basic weighted-average common shares 588,817 529,239 427,075 Dilutive potential common shares 1,322 1,222 1,224 Diluted weighted-average common shares 590,139 530,461 428,299 MPT Operating Partnership, L.P. Our earnings per unit were calculated based on the following (amounts in thousands): For the Years Ended December 31, 2021 2020 2019 Numerator: Net income $ 656,940 $ 432,272 $ 376,401 Non-controlling interests’ share in earnings (919 ) (822 ) (1,717 ) Participating securities’ share in earnings (2,161 ) (2,105 ) (2,308 ) Net income, less participating securities’ share in earnings $ 653,860 $ 429,345 $ 372,376 Denominator: Basic weighted-average units 588,817 529,239 427,075 Dilutive potential units 1,322 1,222 1,224 Diluted weighted-average units 590,139 530,461 428,299 |
Stock Awards (Tables)
Stock Awards (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |
Stock-based Award Activity | The following summarizes stock-based award activity in 2021 and 2020 (which includes awards granted in 2021, 2020, 2019, and any applicable prior years), respectively: For the Year Ended December 31, 2021: Vesting Based on Service Vesting Based on Market/Performance Conditions Shares Weighted-Average Value at Award Date Shares Weighted-Average Value at Award Date Nonvested awards at beginning of the year 1,057,054 $ 18.79 5,086,983 $ 14.41 Awarded 651,113 $ 20.83 1,957,802 $ 17.94 Vested (781,076 ) $ 18.77 (1,551,482 ) $ 13.73 Forfeited (4,137 ) $ 18.69 (15,767 ) $ 16.72 Nonvested awards at end of year 922,954 $ 20.26 5,477,536 $ 15.86 For the Year Ended December 31, 2020: Vesting Based on Service Vesting Based on Market/Performance Conditions Shares Weighted-Average Value at Award Date Shares Weighted-Average Value at Award Date Nonvested awards at beginning of the year 1,122,440 $ 17.11 5,481,155 $ 11.66 Awarded 635,855 $ 19.65 1,800,898 $ 19.42 Vested (699,215 ) $ 16.80 (2,193,906 ) $ 11.35 Forfeited (2,026 ) $ 18.40 (1,164 ) $ 18.22 Nonvested awards at end of year 1,057,054 $ 18.79 5,086,983 $ 14.41 |
Fair Value of Financial Instr_2
Fair Value of Financial Instruments (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Summary of Fair Value Information of Financial Instruments | The following table summarizes fair value estimates for our financial instruments (in thousands): December 31, 2021 December 31, 2020 Asset (Liability) Book Value Fair Value Book Value Fair Value Interest and rent receivables $ 56,229 $ 56,564 $ 46,208 $ 45,381 Loans(1) 991,609 991,954 751,341 756,608 Debt, net (11,282,770 ) (11,526,388 ) (8,865,458 ) (9,226,564 ) (1) Excludes the acquisition loan and mortgage loan made in October 2021 to Springstone and the acquisition loan made in May 2020 to our international joint venture, along with the related subsequent investment in the real estate of three hospitals in Colombia (see Note 3 for further details), as these assets are accounted for under the fair value option method . |
Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis | At December 31, 2021 and 2020, the amounts recorded under the fair value option method were as follows (in thousands): As of December 31, 2021 As of December 31, 2020 Asset (Liability) Fair Value Original Cost Fair Value Original Cost Asset Type Classification Mortgage loans $ 143,068 $ 143,068 $ 136,332 $ 136,332 Mortgage loans Equity investment and other loans 409,638 409,638 218,775 218,775 Equity investments/Other loans |
Schedule of Effects of Movement in DLOM by Sensitivity Analysis by Using Basis Point Variations | The DLOM on our Springstone and international joint venture equity investments was 40% at December 31, 2021. In arriving at the DLOM, we started with a DLOM range based on the results of studies supporting valuation discounts for other transactions or structures without a public market. To select the appropriate DLOM within the range, we then considered many qualitative factors, including the percent of control, the nature of the underlying investee’s business along with our rights as an investor pursuant to the operating agreement, the size of investment, expected holding period, number of shareholders, access to capital marketplace, etc. To illustrate the effect of movements in the DLOM, we performed a sensitivity analysis below by using basis point variations (dollars in thousands): Basis Point Change in Marketability Discount Estimated Increase (Decrease) in Fair Value + 100 basis points $ (41 ) - 100 basis points 41 |
Leases (Lessee) (Tables)
Leases (Lessee) (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Leases [Abstract] | |
Summary of Lease Expense | The following is a summary of our lease expense (in thousands): Income Statement For the Years Ended December 31, Classification 2021 2020 Operating lease cost (1) (2) $ 10,694 $ 9,910 Finance lease cost: Amortization of right-of-use assets Real estate depreciation and amortization 51 51 Interest on lease liabilities Interest 128 128 Sublease income Other (4,466 ) (2,614 ) Total lease cost $ 6,407 $ 7,475 (1) Includes short-term leases. (2) $6.3 million and $6.0 million included in “Property-related”, with the remainder reflected in the “General and administrative” line of our consolidated statements of net income for 2021 and 2020, respectively. |
Schedule Of Future Minimum Rental Payments For Leases Sublease Receivable And Net Payments | Fixed minimum payments due over the remaining lease term under non-cancelable leases of more than one year and amounts to be received in the future from non-cancelable subleases over their remaining lease term at December 31, 2021 are as follows (amounts in thousands): Operating Leases Finance Leases Amounts To Be Received From Subleases Net Payments 2022 $ 7,376 $ 128 $ (4,143 ) $ 3,361 2023 7,448 129 (3,963 ) 3,614 2024 6,559 130 (3,987 ) 2,702 2025 5,666 131 (4,044 ) 1,753 2026 5,255 133 (4,015 ) 1,373 Thereafter 239,727 4,650 (71,286 ) 173,091 (1) Total undiscounted minimum lease payments $ 272,031 $ 5,301 $ (91,438 ) $ 185,894 Less: interest (186,814 ) (3,364 ) Present value of lease liabilities $ 85,217 $ 1,937 (1) Reflects certain ground leases, in which we are the lessee, that have longer initial fixed terms than our existing sublease to our tenants. However, we would expect to either renew the related sublease, enter into a lease with a new tenant, or early terminate the ground lease to reduce or avoid any significant impact from such ground leases. |
Summary of Supplemental Balance Sheet Information | Supplemental balance sheet information is as follows (in thousands, except lease terms and discount rate): Balance Sheet Classification December 31, 2021 December 31, 2020 Right of use assets: Operating leases - real estate Land $ 68,616 $ 73,373 Finance leases - real estate Land 1,785 1,836 Total real estate right of use assets $ 70,401 $ 75,209 Operating leases - corporate Other assets 7,458 8,234 Total right of use assets $ 77,859 $ 83,443 Lease liabilities: Operating leases Obligations to tenants and other lease liabilities $ 85,217 $ 90,006 Financing leases Obligations to tenants and other lease liabilities 1,937 1,935 Total lease liabilities $ 87,154 $ 91,941 Weighted-average remaining lease term: Operating leases 40.6 41.1 Finance leases 34.9 35.9 Weighted-average discount rate: Operating leases 6.4 % 6.4 % Finance leases 6.6 % 6.6 % |
Summary of Supplemental Cash Flow Information | The following is supplemental cash flow information (in thousands): For the Years Ended December 31, 2021 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 7,330 $ 6,080 Operating cash flows from finance leases 126 125 Non-cash activities - Right-of-use assets obtained in exchange for lease obligations: Operating leases 1,120 13,832 |
Other Assets (Tables)
Other Assets (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract] | |
Summary of Other Assets | The following is a summary of our other assets on our consolidated balance sheets (in thousands): As of December 31, 2021 2020 Debt issue costs, net(1) $ 5,488 $ 192 Other corporate assets 193,749 167,929 Prepaids and other assets 134,243 87,948 Total other assets $ 333,480 $ 256,069 (1) Relates to our revolving credit facility |
Organization - Additional Infor
Organization - Additional Information (Detail) | Dec. 31, 2021FacilityStateCountry |
Business Acquisition [Line Items] | |
Number of facilities | Facility | 438 |
Number of states | State | 32 |
Europe [Member] | |
Business Acquisition [Line Items] | |
Number of countries | 6 |
South America [Member] | |
Business Acquisition [Line Items] | |
Number of countries | 1 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Significant Accounting Policies [Line Items] | |||
Threshold ownership percentage for inter company balances and transactions elimination | 100.00% | ||
Loans and/or equity investments in variable interest entities | $ 570 | ||
Expected lease-up periods for estimating lost rentals, in months | 6 months | ||
Change in Accounting Principle, Accounting Standards Update, Adopted [true false] | true | ||
Change in Accounting Principle, Accounting Standards Update, Adoption Date | Jan. 1, 2020 | ||
Accounting Standards Update [Extensible List] | Accounting Standards Update 2016-13 | ||
Percentage of ordinary taxable income to be distributed for real estate investment trust qualification | 90.00% | 90.00% | 90.00% |
Number of years of federal income tax at corporate rates on failure to qualify as REIT | 4 years | ||
Time-Based Awards [Member] | |||
Significant Accounting Policies [Line Items] | |||
Stock award service period in years | 3 years | ||
Market Conditions Based Awards [Member] | Minimum [Member] | |||
Significant Accounting Policies [Line Items] | |||
Stock award service period in years | 3 years | ||
Market Conditions Based Awards [Member] | Maximum [Member] | |||
Significant Accounting Policies [Line Items] | |||
Stock award service period in years | 5 years |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Estimated Useful Lives of Related Real Estate and Other Assets (Detail) | 12 Months Ended |
Dec. 31, 2021 | |
Buildings and improvements [Member] | |
Property, Plant and Equipment [Line Items] | |
Weighted average useful lives of related real estate and other assets | 35 years 9 months 18 days |
Lease Intangibles [Member] | |
Property, Plant and Equipment [Line Items] | |
Weighted average useful lives of related real estate and other assets | 24 years 10 months 24 days |
Leasehold improvements [Member] | |
Property, Plant and Equipment [Line Items] | |
Weighted average useful lives of related real estate and other assets | 17 years |
Furniture, equipment and other [Member] | |
Property, Plant and Equipment [Line Items] | |
Weighted average useful lives of related real estate and other assets | 7 years 7 months 6 days |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies - Summary of Credit Loss Reserves (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Accounting Policies [Abstract] | ||
Balance at beginning of the year | $ 8,726 | |
Cumulative effect of change in accounting principle | $ 8,399 | |
Provision for credit loss | 41,710 | 3,255 |
Expected credit losses related to financial instruments sold or repaid | (1,909) | (2,928) |
Balance at end of year | $ 48,527 | $ 8,726 |
Real Estate and Other Activit_3
Real Estate and Other Activities - Net Assets Acquired (Detail) - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Business Acquisition [Line Items] | ||||
Total assets acquired | $ 5,350,239 | $ 4,249,180 | $ 4,565,594 | |
Liabilities assumed | (82,508) | (140,866) | (2,637) | |
Loans repaid | [1] | (1,103,410) | (834,743) | |
Total net assets acquired | 4,246,829 | 3,414,437 | 4,565,594 | |
Land and Land Improvements [Member] | ||||
Business Acquisition [Line Items] | ||||
Total assets acquired | 642,312 | 365,281 | 400,539 | |
Building [Member] | ||||
Business Acquisition [Line Items] | ||||
Total assets acquired | 2,381,654 | 2,547,313 | 1,951,066 | |
Intangible Lease Assets {Member] | ||||
Business Acquisition [Line Items] | ||||
Total assets acquired | 262,385 | 642,699 | 227,468 | |
Mortgage Loans [Member] | ||||
Business Acquisition [Line Items] | ||||
Total assets acquired | 1,113,300 | 176,840 | 51,267 | |
Investments in Financing Leases [Member] | ||||
Business Acquisition [Line Items] | ||||
Total assets acquired | 114,797 | 1,386,797 | ||
Equity Investments [Member] | ||||
Business Acquisition [Line Items] | ||||
Total assets acquired | 123,427 | 233,593 | 415,836 | |
Other Loans and Assets [Member] | ||||
Business Acquisition [Line Items] | ||||
Total assets acquired | $ 909,669 | $ 309,523 | $ 135,258 | |
[1] | The 2021 column includes an £800 million mortgage loan advanced to the Priory Group (“Priory”) in the first quarter of 2021 and converted to fee simple ownership in a portfolio of 35 properties in the second quarter of 2021 as described below. The 2020 column includes approximately $740 million of loans advanced to Steward in 2017 and exchanged for the fee simple real estate of two hospitals as described below, as well as approximately $100 million of loans advanced to Ernest Health, Inc. (“Ernest”) in 2012 and exchanged for the fee simple real estate of four hospitals as described below. |
Real Estate and Other Activit_4
Real Estate and Other Activities - Net Assets Acquired (Parenthetical) (Detail) $ in Thousands, £ in Millions | 12 Months Ended | |||||
Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($)Hospital | Dec. 31, 2019USD ($)Hospital | Jun. 30, 2021Property | Mar. 31, 2021GBP (£) | ||
Business Acquisition [Line Items] | ||||||
Weighted-average useful life of acquired intangible lease assets (in years) | 22 years 10 months 24 days | |||||
Advanced to the mortgage loan | [1] | $ 1,103,410 | $ 834,743 | |||
Ernest [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Number of facilities acquired | Hospital | 4 | |||||
Priory Group [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Number of real estate assets acquired | Property | 35 | |||||
Steward Health Care System LLC [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Number of facilities acquired | Hospital | 2 | |||||
Mortgage Loans [Member] | Ernest [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Advanced to the mortgage loan | $ 100,000 | |||||
Mortgage Loans [Member] | Priory Group [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Advanced to the mortgage loan | £ | £ 800 | |||||
Mortgage Loans [Member] | Steward Health Care System LLC [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Advanced to the mortgage loan | $ 740,000 | |||||
Intangible Lease Assets {Member] | ||||||
Business Acquisition [Line Items] | ||||||
Weighted-average useful life of acquired intangible lease assets (in years) | 34 years 6 months | 27 years 6 months | 19 years 1 month 6 days | |||
[1] | The 2021 column includes an £800 million mortgage loan advanced to the Priory Group (“Priory”) in the first quarter of 2021 and converted to fee simple ownership in a portfolio of 35 properties in the second quarter of 2021 as described below. The 2020 column includes approximately $740 million of loans advanced to Steward in 2017 and exchanged for the fee simple real estate of two hospitals as described below, as well as approximately $100 million of loans advanced to Ernest Health, Inc. (“Ernest”) in 2012 and exchanged for the fee simple real estate of four hospitals as described below. |
Real Estate and Other Activit_5
Real Estate and Other Activities - 2021 Activity - Additional Information (Detail) € in Millions, £ in Millions, SFr in Millions, $ in Millions | Dec. 02, 2021EUR (€) | Oct. 21, 2021EUR (€) | Oct. 19, 2021USD ($) | Oct. 13, 2021EUR (€) | Aug. 01, 2021USD ($)Hospital | Jul. 06, 2021USD ($)Hospital | Jul. 06, 2021GBP (£)Hospital | Jun. 25, 2021GBP (£)Property | Jan. 19, 2021GBP (£) | Nov. 25, 2020GBP (£) | Dec. 17, 2019USD ($)Hospital | Nov. 28, 2019EUR (€) | Dec. 31, 2021Hospital | Dec. 31, 2020Hospital | Jun. 30, 2021Property | Apr. 16, 2021CHF (SFr) | Jan. 08, 2021USD ($) | Aug. 31, 2018USD ($) |
Swiss Medical Network [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Equity investment | SFr | SFr 145 | |||||||||||||||||
Acute Care Hospital [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | $ 700 | |||||||||||||||||
Number of facilities acquired | Hospital | 10 | 2 | ||||||||||||||||
United Kingdom [Member] | Acute Care Hospital [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | £ | £ 50 | |||||||||||||||||
Valencia, Spain [Member] | General Acute Hospital [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | € | € 46 | |||||||||||||||||
Ownership interest | 50.00% | |||||||||||||||||
Portugal [Member] | Acute Care Hospital [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | € | € 17.8 | € 28.2 | ||||||||||||||||
Florida [Member] | General Acute Care Hospitals [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | $ 900 | |||||||||||||||||
Number of facilities acquired | Hospital | 5 | |||||||||||||||||
Los Angeles, California [Member] | Acute Care Hospital [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 4 | 4 | ||||||||||||||||
Los Angeles, California [Member] | On Campus Medical Office Buildings [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 2 | 2 | ||||||||||||||||
Los Angeles, California [Member] | Acute Care Hospital and On Campus Medical Office Buildings [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | $ 215 | |||||||||||||||||
Stirling, Scotland [Member] | Acute Care Hospital [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | £ | £ 15.6 | |||||||||||||||||
Priory Group [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | € | € 27 | |||||||||||||||||
Number of real estate assets acquired | Property | 35 | |||||||||||||||||
Deferred income tax liabilities and other liabilities, incurred | £ | £ 47.1 | |||||||||||||||||
Ownership interest | 9.90% | |||||||||||||||||
Waterland Private Equity Fund VII C.V. [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | £ | £ 250 | |||||||||||||||||
Number of real estate assets acquired | Property | 35 | |||||||||||||||||
Payment for acquisition | £ | £ 800 | |||||||||||||||||
Ownership interest | 9.90% | |||||||||||||||||
Waterland Private Equity Fund VII C.V. [Member] | United Kingdom [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | £ | £ 800 | |||||||||||||||||
Springstone Inc. [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | $ 185 | |||||||||||||||||
Consideration of other transaction costs | 950 | |||||||||||||||||
Incurred deferred income tax liabilities | $ 8 | |||||||||||||||||
Steward Health Care System LLC [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Ownership interest | 9.90% | |||||||||||||||||
Number of facilities acquired | Hospital | 2 | |||||||||||||||||
Other loan to affiliates | $ 335 | $ 335 | ||||||||||||||||
Steward Health Care System LLC [Member] | Florida [Member] | General Acute Care Hospitals [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Lease extension expiration term | 10 years | |||||||||||||||||
Lease extension expiration year | 2041 |
Real Estate and Other Activit_6
Real Estate and Other Activities - 2020 Activity - Additional Information (Detail) $ in Thousands, € in Millions, £ in Millions, SFr in Millions | Dec. 29, 2020CHF (SFr) | Dec. 18, 2020GBP (£)Hospital | Dec. 17, 2020USD ($)Hospital | Nov. 25, 2020GBP (£) | Nov. 17, 2020USD ($)Hospital | Aug. 13, 2020USD ($) | Aug. 07, 2020GBP (£)Hospital | Aug. 05, 2020EUR (€) | Jul. 08, 2020USD ($)Hospital | Jun. 16, 2020RenewalOption | Jan. 08, 2020GBP (£)Hospital | Dec. 17, 2019USD ($)Hospital | Dec. 31, 2021USD ($)Hospital | Dec. 31, 2020USD ($)FacilityHospital | Jun. 24, 2020CHF (SFr) | May 13, 2020USD ($) | Dec. 31, 2019USD ($) |
Business Acquisition [Line Items] | |||||||||||||||||
Term of lease extension, years | 5 years | ||||||||||||||||
Acquisition loan | $ | $ 5,350,239 | $ 4,249,180 | $ 4,565,594 | ||||||||||||||
Term of lease | 15 years | ||||||||||||||||
Joint Venture Partner [Member] | Other Loans [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Acquisition loan | $ | $ 205,000 | ||||||||||||||||
Steward [Member] | Joint Venture Partner [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Ownership interest | 49.00% | ||||||||||||||||
Infracore [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Purchase price of acquisition | SFr | SFr 206.5 | ||||||||||||||||
Secured loan | SFr | SFr 45 | ||||||||||||||||
South Carolina [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Purchase price of acquisition | $ | 17,000 | ||||||||||||||||
Net investment in lease | $ | $ 115,000 | ||||||||||||||||
Investment in number of facilities | Facility | 5 | ||||||||||||||||
Utah [Member] | Steward [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Number of facilities acquired | Hospital | 2 | ||||||||||||||||
Purchase price of acquisition | $ | $ 200,000 | ||||||||||||||||
Utah [Member] | Steward [Member] | Davis and Jordan Valley Facilities [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Net investment in lease | $ | $ 950,000 | ||||||||||||||||
Acute Care Hospital [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Number of facilities acquired | Hospital | 10 | 2 | |||||||||||||||
Purchase price of acquisition | $ | $ 700,000 | ||||||||||||||||
Acute Care Hospital [Member] | United Kingdom [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Purchase price of acquisition | £ | £ 50 | ||||||||||||||||
Lessor operating lease ground lease term | 999 years | ||||||||||||||||
Acute Care Hospital [Member] | United Kingdom [Member] | BMI [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Number of facilities acquired | Hospital | 30 | ||||||||||||||||
Purchase price of acquisition | £ | £ 1,500 | ||||||||||||||||
Initial fixed term of lease | 2050 | ||||||||||||||||
Existence of option to extend | true | false | |||||||||||||||
Number of lease extension options | RenewalOption | 2 | ||||||||||||||||
Term of lease extension, years | 5 years | ||||||||||||||||
Lease extension options, description | two five-year renewal options | ||||||||||||||||
Acute Care Hospital [Member] | South Carolina [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Number of facilities acquired | Hospital | 1 | ||||||||||||||||
Acute Care Hospital [Member] | California [Member] | Prime Healthcare Services [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Purchase price of acquisition | $ | $ 300,000 | ||||||||||||||||
Acute Care Hospital [Member] | Colombia [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Number of facilities acquired | Hospital | 3 | ||||||||||||||||
Purchase price of acquisition | $ | $ 135,000 | ||||||||||||||||
Acute Care Hospital [Member] | Darlington, United Kingdom [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Number of facilities acquired | Hospital | 1 | ||||||||||||||||
Purchase price of acquisition | £ | £ 29.4 | ||||||||||||||||
Inpatient Rehabilitation Hospital [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Purchase price of acquisition | $ | $ 58,000 | ||||||||||||||||
Inpatient Rehabilitation Hospital [Member] | South Carolina [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Number of facilities acquired | Hospital | 3 | ||||||||||||||||
Inpatient Rehabilitation Hospital [Member] | Dahlen, Germany [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Number of facilities acquired | Hospital | 3 | ||||||||||||||||
Purchase price of acquisition | € | € 12.5 | ||||||||||||||||
Inpatient Rehabilitation Hospital [Member] | Texas [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Number of facilities acquired | Hospital | 1 | ||||||||||||||||
Inpatient Rehabilitation Hospital [Member] | Indiana [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Number of facilities acquired | Hospital | 1 | ||||||||||||||||
Private Acute Care Hospital [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Number of facilities acquired | Hospital | 1 | ||||||||||||||||
Private Acute Care Hospital [Member] | Reading, United Kingdom [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Purchase price of acquisition | £ | £ 85 | ||||||||||||||||
Inpatient Rehabilitation Hospital, Acute Care Hospital and Private Acute Care Hospital [Member] | |||||||||||||||||
Business Acquisition [Line Items] | |||||||||||||||||
Purchase price of acquisition | $ | $ 300,000 |
Real Estate and Other Activit_7
Real Estate and Other Activities - 2019 Activity - Additional Information (Detail) € in Millions, £ in Millions, SFr in Millions, $ in Millions | Oct. 21, 2021EUR (€) | Dec. 29, 2020CHF (SFr) | Dec. 17, 2020USD ($)Hospital | Nov. 25, 2020GBP (£) | Dec. 17, 2019USD ($)HospitalRenewalOptionLease | Dec. 03, 2019EUR (€)Hospital | Nov. 28, 2019EUR (€) | Aug. 30, 2019USD ($)RenewalOption | Aug. 23, 2019USD ($)HospitalRenewalOptionHealth_Center | Aug. 16, 2019GBP (£)Hospital | Jun. 28, 2019CHF (SFr) | Jun. 10, 2019USD ($)HospitalRenewalOption | Jun. 06, 2019AUD ($)Hospital | May 27, 2019CHF (SFr)_Campus | Apr. 12, 2019Hospital | Dec. 31, 2021USD ($)Hospital | Dec. 31, 2019USD ($)Hospital | Dec. 31, 2020USD ($) |
Business Acquisition [Line Items] | ||||||||||||||||||
Term of lease | 15 years | |||||||||||||||||
Term of lease extension, years | 5 years | |||||||||||||||||
Mortgage loan balance | $ | $ 1,541,864,000 | $ 1,106,448,000 | ||||||||||||||||
Weighted average remaining lease term | 40 years 7 months 6 days | 41 years 1 month 6 days | ||||||||||||||||
Other Acquisitions [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | $ | $ 135,000,000 | |||||||||||||||||
Infracore [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | SFr | SFr 206.5 | |||||||||||||||||
Swiss Medical Network [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Weighted average remaining lease term | 23 years | |||||||||||||||||
Aevis Victoria SA [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | SFr | SFr 47 | |||||||||||||||||
Ownership interest in joint venture under the cost method | 4.90% | 4.90% | ||||||||||||||||
Vibra [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | $ | $ 254,000,000 | |||||||||||||||||
Term of lease | 20 years | |||||||||||||||||
Number of lease extension options | RenewalOption | 3 | |||||||||||||||||
Lease extension options, description | three five-year extension options | |||||||||||||||||
Existence of option to extend | true | |||||||||||||||||
Term of lease extension, years | 5 years | |||||||||||||||||
Switzerland [Member] | Infracore [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | SFr | SFr 236.6 | |||||||||||||||||
Spain [Member] | Spanish Prop Co. [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Ownership interest | 45.00% | |||||||||||||||||
Prospect [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | $ | $ 1,550,000,000 | |||||||||||||||||
Term of lease | 15 years | |||||||||||||||||
Number of lease extension options | RenewalOption | 3 | |||||||||||||||||
Existence of option to extend | true | |||||||||||||||||
Term loan | $ | $ 112,900,000 | |||||||||||||||||
Future purchase price adjustment | $ | $ 250,000,000 | |||||||||||||||||
Performance thresholds achievement period | 3 years | |||||||||||||||||
Prospect [Member] | Investment in Financing Leases [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | $ | $ 1,400,000,000 | |||||||||||||||||
Secure Income REIT [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | £ | £ 347 | |||||||||||||||||
Secure Income REIT [Member] | United Kingdom [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of private hospitals acquired | Hospital | 8 | |||||||||||||||||
Acute Care Hospital [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 10 | 2 | ||||||||||||||||
Purchase price of acquisition | $ | $ 700,000,000 | |||||||||||||||||
Acute Care Hospital [Member] | Other Acquisitions [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 3 | |||||||||||||||||
Acute Care Hospital [Member] | United Kingdom [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | £ | £ 50 | |||||||||||||||||
Acute Care Hospital [Member] | Spain [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 2 | |||||||||||||||||
Purchase price of acquisition | € | € 117.3 | |||||||||||||||||
Acute Care Hospital [Member] | Portugal [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | € | € 17.8 | € 28.2 | ||||||||||||||||
Acute Care Hospital [Member] | Texas [Member] | Steward [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 1 | |||||||||||||||||
Acute Care Hospital [Member] | Poole, England [Member] | Circle [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 1 | |||||||||||||||||
Acute Care Hospital [Member] | California [Member] | Halsen Healthcare [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 1 | |||||||||||||||||
Acute Care Hospital [Member] | Prospect [Member] | Mortgage Loans [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Mortgage loan balance | $ | $ 51,300,000 | |||||||||||||||||
Life Point [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of master leases | Lease | 1 | |||||||||||||||||
Term of lease | 20 years | |||||||||||||||||
Number of lease extension options | RenewalOption | 2 | |||||||||||||||||
Lease extension options, description | two five-year extension options | |||||||||||||||||
Existence of option to extend | true | |||||||||||||||||
Term of lease extension, years | 5 years | |||||||||||||||||
Acute Care Campus [Member] | Switzerland [Member] | Infracore [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | _Campus | 13 | |||||||||||||||||
Acute Care Campus [Member] | Prospect [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 14 | |||||||||||||||||
Acute Care Campus [Member] | Prospect [Member] | Investment in Financing Leases [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 11 | |||||||||||||||||
Behavioral Health Care Facility [Member] | Prospect [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Health_Center | 2 | |||||||||||||||||
Behavioral Health Care Facility [Member] | Prospect [Member] | Investment in Financing Leases [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Health_Center | 2 | |||||||||||||||||
Hospital [Member] | Healthscope [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Term of lease | 20 years | |||||||||||||||||
Hospital [Member] | Australia [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 11 | |||||||||||||||||
Purchase price of acquisition | $ | $ 1,200 | |||||||||||||||||
Stamp duties and registration fees | $ | $ 66.6 | |||||||||||||||||
Additional Properties [Member] | Switzerland [Member] | Infracore [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | _Campus | 2 | |||||||||||||||||
HM Hospital [Member] | Spain [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Term of lease | 25 years | |||||||||||||||||
Jose de Mello [Member] | Portugal [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Term of lease | 17 years | |||||||||||||||||
Inpatient Rehabilitation Hospital [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | $ | $ 58,000,000 | |||||||||||||||||
Inpatient Rehabilitation Hospital [Member] | Texas [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 1 | |||||||||||||||||
Inpatient Rehabilitation Hospital [Member] | Germany [Member] | Other Acquisitions [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 1 | |||||||||||||||||
Community Hospital [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of lease extension options | RenewalOption | 2 | |||||||||||||||||
Lease extension options, description | two five-year extension options | |||||||||||||||||
Existence of option to extend | true | |||||||||||||||||
Term of lease extension, years | 5 years | |||||||||||||||||
Leases fixed escalations | 5 years | |||||||||||||||||
Community Hospital [Member] | Saint Luke's Health System [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Term of lease | 14 years | |||||||||||||||||
Community Hospital [Member] | Kansas [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 7 | |||||||||||||||||
Purchase price of acquisition | $ | $ 145,400,000 |
Real Estate and Other Activit_8
Real Estate and Other Activities - Development Activities - Additional Information (Detail) $ in Thousands | Dec. 17, 2019Hospital | Oct. 25, 2019USD ($) | Jun. 30, 2020Hospital | Dec. 31, 2021USD ($)Hospital | Dec. 31, 2019Hospital | Nov. 23, 2020USD ($) | May 15, 2020USD ($) |
Business Acquisition [Line Items] | |||||||
Expected commence rent | $ | $ 265,037 | ||||||
Acute Care Hospital [Member] | |||||||
Business Acquisition [Line Items] | |||||||
Number of facilities acquired | 10 | 2 | |||||
Behavioral Hospital [Member] | Houston, Texas [Member] | |||||||
Business Acquisition [Line Items] | |||||||
Estimated total development cost | $ | $ 27,500 | ||||||
Ernest [Member] | |||||||
Business Acquisition [Line Items] | |||||||
Number of facilities acquired | 4 | ||||||
Development Activities [Member] | Ernest [Member] | |||||||
Business Acquisition [Line Items] | |||||||
Expected commence rent | $ | $ 47,700 | $ 47,900 | |||||
Development Activities [Member] | Circle [Member] | Birmingham, England [Member] | |||||||
Business Acquisition [Line Items] | |||||||
Number of facilities acquired | 2 | ||||||
Development Activities [Member] | Circle [Member] | Acute Care Hospital [Member] | Birmingham, England [Member] | |||||||
Business Acquisition [Line Items] | |||||||
Number of facilities acquired | 1 | ||||||
Development Activities [Member] | Circle [Member] | Inpatient Rehabilitation Hospital [Member] | Birmingham, England [Member] | |||||||
Business Acquisition [Line Items] | |||||||
Number of facilities acquired | 1 | ||||||
Development Activities [Member] | Steward [Member] | |||||||
Business Acquisition [Line Items] | |||||||
Expected commence rent | $ | $ 169,400 |
Real Estate and Other Activit_9
Real Estate and Other Activities - Summary of Status on Current Development Projects (Detail) $ in Thousands | 12 Months Ended |
Dec. 31, 2021USD ($) | |
Business Acquisition [Line Items] | |
Commitment | $ 265,037 |
Costs Incurred as of December 31, 2021 | 101,439 |
Ernest [Member] | Bakersfield, California [Member] | |
Business Acquisition [Line Items] | |
Commitment | 47,929 |
Costs Incurred as of December 31, 2021 | $ 42,132 |
Estimated Rent Commencement Date | 1Q 2022 |
Ernest [Member] | Stockton, California [Member] | |
Business Acquisition [Line Items] | |
Commitment | $ 47,700 |
Costs Incurred as of December 31, 2021 | $ 31,197 |
Estimated Rent Commencement Date | 2Q 2022 |
Steward [Member] | Texarkana, Texas [Member] | |
Business Acquisition [Line Items] | |
Commitment | $ 169,408 |
Costs Incurred as of December 31, 2021 | $ 28,110 |
Estimated Rent Commencement Date | 2Q 2024 |
Real Estate and Other Activi_10
Real Estate and Other Activities - Disposals - Additional Information (Detail) $ in Millions | Aug. 28, 2021USD ($)Hospital | Dec. 31, 2021USD ($) | Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($)Hospital | Jan. 08, 2021 |
Business Acquisition [Line Items] | |||||
Gain (loss) on real estate dispositions | $ (40) | $ 52.5 | $ (2.8) | ||
Steward Health Care System LLC [Member] | |||||
Business Acquisition [Line Items] | |||||
Ownership interest | 9.90% | ||||
Number of facilities acquired | Hospital | 2 | ||||
Massachusetts-based General Acute Care Hospitals [Member] | |||||
Business Acquisition [Line Items] | |||||
Ownership interest | 50.00% | ||||
Number of facilities acquired | Hospital | 8 | ||||
Purchase price of acquisition | $ 1,700 | ||||
Gain (loss) on real estate dispositions | $ 500 | ||||
Massachusetts-based General Acute Care Hospitals [Member] | Steward Health Care System LLC [Member] | |||||
Business Acquisition [Line Items] | |||||
Number of facilities acquired | Hospital | 8 | ||||
Maximum secured debt percentage of asset value | 55.00% | ||||
Proceeds from expected secured debt | $ 1,300 |
Real Estate and Other Activi_11
Real Estate and Other Activities - Summary of Joint Venture Designated as Held for Sale (Detail) - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 |
Business Acquisition [Line Items] | ||
Real estate held for sale | $ 1,096,505 | |
Straight-line rent receivables | 728,522 | $ 490,462 |
Other assets | 333,480 | 256,069 |
Total Assets | 20,519,801 | $ 16,829,014 |
Massachusetts-based General Acute Care Hospitals [Member] | ||
Business Acquisition [Line Items] | ||
Real estate held for sale | 1,096,505 | |
Straight-line rent receivables | 120,268 | |
Other assets | 4,234 | |
Total Assets | $ 1,221,007 |
Real Estate and Other Activi_12
Real Estate and Other Activities - Other Disposal Transactions - Additional Information (Detail) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Dec. 31, 2021USD ($)Operator | Dec. 31, 2021USD ($)FacilityOperator | Dec. 31, 2020USD ($)FacilityProperty | Dec. 31, 2019USD ($)Hospital | |
Business Acquisition [Line Items] | ||||
Number of operations sold | Operator | 3 | 3 | ||
Proceeds from sale of facilities | $ 54,500 | $ 246,000 | $ 94 | |
Gain (loss) on real estate dispositions | $ (40,000) | $ 52,500 | $ (2,800) | |
Number of facilities sold | Facility | 16 | 9 | ||
Number of properties sold | Property | 6 | |||
Acute Care Hospital [Member] | ||||
Business Acquisition [Line Items] | ||||
Gain (loss) on real estate dispositions | $ 41,600 | |||
Number of hospitals sold | Hospital | 5 |
Real Estate and Other Activi_13
Real Estate and Other Activities - Intangible Assets - Additional Information (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Business Combinations [Abstract] | |||
Intangible lease assets | $ 1,417,813 | $ 1,299,081 | |
Accumulated amortization, net | 1,300,000 | 1,200,000 | |
Amortization expense related to intangible lease assets | $ 56,000 | $ 42,400 | $ 21,500 |
Capitalized lease intangibles, weighted average life (in years) | 22 years 10 months 24 days |
Real Estate and Other Activi_14
Real Estate and Other Activities - Amortization Expense from Existing Lease Intangible Assets (Detail) $ in Thousands | Dec. 31, 2021USD ($) |
Business Combinations [Abstract] | |
2022 | $ 57,433 |
2023 | 57,368 |
2024 | 57,334 |
2025 | 57,186 |
2026 | $ 56,917 |
Real Estate and Other Activi_15
Real Estate and Other Activities - Leasing Operations (Lessor) - Additional Information (Detail) $ in Millions | 12 Months Ended |
Dec. 31, 2021USD ($)PropertyLease | |
Lessor Lease Description [Line Items] | |
Term of lease | 15 years |
Lease renewal term | 5 years |
Annual rent escalations | 99.00% |
Number of properties | Property | 5 |
Carrying value of lease requiring residual value guarantee | $ | $ 231 |
Ernest [Member] | |
Lessor Lease Description [Line Items] | |
Number of direct financing leases | 13 |
Number of financing leases | 5 |
Prime Facilities [Member] | |
Lessor Lease Description [Line Items] | |
Number of direct financing leases | 5 |
Prospect [Member] | |
Lessor Lease Description [Line Items] | |
Number of financing leases | 13 |
Real Estate and Other Activi_16
Real Estate and Other Activities - Summary of Total Future Minimum Lease Payments to be Received (Detail) - Minimum [Member] $ in Thousands | Dec. 31, 2021USD ($) |
Lessor Lease Description [Line Items] | |
2022 | $ 1,246,338 |
2023 | 1,270,580 |
2024 | 1,292,337 |
2025 | 1,314,179 |
2026 | 1,336,340 |
Thereafter | 34,069,146 |
Future minimum lease payments to be received | 40,528,920 |
Operating Leases [Member] | |
Lessor Lease Description [Line Items] | |
2022 | 1,078,148 |
2023 | 1,099,027 |
2024 | 1,117,353 |
2025 | 1,135,695 |
2026 | 1,154,286 |
Thereafter | 29,555,221 |
Future minimum lease payments to be received | 35,139,730 |
Financing Leases [Member] | |
Lessor Lease Description [Line Items] | |
2022 | 168,190 |
2023 | 171,553 |
2024 | 174,984 |
2025 | 178,484 |
2026 | 182,054 |
Thereafter | 4,513,925 |
Future minimum lease payments to be received | $ 5,389,190 |
Real Estate and Other Activi_17
Real Estate and Other Activities - Components of Total Investment in Financing Leases (Detail) - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 |
Direct Financing Lease Net Investment In Leases [Abstract] | ||
Minimum lease payments receivable | $ 1,183,855 | $ 1,228,966 |
Estimated residual values | 203,818 | 203,818 |
Less: Unearned income and allowance for credit loss | (918,584) | (969,061) |
Net investment in direct financing leases | 469,089 | 463,723 |
Other financing leases (net of allowance for credit loss) | 1,584,238 | 1,547,199 |
Total investment in financing leases | $ 2,053,327 | $ 2,010,922 |
Real Estate and Other Activi_18
Real Estate and Other Activities - Rent Deferrals - Additional Information (Detail) $ in Millions | Dec. 31, 2021USD ($) |
Business Acquisition [Line Items] | |
Maximum percentage of deferred rent on annual rent | 2.00% |
COVID-19 Pandemic [Member] | |
Business Acquisition [Line Items] | |
Deferred lease income | $ 2.8 |
Percentage of deferred revenue lease | $ 8.6 |
Real Estate and Other Activi_19
Real Estate and Other Activities - Adeptus Health - Additional Information (Detail) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Dec. 31, 2021USD ($) | Dec. 31, 2021USD ($)FacilityPropertyLease | Dec. 31, 2020USD ($)Property | Dec. 31, 2019USD ($) | |
Business Acquisition [Line Items] | ||||
Number of properties sold | Property | 6 | |||
Proceeds from sale of facilities | $ 54,500 | $ 246,000 | $ 94 | |
Adeptus Health [Member] | ||||
Business Acquisition [Line Items] | ||||
Number of leased properties | Lease | 60 | |||
Real estate impairment charge | $ 20,000 | $ 2,000 | ||
Number of properties sold | Property | 12 | |||
Proceeds from sale of facilities | $ 43 | |||
Number of facilities transitioned | Facility | 3 | |||
Adeptus Health [Member] | Maximum [Member] | ||||
Business Acquisition [Line Items] | ||||
Percentage of vacant on leased property | 0.50% | 0.50% |
Real Estate and Other Activi_20
Real Estate and Other Activities - Alecto Facilities - Additional Information (Detail) - Alecto Healthcare Services [Member] $ in Millions | 3 Months Ended | 12 Months Ended | ||
Mar. 31, 2020USD ($) | Dec. 31, 2021USD ($)Property | Dec. 31, 2020Property | Dec. 31, 2019USD ($) | |
Business Acquisition [Line Items] | ||||
Number of leased properties | 4 | |||
Real estate impairment charge | $ | $ 9.1 | $ 20 | ||
Number of re-leased properties | 1 | |||
Number of additional leased properties | 1 | |||
Proceeds from sale of mortgage loans | $ | $ 51 | |||
Total Gross Assets [Member] | Customer Concentration Risk [Member] | Maximum [Member] | ||||
Business Acquisition [Line Items] | ||||
Percentage of total assets | 0.10% |
Real Estate and Other Activi_21
Real Estate and Other Activities - Halsen Healthcare - Additional Information (Detail) - USD ($) $ in Thousands | Dec. 17, 2019 | Sep. 30, 2019 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2020 |
Business Acquisition [Line Items] | |||||
Credit loss reserve | $ 8,399 | ||||
Halsen Healthcare [Member] | |||||
Business Acquisition [Line Items] | |||||
Credit loss reserve | $ 40,000 | $ 40,000 | |||
Write off of billed and straight-line rent receivables | $ 2,500 | ||||
Watsonville, California [Member] | Halsen Healthcare [Member] | Maximum [Member] | |||||
Business Acquisition [Line Items] | |||||
Percentage of assets fully recoverable | 0.50% | ||||
Acute Care Hospital [Member] | |||||
Business Acquisition [Line Items] | |||||
Purchase price of acquisition | $ 700,000 | ||||
Acute Care Hospital [Member] | Watsonville, California [Member] | |||||
Business Acquisition [Line Items] | |||||
Purchase price of acquisition | $ 40,000 |
Real Estate and Other Activi_22
Real Estate and Other Activities - Other Leasing Activity - Additional Information (Detail) $ in Millions | Jul. 24, 2020USD ($)Property | Sep. 30, 2020USD ($) | Dec. 23, 2021Property |
ScionHealth Master Lease [Member] | |||
Business Acquisition [Line Items] | |||
Number of properties | 8 | ||
LifePoint Master Lease [Member] | |||
Business Acquisition [Line Items] | |||
Number of properties | 9 | ||
Methodist [Member] | Texas [Member] | |||
Business Acquisition [Line Items] | |||
Total investments | $ | $ 30 | ||
Number of re-leased properties | 5 | ||
Straight-line rent and other write-off, net of tax | $ | $ 1.5 |
Real Estate and Other Activi_23
Real Estate and Other Activities - Summary of Loans (Net of Allowance for Credit Loss) (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Loans [Line Items] | ||
Mortgage loans | $ 213,211 | $ 248,080 |
Mortgage loan balance | 1,541,864 | 1,106,448 |
Mortgage Loans [Member] | ||
Loans [Line Items] | ||
Mortgage loans | $ 213,211 | $ 248,080 |
Loans, Weighted Average Interest Rate | 8.70% | 8.50% |
Acquisition Loans [Member] | ||
Loans [Line Items] | ||
Acquisition loans | $ 523,829 | $ 338,273 |
Loans, Weighted Average Interest Rate | 7.70% | 7.60% |
Other Loans [Member] | ||
Loans [Line Items] | ||
Other loans | $ 804,824 | $ 520,095 |
Loans, Weighted Average Interest Rate | 6.20% | 5.80% |
Real Estate and Other Activi_24
Real Estate and Other Activities - Loans - Additional Information (Detail) € in Millions, $ in Millions | 12 Months Ended | |||
Dec. 31, 2021USD ($)PropertyOperator | Dec. 31, 2021EUR (€)PropertyOperator | Jan. 08, 2021USD ($) | Aug. 31, 2018USD ($) | |
Springstone Inc. [Member] | ||||
Loans [Line Items] | ||||
Acquisition loans | $ 185 | |||
Steward Health Care System LLC [Member] | ||||
Loans [Line Items] | ||||
Other loan to affiliates | $ 335 | $ 335 | ||
Repayments of other loan | $ 75 | |||
Primotop Holdings S.a.r.l. [Member] | ||||
Loans [Line Items] | ||||
Shareholder loan to joint venture | € | € 297 | |||
Mortgage Loans [Member] | Steward Health Care System LLC [Member] | ||||
Loans [Line Items] | ||||
Number of real estate assets acquired | Property | 5 | 5 | ||
Number of operators | Operator | 3 | 3 |
Real Estate and Other Activi_25
Real Estate and Other Activities - Other Investment Activities - Additional Information (Detail) € in Millions, SFr in Millions | Oct. 13, 2021EUR (€) | Jan. 08, 2021USD ($) | Jun. 28, 2019CHF (SFr) | Dec. 31, 2021USD ($) |
COVID-19 Pandemic [Member] | ||||
Business Acquisition [Line Items] | ||||
Unfavorable non-cash fair value adjustment on investment | $ 5,800 | |||
Aevis Victoria SA [Member] | ||||
Business Acquisition [Line Items] | ||||
Purchase price of acquisition | SFr | SFr 47 | |||
Favorable non-cash fair value adjustment on investment | $ 8,200 | |||
Ownership interest in joint venture under the cost method | 4.90% | 4.90% | ||
Priory Group [Member] | ||||
Business Acquisition [Line Items] | ||||
Purchase price of acquisition | € | € 27 | |||
Ownership interest | 9.90% | |||
Steward Health Care System LLC [Member] | ||||
Business Acquisition [Line Items] | ||||
Distribution on Steward equity investment | $ 11,000,000 | |||
Ownership interest | 9.90% |
Real Estate and Other Activi_26
Real Estate and Other Activities - Concentration of Credit Risks and Related Party Transactions - Additional Information (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Related Party Transactions [Member] | |||
Business Acquisition [Line Items] | |||
Lease and interest revenue earned from tenants | $ 63.9 | $ 29.8 | $ 85.3 |
Total Gross Assets [Member] | Geographic Concentration [Member] | U.S. [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 64.00% | 65.00% | |
Total Gross Assets [Member] | Geographic Concentration [Member] | Europe [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 30.00% | 28.00% | |
Total Gross Assets [Member] | Geographic Concentration [Member] | Australia [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 5.00% | 6.00% | |
Total Gross Assets [Member] | Geographic Concentration [Member] | South America [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 1.00% | 1.00% | |
Revenue [Member] | Customer Concentration Risk [Member] | General Acute Care Hospital And Healthcare System | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 81.00% | 87.00% | |
Revenue [Member] | Customer Concentration Risk [Member] | Rehabilitation Hospital | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 8.00% | 8.00% | |
Revenue [Member] | Customer Concentration Risk [Member] | Freestanding ER/Urgent Care Facilities and Behavioral Health Facilities [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 4.00% | 2.00% | |
Revenue [Member] | Customer Concentration Risk [Member] | Long Term Acute Care Hospital | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 7.00% | 3.00% | |
Revenue [Member] | Operator Concentration Risk [Member] | Steward Health Care System LLC [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 10.00% | 10.00% | |
Revenue [Member] | Operator Concentration Risk [Member] | Circle [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 10.00% | ||
Revenue [Member] | Operator Concentration Risk [Member] | Circle [Member] | Maximum [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 10.00% | ||
Revenue [Member] | Operator Concentration Risk [Member] | Prospect [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 10.00% | ||
Revenue [Member] | Operator Concentration Risk [Member] | Prospect [Member] | Maximum [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 10.00% | ||
Pro Forma [Member] | Total Gross Assets [Member] | Customer Concentration Risk [Member] | |||
Business Acquisition [Line Items] | |||
Maximum percentage of entity's assets invested on single property | 2.70% | 3.20% |
Debt - Summary of Debt (Detail)
Debt - Summary of Debt (Detail) - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 | |
Debt Instrument [Line Items] | |||
Debt | $ 11,358,826 | $ 8,934,187 | |
Debt issue costs and discount, net | (76,056) | (68,729) | |
Debt, net | 11,282,770 | 8,865,458 | |
Revolving Credit Facility [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [1] | 730,000 | 165,407 |
Interim Credit Facility [Member] | |||
Debt Instrument [Line Items] | |||
Debt | 869,606 | ||
Term Loan [Member] | |||
Debt Instrument [Line Items] | |||
Debt | 200,000 | 200,000 | |
Term Loan [Member] | British Pound Sterling [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 947,240 | 956,900 |
Term Loan [Member] | Australia [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 871,560 | 923,280 |
4.000% Senior Unsecured Notes Due 2022 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 610,800 | |
2.550% Senior Unsecured Notes due 2023 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 541,280 | 546,800 |
3.325% Senior Unsecured Notes Due 2025 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 568,500 | 610,800 |
0.993% Senior Unsecured Notes due 2026 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 568,500 | |
2.500% Senior Unsecured Notes due 2026 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 676,600 | |
5.250% Senior Unsecured Notes Due 2026 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | 500,000 | 500,000 | |
5.000% Senior Unsecured Notes Due 2027 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | 1,400,000 | 1,400,000 | |
3.692% Senior Unsecured Notes due 2028 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 811,920 | 820,200 |
4.625% Senior Unsecured Notes Due 2029 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | 900,000 | 900,000 | |
3.375% Senior Unsecured Notes Due 2030 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 473,620 | |
3.500% Senior Unsecured Notes Due 2031 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | $ 1,300,000 | $ 1,300,000 | |
[1] | The 2020 column includes £121 million of GBP-denominated borrowings that reflect the exchange rate at December 31, 2020. | ||
[2] | Non-U.S. dollar denominated debt that reflects the exchange rate at period-end. |
Debt - Summary of Debt (Parenth
Debt - Summary of Debt (Parenthetical) (Detail) $ in Thousands, £ in Millions | Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($) | Dec. 31, 2020GBP (£) | |
Debt Instrument [Line Items] | ||||
Debt | $ 11,358,826 | $ 8,934,187 | ||
GBP-denominated Borrowings [Member] | ||||
Debt Instrument [Line Items] | ||||
Debt | £ | £ 121 | |||
4.000% Senior Unsecured Notes Due 2022 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | [1] | 4.00% | 4.00% | 4.00% |
Debt | [1] | $ 610,800 | ||
2.550% Senior Unsecured Notes due 2023 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | [1] | 2.55% | 2.55% | 2.55% |
Debt | [1] | $ 541,280 | $ 546,800 | |
3.325% Senior Unsecured Notes Due 2025 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | [1] | 3.325% | 3.325% | 3.325% |
Debt | [1] | $ 568,500 | $ 610,800 | |
0.993% Senior Unsecured Notes due 2026 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | [1] | 0.993% | 0.993% | 0.993% |
Debt | [1] | $ 568,500 | ||
2.500% Senior Unsecured Notes due 2026 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | [1] | 2.50% | 2.50% | 2.50% |
Debt | [1] | $ 676,600 | ||
5.250% Senior Unsecured Notes Due 2026 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | 5.25% | 5.25% | 5.25% | |
Debt | $ 500,000 | $ 500,000 | ||
5.000% Senior Unsecured Notes Due 2027 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | 5.00% | 5.00% | 5.00% | |
Debt | $ 1,400,000 | $ 1,400,000 | ||
3.692% Senior Unsecured Notes due 2028 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | [1] | 3.692% | 3.692% | 3.692% |
Debt | [1] | $ 811,920 | $ 820,200 | |
4.625% Senior Unsecured Notes Due 2029 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | 4.625% | 4.625% | 4.625% | |
Debt | $ 900,000 | $ 900,000 | ||
3.375% Senior Unsecured Notes Due 2030 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | [1] | 3.375% | 3.375% | 3.375% |
Debt | [1] | $ 473,620 | ||
3.500% Senior Unsecured Notes Due 2031 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | 3.50% | 3.50% | 3.50% | |
Debt | $ 1,300,000 | $ 1,300,000 | ||
[1] | Non-U.S. dollar denominated debt that reflects the exchange rate at period-end. |
Debt - Principal Payments Due f
Debt - Principal Payments Due for Debt (Detail) - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 |
Debt Disclosure [Abstract] | ||
2022 | $ 869,606 | |
2023 | 541,280 | |
2024 | 1,601,560 | |
2025 | 1,515,740 | |
2026 | 1,945,100 | |
Thereafter | 4,885,540 | |
Total | $ 11,358,826 | $ 8,934,187 |
Debt - Credit Facility - Additi
Debt - Credit Facility - Additional Information (Detail) - USD ($) | Jan. 15, 2021 | Dec. 31, 2021 | Dec. 31, 2020 | Feb. 01, 2017 |
Minimum [Member] | ||||
Debt Instrument [Line Items] | ||||
Commitment fee | 0.125% | |||
Maximum [Member] | ||||
Debt Instrument [Line Items] | ||||
Commitment fee | 0.30% | |||
Unsecured Revolving Credit Facility [Member] | ||||
Debt Instrument [Line Items] | ||||
Amount of senior unsecured debt | $ 1,300,000,000 | |||
Debt instrument maturity date | Feb. 1, 2024 | |||
Credit facilities, amount outstanding | $ 730,000,000 | $ 165,400,000 | ||
Line of credit facility, Borrowing capacity | $ 600,000,000 | $ 1,100,000,000 | ||
Credit facilities, weighted average interest rate | 1.30% | 1.40% | ||
Alternate Base Rate [Member] | Minimum [Member] | ||||
Debt Instrument [Line Items] | ||||
Applicable margin for term loan | 0.00% | |||
Applicable margin for revolving loans | 0.00% | |||
Alternate Base Rate [Member] | Maximum [Member] | ||||
Debt Instrument [Line Items] | ||||
Applicable margin for term loan | 0.85% | |||
Applicable margin for revolving loans | 0.55% | |||
Eurodollar Loans [Member] | Minimum [Member] | ||||
Debt Instrument [Line Items] | ||||
Applicable margin for term loan | 0.85% | |||
Applicable margin for revolving loans | 0.825% | |||
Eurodollar Loans [Member] | Maximum [Member] | ||||
Debt Instrument [Line Items] | ||||
Applicable margin for term loan | 1.85% | |||
Applicable margin for revolving loans | 1.55% | |||
Term Loans [Member] | ||||
Debt Instrument [Line Items] | ||||
Amount of senior unsecured debt | $ 200,000,000 | |||
Debt instrument maturity date | Feb. 1, 2026 | |||
Interest rate at end of period | 1.56% | 1.65% |
Debt - Interim Credit Facility
Debt - Interim Credit Facility - Additional Information (Detail) £ in Millions | Jan. 15, 2021USD ($) | Dec. 31, 2021 | Jan. 15, 2021GBP (£) | Dec. 31, 2020 | |
2.500% Senior Unsecured Notes due 2026 [Member] | |||||
Debt Instrument [Line Items] | |||||
Senior unsecured notes, interest rate | [1] | 2.50% | 2.50% | ||
3.375% Senior Unsecured Notes Due 2030 [Member] | |||||
Debt Instrument [Line Items] | |||||
Senior unsecured notes, interest rate | [1] | 3.375% | 3.375% | ||
Interim Credit Facility [Member] | |||||
Debt Instrument [Line Items] | |||||
Line of credit facility, Borrowing capacity | $ | $ 900,000,000 | ||||
Line of credit | £ | £ 500 | ||||
Line of credit, terminated date | Mar. 26, 2021 | ||||
Interim Credit Facility [Member] | 2.500% Senior Unsecured Notes due 2026 [Member] | |||||
Debt Instrument [Line Items] | |||||
Senior unsecured notes, interest rate | 2.50% | 2.50% | |||
Interim Credit Facility [Member] | 3.375% Senior Unsecured Notes Due 2030 [Member] | |||||
Debt Instrument [Line Items] | |||||
Senior unsecured notes, interest rate | 3.375% | 3.375% | |||
[1] | Non-U.S. dollar denominated debt that reflects the exchange rate at period-end. |
Debt - July 2021 Interim Credit
Debt - July 2021 Interim Credit Facility - Additional Information (Detail) - Interim Credit Facility [Member] £ in Millions | Jul. 27, 2021USD ($) | Dec. 31, 2021USD ($) | Jan. 15, 2021USD ($) | Jan. 15, 2021GBP (£) |
Debt Instrument [Line Items] | ||||
Line of credit facility, Borrowing capacity | $ 900,000,000 | |||
Line of credit | £ | £ 500 | |||
Barclays Bank PLC [Member] | ||||
Debt Instrument [Line Items] | ||||
Line of credit facility, Borrowing capacity | $ 1,000,000,000 | |||
Debt instrument maturity date | Jul. 28, 2022 | |||
Line of credit | $ 869,600,000 | |||
Line of credit facility, interest rate | 1.61% |
Debt - British Pound Sterling T
Debt - British Pound Sterling Term Loan - Additional Information (Detail) - Term Loan [Member] - Bank of America, N.A - British Pound Sterling [Member] - GBP (£) | Mar. 04, 2020 | Jan. 06, 2020 | Dec. 31, 2021 |
Debt Instrument [Line Items] | |||
Maximum borrowing capacity | £ 700,000,000 | ||
Debt instrument maturity date | Jan. 15, 2025 | ||
Debt instrument effective date | Mar. 6, 2020 | ||
Effective interest rate | 0.70% | ||
Senior unsecured notes, interest rate | 1.95% | ||
Minimum [Member] | |||
Debt Instrument [Line Items] | |||
Applicable margin adjustable based on pricing grid, percentage | 0.85% | ||
Maximum [Member] | |||
Debt Instrument [Line Items] | |||
Applicable margin adjustable based on pricing grid, percentage | 1.65% | ||
Credit Rating | |||
Debt Instrument [Line Items] | |||
Variable interest rate | 1.25% |
Debt - Australian Term Loan - A
Debt - Australian Term Loan - Additional Information (Detail) $ in Millions | Jun. 27, 2019 | May 23, 2019AUD ($) | Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($) |
Accounts Payable and Accrued Expenses | ||||
Debt Instrument [Line Items] | ||||
Derivative liability | $ 4.2 | $ 51.3 | ||
Other Assets [Member] | ||||
Debt Instrument [Line Items] | ||||
Derivative asset | $ 12.4 | |||
Term Loan [Member] | Bank of America, N.A | Australia [Member] | ||||
Debt Instrument [Line Items] | ||||
Maximum borrowing capacity | $ 1,200,000,000 | |||
Debt instrument maturity date | May 23, 2024 | |||
Debt instrument effective date | Jul. 3, 2019 | |||
Effective interest rate | 1.20% | |||
Senior unsecured notes, interest rate | 2.45% | |||
Reference rate | 0.00% | |||
Term Loan [Member] | Bank of America, N.A | Australia [Member] | Minimum [Member] | ||||
Debt Instrument [Line Items] | ||||
Applicable margin adjustable based on pricing grid, percentage | 0.85% | |||
Term Loan [Member] | Bank of America, N.A | Australia [Member] | Maximum [Member] | ||||
Debt Instrument [Line Items] | ||||
Applicable margin adjustable based on pricing grid, percentage | 1.65% | |||
Term Loan [Member] | Bank of America, N.A | Australia [Member] | Credit Rating | ||||
Debt Instrument [Line Items] | ||||
Variable interest rate | 1.25% |
Debt - Basic Terms of Senior Un
Debt - Basic Terms of Senior Unsecured Notes (Details) - 12 months ended Dec. 31, 2021 | USD ($) | GBP (£) | EUR (€) |
2.550% Senior Unsecured Notes due 2023 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Dec. 5, 2019 | ||
Debt instrument maturity date | Dec. 5, 2023 | ||
Par Value | € | € 400,000,000 | ||
% of Par Value | 100.00% | ||
Interest Payment Frequency | Annually | ||
3.325% Senior Unsecured Notes Due 2025 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Mar. 24, 2017 | ||
Debt instrument maturity date | Mar. 24, 2025 | ||
Par Value | £ 500,000,000 | ||
% of Par Value | 100.00% | ||
Interest Payment Frequency | Annually | ||
0.993% Senior Unsecured Notes due 2026 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Oct. 6, 2021 | ||
Debt instrument maturity date | Oct. 15, 2026 | ||
Par Value | € | 500,000,000 | ||
% of Par Value | 100.00% | ||
Interest Payment Frequency | Annually | ||
2.500% Senior Unsecured Notes due 2026 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Mar. 24, 2021 | ||
Debt instrument maturity date | Mar. 24, 2026 | ||
Par Value | 500,000,000 | ||
% of Par Value | 99.937% | ||
Interest Payment Frequency | Annually | ||
5.250% Senior Unsecured Notes Due 2026 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Jul. 22, 2016 | ||
Debt instrument maturity date | Aug. 1, 2026 | ||
Par Value | $ | $ 500,000,000 | ||
% of Par Value | 100.00% | ||
Interest Payment Frequency | Semi-annually | ||
5.000% Senior Unsecured Notes Due 2027 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Sep. 7, 2017 | ||
Debt instrument maturity date | Oct. 15, 2027 | ||
Par Value | € | € 1,400,000,000 | ||
% of Par Value | 100.00% | ||
Interest Payment Frequency | Semi-annually | ||
3.692% Senior Unsecured Notes due 2028 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Dec. 5, 2019 | ||
Debt instrument maturity date | Jun. 5, 2028 | ||
Par Value | $ | $ 600,000,000 | ||
% of Par Value | 99.998% | ||
Interest Payment Frequency | Annually | ||
4.625% Senior Unsecured Notes Due 2029 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Jul. 26, 2019 | ||
Debt instrument maturity date | Aug. 1, 2029 | ||
Par Value | 900,000,000 | ||
% of Par Value | 99.50% | ||
Interest Payment Frequency | Semi-annually | ||
3.375% Senior Unsecured Notes Due 2030 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Mar. 24, 2021 | ||
Debt instrument maturity date | Apr. 24, 2030 | ||
Par Value | $ | $ 350,000,000 | ||
% of Par Value | 99.448% | ||
Interest Payment Frequency | Annually | ||
3.500% Senior Unsecured Notes Due 2031 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Dec. 4, 2020 | ||
Debt instrument maturity date | Mar. 15, 2031 | ||
Par Value | £ 1,300,000,000 | ||
% of Par Value | 100.00% | ||
Interest Payment Frequency | Semi-annually |
Debt - Senior Unsecured Notes -
Debt - Senior Unsecured Notes - Additional Information (Detail) | 12 Months Ended |
Dec. 31, 2021 | |
Senior Unsecured Notes [Member] | |
Debt Instrument [Line Items] | |
Senior notes, repurchased price percentage on principal amount plus accrued and unpaid interest | 101.00% |
Debt - Additional Information (
Debt - Additional Information (Detail) € in Millions, $ in Millions | 1 Months Ended | 12 Months Ended | ||||
Jul. 31, 2019USD ($) | Dec. 31, 2021USD ($) | Dec. 31, 2021EUR (€) | Dec. 31, 2020USD ($) | Dec. 23, 2019USD ($) | ||
0.993% Senior Unsecured Notes due 2026 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Senior unsecured notes, interest rate | [1] | 0.993% | 0.993% | 0.993% | ||
Senior unsecured notes, maturity year | 2026 | 2026 | ||||
4.000% Senior Unsecured Notes Due 2022 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Senior unsecured notes, interest rate | [1] | 4.00% | 4.00% | 4.00% | ||
Senior unsecured notes, maturity year | 2022 | 2022 | ||||
Senior unsecured notes redemption amount including accrued and unpaid interest | € | € 500 | |||||
Term Loans [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Debt refinancing costs | € 20 | $ 28 | ||||
Accelerated debt issue cost amortization expense | $ 2 | |||||
3.500% Senior Unsecured Notes Due 2031 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Senior unsecured notes, interest rate | 3.50% | 3.50% | 3.50% | |||
Senior unsecured notes, maturity year | 2031 | |||||
6.375% Senior Unsecured Notes due 2024 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Senior unsecured notes, interest rate | 6.375% | |||||
Senior unsecured notes, maturity year | 2024 | |||||
Senior unsecured notes redemption amount including accrued and unpaid interest | $ 500 | |||||
5.500% Senior Unsecured Notes due 2024 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Senior unsecured notes, interest rate | 5.50% | |||||
Senior unsecured notes, maturity year | 2024 | |||||
Senior unsecured notes redemption amount including accrued and unpaid interest | $ 300 | |||||
Senior Unsecured Term Loan Facility [Member] | Barclays Bank PLC [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Underwriting and other fees | $ 4 | |||||
Waterland Private Equity Fund VII C.V. [Member] | Interim Credit Facility [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Debt refinancing costs | $ 7.3 | |||||
[1] | Non-U.S. dollar denominated debt that reflects the exchange rate at period-end. |
Debt - Covenants - Additional I
Debt - Covenants - Additional Information (Detail) | 12 Months Ended |
Dec. 31, 2021 | |
Debt Disclosure [Abstract] | |
Percentage of dividends which could be paid from adjusted operating funds | 95.00% |
Percentage of dividends which could be paid from operation funds | 95.00% |
Maximum percentage of total unencumbered assets | 150.00% |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Detail) - USD ($) | Apr. 01, 2023 | Jun. 30, 2021 | Sep. 30, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Income Taxes [Line Items] | ||||||
Percentage of ordinary taxable income to be distributed for real estate investment trust qualification | 90.00% | 90.00% | 90.00% | |||
Percentage of taxable income to be distributed for federal income tax assumption | 100.00% | |||||
Amount of foreign income (loss) before income taxes | $ 164,000,000 | $ 62,100,000 | $ 10,700,000 | |||
Amount of domestic income (loss) before income taxes | $ (29,700,000) | $ 6,400,000 | $ (44,100,000) | |||
Income tax at the US statutory federal rate | 21.00% | 21.00% | 21.00% | |||
Change in the corporate income tax rate , charge | $ 43,924,000 | $ 9,471,000 | ||||
Valuation allowance not expected to be realized | 24,800,000 | |||||
Uncertain tax position liabilities and related interest or penalties | $ 0 | |||||
United Kingdom [Member] | ||||||
Income Taxes [Line Items] | ||||||
Income tax at the US statutory federal rate | 19.00% | |||||
Deferred tax liabilities, one time adjustment | $ 43,000,000 | |||||
Change in the corporate income tax rate , charge | $ 9,000,000 | |||||
United Kingdom [Member] | Minimum [Member] | ||||||
Income Taxes [Line Items] | ||||||
Income tax at the US statutory federal rate | 17.00% | |||||
United Kingdom [Member] | Maximum [Member] | ||||||
Income Taxes [Line Items] | ||||||
Income tax at the US statutory federal rate | 19.00% | |||||
United Kingdom [Member] | Forecast [Member] | ||||||
Income Taxes [Line Items] | ||||||
Income tax at the US statutory federal rate | 25.00% |
Income Taxes - Schedule of Inco
Income Taxes - Schedule of Income Tax (Expense) Benefit (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Current income tax (expense) benefit: | |||
Domestic | $ (1,559) | $ 63 | $ 61 |
Foreign | (18,964) | (10,203) | (1,669) |
Total income tax expense | (20,523) | (10,140) | (1,608) |
Deferred income tax (expense) benefit: | |||
Domestic | 6,915 | (10,680) | 5,490 |
Foreign | (60,340) | (10,236) | (1,261) |
Total income tax expense | (53,425) | (20,916) | 4,229 |
Income tax (expense) benefit | $ (73,948) | $ (31,056) | $ 2,621 |
Income Taxes - Summary of Recon
Income Taxes - Summary of Reconciliation of Income Tax (Expense) Benefit from the Statutory Income Tax Rate to the Effective Tax Rate Based on Income before Income Taxes (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Income Tax Disclosure [Abstract] | |||
Income before income tax | $ 730,888 | $ 463,328 | $ 373,780 |
Income tax at the U.S. statutory federal rate (21% in 2021, 2020, and 2019) | (153,486) | (97,299) | (78,494) |
Decrease (increase) in income tax resulting from: | |||
Foreign rate differential | 2,742 | 2,160 | 438 |
State income taxes, net of federal benefit | 970 | 1,621 | |
U.S. earnings not subject to federal income tax | 132,266 | 82,921 | 85,495 |
Equity investments | 380 | 1,091 | |
Change in valuation allowance | (10,040) | (8,514) | (7,911) |
Statutory tax rate change | (43,924) | (9,471) | |
Interest disallowance | (646) | ||
Other items, net | (860) | (2,203) | 381 |
Income tax (expense) benefit | $ (73,948) | $ (31,056) | $ 2,621 |
Income Taxes - Summary of Rec_2
Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) from the Statutory Income Tax Rate to the Effective Tax Rate Based on Income before Income Taxes (Parenthetical) (Detail) | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Income Tax Disclosure [Abstract] | |||
Income tax at the US statutory federal rate | 21.00% | 21.00% | 21.00% |
Income Taxes - Schedule of Defe
Income Taxes - Schedule of Deferred Tax Assets and liabilities (Detail) - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 |
Income Tax Disclosure [Abstract] | ||
Operating loss and interest deduction carry forwards | $ 197,876 | $ 150,001 |
Interest rate swap | 9,150 | |
Other | 1,815 | 6,973 |
Total deferred tax assets | 199,691 | 166,124 |
Valuation allowance | (61,747) | (36,977) |
Total net deferred tax assets | 137,944 | 129,147 |
Property and equipment | (320,546) | (211,018) |
Net unbilled revenue | (43,366) | (14,776) |
Partnership investments | (15,963) | |
Other | (3,836) | (4,010) |
Total deferred tax liabilities | (383,711) | (229,804) |
Net deferred tax asset (liability) | $ (245,767) | $ (100,657) |
Income Taxes - Schedule of Net
Income Taxes - Schedule of Net NOL and Other Tax Attribute Carryforwards (Detail) $ in Thousands | 12 Months Ended |
Dec. 31, 2021USD ($) | |
U.S. [Member] | |
Income Taxes [Line Items] | |
Gross NOL carryforwards | $ 239,520 |
Tax-effected NOL carryforwards | 28,837 |
Valuation allowance | (6,291) |
Net deferred tax asset - NOL carryforwards | $ 22,546 |
Expiration periods | 2030 |
Expiration periods | indefinite |
Foreign [Member] | |
Income Taxes [Line Items] | |
Gross NOL carryforwards | $ 699,514 |
Tax-effected NOL carryforwards | 169,039 |
Valuation allowance | (45,578) |
Net deferred tax asset - NOL carryforwards | $ 123,461 |
Expiration periods | indefinite |
Income Taxes - Schedule of Per
Income Taxes - Schedule of Per Share Distributions to Stockholders (Detail) - $ / shares | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Income Tax Disclosure [Abstract] | |||
Common share distribution | $ 1.110000 | $ 1.070000 | $ 1.010000 |
Ordinary income | 0.764580 | 0.603050 | 0.701910 |
Capital gains | 0.165420 | 0.275040 | |
Unrecaptured Sec. 1250 gain | 0.058270 | 0.041160 | |
Section 199A Dividends | 0.764580 | 0.603050 | 0.701910 |
Return of capital | $ 0.180000 | $ 0.466950 | $ 0.033050 |
Earnings Per Share_Unit - Calcu
Earnings Per Share/Unit - Calculation of Earnings Per Share (Detail) - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | |||
Net income | $ 656,940 | $ 432,272 | $ 376,401 |
Non-controlling interests’ share in earnings | (919) | (822) | (1,717) |
Participating securities’ share in earnings | (2,161) | (2,105) | (2,308) |
Net income, less participating securities’ share in earnings | $ 653,860 | $ 429,345 | $ 372,376 |
Basic weighted-average common shares | 588,817 | 529,239 | 427,075 |
Dilutive potential common shares | 1,322 | 1,222 | 1,224 |
Diluted weighted-average common shares | 590,139 | 530,461 | 428,299 |
MPT Operating Partnership, L.P. [Member] | |||
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | |||
Net income | $ 656,940 | $ 432,272 | $ 376,401 |
Non-controlling interests’ share in earnings | (919) | (822) | (1,717) |
Participating securities’ share in earnings | (2,161) | (2,105) | (2,308) |
Net income, less participating securities’ share in earnings | $ 653,860 | $ 429,345 | $ 372,376 |
Basic weighted-average common shares | 588,817 | 529,239 | 427,075 |
Dilutive potential common shares | 1,322 | 1,222 | 1,224 |
Diluted weighted-average common shares | 590,139 | 530,461 | 428,299 |
Stock Awards - Additional Infor
Stock Awards - Additional Information (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share / (Unit)-based compensation expense | $ 52,110 | $ 47,154 | $ 32,188 |
Stock-based compensation expense, unrecognized cost | $ 49,900 | ||
Stock-based compensation expense, unrecognized cost, reorganization period (in years) | 1 year 1 month 6 days | ||
Stock-based awards, fair value | $ 49,900 | $ 58,900 | $ 25,900 |
Maximum [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Stock awards vesting period in years | 10 years | ||
Equity Incentive Plan [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Reserved shares of new common stock for awards under the Equity Incentive Plan | 12,900,000 | ||
Common stock remaining for future stock awards transferred to the equity incentive plan | 5,700,000 | ||
Maximum number of shares of common stock that may be awarded | 5,000,000 | ||
Service-Based Awards [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based compensation arrangement by share based payment award, expected service period (in years) | 3 years | ||
Performance-Based Awards [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based compensation arrangement by share based payment award, expected service period (in years) | 3 years |
Stock Awards - Stock-based Awar
Stock Awards - Stock-based Award Activity (Detail) - $ / shares | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Vesting Based on Service [Member] | ||
Employee Restricted Equity Awards Vesting Activity [Line Items] | ||
Nonvested awards at beginning of the year, Shares | 1,057,054 | 1,122,440 |
Awarded, Shares | 651,113 | 635,855 |
Vested, Shares | (781,076) | (699,215) |
Forfeited, Shares | (4,137) | (2,026) |
Nonvested awards at end of year, Shares | 922,954 | 1,057,054 |
Nonvested awards at beginning of the year, Weighted Average Value at Award Date | $ 18.79 | $ 17.11 |
Awarded, Weighted Average Value at Award Date | 20.83 | 19.65 |
Vested, Weighted Average Value at Award Date | 18.77 | 16.80 |
Forfeited, Weighted Average Value at Award Date | 18.69 | 18.40 |
Nonvested awards at end of year, Weighted Average Value at Award Date | $ 20.26 | $ 18.79 |
Vesting Based on Market/Performance Conditions [Member] | ||
Employee Restricted Equity Awards Vesting Activity [Line Items] | ||
Nonvested awards at beginning of the year, Shares | 5,086,983 | 5,481,155 |
Awarded, Shares | 1,957,802 | 1,800,898 |
Vested, Shares | (1,551,482) | (2,193,906) |
Forfeited, Shares | (15,767) | (1,164) |
Nonvested awards at end of year, Shares | 5,477,536 | 5,086,983 |
Nonvested awards at beginning of the year, Weighted Average Value at Award Date | $ 14.41 | $ 11.66 |
Awarded, Weighted Average Value at Award Date | 17.94 | 19.42 |
Vested, Weighted Average Value at Award Date | 13.73 | 11.35 |
Forfeited, Weighted Average Value at Award Date | 16.72 | 18.22 |
Nonvested awards at end of year, Weighted Average Value at Award Date | $ 15.86 | $ 14.41 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Detail) - Hospital | Sep. 15, 2021 | Dec. 17, 2019 | Dec. 31, 2021 | Dec. 31, 2020 |
Steward Health Care System LLC [Member] | ||||
Commitment And Contingencies [Line Items] | ||||
Number of facilities acquired | 2 | |||
HCA Healthcare [Member] | ||||
Commitment And Contingencies [Line Items] | ||||
Number of facilities acquired | 5 | |||
Percentage of total assets leased | 5.50% | |||
HCA Healthcare [Member] | Steward Health Care System LLC [Member] | ||||
Commitment And Contingencies [Line Items] | ||||
Number of facilities acquired | 5 | |||
Acute Care Hospital [Member] | ||||
Commitment And Contingencies [Line Items] | ||||
Number of facilities acquired | 10 | 2 | ||
Acute Care Hospital [Member] | HCA Healthcare [Member] | ||||
Commitment And Contingencies [Line Items] | ||||
Number of facilities acquired | 5 |
Common Stock_Partners' Capital
Common Stock/Partners' Capital - Additional Information (Detail) - USD ($) shares in Thousands, $ in Thousands | Jan. 11, 2021 | Dec. 28, 2020 | Nov. 08, 2019 | Jul. 18, 2019 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Class Of Stock [Line Items] | |||||||
Common stock, shares issued | 596,814 | 541,419 | |||||
Proceeds from sale of common shares / units, net of offering costs | $ 1,051,229 | $ 411,101 | $ 2,533,210 | ||||
Redemption of common units | 4,928 | ||||||
MPT Operating Partnership, L.P. [Member] | |||||||
Class Of Stock [Line Items] | |||||||
Redemption of common units | $ 4,900 | $ 4,928 | |||||
MPT Operating Partnership, L.P. [Member] | Medical Properties Trust, LLC. [Member] | |||||||
Class Of Stock [Line Items] | |||||||
Percentage of ownership of general partner | 100.00% | ||||||
MPT Operating Partnership, L.P. [Member] | MPT TRS, Inc [Member] | |||||||
Class Of Stock [Line Items] | |||||||
Percentage of ownership of general partner | 100.00% | ||||||
MPT Operating Partnership, L.P. [Member] | Operating Partnership [Member] | |||||||
Class Of Stock [Line Items] | |||||||
Percentage of ownership limited partner | 100.00% | ||||||
Common Units [Member] | |||||||
Class Of Stock [Line Items] | |||||||
Number of share sold | 53,063 | 21,004 | 145,349 | ||||
Common Units [Member] | MPT Operating Partnership, L.P. [Member] | Limited Partner [Member] | |||||||
Class Of Stock [Line Items] | |||||||
Number of share sold | 52,532 | 20,795 | 143,894 | ||||
Conversion of LTIP units to common units | 232 | 232 | |||||
Redemption of common units | $ 4,928 | ||||||
Public Offering [Member] | |||||||
Class Of Stock [Line Items] | |||||||
Common stock, shares issued | 36,800 | 57,500 | 51,750 | ||||
Proceeds from sale of common shares / units, net of offering costs | $ 711,000 | $ 1,026,000 | |||||
Additional shares purchased by underwriters | 858,100 | ||||||
At-the-Market Equity Offering Program [Member] | |||||||
Class Of Stock [Line Items] | |||||||
Proceeds from sale of common shares / units, net of offering costs | $ 340,000 | $ 650,000 | |||||
At-the-Market Equity Offering Program [Member] | Common Units [Member] | |||||||
Class Of Stock [Line Items] | |||||||
Number of share sold | 16,300 | 21,000 | 36,100 |
Fair Value of Financial Instr_3
Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail) - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 |
Fair Value Disclosures [Abstract] | ||
Interest and rent receivables, Book value | $ 56,229 | $ 46,208 |
Loans, Book value | 991,609 | 751,341 |
Debt, net Book value | (11,282,770) | (8,865,458) |
Interest and rent receivables, Fair value | 56,564 | 45,381 |
Loans, Fair value | 991,954 | 756,608 |
Debt, net Fair value | $ (11,526,388) | $ (9,226,564) |
Fair Value of Financial Instr_4
Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Parenthetical) (Detail) - Fair Value, Recurring - Colombia [Member] | 12 Months Ended |
Dec. 31, 2021Health_Center | |
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | |
Number of facilities acquired | 3 |
Acquisition Loans [Member] | |
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | |
Number of facilities acquired | 3 |
Fair Value of Financial Instr_5
Fair Value of Financial Instruments - Additional Information (Detail) | 12 Months Ended |
Dec. 31, 2021Health_Center | |
Springstone Inc. and International Joint Venture [Member] | |
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | |
Percentage of equity investment | 40.00% |
Fair Value, Recurring | Colombia [Member] | |
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | |
Number of facilities acquired | 3 |
Fair Value of Financial Instr_6
Fair Value of Financial Instruments - Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis (Detail) - Fair Value, Recurring - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 |
Mortgage Loans [Member] | ||
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | ||
Fair Value | $ 143,068 | $ 136,332 |
Original Cost | 143,068 | 136,332 |
Equity Method Investment and Other Loans [Member] | ||
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | ||
Fair Value | 409,638 | 218,775 |
Original Cost | $ 409,638 | $ 218,775 |
Fair Value of Financial Instr_7
Fair Value of Financial Instruments - Schedule of Effects of Movement in DLOM by Sensitivity Analysis by Using Basis Point Variations (Detail) - Springstone Inc. and International Joint Venture [Member] $ in Thousands | 12 Months Ended |
Dec. 31, 2021USD ($) | |
+ 100 Basis Points [Member] | |
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | |
Estimated Increase (Decrease) in Fair Value | $ (41) |
- 100 Basis Points [Member] | |
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | |
Estimated Increase (Decrease) in Fair Value | $ 41 |
Leases (Lessee) - Summary of Le
Leases (Lessee) - Summary of Lease Expense (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | ||
Lessee Lease Description [Line Items] | |||
Operating lease cost | [1],[2] | $ 10,694 | $ 9,910 |
Finance lease cost: | |||
Total lease cost | 6,407 | 7,475 | |
Real Estate Depreciation and Amortization [Member] | |||
Finance lease cost: | |||
Amortization of right-of-use assets | 51 | 51 | |
Interest [Member] | |||
Finance lease cost: | |||
Interest on lease liabilities | 128 | 128 | |
Other [Member] | |||
Finance lease cost: | |||
Sublease income | $ (4,466) | $ (2,614) | |
[1] | $6.3 million and $6.0 million included in “Property-related”, with the remainder reflected in the “General and administrative” line of our consolidated statements of net income for 2021 and 2020, respectively. | ||
[2] | Includes short-term leases. |
Leases (Lessee) - Summary of _2
Leases (Lessee) - Summary of Lease Expense (Parenthetical) (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | ||
Lessee Lease Description [Line Items] | |||
Operating lease cost | [1],[2] | $ 10,694 | $ 9,910 |
Property-related [Member] | |||
Lessee Lease Description [Line Items] | |||
Operating lease cost | $ 6,300 | $ 6,000 | |
[1] | $6.3 million and $6.0 million included in “Property-related”, with the remainder reflected in the “General and administrative” line of our consolidated statements of net income for 2021 and 2020, respectively. | ||
[2] | Includes short-term leases. |
Leases (Lessee) - Schedule of F
Leases (Lessee) - Schedule of Fixed Minimum Rental Payments Due under Leases with Non-Cancelable Terms (Detail) - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 | |
Leases [Abstract] | |||
Operating Leases, 2021 | $ 7,376 | ||
Operating Leases, 2022 | 7,448 | ||
Operating Leases, 2023 | 6,559 | ||
Operating Leases, 2024 | 5,666 | ||
Operating Leases, 2025 | 5,255 | ||
Operating Leases, Thereafter | 239,727 | ||
Operating Leases, Total undiscounted minimum lease payments | 272,031 | ||
Operating Leases, Less: interest | (186,814) | ||
Operating Leases, Present value of lease liabilities | 85,217 | $ 90,006 | |
Finance Leases, 2021 | 128 | ||
Finance Leases, 2022 | 129 | ||
Finance Leases, 2023 | 130 | ||
Finance Leases, 2024 | 131 | ||
Finance Leases, 2025 | 133 | ||
Finance Leases, Thereafter | 4,650 | ||
Finance Leases, Total undiscounted minimum lease payments | 5,301 | ||
Finance Leases, Less: interest | (3,364) | ||
Finance Leases, Present value of lease liabilities | 1,937 | $ 1,935 | |
Amounts To Be Received From Subleases, 2021 | (4,143) | ||
Amounts To Be Received From Subleases, 2022 | (3,963) | ||
Amounts To Be Received From Subleases, 2023 | (3,987) | ||
Amounts To Be Received From Subleases, 2024 | (4,044) | ||
Amounts To Be Received From Subleases, 2025 | (4,015) | ||
Amounts To Be Received From Subleases, Thereafter | (71,286) | ||
Amounts To Be Received From Subleases, Total undiscounted minimum lease payments | (91,438) | ||
Net Payments, 2021 | 3,361 | ||
Net Payments, 2022 | 3,614 | ||
Net Payments, 2023 | 2,702 | ||
Net Payments, 2024 | 1,753 | ||
Net Payments, 2025 | 1,373 | ||
Net Payments, Thereafter | [1] | 173,091 | |
Net Payments, Total undiscounted minimum lease payments | $ 185,894 | ||
[1] | Reflects certain ground leases, in which we are the lessee, that have longer initial fixed terms than our existing sublease to our tenants. However, we would expect to either renew the related sublease, enter into a lease with a new tenant, or early terminate the ground lease to reduce or avoid any significant impact from such ground leases. |
Leases (Lessee) - Summary of Su
Leases (Lessee) - Summary of Supplemental Balance Sheet Information (Detail) - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Right of use assets: | |||
Operating leases | $ 7,458 | $ 8,234 | |
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] | Other assets | Other assets | |
Total real estate right of use assets | $ 70,401 | $ 75,209 | $ 61,400 |
Total right of use assets | 77,859 | 83,443 | |
Lease liabilities: | |||
Operating leases | $ 85,217 | $ 90,006 | |
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] | us-gaap:OtherLiabilities | us-gaap:OtherLiabilities | |
Financing leases | $ 1,937 | $ 1,935 | |
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration] | us-gaap:OtherLiabilities | us-gaap:OtherLiabilities | |
Total lease liabilities | $ 87,154 | $ 91,941 | |
Weighted-average remaining lease term: | |||
Operating leases | 40 years 7 months 6 days | 41 years 1 month 6 days | |
Finance leases | 34 years 10 months 24 days | 35 years 10 months 24 days | |
Weighted-average discount rate: | |||
Operating leases | 6.40% | 6.40% | |
Finance leases | 6.60% | 6.60% | |
Real Estate [Member] | |||
Right of use assets: | |||
Operating leases | $ 68,616 | $ 73,373 | |
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] | Land | Land | |
Finance leases | $ 1,785 | $ 1,836 | |
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] | Land | Land |
Leases (Lessee) - Summary of _3
Leases (Lessee) - Summary of Supplemental Cash Flow Information (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Cash paid for amounts included in the measurement of lease liabilities: | ||
Operating cash flows from operating leases | $ 7,330 | $ 6,080 |
Operating cash flows from finance leases | 126 | 125 |
Non-cash activities - Right-of-use assets obtained in exchange for lease obligations: | ||
Operating leases | $ 1,120 | $ 13,832 |
Other Assets - Summary of Other
Other Assets - Summary of Other Assets on our Condensed Consolidated Balance Sheets (Detail) - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 | |
Other Assets [Abstract] | |||
Debt issue costs, net | [1] | $ 5,488 | $ 192 |
Other corporate assets | 193,749 | 167,929 | |
Prepaids and other assets | 134,243 | 87,948 | |
Total other assets | $ 333,480 | $ 256,069 | |
[1] | Relates to our revolving credit facility |
Other Assets - Additional Infor
Other Assets - Additional Information (Detail) - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 |
Other Assets [Abstract] | ||
Equity investments | $ 1,181,025 | $ 1,123,623 |
Schedule II - Schedule of Valua
Schedule II - Schedule of Valuation and Qualifying Accounts (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Valuation And Qualifying Accounts [Abstract] | |||
Balance at Beginning of Year | $ 146,637 | $ 109,803 | $ 66,131 |
Additions, Charged Against Operations | 69,131 | 58,044 | 50,893 |
Addition, Charged to Other Accounts | 7,340 | 22,944 | |
Deductions, Net Recoveries/Write-offs | (68,947) | (44,154) | (7,221) |
Balance at End of Year | $ 154,161 | $ 146,637 | $ 109,803 |
Schedule II - Schedule of Val_2
Schedule II - Schedule of Valuation and Qualifying Accounts (Parenthetical) (Detail) - USD ($) $ in Thousands | Jan. 08, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Jan. 01, 2020 |
Increase in real estate impairment reserves | $ 19,000 | $ 21,000 | |||
Equity investment impairments reserve related to disposals | $ 6,000 | ||||
Increase in accounts receivable and other reserves | 8,000 | 23,900 | 22,000 | ||
Decrease in accounts receivable and other reserves | 38,700 | ||||
Increase (decrease) in valuation allowances | 800 | ||||
Tax valuation allowances recorded as part of purchase price allocation | 7,340 | 22,944 | |||
Cumulative effect of change in accounting principle | 8,399 | ||||
Valuation allowances recorded as part of the purchase price allocation of the Circle Transaction | $ 14,500 | ||||
Increase (decrease) in real estate impairment reserves related to disposals | (22,400) | (40,500) | (7,200) | ||
Credit loss recovery related to loan paydowns | 1,900 | 2,900 | |||
Increase in credit loss reserves on financing-type receivables | 41,700 | 3,300 | |||
Priory Group [Member] | |||||
Tax valuation allowances recorded as part of purchase price allocation | 7,300 | ||||
Accounting Standards Update 2016-13 | |||||
Cumulative effect of change in accounting principle | $ 8,400 | ||||
Valuation Allowance, Deferred Tax Asset [Member] | |||||
Increase (decrease) in valuation allowances | $ 20,000 | $ 11,900 | $ 7,900 |
Schedule III - Real Estate In_2
Schedule III - Real Estate Investments and Accumulated Depreciation (Detail) - USD ($) $ in Thousands | 12 Months Ended | |||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Initial costs, land | $ 2,003,814 | |||
Initial costs, buildings | 10,998,157 | |||
Additions subsequent to acquisition, Improvements | 604,911 | |||
Additions subsequent to acquisition, carrying costs | 21,867 | |||
Land at cost | 2,059,236 | |||
Buildings at cost | 11,569,513 | |||
Total at cost | 13,628,749 | $ 10,749,707 | $ 7,312,486 | $ 4,781,149 |
Accumulated Depreciation | 853,879 | $ 728,176 | ||
Property Including Held for Sale [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Accumulated Depreciation | $ 950,369 | |||
Princes Risborough, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 4,955 | |||
Land at cost | 4,955 | |||
Total at cost | 4,955 | |||
Encumbrances | $ 0 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1981 [Member] | Ashtead, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 39,119 | |||
Initial costs, buildings | 75,253 | |||
Additions subsequent to acquisition, Improvements | 1,019 | |||
Land at cost | 40,138 | |||
Buildings at cost | 75,253 | |||
Total at cost | 115,391 | |||
Accumulated Depreciation | 4,588 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1981 | |||
Date Acquired | Aug. 16, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1981 [Member] | Beckenham, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 5,751 | |||
Initial costs, buildings | 22,266 | |||
Additions subsequent to acquisition, Improvements | 54 | |||
Land at cost | 5,805 | |||
Buildings at cost | 22,266 | |||
Total at cost | 28,071 | |||
Accumulated Depreciation | 1,121 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1981 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1981 [Member] | Cheadle, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 32,477 | |||
Initial costs, buildings | 173,216 | |||
Additions subsequent to acquisition, Improvements | 406 | |||
Land at cost | 32,883 | |||
Buildings at cost | 173,216 | |||
Total at cost | 206,099 | |||
Accumulated Depreciation | 8,715 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1981 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1981 [Member] | Dorchester, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 513 | |||
Initial costs, buildings | 33,313 | |||
Additions subsequent to acquisition, Improvements | 61 | |||
Land at cost | 574 | |||
Buildings at cost | 33,313 | |||
Total at cost | 33,887 | |||
Accumulated Depreciation | 1,674 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1981 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1981 [Member] | Euxton, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 4,047 | |||
Initial costs, buildings | 37,797 | |||
Additions subsequent to acquisition, Improvements | 861 | |||
Land at cost | 4,908 | |||
Buildings at cost | 37,797 | |||
Total at cost | 42,705 | |||
Accumulated Depreciation | 2,372 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1981 | |||
Date Acquired | Aug. 16, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1981 [Member] | Great Missenden, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 12,179 | |||
Initial costs, buildings | 111,784 | |||
Additions subsequent to acquisition, Improvements | 332 | |||
Land at cost | 12,511 | |||
Buildings at cost | 111,784 | |||
Total at cost | 124,295 | |||
Accumulated Depreciation | 5,633 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1981 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1981 [Member] | Torquay, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,812 | |||
Initial costs, buildings | 37,991 | |||
Additions subsequent to acquisition, Improvements | 357 | |||
Land at cost | 3,168 | |||
Buildings at cost | 37,992 | |||
Total at cost | 41,160 | |||
Accumulated Depreciation | 2,286 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1981 | |||
Date Acquired | Aug. 16, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2008 [Member] | Bath, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,604 | |||
Initial costs, buildings | 33,245 | |||
Land at cost | 1,604 | |||
Buildings at cost | 33,245 | |||
Total at cost | 34,849 | |||
Accumulated Depreciation | 6,233 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2008 | |||
Date Acquired | Jul. 1, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2008 [Member] | Arnold, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 147 | |||
Initial costs, buildings | 10,540 | |||
Additions subsequent to acquisition, Improvements | 360 | |||
Land at cost | 507 | |||
Buildings at cost | 10,540 | |||
Total at cost | 11,047 | |||
Accumulated Depreciation | 145 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2008 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2008 [Member] | Boise, ID [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Long term acute care hospital | |||
Initial costs, land | $ 1,558 | |||
Initial costs, buildings | 11,027 | |||
Land at cost | 1,558 | |||
Buildings at cost | 11,027 | |||
Total at cost | 12,585 | |||
Accumulated Depreciation | 864 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2008 | |||
Date Acquired | Feb. 29, 2012 | |||
Life on which depreciation in latest income statements is computed (Years) | 50 years | |||
2008 [Member] | Boardman, OH [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Long term acute care hospital | |||
Initial costs, land | $ 79 | |||
Initial costs, buildings | 275 | |||
Land at cost | 79 | |||
Buildings at cost | 275 | |||
Total at cost | 354 | |||
Accumulated Depreciation | 18 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2008 | |||
Date Acquired | Aug. 30, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2008 [Member] | Crown Point, IN [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Long term acute care hospital | |||
Initial costs, land | $ 302 | |||
Initial costs, buildings | 528 | |||
Land at cost | 302 | |||
Buildings at cost | 528 | |||
Total at cost | 830 | |||
Accumulated Depreciation | 39 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2008 | |||
Date Acquired | Aug. 30, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2008 [Member] | Denville, NJ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 15,709 | |||
Initial costs, buildings | 55,772 | |||
Land at cost | 15,709 | |||
Buildings at cost | 55,772 | |||
Total at cost | 71,481 | |||
Accumulated Depreciation | 1,781 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2008 | |||
Date Acquired | Sep. 30, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2008 [Member] | Dover NJ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,865 | |||
Initial costs, buildings | 8,693 | |||
Land at cost | 3,865 | |||
Buildings at cost | 8,693 | |||
Total at cost | 12,558 | |||
Accumulated Depreciation | 295 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2008 | |||
Date Acquired | Sep. 30, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2008 [Member] | Lubbock, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 1,376 | |||
Initial costs, buildings | 28,292 | |||
Additions subsequent to acquisition, Improvements | 3,648 | |||
Land at cost | 1,376 | |||
Buildings at cost | 31,940 | |||
Total at cost | 33,316 | |||
Accumulated Depreciation | 5,094 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2008 | |||
Date Acquired | Jun. 16, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2008 [Member] | Sheffield, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 6,766 | |||
Initial costs, buildings | 47,422 | |||
Additions subsequent to acquisition, Improvements | 264 | |||
Land at cost | 7,030 | |||
Buildings at cost | 47,422 | |||
Total at cost | 54,452 | |||
Accumulated Depreciation | 2,406 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2008 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Two Thousand Fourteen | Altoona, WI [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, buildings | $ 29,062 | |||
Buildings at cost | 29,062 | |||
Total at cost | 29,062 | |||
Accumulated Depreciation | 5,328 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2014 | |||
Date Acquired | Aug. 31, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Two Thousand Fourteen | Alvin, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 105 | |||
Initial costs, buildings | 4,087 | |||
Land at cost | 105 | |||
Buildings at cost | 4,087 | |||
Total at cost | 4,192 | |||
Accumulated Depreciation | 769 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2014 | |||
Date Acquired | Mar. 19, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Two Thousand Fourteen | Commerce City, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 707 | |||
Initial costs, buildings | 4,248 | |||
Land at cost | 707 | |||
Buildings at cost | 4,248 | |||
Total at cost | 4,955 | |||
Accumulated Depreciation | 752 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2014 | |||
Date Acquired | Dec. 11, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Two Thousand Fourteen | Broomfield, CO [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 825 | |||
Initial costs, buildings | 3,895 | |||
Land at cost | 825 | |||
Buildings at cost | 3,895 | |||
Total at cost | 4,720 | |||
Accumulated Depreciation | 730 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2014 | |||
Date Acquired | Jul. 3, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Two Thousand Fourteen | Colorado Springs CO [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 600 | |||
Initial costs, buildings | 4,231 | |||
Land at cost | 600 | |||
Buildings at cost | 4,231 | |||
Total at cost | 4,831 | |||
Accumulated Depreciation | 802 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2014 | |||
Date Acquired | Jun. 5, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Two Thousand Fourteen | Firestone, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 495 | |||
Initial costs, buildings | 3,963 | |||
Land at cost | 495 | |||
Buildings at cost | 3,963 | |||
Total at cost | 4,458 | |||
Accumulated Depreciation | 751 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2014 | |||
Date Acquired | Jun. 6, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Two Thousand Fourteen | Fort Worth T X | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 3,406 | |||
Initial costs, buildings | 34,862 | |||
Land at cost | 3,406 | |||
Buildings at cost | 34,862 | |||
Total at cost | 38,268 | |||
Accumulated Depreciation | 161 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2014 | |||
Date Acquired | Oct. 19, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Two Thousand Fourteen | Fountain, CO [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 1,508 | |||
Initial costs, buildings | 4,131 | |||
Land at cost | 1,508 | |||
Buildings at cost | 4,131 | |||
Total at cost | 5,639 | |||
Accumulated Depreciation | 766 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2014 | |||
Date Acquired | Jul. 31, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Two Thousand Fourteen | Georgetown, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 4,569 | |||
Initial costs, buildings | 23,028 | |||
Land at cost | 4,569 | |||
Buildings at cost | 23,028 | |||
Total at cost | 27,597 | |||
Accumulated Depreciation | 106 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2014 | |||
Date Acquired | Oct. 19, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Two Thousand Fourteen | Pearland, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 1,075 | |||
Initial costs, buildings | 3,577 | |||
Land at cost | 1,075 | |||
Buildings at cost | 3,577 | |||
Total at cost | 4,652 | |||
Accumulated Depreciation | 656 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2014 | |||
Date Acquired | Sep. 8, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Two Thousand Fourteen | San Antonio, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 351 | |||
Initial costs, buildings | 3,952 | |||
Land at cost | 351 | |||
Buildings at cost | 3,952 | |||
Total at cost | 4,303 | |||
Accumulated Depreciation | 765 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2014 | |||
Date Acquired | Jan. 1, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Two Thousand Fourteen | Richmond, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 4,602 | |||
Initial costs, buildings | 6,224 | |||
Land at cost | 4,602 | |||
Buildings at cost | 6,224 | |||
Total at cost | 10,826 | |||
Accumulated Depreciation | 36 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2014 | |||
Date Acquired | Oct. 19, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Two Thousand Fourteen | Thornton, CO [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 1,350 | |||
Initial costs, buildings | 4,259 | |||
Land at cost | 1,350 | |||
Buildings at cost | 4,259 | |||
Total at cost | 5,609 | |||
Accumulated Depreciation | 781 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2014 | |||
Date Acquired | Aug. 29, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1887 [Member} | Bassenheim, Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 999 | |||
Initial costs, buildings | 5,448 | |||
Additions subsequent to acquisition, Improvements | 170 | |||
Land at cost | 1,169 | |||
Buildings at cost | 5,448 | |||
Total at cost | 6,617 | |||
Accumulated Depreciation | 441 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1887 | |||
Date Acquired | Feb. 9, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 39 years | |||
1964 [Member] | Anaheim, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,875 | |||
Initial costs, buildings | 21,813 | |||
Additions subsequent to acquisition, carrying costs | 10 | |||
Land at cost | 1,875 | |||
Buildings at cost | 21,823 | |||
Total at cost | 23,698 | |||
Accumulated Depreciation | 8,275 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1964 | |||
Date Acquired | Nov. 8, 2006 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1964 [Member] | San Diego, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 6,550 | |||
Initial costs, buildings | 15,653 | |||
Additions subsequent to acquisition, carrying costs | 77 | |||
Land at cost | 6,550 | |||
Buildings at cost | 15,730 | |||
Total at cost | 22,280 | |||
Accumulated Depreciation | 5,766 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1964 | |||
Date Acquired | May 9, 2007 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1974 [Member] | Bad Salzuflen, Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 9,888 | |||
Initial costs, buildings | 27,378 | |||
Additions subsequent to acquisition, Improvements | 930 | |||
Land at cost | 10,818 | |||
Buildings at cost | 27,378 | |||
Total at cost | 38,196 | |||
Accumulated Depreciation | 3,048 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1974 | |||
Date Acquired | Nov. 30, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1974 [Member] | Redding, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,555 | |||
Initial costs, buildings | 53,863 | |||
Additions subsequent to acquisition, carrying costs | 13 | |||
Land at cost | 1,555 | |||
Buildings at cost | 53,876 | |||
Total at cost | 55,431 | |||
Accumulated Depreciation | 19,425 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1974 | |||
Date Acquired | Aug. 10, 2007 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1974 [Member] | Sebastian Fl | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 5,733 | |||
Initial costs, buildings | 49,136 | |||
Additions subsequent to acquisition, Improvements | 54,977 | |||
Land at cost | 5,733 | |||
Buildings at cost | 104,113 | |||
Total at cost | 109,846 | |||
Accumulated Depreciation | 8,269 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1974 | |||
Date Acquired | May 1, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
2017 [Member] | Birmingham, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 9,103 | |||
Initial costs, buildings | 47,756 | |||
Land at cost | 9,103 | |||
Buildings at cost | 47,756 | |||
Total at cost | 56,859 | |||
Accumulated Depreciation | 1,784 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2017 | |||
Date Acquired | Apr. 3, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2017 [Member] | Austin T X | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 3,722 | |||
Initial costs, buildings | 4,200 | |||
Land at cost | 3,722 | |||
Buildings at cost | 4,200 | |||
Total at cost | 7,922 | |||
Accumulated Depreciation | 538 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2017 | |||
Date Acquired | Mar. 2, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2017 [Member] | Columbus OH [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 2,101 | |||
Initial costs, buildings | 44,504 | |||
Land at cost | 2,101 | |||
Buildings at cost | 44,504 | |||
Total at cost | 46,605 | |||
Accumulated Depreciation | 203 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2017 | |||
Date Acquired | Oct. 19, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2017 [Member] | Englewood, CO [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 3,369 | |||
Initial costs, buildings | 65,905 | |||
Land at cost | 3,369 | |||
Buildings at cost | 65,905 | |||
Total at cost | 69,274 | |||
Accumulated Depreciation | 297 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2017 | |||
Date Acquired | Oct. 19, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2017 [Member] | Frome, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 9,920 | |||
Initial costs, buildings | 11,388 | |||
Additions subsequent to acquisition, Improvements | 1,660 | |||
Land at cost | 11,580 | |||
Buildings at cost | 11,388 | |||
Total at cost | 22,968 | |||
Accumulated Depreciation | 212 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2017 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2017 [Member] | Kansas City, KS [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,351 | |||
Initial costs, buildings | 13,665 | |||
Land at cost | 2,351 | |||
Buildings at cost | 13,665 | |||
Total at cost | 16,016 | |||
Accumulated Depreciation | 763 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2017 | |||
Date Acquired | Jun. 10, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 50 years | |||
2017 [Member] | Leawood, KS [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,513 | |||
Initial costs, buildings | 13,938 | |||
Land at cost | 2,513 | |||
Buildings at cost | 13,938 | |||
Total at cost | 16,451 | |||
Accumulated Depreciation | 774 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2017 | |||
Date Acquired | Jun. 10, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 50 years | |||
2017 [Member] | Overland Park, KS [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,974 | |||
Initial costs, buildings | 14,405 | |||
Land at cost | 2,974 | |||
Buildings at cost | 14,405 | |||
Total at cost | 17,379 | |||
Accumulated Depreciation | 812 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2017 | |||
Date Acquired | Jun. 10, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 50 years | |||
2017 [Member] | Monmouth, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 15,189 | |||
Initial costs, buildings | 12,283 | |||
Additions subsequent to acquisition, Improvements | 1,293 | |||
Land at cost | 16,482 | |||
Buildings at cost | 12,283 | |||
Total at cost | 28,765 | |||
Accumulated Depreciation | 208 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2017 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2017 [Member] | Oklahoma City, OK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 3,641 | |||
Initial costs, buildings | 3,091 | |||
Land at cost | 3,641 | |||
Buildings at cost | 3,091 | |||
Total at cost | 6,732 | |||
Accumulated Depreciation | 26 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2017 | |||
Date Acquired | Oct. 19, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2017 [Member] | Phoenix A Z | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 5,576 | |||
Initial costs, buildings | 45,782 | |||
Land at cost | 5,576 | |||
Buildings at cost | 45,782 | |||
Total at cost | 51,358 | |||
Accumulated Depreciation | 5,627 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2017 | |||
Date Acquired | Feb. 10, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2017 [Member] | Phoenix, AZ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 1,132 | |||
Initial costs, buildings | 5,052 | |||
Land at cost | 1,132 | |||
Buildings at cost | 5,052 | |||
Total at cost | 6,184 | |||
Accumulated Depreciation | 600 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2017 | |||
Date Acquired | Apr. 13, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2017 [Member] | Texarkana, Texas [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 14,562 | |||
Land at cost | 14,562 | |||
Total at cost | 14,562 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2017 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 0 years | |||
2017 [Member] | Valencia, Spain [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 7,354 | |||
Initial costs, buildings | 71,087 | |||
Additions subsequent to acquisition, Improvements | 4,107 | |||
Land at cost | 11,461 | |||
Buildings at cost | 71,087 | |||
Total at cost | 82,548 | |||
Accumulated Depreciation | 171 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2017 | |||
Date Acquired | Dec. 2, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Bad Salzuflen, Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 9,888 | |||
Initial costs, buildings | 27,378 | |||
Additions subsequent to acquisition, Improvements | 930 | |||
Land at cost | 10,818 | |||
Buildings at cost | 27,378 | |||
Total at cost | 38,196 | |||
Accumulated Depreciation | 3,048 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Nov. 30, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Birmingham, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, buildings | $ 20,376 | |||
Additions subsequent to acquisition, Improvements | 438 | |||
Land at cost | 438 | |||
Buildings at cost | 20,376 | |||
Total at cost | 20,814 | |||
Accumulated Depreciation | 273 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Avondale, AZ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 5,383 | |||
Initial costs, buildings | 65,080 | |||
Land at cost | 5,383 | |||
Buildings at cost | 65,080 | |||
Total at cost | 70,463 | |||
Accumulated Depreciation | 293 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Oct. 19, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Goodyear, AZ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 1,800 | |||
Initial costs, buildings | 4,713 | |||
Land at cost | 1,800 | |||
Buildings at cost | 4,713 | |||
Total at cost | 6,513 | |||
Accumulated Depreciation | 677 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Apr. 4, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Flagstaff, AZ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 3,049 | |||
Initial costs, buildings | 22,464 | |||
Land at cost | 3,049 | |||
Buildings at cost | 22,464 | |||
Total at cost | 25,513 | |||
Accumulated Depreciation | 2,153 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Aug. 23, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Helotes, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 1,900 | |||
Initial costs, buildings | 5,115 | |||
Land at cost | 1,900 | |||
Buildings at cost | 5,115 | |||
Total at cost | 7,015 | |||
Accumulated Depreciation | 746 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Mar. 10, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | 2020 [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 1,144 | |||
Initial costs, buildings | 6,087 | |||
Land at cost | 1,144 | |||
Buildings at cost | 6,087 | |||
Total at cost | 7,231 | |||
Accumulated Depreciation | 786 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Oct. 21, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Houston, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 950 | |||
Initial costs, buildings | 3,996 | |||
Land at cost | 950 | |||
Buildings at cost | 3,996 | |||
Total at cost | 4,946 | |||
Accumulated Depreciation | 525 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Sep. 26, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Highlands Ranch, CO [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 4,200 | |||
Initial costs, buildings | 4,779 | |||
Land at cost | 4,200 | |||
Buildings at cost | 4,779 | |||
Total at cost | 8,979 | |||
Accumulated Depreciation | 647 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Jul. 25, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Katy, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 1,580 | |||
Initial costs, buildings | 4,174 | |||
Land at cost | 1,580 | |||
Buildings at cost | 4,174 | |||
Total at cost | 5,754 | |||
Accumulated Depreciation | 548 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Oct. 10, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Houston T X | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 4,047 | |||
Initial costs, buildings | 36,862 | |||
Land at cost | 4,047 | |||
Buildings at cost | 36,862 | |||
Total at cost | 40,909 | |||
Accumulated Depreciation | 5,069 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Jul. 7, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Longmont, CO [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 1,799 | |||
Initial costs, buildings | 4,181 | |||
Land at cost | 1,799 | |||
Buildings at cost | 4,181 | |||
Total at cost | 5,980 | |||
Accumulated Depreciation | 618 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Feb. 10, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Mandeville Louisiana | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 2,800 | |||
Initial costs, buildings | 5,370 | |||
Land at cost | 2,800 | |||
Buildings at cost | 5,370 | |||
Total at cost | 8,170 | |||
Accumulated Depreciation | 694 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Oct. 28, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Marrero Louisiana | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 1,608 | |||
Initial costs, buildings | 5,801 | |||
Land at cost | 1,608 | |||
Buildings at cost | 5,801 | |||
Total at cost | 7,409 | |||
Accumulated Depreciation | 798 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Jul. 15, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | New Orleans, LA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 2,850 | |||
Initial costs, buildings | 6,125 | |||
Land at cost | 2,850 | |||
Buildings at cost | 6,125 | |||
Total at cost | 8,975 | |||
Accumulated Depreciation | 804 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Sep. 23, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | San Antonio, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 3,167 | |||
Initial costs, buildings | 4,801 | |||
Land at cost | 3,167 | |||
Buildings at cost | 4,801 | |||
Total at cost | 7,968 | |||
Accumulated Depreciation | 610 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Dec. 9, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Plano T X | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 4,272 | |||
Initial costs, buildings | 2,492 | |||
Land at cost | 4,272 | |||
Buildings at cost | 2,492 | |||
Total at cost | 6,764 | |||
Accumulated Depreciation | 435 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Sep. 30, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Rosenberg, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 1,289 | |||
Initial costs, buildings | 4,505 | |||
Land at cost | 1,289 | |||
Buildings at cost | 4,505 | |||
Total at cost | 5,794 | |||
Accumulated Depreciation | 676 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Jan. 15, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | San Antonio, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 2,448 | |||
Initial costs, buildings | 4,253 | |||
Land at cost | 2,448 | |||
Buildings at cost | 4,253 | |||
Total at cost | 6,701 | |||
Accumulated Depreciation | 549 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Oct. 27, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | The Woodlands, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 2,035 | |||
Initial costs, buildings | 4,524 | |||
Land at cost | 2,035 | |||
Buildings at cost | 4,524 | |||
Total at cost | 6,559 | |||
Accumulated Depreciation | 650 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Mar. 28, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Toledo, OH [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 1,168 | |||
Initial costs, buildings | 17,740 | |||
Land at cost | 1,168 | |||
Buildings at cost | 17,740 | |||
Total at cost | 18,908 | |||
Accumulated Depreciation | 2,550 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Apr. 1, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Viseu, Portugal [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,158 | |||
Initial costs, buildings | 29,750 | |||
Additions subsequent to acquisition, Improvements | 453 | |||
Land at cost | 2,611 | |||
Buildings at cost | 29,750 | |||
Total at cost | 32,361 | |||
Accumulated Depreciation | 1,738 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Nov. 28, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 37 years | |||
1989 [Member] | Bad Salzuflen, Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 7,002 | |||
Initial costs, buildings | 24,077 | |||
Additions subsequent to acquisition, Improvements | 350 | |||
Land at cost | 7,352 | |||
Buildings at cost | 24,077 | |||
Total at cost | 31,429 | |||
Accumulated Depreciation | 2,553 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1989 | |||
Date Acquired | Nov. 30, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1989 [Member] | Bolton, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,624 | |||
Initial costs, buildings | 47,335 | |||
Additions subsequent to acquisition, Improvements | 61 | |||
Land at cost | 1,685 | |||
Buildings at cost | 47,335 | |||
Total at cost | 49,020 | |||
Accumulated Depreciation | 2,375 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1989 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1989 [Member] | Guildford, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 7,185 | |||
Initial costs, buildings | 38,719 | |||
Additions subsequent to acquisition, Improvements | 129 | |||
Land at cost | 7,314 | |||
Buildings at cost | 38,719 | |||
Total at cost | 46,033 | |||
Accumulated Depreciation | 1,953 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1989 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1989 [Member] | Lynwood, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 30,116 | |||
Initial costs, buildings | 148,527 | |||
Land at cost | 30,116 | |||
Buildings at cost | 148,527 | |||
Total at cost | 178,643 | |||
Accumulated Depreciation | 5,286 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1989 | |||
Date Acquired | Aug. 13, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1989 [Member] | Richmond, VA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Long term acute care hospital | |||
Initial costs, land | $ 1,302 | |||
Initial costs, buildings | 10,071 | |||
Land at cost | 1,302 | |||
Buildings at cost | 10,071 | |||
Total at cost | 11,373 | |||
Accumulated Depreciation | 761 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1989 | |||
Date Acquired | Aug. 30, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1989 [Member] | Rochdale, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Long term acute care hospital | |||
Initial costs, land | $ 654 | |||
Initial costs, buildings | 3,368 | |||
Land at cost | 654 | |||
Buildings at cost | 3,368 | |||
Total at cost | 4,022 | |||
Accumulated Depreciation | 230 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1989 | |||
Date Acquired | Aug. 30, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1989 [Member] | Rochdale, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 67 | |||
Initial costs, buildings | 344 | |||
Land at cost | 67 | |||
Buildings at cost | 344 | |||
Total at cost | 411 | |||
Accumulated Depreciation | 23 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1989 | |||
Date Acquired | Aug. 30, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2004 [Member] | Ayr, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 17,729 | |||
Initial costs, buildings | 51,716 | |||
Additions subsequent to acquisition, Improvements | 329 | |||
Land at cost | 18,058 | |||
Buildings at cost | 51,716 | |||
Total at cost | 69,774 | |||
Accumulated Depreciation | 661 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2004 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2004 [Member] | Odessa, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 6,535 | |||
Initial costs, buildings | 123,518 | |||
Additions subsequent to acquisition, Improvements | 11,629 | |||
Land at cost | 6,535 | |||
Buildings at cost | 135,147 | |||
Total at cost | 141,682 | |||
Accumulated Depreciation | 13,569 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2004 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
2004 [Member] | Webster Texas | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Long term acute care hospital | |||
Initial costs, land | $ 663 | |||
Initial costs, buildings | 33,751 | |||
Land at cost | 663 | |||
Buildings at cost | 33,751 | |||
Total at cost | 34,414 | |||
Accumulated Depreciation | 9,282 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2004 | |||
Date Acquired | Dec. 21, 2010 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1973 [Member] | Bad Oeynhausen, Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 1,033 | |||
Initial costs, buildings | 2,835 | |||
Additions subsequent to acquisition, Improvements | 126 | |||
Land at cost | 1,159 | |||
Buildings at cost | 2,835 | |||
Total at cost | 3,994 | |||
Accumulated Depreciation | 324 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1973 | |||
Date Acquired | Nov. 30, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1973 [Member] | Big Spring, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,655 | |||
Initial costs, buildings | 21,254 | |||
Additions subsequent to acquisition, Improvements | 816 | |||
Land at cost | 1,655 | |||
Buildings at cost | 22,070 | |||
Total at cost | 23,725 | |||
Accumulated Depreciation | 1,671 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1973 | |||
Date Acquired | Apr. 12, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1973 [Member] | Odessa, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 6,535 | |||
Initial costs, buildings | 123,518 | |||
Additions subsequent to acquisition, Improvements | 11,629 | |||
Land at cost | 6,535 | |||
Buildings at cost | 135,147 | |||
Total at cost | 141,682 | |||
Accumulated Depreciation | 13,569 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1973 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1973 [Member] | Port Huron, MI | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,531 | |||
Initial costs, buildings | 14,252 | |||
Land at cost | 2,531 | |||
Buildings at cost | 14,252 | |||
Total at cost | 16,783 | |||
Accumulated Depreciation | 2,921 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1973 | |||
Date Acquired | Dec. 31, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 30 years | |||
1973 [Member] | Ringwood, Australia [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 4,166 | |||
Initial costs, buildings | 19,323 | |||
Additions subsequent to acquisition, Improvements | 138 | |||
Land at cost | 4,304 | |||
Buildings at cost | 19,323 | |||
Total at cost | 23,627 | |||
Accumulated Depreciation | 1,469 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1973 | |||
Date Acquired | Jun. 7, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 35 years | |||
1973 [Member] | San Diego, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 12,663 | |||
Initial costs, buildings | 52,431 | |||
Land at cost | 12,663 | |||
Buildings at cost | 52,431 | |||
Total at cost | 65,094 | |||
Accumulated Depreciation | 14,309 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1973 | |||
Date Acquired | Feb. 9, 2011 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 [Member] | Aurora, CO [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 2,891 | |||
Initial costs, buildings | 4,812 | |||
Land at cost | 2,891 | |||
Buildings at cost | 4,812 | |||
Total at cost | 7,703 | |||
Accumulated Depreciation | 752 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Sep. 17, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 [Member] | Chandler, AZ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 3,619 | |||
Initial costs, buildings | 4,783 | |||
Land at cost | 3,619 | |||
Buildings at cost | 4,783 | |||
Total at cost | 8,402 | |||
Accumulated Depreciation | 797 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Apr. 24, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 [Member] | Carrollton, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 729 | |||
Initial costs, buildings | 34,342 | |||
Additions subsequent to acquisition, Improvements | 374 | |||
Land at cost | 729 | |||
Buildings at cost | 34,716 | |||
Total at cost | 35,445 | |||
Accumulated Depreciation | 5,559 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Jul. 17, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 [Member] | Converse, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 750 | |||
Initial costs, buildings | 4,423 | |||
Land at cost | 750 | |||
Buildings at cost | 4,423 | |||
Total at cost | 5,173 | |||
Accumulated Depreciation | 746 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Apr. 10, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 [Member] | Denver, CO [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 1,276 | |||
Initial costs, buildings | 4,276 | |||
Land at cost | 1,276 | |||
Buildings at cost | 4,276 | |||
Total at cost | 5,552 | |||
Accumulated Depreciation | 704 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Jun. 8, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 [Member] | Dorchester, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 14,428 | |||
Initial costs, buildings | 219,575 | |||
Additions subsequent to acquisition, Improvements | 6,725 | |||
Land at cost | 14,428 | |||
Buildings at cost | 226,300 | |||
Total at cost | 240,728 | |||
Accumulated Depreciation | 16,117 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Oct. 15, 2018 | |||
Life on which depreciation in latest income statements is computed (Years) | 42 years | |||
2015 [Member] | Fort Worth T X | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 2,701 | |||
Initial costs, buildings | 4,392 | |||
Land at cost | 2,701 | |||
Buildings at cost | 4,392 | |||
Total at cost | 7,093 | |||
Accumulated Depreciation | 741 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Mar. 27, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 [Member] | Frome, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 9,920 | |||
Initial costs, buildings | 11,388 | |||
Additions subsequent to acquisition, Improvements | 1,660 | |||
Land at cost | 11,580 | |||
Buildings at cost | 11,388 | |||
Total at cost | 22,968 | |||
Accumulated Depreciation | 212 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 [Member] | Gilbert, AZ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 1,517 | |||
Initial costs, buildings | 4,661 | |||
Land at cost | 1,517 | |||
Buildings at cost | 4,661 | |||
Total at cost | 6,178 | |||
Accumulated Depreciation | 748 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Jul. 22, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 [Member] | 2020 [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 1,210 | |||
Initial costs, buildings | 4,046 | |||
Land at cost | 1,210 | |||
Buildings at cost | 4,046 | |||
Total at cost | 5,256 | |||
Accumulated Depreciation | 666 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Jun. 5, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 [Member] | Highland Hills, OH [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 3,148 | |||
Initial costs, buildings | 44,181 | |||
Land at cost | 3,148 | |||
Buildings at cost | 44,181 | |||
Total at cost | 47,329 | |||
Accumulated Depreciation | 202 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Oct. 19, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 [Member] | Highland Village T X | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 3,265 | |||
Initial costs, buildings | 1,551 | |||
Land at cost | 3,265 | |||
Buildings at cost | 1,551 | |||
Total at cost | 4,816 | |||
Accumulated Depreciation | 411 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Sep. 22, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 [Member] | Hoover Al | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, buildings | $ 7,581 | |||
Buildings at cost | 7,581 | |||
Total at cost | 7,581 | |||
Accumulated Depreciation | 1,476 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | May 1, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 34 years | |||
2015 [Member] | Katy, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 2,178 | |||
Initial costs, buildings | 3,873 | |||
Land at cost | 2,178 | |||
Buildings at cost | 3,873 | |||
Total at cost | 6,051 | |||
Accumulated Depreciation | 597 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Oct. 21, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 [Member] | Lehi, UT [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 13,403 | |||
Initial costs, buildings | 29,950 | |||
Additions subsequent to acquisition, Improvements | 1,675 | |||
Additions subsequent to acquisition, carrying costs | (35) | |||
Land at cost | 13,368 | |||
Buildings at cost | 31,625 | |||
Total at cost | 44,993 | |||
Accumulated Depreciation | 3,812 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 45 years | |||
2015 [Member] | League City, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 1,316 | |||
Initial costs, buildings | 3,901 | |||
Land at cost | 1,316 | |||
Buildings at cost | 3,901 | |||
Total at cost | 5,217 | |||
Accumulated Depreciation | 634 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Jun. 19, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 [Member] | Mc Kinney T X | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 2,668 | |||
Initial costs, buildings | 4,060 | |||
Land at cost | 2,668 | |||
Buildings at cost | 4,060 | |||
Total at cost | 6,728 | |||
Accumulated Depreciation | 876 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Jul. 31, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 30 years | |||
2015 [Member] | Olathe, KS [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 5,966 | |||
Initial costs, buildings | 56,125 | |||
Land at cost | 5,966 | |||
Buildings at cost | 56,125 | |||
Total at cost | 62,091 | |||
Accumulated Depreciation | 260 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Oct. 19, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 50 years | |||
2015 [Member] | Parker, CO [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 1,300 | |||
Initial costs, buildings | 4,448 | |||
Land at cost | 1,300 | |||
Buildings at cost | 4,448 | |||
Total at cost | 5,748 | |||
Accumulated Depreciation | 686 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Nov. 6, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 [Member] | Santa Maria de Feira, PT [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,535 | |||
Initial costs, buildings | 18,199 | |||
Additions subsequent to acquisition, Improvements | 364 | |||
Land at cost | 1,899 | |||
Buildings at cost | 18,199 | |||
Total at cost | 20,098 | |||
Accumulated Depreciation | 80 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Oct. 21, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 [Member] | Taunton, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 4,428 | |||
Initial costs, buildings | 73,228 | |||
Additions subsequent to acquisition, Improvements | 11,500 | |||
Land at cost | 4,428 | |||
Buildings at cost | 84,728 | |||
Total at cost | 89,156 | |||
Accumulated Depreciation | 9,992 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Oct. 3, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1970 [Member] | Ayer, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 9,048 | |||
Initial costs, buildings | 77,913 | |||
Additions subsequent to acquisition, Improvements | 4,548 | |||
Land at cost | 9,048 | |||
Buildings at cost | 82,461 | |||
Total at cost | 91,509 | |||
Accumulated Depreciation | 5,898 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1970 | |||
Date Acquired | Jun. 27, 2018 | |||
Life on which depreciation in latest income statements is computed (Years) | 47 years | |||
1970 [Member] | Bussage, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 8,848 | |||
Initial costs, buildings | 3,990 | |||
Additions subsequent to acquisition, Improvements | 176 | |||
Land at cost | 9,024 | |||
Buildings at cost | 3,990 | |||
Total at cost | 13,014 | |||
Accumulated Depreciation | 56 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1970 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1970 [Member] | Rockledge, FL [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 13,919 | |||
Initial costs, buildings | 23,282 | |||
Additions subsequent to acquisition, Improvements | 7,565 | |||
Land at cost | 13,919 | |||
Buildings at cost | 30,847 | |||
Total at cost | 44,766 | |||
Accumulated Depreciation | 4,458 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1970 | |||
Date Acquired | May 1, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 42 years | |||
1970 [Member] | Royston, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 5,636 | |||
Initial costs, buildings | 21,310 | |||
Additions subsequent to acquisition, Improvements | 1,521 | |||
Land at cost | 7,157 | |||
Buildings at cost | 21,310 | |||
Total at cost | 28,467 | |||
Accumulated Depreciation | 336 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1970 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1992 [Member] | Bath, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 7,443 | |||
Initial costs, buildings | 13,874 | |||
Additions subsequent to acquisition, Improvements | 203 | |||
Land at cost | 7,646 | |||
Buildings at cost | 13,874 | |||
Total at cost | 21,520 | |||
Accumulated Depreciation | 721 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1992 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1992 [Member] | Bowling Green, KY [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 3,486 | |||
Initial costs, buildings | 56,296 | |||
Land at cost | 3,486 | |||
Buildings at cost | 56,296 | |||
Total at cost | 59,782 | |||
Accumulated Depreciation | 3,662 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1992 | |||
Date Acquired | Aug. 30, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1992 [Member] | London, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 14,391 | |||
Initial costs, buildings | 7,241 | |||
Additions subsequent to acquisition, Improvements | 288 | |||
Land at cost | 14,679 | |||
Buildings at cost | 7,241 | |||
Total at cost | 21,920 | |||
Accumulated Depreciation | 104 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1992 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1992 [Member] | Stirling, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 771 | |||
Initial costs, buildings | 20,738 | |||
Additions subsequent to acquisition, Improvements | 349 | |||
Land at cost | 1,120 | |||
Buildings at cost | 20,738 | |||
Total at cost | 21,858 | |||
Accumulated Depreciation | 271 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1992 | |||
Date Acquired | Jul. 6, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1992 [Member] | Wichita, KS [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 1,019 | |||
Initial costs, buildings | 18,373 | |||
Additions subsequent to acquisition, carrying costs | 1 | |||
Land at cost | 1,019 | |||
Buildings at cost | 18,374 | |||
Total at cost | 19,393 | |||
Accumulated Depreciation | 6,315 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1992 | |||
Date Acquired | Apr. 4, 2008 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1984 [Member] | Birmingham, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, buildings | $ 20,376 | |||
Additions subsequent to acquisition, Improvements | 438 | |||
Land at cost | 438 | |||
Buildings at cost | 20,376 | |||
Total at cost | 20,814 | |||
Accumulated Depreciation | 273 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1984 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1984 [Member] | Bennettsville, SC [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 794 | |||
Initial costs, buildings | 15,773 | |||
Land at cost | 794 | |||
Buildings at cost | 15,773 | |||
Total at cost | 16,567 | |||
Accumulated Depreciation | 7,689 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1984 | |||
Date Acquired | Apr. 1, 2008 | |||
Life on which depreciation in latest income statements is computed (Years) | 42 years | |||
1984 [Member] | Basingstoke, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 13,532 | |||
Initial costs, buildings | 53,347 | |||
Additions subsequent to acquisition, Improvements | 203 | |||
Land at cost | 13,735 | |||
Buildings at cost | 53,347 | |||
Total at cost | 67,082 | |||
Accumulated Depreciation | 2,694 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1984 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1984 [Member] | Droitwich, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, buildings | $ 16,261 | |||
Additions subsequent to acquisition, Improvements | 81 | |||
Land at cost | 81 | |||
Buildings at cost | 16,261 | |||
Total at cost | 16,342 | |||
Accumulated Depreciation | 824 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1984 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1984 [Member] | Hope A R | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,651 | |||
Initial costs, buildings | 3,359 | |||
Additions subsequent to acquisition, Improvements | 2,732 | |||
Land at cost | 1,651 | |||
Buildings at cost | 6,091 | |||
Total at cost | 7,742 | |||
Accumulated Depreciation | 897 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1984 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1984 [Member] | London, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 9,743 | |||
Initial costs, buildings | 64,842 | |||
Additions subsequent to acquisition, Improvements | 81 | |||
Land at cost | 9,824 | |||
Buildings at cost | 64,842 | |||
Total at cost | 74,666 | |||
Accumulated Depreciation | 3,253 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1984 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1984 [Member] | Swindon, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 5,521 | |||
Initial costs, buildings | 63,533 | |||
Additions subsequent to acquisition, Improvements | 142 | |||
Land at cost | 5,663 | |||
Buildings at cost | 63,533 | |||
Total at cost | 69,196 | |||
Accumulated Depreciation | 3,196 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1984 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1984 [Member] | Wantirna, Australia [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 26,294 | |||
Initial costs, buildings | 216,294 | |||
Additions subsequent to acquisition, Improvements | 7,682 | |||
Land at cost | 27,285 | |||
Buildings at cost | 222,985 | |||
Total at cost | 250,270 | |||
Accumulated Depreciation | 14,206 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1984 | |||
Date Acquired | Jun. 7, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1980 [Member] | Blue Springs, MO [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 4,347 | |||
Initial costs, buildings | 23,494 | |||
Land at cost | 4,347 | |||
Buildings at cost | 23,494 | |||
Total at cost | 27,841 | |||
Accumulated Depreciation | 4,269 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1980 | |||
Date Acquired | Feb. 13, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1980 [Member] | Frome, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 2,419 | |||
Initial costs, buildings | 18,655 | |||
Additions subsequent to acquisition, Improvements | 660 | |||
Land at cost | 3,079 | |||
Buildings at cost | 18,655 | |||
Total at cost | 21,734 | |||
Accumulated Depreciation | 263 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1980 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1980 [Member] | Glasgow, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 1,135 | |||
Initial costs, buildings | 16,606 | |||
Additions subsequent to acquisition, Improvements | 383 | |||
Land at cost | 1,518 | |||
Buildings at cost | 16,606 | |||
Total at cost | 18,124 | |||
Accumulated Depreciation | 225 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1980 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1980 [Member] | Harrow, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 40,596 | |||
Initial costs, buildings | 42,958 | |||
Additions subsequent to acquisition, Improvements | 223 | |||
Land at cost | 40,819 | |||
Buildings at cost | 42,958 | |||
Total at cost | 83,777 | |||
Accumulated Depreciation | 2,178 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1980 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1980 [Member] | Hill County, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,120 | |||
Initial costs, buildings | 17,882 | |||
Additions subsequent to acquisition, Improvements | 374 | |||
Land at cost | 1,120 | |||
Buildings at cost | 18,256 | |||
Total at cost | 19,376 | |||
Accumulated Depreciation | 13,549 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1980 | |||
Date Acquired | Sep. 17, 2010 | |||
Life on which depreciation in latest income statements is computed (Years) | 15 years | |||
1980 [Member] | Hook, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 5,269 | |||
Initial costs, buildings | 10,968 | |||
Additions subsequent to acquisition, Improvements | 487 | |||
Land at cost | 5,756 | |||
Buildings at cost | 10,968 | |||
Total at cost | 16,724 | |||
Accumulated Depreciation | 162 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1980 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1980 [Member] | Nottingham, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 10,678 | |||
Initial costs, buildings | 3,451 | |||
Additions subsequent to acquisition, Improvements | 121 | |||
Land at cost | 10,799 | |||
Buildings at cost | 3,451 | |||
Total at cost | 14,250 | |||
Accumulated Depreciation | 48 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1980 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1980 [Member] | Poplar Bluff, MO [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,659 | |||
Initial costs, buildings | 38,693 | |||
Additions subsequent to acquisition, carrying costs | 1 | |||
Land at cost | 2,659 | |||
Buildings at cost | 38,694 | |||
Total at cost | 41,353 | |||
Accumulated Depreciation | 13,247 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1980 | |||
Date Acquired | Apr. 22, 2008 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1980 [Member] | Romford, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 4,958 | |||
Initial costs, buildings | 9,317 | |||
Additions subsequent to acquisition, Improvements | 733 | |||
Land at cost | 5,691 | |||
Buildings at cost | 9,317 | |||
Total at cost | 15,008 | |||
Accumulated Depreciation | 147 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1980 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1980 [Member] | Sharon, PA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 6,179 | |||
Initial costs, buildings | 9,066 | |||
Additions subsequent to acquisition, Improvements | 5,428 | |||
Land at cost | 6,179 | |||
Buildings at cost | 14,494 | |||
Total at cost | 20,673 | |||
Accumulated Depreciation | 2,731 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1980 | |||
Date Acquired | May 1, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1980 [Member] | Usk, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 1,442 | |||
Initial costs, buildings | 23,599 | |||
Additions subsequent to acquisition, Improvements | 397 | |||
Land at cost | 1,839 | |||
Buildings at cost | 23,599 | |||
Total at cost | 25,438 | |||
Accumulated Depreciation | 313 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1980 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1980 [Member] | West Valley City, UT [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 5,374 | |||
Initial costs, buildings | 58,314 | |||
Additions subsequent to acquisition, Improvements | 6,644 | |||
Additions subsequent to acquisition, carrying costs | (114) | |||
Land at cost | 5,260 | |||
Buildings at cost | 64,958 | |||
Total at cost | 70,218 | |||
Accumulated Depreciation | 20,731 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1980 | |||
Date Acquired | Apr. 22, 2008 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1980 [Member] | York, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 21,810 | |||
Initial costs, buildings | 76,287 | |||
Additions subsequent to acquisition, Improvements | 1,187 | |||
Land at cost | 22,997 | |||
Buildings at cost | 76,287 | |||
Total at cost | 99,284 | |||
Accumulated Depreciation | 1,009 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1980 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1985 [Member] | Aberdeen, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 4,384 | |||
Initial costs, buildings | 107,058 | |||
Additions subsequent to acquisition, Improvements | 135 | |||
Land at cost | 4,519 | |||
Buildings at cost | 107,058 | |||
Total at cost | 111,577 | |||
Accumulated Depreciation | 5,371 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1985 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1985 [Member] | Hot Springs, AR [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 5,844 | |||
Initial costs, buildings | 59,432 | |||
Additions subsequent to acquisition, Improvements | 21,221 | |||
Land at cost | 5,844 | |||
Buildings at cost | 80,653 | |||
Total at cost | 86,497 | |||
Accumulated Depreciation | 13,122 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1985 | |||
Date Acquired | Aug. 31, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1985 [Member] | Lawton, OK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,944 | |||
Initial costs, buildings | 63,031 | |||
Land at cost | 3,944 | |||
Buildings at cost | 63,031 | |||
Total at cost | 66,975 | |||
Accumulated Depreciation | 3,385 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1985 | |||
Date Acquired | Dec. 17, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1985 [Member] | Southampton, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 5,527 | |||
Initial costs, buildings | 20,121 | |||
Additions subsequent to acquisition, Improvements | 1,323 | |||
Land at cost | 6,850 | |||
Buildings at cost | 20,121 | |||
Total at cost | 26,971 | |||
Accumulated Depreciation | 312 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1985 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1985 [Member] | St. Albans Park, Australia [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,169 | |||
Initial costs, buildings | 22,159 | |||
Additions subsequent to acquisition, Improvements | 11,736 | |||
Land at cost | 2,731 | |||
Buildings at cost | 33,333 | |||
Total at cost | 36,064 | |||
Accumulated Depreciation | 1,552 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1985 | |||
Date Acquired | Jun. 7, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1985 [Member] | Strathpine, Australia [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,625 | |||
Initial costs, buildings | 36,767 | |||
Additions subsequent to acquisition, Improvements | 312 | |||
Land at cost | 2,937 | |||
Buildings at cost | 36,767 | |||
Total at cost | 39,704 | |||
Accumulated Depreciation | 2,442 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1985 | |||
Date Acquired | Jun. 7, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1982 [Member] | Birmingham, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 10,098 | |||
Initial costs, buildings | 99,773 | |||
Additions subsequent to acquisition, Improvements | 386 | |||
Land at cost | 10,484 | |||
Buildings at cost | 99,773 | |||
Total at cost | 110,257 | |||
Accumulated Depreciation | 5,040 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1982 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1982 [Member] | Bedford, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,583 | |||
Initial costs, buildings | 7,976 | |||
Additions subsequent to acquisition, Improvements | 54 | |||
Land at cost | 1,637 | |||
Buildings at cost | 7,976 | |||
Total at cost | 9,613 | |||
Accumulated Depreciation | 406 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1982 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1982 [Member] | Bossier City, LA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Long term acute care hospital | |||
Initial costs, land | $ 900 | |||
Initial costs, buildings | 17,818 | |||
Additions subsequent to acquisition, Improvements | 944 | |||
Land at cost | 900 | |||
Buildings at cost | 18,762 | |||
Total at cost | 19,662 | |||
Accumulated Depreciation | 6,214 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1982 | |||
Date Acquired | Apr. 1, 2008 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1982 [Member] | Cheraw, SC [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 657 | |||
Initial costs, buildings | 19,576 | |||
Land at cost | 657 | |||
Buildings at cost | 19,576 | |||
Total at cost | 20,233 | |||
Accumulated Depreciation | 9,542 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1982 | |||
Date Acquired | Apr. 1, 2008 | |||
Life on which depreciation in latest income statements is computed (Years) | 42 years | |||
1982 [Member] | Caterham, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 10,816 | |||
Initial costs, buildings | 22,158 | |||
Additions subsequent to acquisition, Improvements | 400 | |||
Land at cost | 11,216 | |||
Buildings at cost | 22,158 | |||
Total at cost | 33,374 | |||
Accumulated Depreciation | 1,370 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1982 | |||
Date Acquired | Aug. 16, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1982 [Member] | Canterbury, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 9,675 | |||
Initial costs, buildings | 29,325 | |||
Additions subsequent to acquisition, Improvements | 88 | |||
Land at cost | 9,763 | |||
Buildings at cost | 29,325 | |||
Total at cost | 39,088 | |||
Accumulated Depreciation | 1,478 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1982 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1982 [Member] | Croydon, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 10,352 | |||
Initial costs, buildings | 44,330 | |||
Additions subsequent to acquisition, Improvements | 217 | |||
Land at cost | 10,569 | |||
Buildings at cost | 44,330 | |||
Total at cost | 54,899 | |||
Accumulated Depreciation | 2,245 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1982 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1982 [Member] | Haverhill, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 5,651 | |||
Initial costs, buildings | 105,848 | |||
Additions subsequent to acquisition, Improvements | 3,185 | |||
Land at cost | 5,651 | |||
Buildings at cost | 109,033 | |||
Total at cost | 114,684 | |||
Accumulated Depreciation | 8,594 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1982 | |||
Date Acquired | Aug. 31, 2018 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1982 [Member] | Garden Grove, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 5,502 | |||
Initial costs, buildings | 10,748 | |||
Additions subsequent to acquisition, carrying costs | 51 | |||
Land at cost | 5,502 | |||
Buildings at cost | 10,799 | |||
Total at cost | 16,301 | |||
Accumulated Depreciation | 3,547 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1982 | |||
Date Acquired | Nov. 25, 2008 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1982 [Member] | Warren, OH [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 5,385 | |||
Initial costs, buildings | 47,588 | |||
Additions subsequent to acquisition, Improvements | 10,486 | |||
Land at cost | 5,385 | |||
Buildings at cost | 58,074 | |||
Total at cost | 63,459 | |||
Accumulated Depreciation | 7,695 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1982 | |||
Date Acquired | May 1, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
2018 [Member] | Birmingham, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, buildings | $ 19,885 | |||
Buildings at cost | 19,885 | |||
Total at cost | 19,885 | |||
Accumulated Depreciation | 743 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2018 | |||
Date Acquired | Jun. 29, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2018 [Member] | Conroe, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 3,855 | |||
Initial costs, buildings | 39,156 | |||
Land at cost | 3,855 | |||
Buildings at cost | 39,156 | |||
Total at cost | 43,011 | |||
Accumulated Depreciation | 182 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2018 | |||
Date Acquired | Oct. 19, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2018 [Member] | Cheadle, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 29,205 | |||
Initial costs, buildings | 100,805 | |||
Additions subsequent to acquisition, Improvements | 2,485 | |||
Land at cost | 31,690 | |||
Buildings at cost | 100,805 | |||
Total at cost | 132,495 | |||
Accumulated Depreciation | 1,365 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2018 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2018 [Member] | Darlington, United Kingdom [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 20,168 | |||
Initial costs, buildings | 51,315 | |||
Additions subsequent to acquisition, Improvements | 2,415 | |||
Land at cost | 22,583 | |||
Buildings at cost | 51,315 | |||
Total at cost | 73,898 | |||
Accumulated Depreciation | 752 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2018 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2018 [Member] | El Paso, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 4,268 | |||
Initial costs, buildings | 21,345 | |||
Land at cost | 4,268 | |||
Buildings at cost | 21,345 | |||
Total at cost | 25,613 | |||
Accumulated Depreciation | 620 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2018 | |||
Date Acquired | Dec. 17, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 38 years | |||
2018 [Member] | Olathe, KS [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,485 | |||
Initial costs, buildings | 14,484 | |||
Land at cost | 3,485 | |||
Buildings at cost | 14,484 | |||
Total at cost | 17,969 | |||
Accumulated Depreciation | 813 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2018 | |||
Date Acquired | Jun. 10, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 50 years | |||
2018 [Member] | Preston, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 8,748 | |||
Initial costs, buildings | 27,645 | |||
Additions subsequent to acquisition, Improvements | 542 | |||
Land at cost | 9,290 | |||
Buildings at cost | 27,645 | |||
Total at cost | 36,935 | |||
Accumulated Depreciation | 371 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2018 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2018 [Member] | Raleigh, NC [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 3,469 | |||
Initial costs, buildings | 27,707 | |||
Land at cost | 3,469 | |||
Buildings at cost | 27,707 | |||
Total at cost | 31,176 | |||
Accumulated Depreciation | 136 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2018 | |||
Date Acquired | Oct. 19, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2018 [Member] | Roeland Park, KS [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,569 | |||
Initial costs, buildings | 15,103 | |||
Land at cost | 1,569 | |||
Buildings at cost | 15,103 | |||
Total at cost | 16,672 | |||
Accumulated Depreciation | 830 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2018 | |||
Date Acquired | Jun. 10, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 50 years | |||
2018 [Member] | Shawnee, KS [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,076 | |||
Initial costs, buildings | 14,945 | |||
Land at cost | 3,076 | |||
Buildings at cost | 14,945 | |||
Total at cost | 18,021 | |||
Accumulated Depreciation | 958 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2018 | |||
Date Acquired | Jun. 10, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 50 years | |||
1900 [Member] | Birmingham, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, buildings | $ 20,376 | |||
Additions subsequent to acquisition, Improvements | 438 | |||
Land at cost | 438 | |||
Buildings at cost | 20,376 | |||
Total at cost | 20,814 | |||
Accumulated Depreciation | 273 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1900 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1972 [Member] | Bellflower, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 2,563 | |||
Land at cost | 2,563 | |||
Total at cost | 2,563 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1972 | |||
Date Acquired | Aug. 23, 2019 | |||
1972 [Member] | Glen Waverly, Australia [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 30,764 | |||
Initial costs, buildings | 23,768 | |||
Additions subsequent to acquisition, Improvements | 835 | |||
Land at cost | 31,599 | |||
Buildings at cost | 23,768 | |||
Total at cost | 55,367 | |||
Accumulated Depreciation | 2,189 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1972 | |||
Date Acquired | Jun. 7, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 32 years | |||
1972 [Member] | Los Angeles, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 12,562 | |||
Initial costs, buildings | 40,164 | |||
Land at cost | 12,562 | |||
Buildings at cost | 40,164 | |||
Total at cost | 52,726 | |||
Accumulated Depreciation | 519 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1972 | |||
Date Acquired | Jul. 6, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1972 [Member] | San Dimas, CA [member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 6,160 | |||
Initial costs, buildings | 6,839 | |||
Additions subsequent to acquisition, carrying costs | 34 | |||
Land at cost | 6,160 | |||
Buildings at cost | 6,873 | |||
Total at cost | 13,033 | |||
Accumulated Depreciation | 2,252 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1972 | |||
Date Acquired | Nov. 25, 2008 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1957 [Member] | Blackburn, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,706 | |||
Initial costs, buildings | 54,210 | |||
Additions subsequent to acquisition, Improvements | 122 | |||
Land at cost | 2,828 | |||
Buildings at cost | 54,210 | |||
Total at cost | 57,038 | |||
Accumulated Depreciation | 2,727 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1957 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2006 [Member] | Bloomington, IN [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,392 | |||
Initial costs, buildings | 28,212 | |||
Additions subsequent to acquisition, Improvements | 5,000 | |||
Additions subsequent to acquisition, carrying costs | 408 | |||
Land at cost | 2,392 | |||
Buildings at cost | 33,620 | |||
Total at cost | 36,012 | |||
Accumulated Depreciation | 12,608 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2006 | |||
Date Acquired | Aug. 8, 2006 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2006 [Member] | Dallas, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Long term acute care hospital | |||
Initial costs, land | $ 1,000 | |||
Initial costs, buildings | 13,589 | |||
Additions subsequent to acquisition, carrying costs | 368 | |||
Land at cost | 1,421 | |||
Buildings at cost | 13,536 | |||
Total at cost | 14,957 | |||
Accumulated Depreciation | 5,189 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2006 | |||
Date Acquired | Sep. 5, 2006 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2006 [Member] | Dormagen Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 1,827 | |||
Initial costs, buildings | 5,818 | |||
Additions subsequent to acquisition, Improvements | 139 | |||
Land at cost | 1,966 | |||
Buildings at cost | 5,818 | |||
Total at cost | 7,784 | |||
Accumulated Depreciation | 516 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2006 | |||
Date Acquired | Aug. 28, 2018 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2006 [Member] | Petersburg V A | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 1,302 | |||
Initial costs, buildings | 9,121 | |||
Land at cost | 1,302 | |||
Buildings at cost | 9,121 | |||
Total at cost | 10,423 | |||
Accumulated Depreciation | 3,078 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2006 | |||
Date Acquired | Jul. 1, 2008 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1930 [Member] | Blackburn, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 19,620 | |||
Initial costs, buildings | 57,757 | |||
Additions subsequent to acquisition, Improvements | 1,670 | |||
Land at cost | 21,290 | |||
Buildings at cost | 57,757 | |||
Total at cost | 79,047 | |||
Accumulated Depreciation | 792 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1930 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1952 [Member] | Boonton Township, NJ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 6,712 | |||
Initial costs, buildings | 17,031 | |||
Land at cost | 6,712 | |||
Buildings at cost | 17,031 | |||
Total at cost | 23,743 | |||
Accumulated Depreciation | 556 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1952 | |||
Date Acquired | Sep. 30, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2009 [Member] | Bath, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,604 | |||
Initial costs, buildings | 33,245 | |||
Land at cost | 1,604 | |||
Buildings at cost | 33,245 | |||
Total at cost | 34,849 | |||
Accumulated Depreciation | 6,233 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2009 | |||
Date Acquired | Jul. 1, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2009 [Member] | Brighton, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 18,540 | |||
Initial costs, buildings | 146,491 | |||
Additions subsequent to acquisition, Improvements | 52,118 | |||
Land at cost | 18,540 | |||
Buildings at cost | 198,609 | |||
Total at cost | 217,149 | |||
Accumulated Depreciation | 19,400 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2009 | |||
Date Acquired | Oct. 3, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
2009 [Member] | Folsom, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Long term acute care hospital | |||
Initial costs, land | $ 3,291 | |||
Initial costs, buildings | 21,293 | |||
Land at cost | 3,291 | |||
Buildings at cost | 21,293 | |||
Total at cost | 24,584 | |||
Accumulated Depreciation | 1,475 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2009 | |||
Date Acquired | Aug. 30, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1983 [Member} | Bassenheim, Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 999 | |||
Initial costs, buildings | 5,448 | |||
Additions subsequent to acquisition, Improvements | 170 | |||
Land at cost | 1,169 | |||
Buildings at cost | 5,448 | |||
Total at cost | 6,617 | |||
Accumulated Depreciation | 441 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1983 | |||
Date Acquired | Feb. 9, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 39 years | |||
1983 [Member} | Glasgow, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 6,698 | |||
Initial costs, buildings | 139,848 | |||
Additions subsequent to acquisition, Improvements | 149 | |||
Land at cost | 6,847 | |||
Buildings at cost | 139,848 | |||
Total at cost | 146,695 | |||
Accumulated Depreciation | 7,012 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1983 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1983 [Member} | Grefath, Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 1,136 | |||
Initial costs, buildings | 3,119 | |||
Additions subsequent to acquisition, Improvements | 101 | |||
Land at cost | 1,237 | |||
Buildings at cost | 3,119 | |||
Total at cost | 4,356 | |||
Accumulated Depreciation | 282 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1983 | |||
Date Acquired | Aug. 28, 2018 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1983 [Member} | Lander, WY [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 761 | |||
Initial costs, buildings | 42,849 | |||
Land at cost | 761 | |||
Buildings at cost | 42,849 | |||
Total at cost | 43,610 | |||
Accumulated Depreciation | 2,290 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1983 | |||
Date Acquired | Dec. 17, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1983 [Member} | Nottingham, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 5,007 | |||
Initial costs, buildings | 48,842 | |||
Additions subsequent to acquisition, Improvements | 257 | |||
Land at cost | 5,264 | |||
Buildings at cost | 48,842 | |||
Total at cost | 54,106 | |||
Accumulated Depreciation | 2,476 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1983 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1983 [Member} | Milton Keynes, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 5,480 | |||
Initial costs, buildings | 38,117 | |||
Additions subsequent to acquisition, Improvements | 95 | |||
Land at cost | 5,575 | |||
Buildings at cost | 38,117 | |||
Total at cost | 43,692 | |||
Accumulated Depreciation | 1,918 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1983 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1983 [Member} | Port Huron, MI | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,531 | |||
Initial costs, buildings | 14,252 | |||
Land at cost | 2,531 | |||
Buildings at cost | 14,252 | |||
Total at cost | 16,783 | |||
Accumulated Depreciation | 2,921 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1983 | |||
Date Acquired | Dec. 31, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 30 years | |||
1983 [Member} | Remscheid, Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 1,021 | |||
Initial costs, buildings | 2,603 | |||
Additions subsequent to acquisition, Improvements | 59 | |||
Land at cost | 1,080 | |||
Buildings at cost | 2,603 | |||
Total at cost | 3,683 | |||
Accumulated Depreciation | 230 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1983 | |||
Date Acquired | Aug. 28, 2018 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1983 [Member} | Riverton, WY [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,163 | |||
Initial costs, buildings | 29,647 | |||
Land at cost | 1,163 | |||
Buildings at cost | 29,647 | |||
Total at cost | 30,810 | |||
Accumulated Depreciation | 1,838 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1983 | |||
Date Acquired | Dec. 17, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 36 years | |||
1983 [Member} | Watsonville, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 16,488 | |||
Initial costs, buildings | 17,800 | |||
Land at cost | 16,488 | |||
Buildings at cost | 17,800 | |||
Total at cost | 34,288 | |||
Accumulated Depreciation | 1,472 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1983 | |||
Date Acquired | Sep. 30, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 39 years | |||
1983 [Member} | West Jordan, UT [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 16,897 | |||
Initial costs, buildings | 233,256 | |||
Additions subsequent to acquisition, Improvements | 4,146 | |||
Land at cost | 16,897 | |||
Buildings at cost | 237,402 | |||
Total at cost | 254,299 | |||
Accumulated Depreciation | 9,639 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1983 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2016 [Member] | Bad Salzuflen, Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 7,002 | |||
Initial costs, buildings | 24,077 | |||
Additions subsequent to acquisition, Improvements | 350 | |||
Land at cost | 7,352 | |||
Buildings at cost | 24,077 | |||
Total at cost | 31,429 | |||
Accumulated Depreciation | 2,553 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2016 | |||
Date Acquired | Nov. 30, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2010 [Member] | Bad Oeynhausen, Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 1,033 | |||
Initial costs, buildings | 2,835 | |||
Additions subsequent to acquisition, Improvements | 126 | |||
Land at cost | 1,159 | |||
Buildings at cost | 2,835 | |||
Total at cost | 3,994 | |||
Accumulated Depreciation | 324 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2010 | |||
Date Acquired | Nov. 30, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2010 [Member] | Brockton, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 18,328 | |||
Initial costs, buildings | 67,248 | |||
Additions subsequent to acquisition, Improvements | 5,358 | |||
Land at cost | 18,328 | |||
Buildings at cost | 72,606 | |||
Total at cost | 90,934 | |||
Accumulated Depreciation | 10,793 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2010 | |||
Date Acquired | Oct. 3, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
2010 [Member] | Layton, UT [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 14,360 | |||
Initial costs, buildings | 370,154 | |||
Additions subsequent to acquisition, Improvements | 5,369 | |||
Land at cost | 14,360 | |||
Buildings at cost | 375,523 | |||
Total at cost | 389,883 | |||
Accumulated Depreciation | 13,647 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2010 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2010 [Member] | Newburgh, IN [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 1,215 | |||
Initial costs, buildings | 7,266 | |||
Land at cost | 1,215 | |||
Buildings at cost | 7,266 | |||
Total at cost | 8,481 | |||
Accumulated Depreciation | 36 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2010 | |||
Date Acquired | Oct. 19, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2010 [Member] | Sherman, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,363 | |||
Initial costs, buildings | 10,932 | |||
Land at cost | 3,363 | |||
Buildings at cost | 10,932 | |||
Total at cost | 14,295 | |||
Accumulated Depreciation | 3,554 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2010 | |||
Date Acquired | Oct. 31, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1981 [Member] | Lewiston, ID [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 5,389 | |||
Initial costs, buildings | 75,435 | |||
Land at cost | 5,389 | |||
Buildings at cost | 75,435 | |||
Total at cost | 80,824 | |||
Accumulated Depreciation | 11,904 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1922 | |||
Date Acquired | May 1, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1981 [Member] | Warren, OH [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 2,417 | |||
Initial costs, buildings | 15,857 | |||
Additions subsequent to acquisition, Improvements | 1,737 | |||
Land at cost | 2,417 | |||
Buildings at cost | 17,594 | |||
Total at cost | 20,011 | |||
Accumulated Depreciation | 2,576 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1922 | |||
Date Acquired | May 1, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 46 years | |||
2013 [Member] | Ayer, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 9,048 | |||
Initial costs, buildings | 77,913 | |||
Additions subsequent to acquisition, Improvements | 4,548 | |||
Land at cost | 9,048 | |||
Buildings at cost | 82,461 | |||
Total at cost | 91,509 | |||
Accumulated Depreciation | 5,898 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2013 | |||
Date Acquired | Jun. 27, 2018 | |||
Life on which depreciation in latest income statements is computed (Years) | 47 years | |||
2013 [Member] | Hausman, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,500 | |||
Initial costs, buildings | 8,957 | |||
Land at cost | 1,500 | |||
Buildings at cost | 8,957 | |||
Total at cost | 10,457 | |||
Accumulated Depreciation | 1,958 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2013 | |||
Date Acquired | Mar. 1, 2013 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2013 [Member] | Lafayette, IN [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 800 | |||
Initial costs, buildings | 14,968 | |||
Additions subsequent to acquisition, Improvements | (25) | |||
Land at cost | 800 | |||
Buildings at cost | 14,943 | |||
Total at cost | 15,743 | |||
Accumulated Depreciation | 3,320 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2013 | |||
Date Acquired | Feb. 1, 2013 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2013 [Member] | Little Elm, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 1,241 | |||
Initial costs, buildings | 3,491 | |||
Land at cost | 1,241 | |||
Buildings at cost | 3,491 | |||
Total at cost | 4,732 | |||
Accumulated Depreciation | 703 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2013 | |||
Date Acquired | Dec. 1, 2013 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2013 [Member] | Post Falls Idaho | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 417 | |||
Initial costs, buildings | 12,175 | |||
Additions subsequent to acquisition, Improvements | 1,905 | |||
Land at cost | 767 | |||
Buildings at cost | 13,730 | |||
Total at cost | 14,497 | |||
Accumulated Depreciation | 2,755 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2013 | |||
Date Acquired | Dec. 31, 2013 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2013 [Member] | Spartanburg, SC [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 1,135 | |||
Initial costs, buildings | 15,717 | |||
Land at cost | 1,135 | |||
Buildings at cost | 15,717 | |||
Total at cost | 16,852 | |||
Accumulated Depreciation | 3,292 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2013 | |||
Date Acquired | Aug. 1, 2013 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2013 [Member] | West Chester, OH [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 3,670 | |||
Initial costs, buildings | 61,739 | |||
Land at cost | 3,670 | |||
Buildings at cost | 61,739 | |||
Total at cost | 65,409 | |||
Accumulated Depreciation | 282 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2013 | |||
Date Acquired | Oct. 19, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1971 [Member] | Boonton Township, NJ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 6,712 | |||
Initial costs, buildings | 17,031 | |||
Land at cost | 6,712 | |||
Buildings at cost | 17,031 | |||
Total at cost | 23,743 | |||
Accumulated Depreciation | 556 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1971 | |||
Date Acquired | Sep. 30, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1978 [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 7,925 | |||
Initial costs, buildings | 30,465 | |||
Land at cost | 7,925 | |||
Buildings at cost | 30,465 | |||
Total at cost | 38,390 | |||
Accumulated Depreciation | 407 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1978 | |||
Date Acquired | Jul. 6, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1978 [Member] | Boonton Township, NJ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 6,712 | |||
Initial costs, buildings | 17,031 | |||
Land at cost | 6,712 | |||
Buildings at cost | 17,031 | |||
Total at cost | 23,743 | |||
Accumulated Depreciation | 556 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1978 | |||
Date Acquired | Sep. 30, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1978 [Member] | Phoenix A Z | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 12,695 | |||
Initial costs, buildings | 73,773 | |||
Additions subsequent to acquisition, Improvements | 4,499 | |||
Land at cost | 12,695 | |||
Buildings at cost | 78,272 | |||
Total at cost | 90,967 | |||
Accumulated Depreciation | 8,821 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1968 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 43 years | |||
2007 [Member] | Campbelltown, Australia [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,055 | |||
Initial costs, buildings | 54,756 | |||
Additions subsequent to acquisition, Improvements | 51 | |||
Land at cost | 1,106 | |||
Buildings at cost | 54,756 | |||
Total at cost | 55,862 | |||
Accumulated Depreciation | 3,546 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2007 | |||
Date Acquired | Jun. 7, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2007 [Member] | Godalming, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 9,059 | |||
Initial costs, buildings | 20,181 | |||
Additions subsequent to acquisition, Improvements | 886 | |||
Land at cost | 9,945 | |||
Buildings at cost | 20,181 | |||
Total at cost | 30,126 | |||
Accumulated Depreciation | 293 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2007 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2007 [Member] | Hinckley, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 2,175 | |||
Initial costs, buildings | 17,867 | |||
Additions subsequent to acquisition, Improvements | 446 | |||
Land at cost | 2,621 | |||
Buildings at cost | 17,867 | |||
Total at cost | 20,488 | |||
Accumulated Depreciation | 242 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2007 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2007 [Member] | Northland, MO [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Long term acute care hospital | |||
Initial costs, land | $ 834 | |||
Initial costs, buildings | 17,182 | |||
Land at cost | 834 | |||
Buildings at cost | 17,182 | |||
Total at cost | 18,016 | |||
Accumulated Depreciation | 4,689 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2007 | |||
Date Acquired | Feb. 14, 2011 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2007 [Member] | Mesa, AZ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 6,534 | |||
Initial costs, buildings | 100,042 | |||
Additions subsequent to acquisition, Improvements | 4,136 | |||
Land at cost | 6,534 | |||
Buildings at cost | 104,178 | |||
Total at cost | 110,712 | |||
Accumulated Depreciation | 21,948 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2007 | |||
Date Acquired | Sep. 26, 2013 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 One [Member] | Chandler, AZ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, land | $ 750 | |||
Initial costs, buildings | 3,853 | |||
Land at cost | 750 | |||
Buildings at cost | 3,853 | |||
Total at cost | 4,603 | |||
Accumulated Depreciation | 602 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | Oct. 7, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2015 One [Member] | Hoover Al | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Freestanding ER | |||
Initial costs, buildings | $ 1,034 | |||
Additions subsequent to acquisition, Improvements | 296 | |||
Buildings at cost | 1,330 | |||
Total at cost | 1,330 | |||
Accumulated Depreciation | 228 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2015 | |||
Date Acquired | May 1, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 34 years | |||
1978 [Member] | Kansas City, MO [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 10,497 | |||
Initial costs, buildings | 64,419 | |||
Land at cost | 10,497 | |||
Buildings at cost | 64,419 | |||
Total at cost | 74,916 | |||
Accumulated Depreciation | 11,354 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1978 | |||
Date Acquired | Feb. 13, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1978 [Member] | San Antonio, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 8,053 | |||
Initial costs, buildings | 29,333 | |||
Additions subsequent to acquisition, Improvements | 7,981 | |||
Land at cost | 8,053 | |||
Buildings at cost | 37,314 | |||
Total at cost | 45,367 | |||
Accumulated Depreciation | 3,671 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1978 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1977 [Member] | Braunfels Germany | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,183 | |||
Initial costs, buildings | 13,954 | |||
Additions subsequent to acquisition, Improvements | 57 | |||
Land at cost | 2,240 | |||
Buildings at cost | 13,954 | |||
Total at cost | 16,194 | |||
Accumulated Depreciation | 2,292 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1977 | |||
Date Acquired | Jun. 30, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1977 [Member] | London, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 13,207 | |||
Initial costs, buildings | 86,380 | |||
Additions subsequent to acquisition, Improvements | 27 | |||
Land at cost | 13,234 | |||
Buildings at cost | 86,380 | |||
Total at cost | 99,614 | |||
Accumulated Depreciation | 4,323 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1977 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1917 [Member] | Brighton, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 18,540 | |||
Initial costs, buildings | 146,491 | |||
Additions subsequent to acquisition, Improvements | 52,118 | |||
Land at cost | 18,540 | |||
Buildings at cost | 198,609 | |||
Total at cost | 217,149 | |||
Accumulated Depreciation | 19,400 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1917 | |||
Date Acquired | Oct. 3, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1965 [Member] | Brockton, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 18,328 | |||
Initial costs, buildings | 67,248 | |||
Additions subsequent to acquisition, Improvements | 5,358 | |||
Land at cost | 18,328 | |||
Buildings at cost | 72,606 | |||
Total at cost | 90,934 | |||
Accumulated Depreciation | 10,793 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1965 | |||
Date Acquired | Oct. 3, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1965 [Member] | Perth, Australia [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 106,021 | |||
Initial costs, buildings | 37,654 | |||
Additions subsequent to acquisition, Improvements | 2,528 | |||
Land at cost | 106,241 | |||
Buildings at cost | 39,962 | |||
Total at cost | 146,203 | |||
Accumulated Depreciation | 3,386 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1965 | |||
Date Acquired | Jun. 7, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 30 years | |||
1965 [Member] | Rochdale, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,654 | |||
Initial costs, buildings | 43,317 | |||
Additions subsequent to acquisition, Improvements | 149 | |||
Land at cost | 3,803 | |||
Buildings at cost | 43,317 | |||
Total at cost | 47,120 | |||
Accumulated Depreciation | 2,186 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1965 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1714 [Member] | Bromley, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 7,084 | |||
Initial costs, buildings | 16,503 | |||
Additions subsequent to acquisition, Improvements | 594 | |||
Land at cost | 7,678 | |||
Buildings at cost | 16,503 | |||
Total at cost | 24,181 | |||
Accumulated Depreciation | 229 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1714 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1979 [Member] | Bundoora, Australia [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 6,654 | |||
Initial costs, buildings | 64,096 | |||
Additions subsequent to acquisition, Improvements | 4,482 | |||
Land at cost | 6,940 | |||
Buildings at cost | 68,292 | |||
Total at cost | 75,232 | |||
Accumulated Depreciation | 4,607 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1979 | |||
Date Acquired | Jun. 7, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 37 years | |||
1979 [Member] | Phoenix A Z | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 2,396 | |||
Initial costs, buildings | 26,521 | |||
Additions subsequent to acquisition, Improvements | 2,985 | |||
Land at cost | 2,396 | |||
Buildings at cost | 29,506 | |||
Total at cost | 31,902 | |||
Accumulated Depreciation | 3,360 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1979 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 42 years | |||
1979 [Member] | San Dimas, CA [member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,915 | |||
Initial costs, buildings | 5,085 | |||
Additions subsequent to acquisition, carrying costs | 18 | |||
Land at cost | 1,915 | |||
Buildings at cost | 5,103 | |||
Total at cost | 7,018 | |||
Accumulated Depreciation | 1,672 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1979 | |||
Date Acquired | Nov. 25, 2008 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1979 [Member] | Sunnybank, Australia [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 6,019 | |||
Initial costs, buildings | 45,750 | |||
Additions subsequent to acquisition, Improvements | 358 | |||
Land at cost | 6,377 | |||
Buildings at cost | 45,750 | |||
Total at cost | 52,127 | |||
Accumulated Depreciation | 3,570 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1979 | |||
Date Acquired | Jun. 7, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 34 years | |||
2012 [Member] | Carrollton, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 4,941 | |||
Initial costs, buildings | 52,579 | |||
Land at cost | 4,941 | |||
Buildings at cost | 52,579 | |||
Total at cost | 57,520 | |||
Accumulated Depreciation | 237 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2012 | |||
Date Acquired | Oct. 19, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2012 [Member] | Casper, WY [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 1,785 | |||
Land at cost | 1,785 | |||
Total at cost | 1,785 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2012 | |||
Date Acquired | Feb. 29, 2012 | |||
2012 [Member] | Dublin, OH [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 5,118 | |||
Initial costs, buildings | 70,305 | |||
Land at cost | 5,118 | |||
Buildings at cost | 70,305 | |||
Total at cost | 75,423 | |||
Accumulated Depreciation | 312 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2012 | |||
Date Acquired | Oct. 19, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2012 [Member] | Fall River, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,526 | |||
Initial costs, buildings | 82,358 | |||
Additions subsequent to acquisition, Improvements | 28,556 | |||
Land at cost | 3,526 | |||
Buildings at cost | 110,914 | |||
Total at cost | 114,440 | |||
Accumulated Depreciation | 12,508 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2012 | |||
Date Acquired | Oct. 3, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
2012 [Member] | Florence, AZ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 900 | |||
Initial costs, buildings | 28,462 | |||
Additions subsequent to acquisition, Improvements | 105 | |||
Land at cost | 900 | |||
Buildings at cost | 28,567 | |||
Total at cost | 29,467 | |||
Accumulated Depreciation | 6,960 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2012 | |||
Date Acquired | Feb. 7, 2012 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2012 [Member] | Lafayette, IN [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 3,321 | |||
Initial costs, buildings | 10,884 | |||
Land at cost | 3,321 | |||
Buildings at cost | 10,884 | |||
Total at cost | 14,205 | |||
Accumulated Depreciation | 60 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2012 | |||
Date Acquired | Oct. 19, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2012 [Member] | Overlook, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,452 | |||
Initial costs, buildings | 9,666 | |||
Additions subsequent to acquisition, Improvements | 7 | |||
Land at cost | 2,452 | |||
Buildings at cost | 9,673 | |||
Total at cost | 12,125 | |||
Accumulated Depreciation | 2,140 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2012 | |||
Date Acquired | Feb. 1, 2013 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2012 [Member] | Mount Pleasant, SC [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Long term acute care hospital | |||
Initial costs, land | $ 597 | |||
Initial costs, buildings | 2,198 | |||
Land at cost | 597 | |||
Buildings at cost | 2,198 | |||
Total at cost | 2,795 | |||
Accumulated Depreciation | 149 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2012 | |||
Date Acquired | Aug. 30, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2012 [Member] | San Antonio, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,248 | |||
Initial costs, buildings | 5,880 | |||
Land at cost | 2,248 | |||
Buildings at cost | 5,880 | |||
Total at cost | 8,128 | |||
Accumulated Depreciation | 1,346 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2012 | |||
Date Acquired | Oct. 2, 2012 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2012 [Member] | Reading, United Kingdom [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 26,996 | |||
Initial costs, buildings | 88,538 | |||
Additions subsequent to acquisition, Improvements | 635 | |||
Land at cost | 27,631 | |||
Buildings at cost | 88,538 | |||
Total at cost | 116,169 | |||
Accumulated Depreciation | 2,256 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2012 | |||
Date Acquired | Dec. 18, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Two Thousand Three | Bury, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 8,173 | |||
Initial costs, buildings | 20,617 | |||
Additions subsequent to acquisition, Improvements | 872 | |||
Land at cost | 9,045 | |||
Buildings at cost | 20,617 | |||
Total at cost | 29,662 | |||
Accumulated Depreciation | 298 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2003 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Two Thousand Three | Newark, NJ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 32,957 | |||
Initial costs, buildings | 24,553 | |||
Land at cost | 32,957 | |||
Buildings at cost | 24,553 | |||
Total at cost | 57,510 | |||
Accumulated Depreciation | 744 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2003 | |||
Date Acquired | May 2, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Two Thousand Three | Youngstown, OH [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 4,335 | |||
Initial costs, buildings | 3,565 | |||
Additions subsequent to acquisition, Improvements | 488 | |||
Land at cost | 4,335 | |||
Buildings at cost | 4,053 | |||
Total at cost | 8,388 | |||
Accumulated Depreciation | 2,428 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2003 | |||
Date Acquired | May 1, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1990 [Member] | Carmarthen, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 866 | |||
Initial costs, buildings | 27,185 | |||
Additions subsequent to acquisition, Improvements | 101 | |||
Land at cost | 967 | |||
Buildings at cost | 27,185 | |||
Total at cost | 28,152 | |||
Accumulated Depreciation | 1,373 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1990 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1990 [Member] | Darlington, United Kingdom [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 5,108 | |||
Initial costs, buildings | 28,014 | |||
Additions subsequent to acquisition, Improvements | 449 | |||
Land at cost | 5,557 | |||
Buildings at cost | 28,014 | |||
Total at cost | 33,571 | |||
Accumulated Depreciation | 369 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1990 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1990 [Member] | Gloucester, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 4,869 | |||
Initial costs, buildings | 65,235 | |||
Additions subsequent to acquisition, Improvements | 1,062 | |||
Land at cost | 5,931 | |||
Buildings at cost | 65,235 | |||
Total at cost | 71,166 | |||
Accumulated Depreciation | 4,031 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1990 | |||
Date Acquired | Aug. 16, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1990 [Member] | Hemel Hempstead, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 12,480 | |||
Initial costs, buildings | 6,702 | |||
Additions subsequent to acquisition, Improvements | 795 | |||
Land at cost | 13,275 | |||
Buildings at cost | 6,702 | |||
Total at cost | 19,977 | |||
Accumulated Depreciation | 117 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1990 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1990 [Member] | Melton Mowbray, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 5,387 | |||
Initial costs, buildings | 16,993 | |||
Additions subsequent to acquisition, Improvements | 673 | |||
Land at cost | 6,060 | |||
Buildings at cost | 16,993 | |||
Total at cost | 23,053 | |||
Accumulated Depreciation | 243 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1990 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1990 [Member] | Reading, United Kingdom [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 36,489 | |||
Initial costs, buildings | 49,078 | |||
Additions subsequent to acquisition, Improvements | 496 | |||
Land at cost | 36,985 | |||
Buildings at cost | 49,078 | |||
Total at cost | 86,063 | |||
Accumulated Depreciation | 2,991 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1990 | |||
Date Acquired | Aug. 16, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1956 [Member] | Detroit, MI [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Long term acute care hospital | |||
Initial costs, land | $ 1,220 | |||
Initial costs, buildings | 8,687 | |||
Additions subsequent to acquisition, carrying costs | (364) | |||
Land at cost | 1,220 | |||
Buildings at cost | 8,323 | |||
Total at cost | 9,543 | |||
Accumulated Depreciation | 2,893 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1956 | |||
Date Acquired | May 22, 2008 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1953 [Member] | Dorchester, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 14,428 | |||
Initial costs, buildings | 219,575 | |||
Additions subsequent to acquisition, Improvements | 6,725 | |||
Land at cost | 14,428 | |||
Buildings at cost | 226,300 | |||
Total at cost | 240,728 | |||
Accumulated Depreciation | 16,117 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1953 | |||
Date Acquired | Oct. 15, 2018 | |||
Life on which depreciation in latest income statements is computed (Years) | 42 years | |||
1953 [Member] | Denville, NJ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 15,709 | |||
Initial costs, buildings | 55,772 | |||
Land at cost | 15,709 | |||
Buildings at cost | 55,772 | |||
Total at cost | 71,481 | |||
Accumulated Depreciation | 1,781 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1953 | |||
Date Acquired | Sep. 30, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1953 [Member] | Port Huron, MI | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,531 | |||
Initial costs, buildings | 14,252 | |||
Land at cost | 2,531 | |||
Buildings at cost | 14,252 | |||
Total at cost | 16,783 | |||
Accumulated Depreciation | 2,921 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1953 | |||
Date Acquired | Dec. 31, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 30 years | |||
1849 [Member] | Cheadle, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 29,205 | |||
Initial costs, buildings | 100,805 | |||
Additions subsequent to acquisition, Improvements | 2,485 | |||
Land at cost | 31,690 | |||
Buildings at cost | 100,805 | |||
Total at cost | 132,495 | |||
Accumulated Depreciation | 1,365 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1849 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1976 [Member] | Dodge City, KS [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,124 | |||
Initial costs, buildings | 52,705 | |||
Land at cost | 1,124 | |||
Buildings at cost | 52,705 | |||
Total at cost | 53,829 | |||
Accumulated Depreciation | 2,844 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1976 | |||
Date Acquired | Dec. 17, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1976 [Member] | Layton, UT [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 14,360 | |||
Initial costs, buildings | 370,154 | |||
Additions subsequent to acquisition, Improvements | 5,369 | |||
Land at cost | 14,360 | |||
Buildings at cost | 375,523 | |||
Total at cost | 389,883 | |||
Accumulated Depreciation | 13,647 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1976 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1976 [Member] | Phoenix A Z | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 12,695 | |||
Initial costs, buildings | 73,773 | |||
Additions subsequent to acquisition, Improvements | 4,499 | |||
Land at cost | 12,695 | |||
Buildings at cost | 78,272 | |||
Total at cost | 90,967 | |||
Accumulated Depreciation | 8,821 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1976 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 43 years | |||
2019 [Member] | Clarksville, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 2,460 | |||
Initial costs, buildings | 25,540 | |||
Land at cost | 2,460 | |||
Buildings at cost | 25,540 | |||
Total at cost | 28,000 | |||
Accumulated Depreciation | 710 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2019 | |||
Date Acquired | Dec. 17, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 39 years | |||
2019 [Member] | Overland Park, KS [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,191 | |||
Initial costs, buildings | 14,263 | |||
Land at cost | 3,191 | |||
Buildings at cost | 14,263 | |||
Total at cost | 17,454 | |||
Accumulated Depreciation | 845 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2019 | |||
Date Acquired | Jun. 10, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 50 years | |||
2011 [Member] | Cologne Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 4,456 | |||
Initial costs, buildings | 15,413 | |||
Additions subsequent to acquisition, Improvements | 103 | |||
Land at cost | 4,559 | |||
Buildings at cost | 15,413 | |||
Total at cost | 19,972 | |||
Accumulated Depreciation | 1,765 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2011 | |||
Date Acquired | Jun. 23, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2011 [Member] | Methuen, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 23,809 | |||
Initial costs, buildings | 89,505 | |||
Additions subsequent to acquisition, Improvements | 13,365 | |||
Land at cost | 23,809 | |||
Buildings at cost | 102,870 | |||
Total at cost | 126,679 | |||
Accumulated Depreciation | 13,187 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2011 | |||
Date Acquired | Oct. 3, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
2011 [Member] | New Braunfels, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 1,853 | |||
Initial costs, buildings | 10,622 | |||
Land at cost | 1,853 | |||
Buildings at cost | 10,622 | |||
Total at cost | 12,475 | |||
Accumulated Depreciation | 299 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2011 | |||
Date Acquired | Feb. 29, 2012 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1982 [Member] | Coral Gables, FL [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 26,215 | |||
Initial costs, buildings | 84,584 | |||
Land at cost | 26,215 | |||
Buildings at cost | 84,584 | |||
Total at cost | 110,799 | |||
Accumulated Depreciation | 913 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1959 | |||
Date Acquired | Aug. 1, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1982 [Member] | Norwalk, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,811 | |||
Initial costs, buildings | 5,940 | |||
Land at cost | 2,811 | |||
Buildings at cost | 5,940 | |||
Total at cost | 8,751 | |||
Accumulated Depreciation | 93 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1959 | |||
Date Acquired | Jul. 6, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1994 [Member] | Dahlen, Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 948 | |||
Initial costs, buildings | 11,679 | |||
Additions subsequent to acquisition, Improvements | 434 | |||
Land at cost | 1,382 | |||
Buildings at cost | 11,679 | |||
Total at cost | 13,061 | |||
Accumulated Depreciation | 455 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1994 | |||
Date Acquired | Jul. 8, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1994 [Member] | Worthing, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 7,037 | |||
Initial costs, buildings | 32,043 | |||
Additions subsequent to acquisition, Improvements | 101 | |||
Land at cost | 7,138 | |||
Buildings at cost | 32,043 | |||
Total at cost | 39,181 | |||
Accumulated Depreciation | 1,616 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1994 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2001 [Member] | Darlington, United Kingdom [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,854 | |||
Initial costs, buildings | 38,071 | |||
Additions subsequent to acquisition, Improvements | 365 | |||
Land at cost | 2,219 | |||
Buildings at cost | 38,071 | |||
Total at cost | 40,290 | |||
Accumulated Depreciation | 1,383 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2001 | |||
Date Acquired | Aug. 7, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2001 [Member] | Hope A R | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,651 | |||
Initial costs, buildings | 3,359 | |||
Additions subsequent to acquisition, Improvements | 2,732 | |||
Land at cost | 1,651 | |||
Buildings at cost | 6,091 | |||
Total at cost | 7,742 | |||
Accumulated Depreciation | 897 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2001 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
2001 [Member] | Norwood, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 7,073 | |||
Initial costs, buildings | 154,496 | |||
Additions subsequent to acquisition, Improvements | 16,180 | |||
Land at cost | 7,073 | |||
Buildings at cost | 170,676 | |||
Total at cost | 177,749 | |||
Accumulated Depreciation | 12,760 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2001 | |||
Date Acquired | Jun. 27, 2018 | |||
Life on which depreciation in latest income statements is computed (Years) | 46 years | |||
Nineteen Twenty Five | Darlington UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 20,168 | |||
Initial costs, buildings | 51,315 | |||
Additions subsequent to acquisition, Improvements | 2,415 | |||
Land at cost | 22,583 | |||
Buildings at cost | 51,315 | |||
Total at cost | 73,898 | |||
Accumulated Depreciation | 752 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1935 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Nineteen Twenty Five | Dover NJ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,865 | |||
Initial costs, buildings | 8,693 | |||
Land at cost | 3,865 | |||
Buildings at cost | 8,693 | |||
Total at cost | 12,558 | |||
Accumulated Depreciation | 295 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1925 | |||
Date Acquired | Sep. 30, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Nineteen Sixty | Darlington UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 5,108 | |||
Initial costs, buildings | 28,014 | |||
Additions subsequent to acquisition, Improvements | 449 | |||
Land at cost | 5,557 | |||
Buildings at cost | 28,014 | |||
Total at cost | 33,571 | |||
Accumulated Depreciation | 369 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1960 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Nineteen Sixty | Houston T X | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,501 | |||
Initial costs, buildings | 34,530 | |||
Additions subsequent to acquisition, Improvements | 8,477 | |||
Additions subsequent to acquisition, carrying costs | 16,589 | |||
Land at cost | 3,274 | |||
Buildings at cost | 59,823 | |||
Total at cost | 63,097 | |||
Accumulated Depreciation | 17,863 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1960 | |||
Date Acquired | Aug. 10, 2007 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Nineteen Sixty | Huntington Park, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,935 | |||
Initial costs, buildings | 6,103 | |||
Land at cost | 3,935 | |||
Buildings at cost | 6,103 | |||
Total at cost | 10,038 | |||
Accumulated Depreciation | 92 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1960 | |||
Date Acquired | Jul. 6, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Nineteen Sixty | London, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 6,133 | |||
Initial costs, buildings | 16,640 | |||
Additions subsequent to acquisition, Improvements | 416 | |||
Land at cost | 6,549 | |||
Buildings at cost | 16,640 | |||
Total at cost | 23,189 | |||
Accumulated Depreciation | 229 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1960 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Nineteen Sixty | Meyersdale, PA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 390 | |||
Initial costs, buildings | 4,280 | |||
Land at cost | 390 | |||
Buildings at cost | 4,280 | |||
Total at cost | 4,670 | |||
Accumulated Depreciation | 365 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1960 | |||
Date Acquired | Dec. 17, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 30 years | |||
Nineteen Sixty | Sherman, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,363 | |||
Initial costs, buildings | 10,932 | |||
Land at cost | 3,363 | |||
Buildings at cost | 10,932 | |||
Total at cost | 14,295 | |||
Accumulated Depreciation | 3,554 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1960 | |||
Date Acquired | Oct. 31, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1840 [Member] | Diss, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 2,406 | |||
Initial costs, buildings | 11,034 | |||
Additions subsequent to acquisition, Improvements | 687 | |||
Land at cost | 3,093 | |||
Buildings at cost | 11,034 | |||
Total at cost | 14,127 | |||
Accumulated Depreciation | 169 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1840 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Nineteen Ninety Three | Dormagen Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 1,827 | |||
Initial costs, buildings | 5,818 | |||
Additions subsequent to acquisition, Improvements | 139 | |||
Land at cost | 1,966 | |||
Buildings at cost | 5,818 | |||
Total at cost | 7,784 | |||
Accumulated Depreciation | 516 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1993 | |||
Date Acquired | Aug. 28, 2018 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Nineteen Ninety Three | San Bernardino, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,209 | |||
Initial costs, buildings | 37,498 | |||
Land at cost | 2,209 | |||
Buildings at cost | 37,498 | |||
Total at cost | 39,707 | |||
Accumulated Depreciation | 2,390 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1993 | |||
Date Acquired | Aug. 30, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1830 [Member] | Bromley, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 7,084 | |||
Initial costs, buildings | 16,503 | |||
Additions subsequent to acquisition, Improvements | 594 | |||
Land at cost | 7,678 | |||
Buildings at cost | 16,503 | |||
Total at cost | 24,181 | |||
Accumulated Depreciation | 229 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1830 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1969 [Member] | Denville, NJ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 15,709 | |||
Initial costs, buildings | 55,772 | |||
Land at cost | 15,709 | |||
Buildings at cost | 55,772 | |||
Total at cost | 71,481 | |||
Accumulated Depreciation | 1,781 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1969 | |||
Date Acquired | Sep. 30, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1969 [Member] | Hialeah, FL [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 75,339 | |||
Initial costs, buildings | 222,399 | |||
Additions subsequent to acquisition, Improvements | 75,000 | |||
Land at cost | 75,339 | |||
Buildings at cost | 297,399 | |||
Total at cost | 372,738 | |||
Accumulated Depreciation | 2,647 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1969 | |||
Date Acquired | Aug. 1, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1969 [Member] | Huntington Park, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,935 | |||
Initial costs, buildings | 6,103 | |||
Land at cost | 3,935 | |||
Buildings at cost | 6,103 | |||
Total at cost | 10,038 | |||
Accumulated Depreciation | 92 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1969 | |||
Date Acquired | Jul. 6, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Nineteen Twenty Seven | Dover NJ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,865 | |||
Initial costs, buildings | 8,693 | |||
Land at cost | 3,865 | |||
Buildings at cost | 8,693 | |||
Total at cost | 12,558 | |||
Accumulated Depreciation | 295 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1927 | |||
Date Acquired | Sep. 30, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2021 [Member] | Brockton, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 7,084 | |||
Initial costs, buildings | 16,503 | |||
Additions subsequent to acquisition, Improvements | 594 | |||
Land at cost | 7,678 | |||
Buildings at cost | 16,503 | |||
Total at cost | 24,181 | |||
Accumulated Depreciation | 229 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2021 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2021 [Member] | Mc Kinney T X | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 2,934 | |||
Land at cost | 2,934 | |||
Total at cost | 2,934 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2021 | |||
Date Acquired | Oct. 19, 2021 | |||
2021 [Member] | Preston, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 8,748 | |||
Initial costs, buildings | 27,645 | |||
Additions subsequent to acquisition, Improvements | 542 | |||
Land at cost | 9,290 | |||
Buildings at cost | 27,645 | |||
Total at cost | 36,935 | |||
Accumulated Depreciation | 371 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2021 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2021 [Member] | Stockton, California [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 2,886 | |||
Land at cost | 2,886 | |||
Total at cost | 2,886 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2021 | |||
Date Acquired | Nov. 23, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2020 [Member] | Darlington, United Kingdom [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 20,168 | |||
Initial costs, buildings | 51,315 | |||
Additions subsequent to acquisition, Improvements | 2,415 | |||
Land at cost | 22,583 | |||
Buildings at cost | 51,315 | |||
Total at cost | 73,898 | |||
Accumulated Depreciation | 752 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2020 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2020 [Member] | Idaho Falls, ID [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,880 | |||
Initial costs, buildings | 107,403 | |||
Land at cost | 1,880 | |||
Buildings at cost | 107,403 | |||
Total at cost | 109,283 | |||
Accumulated Depreciation | 5,146 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2020 | |||
Date Acquired | Dec. 19, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2020 [Member] | Houston T X | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 6,063 | |||
Initial costs, buildings | 19,881 | |||
Additions subsequent to acquisition, Improvements | 2,565 | |||
Land at cost | 6,063 | |||
Buildings at cost | 22,446 | |||
Total at cost | 28,509 | |||
Accumulated Depreciation | 561 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2020 | |||
Date Acquired | Oct. 25, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2020 [Member] | Tadley, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 20,486 | |||
Initial costs, buildings | 20,266 | |||
Additions subsequent to acquisition, Improvements | 1,748 | |||
Land at cost | 22,234 | |||
Buildings at cost | 20,266 | |||
Total at cost | 42,500 | |||
Accumulated Depreciation | 333 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2020 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2020 [Member] | Windsor, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 7,387 | |||
Initial costs, buildings | 4,976 | |||
Additions subsequent to acquisition, Improvements | 308 | |||
Land at cost | 7,695 | |||
Buildings at cost | 4,976 | |||
Total at cost | 12,671 | |||
Accumulated Depreciation | 76 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2020 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1986 | Halsall, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,524 | |||
Initial costs, buildings | 33,120 | |||
Additions subsequent to acquisition, Improvements | 618 | |||
Land at cost | 2,142 | |||
Buildings at cost | 33,120 | |||
Total at cost | 35,262 | |||
Accumulated Depreciation | 2,052 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1986 | |||
Date Acquired | Aug. 16, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1986 | Rowley, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,489 | |||
Initial costs, buildings | 19,453 | |||
Additions subsequent to acquisition, Improvements | 602 | |||
Land at cost | 3,091 | |||
Buildings at cost | 19,453 | |||
Total at cost | 22,544 | |||
Accumulated Depreciation | 1,243 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1986 | |||
Date Acquired | Aug. 16, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1999 [Member] | Hartsville, SC [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,050 | |||
Initial costs, buildings | 43,970 | |||
Land at cost | 2,050 | |||
Buildings at cost | 43,970 | |||
Total at cost | 46,020 | |||
Accumulated Depreciation | 8,038 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1999 | |||
Date Acquired | Aug. 31, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 34 years | |||
1924 [Member] | Hastings, PA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 603 | |||
Initial costs, buildings | 8,834 | |||
Land at cost | 603 | |||
Buildings at cost | 8,834 | |||
Total at cost | 9,437 | |||
Accumulated Depreciation | 726 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1924 | |||
Date Acquired | Dec. 17, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 30 years | |||
1924 [Member] | Johnstown, PA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 8,877 | |||
Initial costs, buildings | 247,042 | |||
Additions subsequent to acquisition, carrying costs | 117 | |||
Land at cost | 8,877 | |||
Buildings at cost | 247,159 | |||
Total at cost | 256,036 | |||
Accumulated Depreciation | 16,717 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1924 | |||
Date Acquired | Dec. 17, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 30 years | |||
1924 [Member] | Roaring Springs, PA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,446 | |||
Initial costs, buildings | 9,549 | |||
Land at cost | 1,446 | |||
Buildings at cost | 9,549 | |||
Total at cost | 10,995 | |||
Accumulated Depreciation | 811 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1924 | |||
Date Acquired | Dec. 17, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 30 years | |||
1950 [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 28,687 | |||
Initial costs, buildings | 104,028 | |||
Additions subsequent to acquisition, Improvements | 52,051 | |||
Land at cost | 28,687 | |||
Buildings at cost | 156,079 | |||
Total at cost | 184,766 | |||
Accumulated Depreciation | 9,735 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1950 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1950 [Member] | Fall River, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,526 | |||
Initial costs, buildings | 82,358 | |||
Additions subsequent to acquisition, Improvements | 28,556 | |||
Land at cost | 3,526 | |||
Buildings at cost | 110,914 | |||
Total at cost | 114,440 | |||
Accumulated Depreciation | 12,508 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1950 | |||
Date Acquired | Oct. 3, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1950 [Member] | Hialeah, FL [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 18,802 | |||
Initial costs, buildings | 107,783 | |||
Land at cost | 18,802 | |||
Buildings at cost | 107,783 | |||
Total at cost | 126,585 | |||
Accumulated Depreciation | 1,189 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1950 | |||
Date Acquired | Aug. 1, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1950 [Member] | Houston, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 28,687 | |||
Initial costs, buildings | 104,028 | |||
Additions subsequent to acquisition, Improvements | 52,051 | |||
Land at cost | 28,687 | |||
Buildings at cost | 156,079 | |||
Total at cost | 184,766 | |||
Accumulated Depreciation | 9,735 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1940 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1950 [Member] | Lynwood, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 30,116 | |||
Initial costs, buildings | 148,527 | |||
Land at cost | 30,116 | |||
Buildings at cost | 148,527 | |||
Total at cost | 178,643 | |||
Accumulated Depreciation | 5,286 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1940 | |||
Date Acquired | Aug. 13, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1950 [Member] | Ottumwa, IA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,377 | |||
Initial costs, buildings | 48,697 | |||
Land at cost | 2,377 | |||
Buildings at cost | 48,697 | |||
Total at cost | 51,074 | |||
Accumulated Depreciation | 3,623 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1950 | |||
Date Acquired | Dec. 17, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 30 years | |||
1950 [Member] | Methuen, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 23,809 | |||
Initial costs, buildings | 89,505 | |||
Additions subsequent to acquisition, Improvements | 13,365 | |||
Land at cost | 23,809 | |||
Buildings at cost | 102,870 | |||
Total at cost | 126,679 | |||
Accumulated Depreciation | 13,187 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1950 | |||
Date Acquired | Oct. 3, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1950 [Member] | Rockledge, FL [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 13,919 | |||
Initial costs, buildings | 23,282 | |||
Additions subsequent to acquisition, Improvements | 7,565 | |||
Land at cost | 13,919 | |||
Buildings at cost | 30,847 | |||
Total at cost | 44,766 | |||
Accumulated Depreciation | 4,458 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1950 | |||
Date Acquired | May 1, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 42 years | |||
1950 [Member] | Sharon, PA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 6,179 | |||
Initial costs, buildings | 9,066 | |||
Additions subsequent to acquisition, Improvements | 5,428 | |||
Land at cost | 6,179 | |||
Buildings at cost | 14,494 | |||
Total at cost | 20,673 | |||
Accumulated Depreciation | 2,731 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1950 | |||
Date Acquired | May 1, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1991 [Member] | Fresno, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 5,507 | |||
Initial costs, buildings | 70,473 | |||
Land at cost | 5,507 | |||
Buildings at cost | 70,473 | |||
Total at cost | 75,980 | |||
Accumulated Depreciation | 4,430 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1991 | |||
Date Acquired | Aug. 30, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1991 [Member] | Heidelberg, Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 6,350 | |||
Initial costs, buildings | 36,693 | |||
Additions subsequent to acquisition, Improvements | 74 | |||
Land at cost | 6,424 | |||
Buildings at cost | 36,693 | |||
Total at cost | 43,117 | |||
Accumulated Depreciation | 5,072 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1991 | |||
Date Acquired | Jun. 22, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1700 [Member] | Frome, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 9,920 | |||
Initial costs, buildings | 11,388 | |||
Additions subsequent to acquisition, Improvements | 1,660 | |||
Land at cost | 11,580 | |||
Buildings at cost | 11,388 | |||
Total at cost | 22,968 | |||
Accumulated Depreciation | 212 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1700 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1982 One [Member] | Garden Grove, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Medical Office Building | |||
Initial costs, land | $ 862 | |||
Initial costs, buildings | 7,888 | |||
Additions subsequent to acquisition, carrying costs | 28 | |||
Land at cost | 862 | |||
Buildings at cost | 7,916 | |||
Total at cost | 8,778 | |||
Accumulated Depreciation | 2,594 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1982 | |||
Date Acquired | Nov. 25, 2008 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2020 [Member] | Gilbert, AZ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 4,790 | |||
Initial costs, buildings | 45,384 | |||
Land at cost | 4,790 | |||
Buildings at cost | 45,384 | |||
Total at cost | 50,174 | |||
Accumulated Depreciation | 201 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2020 | |||
Date Acquired | Oct. 19, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1966 [Member] | Gardena, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 14,010 | |||
Initial costs, buildings | 65,288 | |||
Land at cost | 14,010 | |||
Buildings at cost | 65,288 | |||
Total at cost | 79,298 | |||
Accumulated Depreciation | 882 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1966 | |||
Date Acquired | Jul. 6, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1900 [Member] | Glasgow, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 1,135 | |||
Initial costs, buildings | 16,606 | |||
Additions subsequent to acquisition, Improvements | 383 | |||
Land at cost | 1,518 | |||
Buildings at cost | 16,606 | |||
Total at cost | 18,124 | |||
Accumulated Depreciation | 225 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1900 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1900 [Member] | London, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 6,133 | |||
Initial costs, buildings | 16,640 | |||
Additions subsequent to acquisition, Improvements | 416 | |||
Land at cost | 6,549 | |||
Buildings at cost | 16,640 | |||
Total at cost | 23,189 | |||
Accumulated Depreciation | 229 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1900 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1900 [Member] | York, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 21,810 | |||
Initial costs, buildings | 76,287 | |||
Additions subsequent to acquisition, Improvements | 1,187 | |||
Land at cost | 22,997 | |||
Buildings at cost | 76,287 | |||
Total at cost | 99,284 | |||
Accumulated Depreciation | 1,009 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1900 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1796 [Member] | Godalming, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 9,059 | |||
Initial costs, buildings | 20,181 | |||
Additions subsequent to acquisition, Improvements | 886 | |||
Land at cost | 9,945 | |||
Buildings at cost | 20,181 | |||
Total at cost | 30,126 | |||
Accumulated Depreciation | 293 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1796 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1886 [Member] | Grefath, Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 1,136 | |||
Initial costs, buildings | 3,119 | |||
Additions subsequent to acquisition, Improvements | 101 | |||
Land at cost | 1,237 | |||
Buildings at cost | 3,119 | |||
Total at cost | 4,356 | |||
Accumulated Depreciation | 282 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1886 | |||
Date Acquired | Aug. 28, 2018 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Nineteen Ninety Eight | Hassocks, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 3,557 | |||
Initial costs, buildings | 30,479 | |||
Additions subsequent to acquisition, Improvements | 2,272 | |||
Land at cost | 5,829 | |||
Buildings at cost | 30,479 | |||
Total at cost | 36,308 | |||
Accumulated Depreciation | 469 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1998 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1885 [Member] | Heidelberg, Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 6,350 | |||
Initial costs, buildings | 36,693 | |||
Additions subsequent to acquisition, Improvements | 74 | |||
Land at cost | 6,424 | |||
Buildings at cost | 36,693 | |||
Total at cost | 43,117 | |||
Accumulated Depreciation | 5,072 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1885 | |||
Date Acquired | Jun. 22, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Nineteen Zero One | Hemel Hempstead, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 12,480 | |||
Initial costs, buildings | 6,702 | |||
Additions subsequent to acquisition, Improvements | 795 | |||
Land at cost | 13,275 | |||
Buildings at cost | 6,702 | |||
Total at cost | 19,977 | |||
Accumulated Depreciation | 117 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1901 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2005 [Member] | Haverhill, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 5,651 | |||
Initial costs, buildings | 105,848 | |||
Additions subsequent to acquisition, Improvements | 3,185 | |||
Land at cost | 5,651 | |||
Buildings at cost | 109,033 | |||
Total at cost | 114,684 | |||
Accumulated Depreciation | 8,594 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2005 | |||
Date Acquired | Aug. 31, 2018 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2005 [Member] | Port Arthur, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 12,972 | |||
Initial costs, buildings | 78,051 | |||
Additions subsequent to acquisition, Improvements | 6,877 | |||
Land at cost | 12,972 | |||
Buildings at cost | 84,928 | |||
Total at cost | 97,900 | |||
Accumulated Depreciation | 16,573 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2005 | |||
Date Acquired | Sep. 26, 2013 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2005 [Member] | Tomball, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Long term acute care hospital | |||
Initial costs, land | $ 1,299 | |||
Initial costs, buildings | 23,982 | |||
Land at cost | 1,299 | |||
Buildings at cost | 23,982 | |||
Total at cost | 25,281 | |||
Accumulated Depreciation | 6,595 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2005 | |||
Date Acquired | Dec. 21, 2010 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2002 [Member] | Idaho Falls, ID [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,823 | |||
Initial costs, buildings | 37,467 | |||
Additions subsequent to acquisition, Improvements | 11,236 | |||
Additions subsequent to acquisition, carrying costs | 4,665 | |||
Land at cost | 1,823 | |||
Buildings at cost | 53,368 | |||
Total at cost | 55,191 | |||
Accumulated Depreciation | 14,993 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2002 | |||
Date Acquired | Apr. 1, 2008 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2002 [Member] | Melbourne F L | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 5,642 | |||
Initial costs, buildings | 17,087 | |||
Additions subsequent to acquisition, Improvements | 21,214 | |||
Land at cost | 5,642 | |||
Buildings at cost | 38,301 | |||
Total at cost | 43,943 | |||
Accumulated Depreciation | 2,947 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2002 | |||
Date Acquired | May 1, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 42 years | |||
2002 [Member] | San Antonio, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 8,053 | |||
Initial costs, buildings | 29,333 | |||
Additions subsequent to acquisition, Improvements | 7,981 | |||
Land at cost | 8,053 | |||
Buildings at cost | 37,314 | |||
Total at cost | 45,367 | |||
Accumulated Depreciation | 3,671 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2002 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1892 [Member] | Hinckley, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 2,175 | |||
Initial costs, buildings | 17,867 | |||
Additions subsequent to acquisition, Improvements | 446 | |||
Land at cost | 2,621 | |||
Buildings at cost | 17,867 | |||
Total at cost | 20,488 | |||
Accumulated Depreciation | 242 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1892 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2000 [Member] | Kingswood, Australia [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 24,282 | |||
Initial costs, buildings | 80,488 | |||
Additions subsequent to acquisition, Improvements | 3,346 | |||
Land at cost | 24,751 | |||
Buildings at cost | 83,365 | |||
Total at cost | 108,116 | |||
Accumulated Depreciation | 5,292 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2000 | |||
Date Acquired | Jun. 7, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2000 [Member] | Lynwood, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 30,116 | |||
Initial costs, buildings | 148,527 | |||
Land at cost | 30,116 | |||
Buildings at cost | 148,527 | |||
Total at cost | 178,643 | |||
Accumulated Depreciation | 5,286 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2000 | |||
Date Acquired | Aug. 13, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2000 [Member] | Nottingham, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 9,748 | |||
Initial costs, buildings | 9,526 | |||
Additions subsequent to acquisition, Improvements | 894 | |||
Land at cost | 10,642 | |||
Buildings at cost | 9,526 | |||
Total at cost | 20,168 | |||
Accumulated Depreciation | 157 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2000 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2000 [Member] | Montclair New Jersey | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 7,900 | |||
Initial costs, buildings | 99,640 | |||
Additions subsequent to acquisition, Improvements | 577 | |||
Land at cost | 8,477 | |||
Buildings at cost | 99,640 | |||
Total at cost | 108,117 | |||
Accumulated Depreciation | 19,799 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2000 | |||
Date Acquired | Apr. 1, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
2000 [Member] | Warren, OH [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 2,417 | |||
Initial costs, buildings | 15,857 | |||
Additions subsequent to acquisition, Improvements | 1,737 | |||
Land at cost | 2,417 | |||
Buildings at cost | 17,594 | |||
Total at cost | 20,011 | |||
Accumulated Depreciation | 2,576 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2000 | |||
Date Acquired | May 1, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 46 years | |||
2000 [Member] | Willenhall, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 7,359 | |||
Initial costs, buildings | 17,285 | |||
Additions subsequent to acquisition, Improvements | 388 | |||
Land at cost | 7,747 | |||
Buildings at cost | 17,285 | |||
Total at cost | 25,032 | |||
Accumulated Depreciation | 234 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2000 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1967 [Member] | Huntington Park, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,132 | |||
Initial costs, buildings | 5,002 | |||
Land at cost | 3,132 | |||
Buildings at cost | 5,002 | |||
Total at cost | 8,134 | |||
Accumulated Depreciation | 77 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1967 | |||
Date Acquired | Jul. 6, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1975 [Member] | Liverpool, Australia [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 13,786 | |||
Initial costs, buildings | 43,209 | |||
Additions subsequent to acquisition, Improvements | 96 | |||
Land at cost | 13,882 | |||
Buildings at cost | 43,209 | |||
Total at cost | 57,091 | |||
Accumulated Depreciation | 3,745 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1975 | |||
Date Acquired | Jun. 7, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 30 years | |||
1975 [Member] | Lauderdale Lakes, FL [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 10,657 | |||
Initial costs, buildings | 150,313 | |||
Land at cost | 10,657 | |||
Buildings at cost | 150,313 | |||
Total at cost | 160,970 | |||
Accumulated Depreciation | 1,776 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1975 | |||
Date Acquired | Aug. 1, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1987 [Member] | London, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,464 | |||
Initial costs, buildings | 4,409 | |||
Additions subsequent to acquisition, Improvements | 27 | |||
Land at cost | 3,491 | |||
Buildings at cost | 4,409 | |||
Total at cost | 7,900 | |||
Accumulated Depreciation | 224 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1987 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1987 [Member] | Orpington, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 10,826 | |||
Initial costs, buildings | 45,401 | |||
Additions subsequent to acquisition, Improvements | 162 | |||
Land at cost | 10,988 | |||
Buildings at cost | 45,401 | |||
Total at cost | 56,389 | |||
Accumulated Depreciation | 2,292 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1987 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1987 [Member] | Salt Lake City, UT [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 13,590 | |||
Initial costs, buildings | 101,915 | |||
Additions subsequent to acquisition, Improvements | 15,268 | |||
Land at cost | 13,590 | |||
Buildings at cost | 117,183 | |||
Total at cost | 130,773 | |||
Accumulated Depreciation | 11,686 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1987 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
Aberdeen, UK [Member] | Leeds, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 2,065 | |||
Initial costs, buildings | 10,123 | |||
Additions subsequent to acquisition, Improvements | 358 | |||
Land at cost | 2,423 | |||
Buildings at cost | 10,123 | |||
Total at cost | 12,546 | |||
Accumulated Depreciation | 142 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1990 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1926 [Member] | Norwood, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 7,073 | |||
Initial costs, buildings | 154,496 | |||
Additions subsequent to acquisition, Improvements | 16,180 | |||
Land at cost | 7,073 | |||
Buildings at cost | 170,676 | |||
Total at cost | 177,749 | |||
Accumulated Depreciation | 12,760 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1926 | |||
Date Acquired | Jun. 27, 2018 | |||
Life on which depreciation in latest income statements is computed (Years) | 46 years | |||
Coral Gables, FL [Member] | Ogden, UT [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 1,759 | |||
Initial costs, buildings | 16,414 | |||
Land at cost | 1,759 | |||
Buildings at cost | 16,414 | |||
Total at cost | 18,173 | |||
Accumulated Depreciation | 3,203 | |||
Encumbrances | $ 0 | |||
Date of Construction | 2014 | |||
Date Acquired | Mar. 1, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1996 [Member] | Mcminnville Oregon | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 5,000 | |||
Initial costs, buildings | 97,900 | |||
Land at cost | 5,000 | |||
Buildings at cost | 97,900 | |||
Total at cost | 102,900 | |||
Accumulated Depreciation | 14,135 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1996 | |||
Date Acquired | Aug. 31, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1996 [Member] | Poole, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,922 | |||
Initial costs, buildings | 40,797 | |||
Additions subsequent to acquisition, Improvements | 549 | |||
Land at cost | 2,471 | |||
Buildings at cost | 40,797 | |||
Total at cost | 43,268 | |||
Accumulated Depreciation | 2,905 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1996 | |||
Date Acquired | Apr. 3, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1955 [Member] | Miami, FL [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 44,400 | |||
Initial costs, buildings | 107,203 | |||
Land at cost | 44,400 | |||
Buildings at cost | 107,203 | |||
Total at cost | 151,603 | |||
Accumulated Depreciation | 1,395 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1955 | |||
Date Acquired | Aug. 1, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1955 [Member] | Windsor, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 12,842 | |||
Initial costs, buildings | 111,315 | |||
Additions subsequent to acquisition, Improvements | 108 | |||
Land at cost | 12,950 | |||
Buildings at cost | 111,315 | |||
Total at cost | 124,265 | |||
Accumulated Depreciation | 5,580 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1955 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1988 [Member] | Palestine, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 1,848 | |||
Initial costs, buildings | 95,257 | |||
Land at cost | 1,848 | |||
Buildings at cost | 95,257 | |||
Total at cost | 97,105 | |||
Accumulated Depreciation | 4,993 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1988 | |||
Date Acquired | Dec. 17, 2019 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1920 [Member] | Montclair, NJ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 7,900 | |||
Initial costs, buildings | 99,640 | |||
Additions subsequent to acquisition, Improvements | 577 | |||
Land at cost | 8,477 | |||
Buildings at cost | 99,640 | |||
Total at cost | 108,117 | |||
Accumulated Depreciation | 19,799 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1920 | |||
Date Acquired | Apr. 1, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1920 [Member] | Pasco, WA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,594 | |||
Initial costs, buildings | 13,195 | |||
Land at cost | 2,594 | |||
Buildings at cost | 13,195 | |||
Total at cost | 15,789 | |||
Accumulated Depreciation | 1,503 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1920 | |||
Date Acquired | Aug. 31, 2018 | |||
Life on which depreciation in latest income statements is computed (Years) | 30 years | |||
1920 [Member] | Newark, NJ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 32,957 | |||
Initial costs, buildings | 24,553 | |||
Land at cost | 32,957 | |||
Buildings at cost | 24,553 | |||
Total at cost | 57,510 | |||
Accumulated Depreciation | 744 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1920 | |||
Date Acquired | May 2, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1920 [Member] | Sussex, NJ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 477 | |||
Initial costs, buildings | 2,097 | |||
Land at cost | 477 | |||
Buildings at cost | 2,097 | |||
Total at cost | 2,574 | |||
Accumulated Depreciation | 70 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1920 | |||
Date Acquired | Sep. 30, 2015 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1919 [Member] | Newark, NJ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 32,957 | |||
Initial costs, buildings | 24,553 | |||
Land at cost | 32,957 | |||
Buildings at cost | 24,553 | |||
Total at cost | 57,510 | |||
Accumulated Depreciation | 744 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1919 | |||
Date Acquired | May 2, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1958 [Member] | Norwalk, CA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 7,925 | |||
Initial costs, buildings | 30,465 | |||
Land at cost | 7,925 | |||
Buildings at cost | 30,465 | |||
Total at cost | 38,390 | |||
Accumulated Depreciation | 407 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1958 | |||
Date Acquired | Jul. 6, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1995 [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 2,811 | |||
Initial costs, buildings | 5,940 | |||
Land at cost | 2,811 | |||
Buildings at cost | 5,940 | |||
Total at cost | 8,751 | |||
Accumulated Depreciation | 93 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1995 | |||
Date Acquired | Jul. 6, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Nineteen Zero Six | Salt Lake City, UT [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 13,590 | |||
Initial costs, buildings | 101,915 | |||
Additions subsequent to acquisition, Improvements | 15,268 | |||
Land at cost | 13,590 | |||
Buildings at cost | 117,183 | |||
Total at cost | 130,773 | |||
Accumulated Depreciation | 11,686 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1906 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
Nineteen Zero Six | Royston, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 5,636 | |||
Initial costs, buildings | 21,310 | |||
Additions subsequent to acquisition, Improvements | 1,521 | |||
Land at cost | 7,157 | |||
Buildings at cost | 21,310 | |||
Total at cost | 28,467 | |||
Accumulated Depreciation | 336 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1906 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1850 [Member] | Preston, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 8,748 | |||
Initial costs, buildings | 27,645 | |||
Additions subsequent to acquisition, Improvements | 542 | |||
Land at cost | 9,290 | |||
Buildings at cost | 27,645 | |||
Total at cost | 36,935 | |||
Accumulated Depreciation | 371 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1850 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1850 [Member] | Usk, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 1,442 | |||
Initial costs, buildings | 23,599 | |||
Additions subsequent to acquisition, Improvements | 397 | |||
Land at cost | 1,839 | |||
Buildings at cost | 23,599 | |||
Total at cost | 25,438 | |||
Accumulated Depreciation | 313 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1850 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1951 [Member] | Remscheid, Germany [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Rehabilitation hospital | |||
Initial costs, land | $ 1,021 | |||
Initial costs, buildings | 2,603 | |||
Additions subsequent to acquisition, Improvements | 59 | |||
Land at cost | 1,080 | |||
Buildings at cost | 2,603 | |||
Total at cost | 3,683 | |||
Accumulated Depreciation | 230 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1951 | |||
Date Acquired | Aug. 28, 2018 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1913 [Member] | Sherman, TX [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 3,363 | |||
Initial costs, buildings | 10,932 | |||
Land at cost | 3,363 | |||
Buildings at cost | 10,932 | |||
Total at cost | 14,295 | |||
Accumulated Depreciation | 3,554 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1913 | |||
Date Acquired | Oct. 31, 2014 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1820 [Member] | Southampton, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 5,527 | |||
Initial costs, buildings | 20,121 | |||
Additions subsequent to acquisition, Improvements | 1,323 | |||
Land at cost | 6,850 | |||
Buildings at cost | 20,121 | |||
Total at cost | 26,971 | |||
Accumulated Depreciation | 312 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1820 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1940 [Member] | Taunton, MA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 4,428 | |||
Initial costs, buildings | 73,228 | |||
Additions subsequent to acquisition, Improvements | 11,500 | |||
Land at cost | 4,428 | |||
Buildings at cost | 84,728 | |||
Total at cost | 89,156 | |||
Accumulated Depreciation | 9,992 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1940 | |||
Date Acquired | Oct. 3, 2016 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1940 [Member] | Tempe, AZ [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 6,051 | |||
Initial costs, buildings | 10,986 | |||
Additions subsequent to acquisition, Improvements | 2,708 | |||
Land at cost | 6,051 | |||
Buildings at cost | 13,694 | |||
Total at cost | 19,745 | |||
Accumulated Depreciation | 1,967 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1940 | |||
Date Acquired | Sep. 29, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years | |||
1770 [Member] | Usk, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 1,442 | |||
Initial costs, buildings | 23,599 | |||
Additions subsequent to acquisition, Improvements | 397 | |||
Land at cost | 1,839 | |||
Buildings at cost | 23,599 | |||
Total at cost | 25,438 | |||
Accumulated Depreciation | 313 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1770 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1962 [Member] | West Monroe, LA [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 12,000 | |||
Initial costs, buildings | 69,433 | |||
Additions subsequent to acquisition, Improvements | 19,116 | |||
Land at cost | 12,552 | |||
Buildings at cost | 87,997 | |||
Total at cost | 100,549 | |||
Accumulated Depreciation | 16,316 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1962 | |||
Date Acquired | Sep. 26, 2013 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1911 [Member] | Winchester, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 6,766 | |||
Initial costs, buildings | 10,923 | |||
Additions subsequent to acquisition, Improvements | 129 | |||
Land at cost | 6,895 | |||
Buildings at cost | 10,923 | |||
Total at cost | 17,818 | |||
Accumulated Depreciation | 563 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1911 | |||
Date Acquired | Jan. 9, 2020 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
Eighteen Hundred | Woking, UK [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Behavioral health facility | |||
Initial costs, land | $ 7,387 | |||
Initial costs, buildings | 4,976 | |||
Additions subsequent to acquisition, Improvements | 308 | |||
Land at cost | 7,695 | |||
Buildings at cost | 4,976 | |||
Total at cost | 12,671 | |||
Accumulated Depreciation | 76 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1800 | |||
Date Acquired | Jun. 25, 2021 | |||
Life on which depreciation in latest income statements is computed (Years) | 40 years | |||
1929 [Member] | Youngstown, OH [Member] | ||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | ||||
Type of property | Acute care general hospital | |||
Initial costs, land | $ 4,335 | |||
Initial costs, buildings | 3,565 | |||
Additions subsequent to acquisition, Improvements | 488 | |||
Land at cost | 4,335 | |||
Buildings at cost | 4,053 | |||
Total at cost | 8,388 | |||
Accumulated Depreciation | 2,428 | |||
Encumbrances | $ 0 | |||
Date of Construction | 1929 | |||
Date Acquired | May 1, 2017 | |||
Life on which depreciation in latest income statements is computed (Years) | 41 years |
Schedule III - Real Estate In_3
Schedule III - Real Estate Investments and Accumulated Depreciation (Parenthetical) (Detail) $ in Billions | Dec. 31, 2021USD ($) |
Real Estate And Accumulated Depreciation Disclosure [Abstract] | |
Aggregate cost for federal income tax purposes | $ 11.3 |
Schedule III - Changes in Total
Schedule III - Changes in Total Real Estate Assets (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |||
Real Estate And Accumulated Depreciation Disclosure [Abstract] | |||||
Balance at beginning of period | $ 10,749,707 | $ 7,312,486 | $ 4,781,149 | ||
Acquisitions | 3,023,966 | 2,912,594 | 2,436,265 | ||
Transfers from construction in progress | 202,999 | ||||
Additions | 167,164 | 55,137 | 173,785 | ||
Dispositions | (229,584) | (105,360) | (106,536) | ||
Other | (82,504) | 371,851 | [1] | 27,823 | [1] |
Balance at end of period | $ 13,628,749 | $ 10,749,707 | $ 7,312,486 | ||
[1] | Includes foreign currency fluctuations for all years and $13.8 million and $61.4 million of right-of-use assets in 2020 and 2019, respectively. |
Schedule III - Changes in Accum
Schedule III - Changes in Accumulated Depreciation (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Real Estate And Accumulated Depreciation Disclosure [Abstract] | |||
Balance at beginning of period | $ 728,176 | $ 504,651 | $ 414,331 |
Depreciation | 262,063 | 222,580 | 130,851 |
Depreciation on disposed property | (35,551) | (6,653) | (40,952) |
Other | (4,319) | 7,598 | 421 |
Balance at end of period | $ 950,369 | $ 728,176 | $ 504,651 |
Schedule III - Changes in Acc_2
Schedule III - Changes in Accumulated Depreciation (Parenthetical) (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Real Estate And Accumulated Depreciation Disclosure [Abstract] | |||
Right-of-use-assets | $ 70,401 | $ 75,209 | $ 61,400 |
Changes in right-of-use asset | 1,120 | $ 13,832 | |
Land and building cost | 1,100,000 | ||
Intangible lease assets included in real estate held for sale | 125,100 | ||
Real estate held for sale accumulated depreciation | 96,500 | ||
Accumulated amortization included in real estate held for sale | $ 17,500 |
Schedule IV - Schedule of Mortg
Schedule IV - Schedule of Mortgage Loans on Real Estate (Detail) - USD ($) | 12 Months Ended | |||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Mortgage Loans on Real Estate [Line Items] | ||||
Prior Liens | $ 0 | |||
Face Amount of Mortgages | 213,320,000 | |||
Carrying Amount of Mortgages | 213,320,000 | $ 248,335,000 | $ 1,274,995,000 | $ 1,213,283,000 |
Principal Amount of Loans Subject to Delinquent Principal or Interest | $ 0 | |||
Long-Term First Mortgage Loan [Member] | ||||
Mortgage Loans on Real Estate [Line Items] | ||||
Periodic Payment Terms | Payable in monthly installments of interest plus principal payable in full at maturity | |||
Long-Term First Mortgage Loan [Member] | Colombia [Member] | ||||
Mortgage Loans on Real Estate [Line Items] | ||||
Interest Rate | 8.95% | |||
Final Maturity Date | 2035 | |||
Face Amount of Mortgages | $ 120,167,000 | |||
Carrying Amount of Mortgages | 120,167,000 | |||
Principal Amount of Loans Subject to Delinquent Principal or Interest | $ 0 | |||
Long-Term First Mortgage Loan [Member] | Springstone Inc. [Member] | ||||
Mortgage Loans on Real Estate [Line Items] | ||||
Interest Rate | 7.00% | |||
Final Maturity Date | 2041 | |||
Face Amount of Mortgages | $ 22,900,000 | |||
Carrying Amount of Mortgages | 22,900,000 | |||
Principal Amount of Loans Subject to Delinquent Principal or Interest | $ 0 | |||
Long-Term First Mortgage Loan [Member] | Vibra [Member] | ||||
Mortgage Loans on Real Estate [Line Items] | ||||
Interest Rate | 11.50% | |||
Final Maturity Date | 2024 | |||
Face Amount of Mortgages | $ 18,986,000 | |||
Carrying Amount of Mortgages | 18,986,000 | |||
Principal Amount of Loans Subject to Delinquent Principal or Interest | $ 0 | |||
Long-Term First Mortgage Loan [Member] | Prospect [Member] | ||||
Mortgage Loans on Real Estate [Line Items] | ||||
Interest Rate | 7.65% | |||
Final Maturity Date | 2034 | |||
Face Amount of Mortgages | $ 51,267,000 | |||
Carrying Amount of Mortgages | 51,267,000 | |||
Principal Amount of Loans Subject to Delinquent Principal or Interest | $ 0 |
Schedule IV - Schedule of Mor_2
Schedule IV - Schedule of Mortgage Loans on Real Estate (Parenthetical) (Detail) | 12 Months Ended |
Dec. 31, 2021USD ($)Property | |
Mortgage Loans on Real Estate [Line Items] | |
Prior Liens | $ 0 |
Carrying amount of mortgages, federal income tax purposes | 213,300,000 |
Unamortized loan issue costs | $ 100,000 |
Colombia [Member] | Long-Term First Mortgage Loan [Member] | |
Mortgage Loans on Real Estate [Line Items] | |
Number of properties | Property | 3 |
Interest Rate | 8.95% |
Schedule IV - Changes in Mortga
Schedule IV - Changes in Mortgage Loans Excluding Unamortized Loan Issue Costs (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Mortgage Loans On Real Estate [Abstract] | |||
Balance at beginning of year | $ 248,335 | $ 1,274,995 | $ 1,213,283 |
New mortgage loans and additional advances on existing loans | 1,128,695 | 193,590 | 61,712 |
Exchange rate fluctuations | (3,640) | 9,785 | |
Mortgage loans on real estate including additions during year | 1,373,390 | 1,478,370 | 1,274,995 |
Collection of principal | (1,160,070) | (1,230,035) | |
Deductions during year | (1,160,070) | (1,230,035) | |
Balance at end of year | $ 213,320 | $ 248,335 | $ 1,274,995 |
Schedule IV - Changes in Mort_2
Schedule IV - Changes in Mortgage Loans Excluding Unamortized Loan Issue Costs (Parenthetical) (Detail) $ in Thousands, £ in Millions | Dec. 31, 2021USD ($) | Mar. 31, 2021GBP (£) | Dec. 31, 2020USD ($) | |
Mortgage Loans on Real Estate [Line Items] | ||||
Advanced to the mortgage loan | [1] | $ 1,103,410 | $ 834,743 | |
Mortgage Loans [Member] | ||||
Mortgage Loans on Real Estate [Line Items] | ||||
Advanced to the mortgage loan | $ 835,000 | |||
Mortgage Loans [Member] | Priory Group [Member] | ||||
Mortgage Loans on Real Estate [Line Items] | ||||
Advanced to the mortgage loan | £ | £ 800 | |||
[1] | The 2021 column includes an £800 million mortgage loan advanced to the Priory Group (“Priory”) in the first quarter of 2021 and converted to fee simple ownership in a portfolio of 35 properties in the second quarter of 2021 as described below. The 2020 column includes approximately $740 million of loans advanced to Steward in 2017 and exchanged for the fee simple real estate of two hospitals as described below, as well as approximately $100 million of loans advanced to Ernest Health, Inc. (“Ernest”) in 2012 and exchanged for the fee simple real estate of four hospitals as described below. |